
<html lang="en"     class="pb-page"  data-request-id="9a4a6c0a-91f6-4e7b-a6c6-8296978d95a7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.1c00475;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-13;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Structure–Activity Relationship Studies of Trisubstituted Isoxazoles as Selective Allosteric Ligands for the Retinoic-Acid-Receptor-Related Orphan Receptor γt" /></meta><meta name="dc.Creator" content="Femke A.  Meijer" /></meta><meta name="dc.Creator" content="Annet O.W.M.  Saris" /></meta><meta name="dc.Creator" content="Richard G.  Doveston" /></meta><meta name="dc.Creator" content="Guido J.M.  Oerlemans" /></meta><meta name="dc.Creator" content="Rens M.J.M.  de Vries" /></meta><meta name="dc.Creator" content="Bente A.  Somsen" /></meta><meta name="dc.Creator" content="Anke  Unger" /></meta><meta name="dc.Creator" content="Bert  Klebl" /></meta><meta name="dc.Creator" content="Christian  Ottmann" /></meta><meta name="dc.Creator" content="Peter J.  Cossar" /></meta><meta name="dc.Creator" content="Luc  Brunsveld" /></meta><meta name="dc.Description" content="The inhibition of the nuclear receptor retinoic-acid-receptor-related orphan receptor γt (RORγt) is a promising strategy in the treatment of autoimmune diseases. RORγt features an allosteric bindin..." /></meta><meta name="Description" content="The inhibition of the nuclear receptor retinoic-acid-receptor-related orphan receptor γt (RORγt) is a promising strategy in the treatment of autoimmune diseases. RORγt features an allosteric bindin..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 19, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00475" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 The Authors. Published by American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00475" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00475" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00475" /></link>
        
    
    

<title>Structure–Activity Relationship Studies of Trisubstituted Isoxazoles as Selective Allosteric Ligands for the Retinoic-Acid-Receptor-Related Orphan Receptor γt | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00475" /></meta><meta property="og:title" content="Structure–Activity Relationship Studies of Trisubstituted Isoxazoles as Selective Allosteric Ligands for the Retinoic-Acid-Receptor-Related Orphan Receptor γt" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0012.jpeg" /></meta><meta property="og:description" content="The inhibition of the nuclear receptor retinoic-acid-receptor-related orphan receptor γt (RORγt) is a promising strategy in the treatment of autoimmune diseases. RORγt features an allosteric binding site within its ligand-binding domain that provides an opportunity to overcome drawbacks associated with orthosteric modulators. Recently, trisubstituted isoxazoles were identified as a novel class of allosteric RORγt inverse agonists. This chemotype offers new opportunities for optimization into selective and efficacious allosteric drug-like molecules. Here, we explore the structure–activity relationship profile of the isoxazole series utilizing a combination of structure-based design, X-ray crystallography, and biochemical assays. The initial lead isoxazole (FM26) was optimized, resulting in compounds with a ∼10-fold increase in potency (low nM), significant cellular activity, promising pharmacokinetic properties, and a good selectivity profile over the peroxisome-proliferated-activated receptor γ and the farnesoid X receptor. We envisage that this work will serve as a platform for the accelerated development of isoxazoles and other novel chemotypes for the effective allosteric targeting of RORγt." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00475"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00475">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00475&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00475&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00475&amp;href=/doi/10.1021/acs.jmedchem.1c00475" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 9238-9258</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.1c00466" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.1c00504" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure–Activity Relationship Studies of Trisubstituted Isoxazoles as Selective Allosteric Ligands for the Retinoic-Acid-Receptor-Related Orphan Receptor γt</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Femke A. Meijer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Femke A. Meijer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Technische Universiteit Eindhoven, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Femke+A.++Meijer">Femke A. Meijer</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0003-4412-9968" title="Orcid link">https://orcid.org/0000-0003-4412-9968</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Annet O.W.M. Saris</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Annet O.W.M. Saris</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Technische Universiteit Eindhoven, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Annet+O.W.M.++Saris">Annet O.W.M. Saris</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Richard G. Doveston</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard G. Doveston</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Technische Universiteit Eindhoven, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands</div><div class="loa-info-affiliations-info">Leicester Institute of Structural and Chemical Biology and School of Chemistry, University of Leicester, University Road, LE1 7RH Leicester, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard+G.++Doveston">Richard G. Doveston</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Guido J.M. Oerlemans</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Guido J.M. Oerlemans</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Technische Universiteit Eindhoven, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Guido+J.M.++Oerlemans">Guido J.M. Oerlemans</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-7562-2654" title="Orcid link">https://orcid.org/0000-0001-7562-2654</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rens M.J.M. de Vries</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rens M.J.M. de Vries</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Technische Universiteit Eindhoven, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rens+M.J.M.++de+Vries">Rens M.J.M. de Vries</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bente A. Somsen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bente A. Somsen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Technische Universiteit Eindhoven, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bente+A.++Somsen">Bente A. Somsen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anke Unger</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anke Unger</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Lead Discovery Center GmbH, 44227 Dortmund, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anke++Unger">Anke Unger</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bert Klebl</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bert Klebl</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Lead Discovery Center GmbH, 44227 Dortmund, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bert++Klebl">Bert Klebl</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christian Ottmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christian Ottmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Technische Universiteit Eindhoven, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Ottmann">Christian Ottmann</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-7315-0315" title="Orcid link">https://orcid.org/0000-0001-7315-0315</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peter J. Cossar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter J. Cossar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Technische Universiteit Eindhoven, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter+J.++Cossar">Peter J. Cossar</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Luc Brunsveld</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Luc Brunsveld</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Technische Universiteit Eindhoven, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#513d7f3323243f2227343d35112524347f3f3d"><span class="__cf_email__" data-cfemail="117d3f7363647f6267747d75516564743f7f7d">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Luc++Brunsveld">Luc Brunsveld</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-5675-511X" title="Orcid link">https://orcid.org/0000-0001-5675-511X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00475&amp;href=/doi/10.1021%2Facs.jmedchem.1c00475" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 9238–9258</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 19, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 March 2021</li><li><span class="item_label"><b>Published</b> online</span>19 May 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 July 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00475" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00475</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 The Authors. Published by American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="https://acsopenscience.org/open-access/licensing-options/"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by-nc"><a href="https://creativecommons.org/licenses/by-nc-nd/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_cc-1612971093887.svg" alt="CC: Creative Commons" /></img><span><strong>CC: </strong>Creative Commons</span></a><a href="https://creativecommons.org/licenses/by-nc-nd/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_by-1612971093257.svg" alt="BY: Credit must be given to the creator" /></img><span><strong>BY: </strong>Credit must be given to the creator</span></a><a href="https://creativecommons.org/licenses/by-nc-nd/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_nc-1612971093307.svg" alt="NC: Only noncommercial uses of the work are permitted" /></img><span><strong>NC: </strong>Only noncommercial uses of the work are permitted</span></a><a href="https://creativecommons.org/licenses/by-nc-nd/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_nd-1612971093637.svg" alt="ND: No derivatives or adaptations of the work are permitted" /></img><span><strong>ND: </strong>No derivatives or adaptations of the work are permitted</span></a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00475"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1634</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00475" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure–Activity Relationship Studies of Trisubstituted Isoxazoles as Selective Allosteric Ligands for the Retinoic-Acid-Receptor-Related Orphan Receptor γt&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Femke&quot;,&quot;last_name&quot;:&quot;A. Meijer&quot;},{&quot;first_name&quot;:&quot;Annet&quot;,&quot;last_name&quot;:&quot;O.W.M. Saris&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;G. Doveston&quot;},{&quot;first_name&quot;:&quot;Guido&quot;,&quot;last_name&quot;:&quot;J.M. Oerlemans&quot;},{&quot;first_name&quot;:&quot;Rens&quot;,&quot;last_name&quot;:&quot;M.J.M. de Vries&quot;},{&quot;first_name&quot;:&quot;Bente&quot;,&quot;last_name&quot;:&quot;A. Somsen&quot;},{&quot;first_name&quot;:&quot;Anke&quot;,&quot;last_name&quot;:&quot;Unger&quot;},{&quot;first_name&quot;:&quot;Bert&quot;,&quot;last_name&quot;:&quot;Klebl&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Ottmann&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;J. Cossar&quot;},{&quot;first_name&quot;:&quot;Luc&quot;,&quot;last_name&quot;:&quot;Brunsveld&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;19&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;9238-9258&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00475&quot;},&quot;abstract&quot;:&quot;The inhibition of the nuclear receptor retinoic-acid-receptor-related orphan receptor γt (RORγt) is a promising strategy in the treatment of autoimmune diseases. RORγt features an allosteric binding site within its ligand-binding domain that provides an opportunity to overcome drawbacks associated with orthosteric modulators. Recently, trisubstituted isoxazoles were identified as a novel class of allosteric RORγt inverse agonists. This chemotype offers new opportunities for optimization into selective and efficacious allosteric drug-like molecules. Here, we explore the structure–activity relationship profile of the isoxazole series utilizing a combination of structure-based design, X-ray crystallography, and biochemical assays. The initial lead isoxazole (FM26) was optimized, resulting in compounds with a ∼10-fold increase in potency (low nM), significant cellular activity, promising pharmacokinetic properties, and a good selectivity profile over the peroxisome-proliferated-activated receptor γ and the farnes&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00475&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00475" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00475&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00475" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00475&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00475" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00475&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00475&amp;href=/doi/10.1021/acs.jmedchem.1c00475" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00475" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00475" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00475%26sid%3Dliteratum%253Aachs%26pmid%3D34008974%26genre%3Darticle%26aulast%3DMeijer%26date%3D2021%26atitle%3DStructure%25E2%2580%2593Activity%2BRelationship%2BStudies%2Bof%2BTrisubstituted%2BIsoxazoles%2Bas%2BSelective%2BAllosteric%2BLigands%2Bfor%2Bthe%2BRetinoic-Acid-Receptor-Related%2BOrphan%2BReceptor%2B%25CE%25B3t%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D13%26spage%3D9238%26epage%3D9258%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292329" title="Pyrroles">Pyrroles</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/medium/jm1c00475_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00475&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The inhibition of the nuclear receptor retinoic-acid-receptor-related orphan receptor γt (RORγt) is a promising strategy in the treatment of autoimmune diseases. RORγt features an allosteric binding site within its ligand-binding domain that provides an opportunity to overcome drawbacks associated with orthosteric modulators. Recently, trisubstituted isoxazoles were identified as a novel class of allosteric RORγt inverse agonists. This chemotype offers new opportunities for optimization into selective and efficacious allosteric drug-like molecules. Here, we explore the structure–activity relationship profile of the isoxazole series utilizing a combination of structure-based design, X-ray crystallography, and biochemical assays. The initial lead isoxazole (<b>FM26</b>) was optimized, resulting in compounds with a ∼10-fold increase in potency (low nM), significant cellular activity, promising pharmacokinetic properties, and a good selectivity profile over the peroxisome-proliferated-activated receptor γ and the farnesoid X receptor. We envisage that this work will serve as a platform for the accelerated development of isoxazoles and other novel chemotypes for the effective allosteric targeting of RORγt.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21813" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21813" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Nuclear receptors (NRs) are a family of ligand-dependent transcription factors and attractive drug targets because of their central role in several regulatory processes in the human body.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1−4)</a> Within the NR family, the retinoic-acid-receptor-related orphan receptor γt (RORγt) has received increased attention because of its essential role in the immune system.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> RORγt is a key regulator in the differentiation of naı̈ve CD4<sup>+</sup> T cells into T helper 17 (Th17) cells, and the production of the pro-inflammatory cytokine IL-17a.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5−7)</a> Elevated IL-17a levels are associated with the development of autoimmune diseases, including psoriasis, multiple sclerosis, and rheumatoid arthritis.<a onclick="showRef(event, 'ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11">(8−11)</a> Disrupting the Th17/IL-17a pathway shows high potential for the treatment of autoimmune disorders, which has already been validated by the clinical success of anti-IL-17a monoclonal antibodies.<a onclick="showRef(event, 'ref8 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref8 ref12 ref13">(8,12,13)</a> The inhibition of RORγt could pose an attractive alternative strategy to decrease IL-17a production in the treatment of autoimmune diseases.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Many research groups have shown significant interest in the identification of small-molecule RORγt inhibitors (or, more specifically, inverse agonists), with several synthetic compounds progressing into clinical trials.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18">(14−18)</a></div><div class="NLM_p">With the exception of <b>RTA-1701</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C),<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> all of the RORγt inverse agonists that have entered clinical trials thus far likely target the highly conserved ligand-binding pocket, termed the orthosteric-binding site, within the ligand-binding domain (LBD) of RORγt (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A).<a onclick="showRef(event, 'ref5 ref14'); return false;" href="javascript:void(0);" class="ref ref5 ref14">(5,14)</a> While orthosteric targeting has been highly successful, novel molecular modalities with alternative modes of action, such as allosteric modulators, offer an interesting alternative for targeting NRs and could circumvent issues related to promiscuity between NRs.<a onclick="showRef(event, 'ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23">(20−23)</a> Recently, an allosteric binding site was identified in the LBD of RORγt (formed by helices 3, 4, 11, and 12), at a location that is topographically distinct to the orthosteric site (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The indazole <b>MRL-871</b> (<b>1</b>) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C) was identified as a prototypical allosteric ligand for RORγt, acting as a potent inverse agonist and decreasing coactivator binding with a similar efficacy as orthosteric inverse agonists.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> The allosteric pocket of RORγt is unique within the NR family and thought not to be the target of endogenous ligands.<a onclick="showRef(event, 'ref24 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref26">(24,26)</a> Therapeutic compounds targeting the allosteric-binding pocket potentially have a higher selectivity profile and do not act in competition, but in synergy, with endogenous agonists.<a onclick="showRef(event, 'ref20 ref21 ref27'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref27">(20,21,27)</a> Therefore, these compounds would be greatly beneficial for drug discovery and chemical biology applications.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/medium/jm1c00475_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Co-crystal structure of the RORγt LBD in complex with allosteric ligand <b>FM26</b> (shown as orange sticks) (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6SAL">6SAL</a>),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> where the allosteric site (orange circle) and the orthosteric site (blue circle) are indicated; (B) enlarged view of <b>FM26</b> (shown as orange sticks) in the allosteric pocket, where H-bond interactions are indicated with orange dashes; (C) chemical structures of allosteric RORγt ligands <b>FM26</b> (<b>2</b>), <b>MRL-871</b> (<b>1</b>), and <b>RTA-1701</b>; and (D) exploration of the hit-to-lead SAR profile of <b>FM26</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00475&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Despite the high potential of allosteric inverse agonists for RORγt, the number of examples have remained limited to compounds based on the indazole core of <b>1</b> or similar chemotypes, and the previously mentioned allosteric ligand <b>RTA-1701</b> (which binds to RORγt <i>via</i> covalent attachment to Cys476 of helix 11 and partly overlaps with the allosteric site).<a onclick="showRef(event, 'ref19 ref24 ref25 ref29 ref30 ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref19 ref24 ref25 ref29 ref30 ref31 ref32 ref33 ref34">(19,24,25,29−34)</a> Follow-up studies improved the pharmacokinetic (PK) and selectivity profile of <b>1</b> and its derivatives. However, off-target effects toward other NRs, most notably toward the peroxisome proliferated-activated receptor γ (PPARγ), and challenges regarding cytotoxicity and metabolic stability have been observed.<a onclick="showRef(event, 'ref24 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref24 ref29 ref30 ref31 ref32">(24,29−32)</a> The scarcity and lack of scaffold diversity of allosteric RORγt ligands, and the limitations regarding specificity and drug-like properties, necessitates further exploration of the allosteric pocket. Specifically, establishing structure–activity relationship (SAR) profiles for allosteric chemotypes distinct from the indazole-analogous ligand classes is of great importance.</div><div class="NLM_p">Recently, we used an <i>in silico</i> pharmacophore search approach to identify a novel class of RORγt allosteric inverse agonists, featuring a trisubstituted isoxazole core.<a onclick="showRef(event, 'ref28 ref35'); return false;" href="javascript:void(0);" class="ref ref28 ref35">(28,35)</a> SAR studies around this novel chemotype resulted in the discovery of <b>FM26</b> (<b>2</b>) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C), which shows sub-micromolar potency as a RORγt inverse agonist and significant inhibition of cellular IL-17a expression levels. Initial SAR studies of <b>2</b> identified two key pharmacophore features, where the 2,6-disubstituted phenyl ring at the C-3 position and a C-4 benzoic acid moiety were shown to be optimal (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D).<a onclick="showRef(event, 'ref24 ref25 ref28 ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref28 ref30 ref31 ref32 ref33">(24,25,28,30−33)</a> Less knowledge has been garnered on the linker at the C-4 position and the C-5 substituent. Regarding the C-4 linker, an amine linker (as is used for <b>2</b>) was found to be preferred for potency over some more rigid linkers.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Additionally, the co-crystal structure (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B) showed that the presence of a hydrogen bond donating <i>N</i>-heterocycle at the C-5 isoxazole position (as is the case for the pyrrole in <b>2</b>) significantly increased the potency toward RORγt by the formation of an additional polar interaction with the backbone carbonyls of residues Leu353 and Lys354.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> To identify compounds suitable for focused lead optimization, crucial explorations around the C-4 and C-5 positions are needed to further explore the SAR, improve the potency of the isoxazole series, increase the RORγt specificity, and direct PK optimization.</div><div class="NLM_p last">Utilizing X-ray crystallography to guide focused library development, herein, we report on the synthesis of allosteric RORγt inverse agonists diversified at the C-4 and C-5 isoxazole positions (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D). The structure-based SAR study was specifically focused on improved RORγt activity, mitigating off-target PPARγ activity, and a first exploration of PK profiles.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31185" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31185" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.1.  <i>In Silico</i> Docking Studies Guide a SAR Study at the Isoxazole C-4 Position</h3><div class="NLM_p">The initial investigation started with expanding the SAR data around the C-4 position of the isoxazole series guided by <i>in silico</i> docking studies. A virtual library of derivatives around <b>2</b>, containing different C-4 linkers and benzoic acid substituents, was designed with a focus on diversity and synthetic feasibility (see <a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">Table S1</a>). This library was docked into the allosteric site of RORγt (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YPQ">4YPQ</a><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a>), using Glide, the molecular docking tool in Schrödinger (12.3, 2020-1).<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> For each ligand, the docking pose was evaluated and given a “glide score”, which is an empirical scoring function that approximates the ligand binding free energy (the more negative the values, the higher the expected potency) but will not always translate into experimental IC<sub>50</sub> values.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a><a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> shows the compounds that resulted in the most promising glide scores, indicating that linkers responsible for an increased <i>c</i>log <i>P</i> of the compounds [i.e., ether (<b>3</b>), thioether (<b>4</b>), methylated amine (<b>5</b>), and alkene (<b>6</b> and <b>7</b>)] would be beneficial for affinity. Additionally, the data suggest that a fluoro substitution at the <i>ortho</i> position of the benzoic acid moiety would be well tolerated (<b>8</b> and <b>9</b>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR Studies around the C-4 Isoxazole Position<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/medium/jm1c00475_0008.gif" alt="" id="GRAPHIC-d7e593-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/medium/jm1c00475_0009.gif" alt="" id="gr7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">cLogP values, glide scores, TR-FRET IC<sub>50</sub> values (μM) from coactivator recruitment and AlexaFluor-MRL-871 displacement assays, Δ<i>T</i><sub>m</sub> values (°C) from thermal shift assays, and fold decrease in IL-17a mRNA expression levels relative to DMSO reverse transcriptase PCR (RT-PCR). Abbreviations: n.d., not determined. TR-FRET and TSA data are recorded in triplicate; values are representative of ≥3 repeated experiments. RT-PCR data are recorded in triplicate; values are representative of ≥2 repeated experiments. cLogP values were predicted using MarvinSketch (20.10).</p></div></div><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">2.2.  Optimized Synthesis Route Allowed the Efficient Synthesis of C-4 Isoxazole Derivatives</h3><div class="NLM_p">Isoxazoles <b>2–9</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) were synthesized (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) in order to biochemically evaluate the predictions from the <i>in silico</i> docking experiments. Common intermediate <b>14</b> was synthesized <i>via</i> a 1,3-dipolar cycloaddition using a nitrile oxide and alkynyl bromide, as described previously (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">Scheme S1</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In order to prepare derivatives <b>2–9</b>, it was important to obtain core intermediate <b>16</b> with a <i>N</i>-Boc-protected pyrrole moiety, instead of the free pyrrole, as was the case in the original synthesis route for <b>2</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">Scheme S2</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> This was achieved <i>via</i> a Suzuki cross-coupling reaction, employing a dppf instead of a tetrakis palladium catalyst (used in previous research), which proved to be essential for maintaining the Boc-protected pyrrole <b>15</b> in an acceptable yield (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). DIBAL was then used to selectively reduce the ethyl ester, yielding <b>16</b> without a concomitant loss of the Boc group (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), which was previously observed with LiAlH<sub>4</sub> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">Scheme S1</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/medium/jm1c00475_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis Route for Different Trisubstituted Isoxazoles (C-4 Library)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00475&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>N</i>-Boc-pyrrole-B(pin), Pd(dppf)Cl<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, and DME, 85 °C, 8 h, 50%; (b) DIBAL and CH<sub>2</sub>Cl<sub>2</sub>, −78 °C, 3 h, 80%; (c) (i) (MeSO<sub>2</sub>)<sub>2</sub>O, Et<sub>3</sub>N, and CH<sub>2</sub>Cl<sub>2</sub>, 0 °C → rt, 3 h, (ii) aniline or <i>N</i>-methylaniline, rt, 3 h, 36% (<b>17</b>) and 52% (<b>18</b>); (d) (i) DMP and CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 h, 44%, (ii) methyl 4-amino benzoate, MeOH, and AcOH, reflux, 24 h, 42%, (iii) NaBH<sub>4</sub> and EtOH, reflux, 3 h, 17% (<b>19</b>); (e) LiOH, EtOH, and H<sub>2</sub>O, 95 °C, 3 h, 29–81%; (f) methyl 4-hydroxybenzoate or methyl 2-fluoro-4-hydroxybenzoate, DIAD, PPh<sub>3</sub>, Et<sub>3</sub>N, and THF, reflux, 3 h, 55% (<b>20</b>), 25% (<b>21</b>); (g) methyl 4-mercaptobenzoate, DIAD, PPh<sub>3</sub>, Et<sub>3</sub>N, and THF, reflux, 3 h, 27%; (h) DMP and CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 h, quant.; (i) (4-(methoxycarbonyl)benzyl)triphenylphosphonium (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for the synthetic procedure of the triphenylphosphonium), LiHMDS, and THF, −78 °C → rt, 24 h, 7% (<b>24</b>), 27% (<b>25</b>).</p></p></figure><div class="NLM_p">The primary alcohol of <b>16</b> was used as a functional handle for the derivatization of the isoxazole C-4 position. Critical to the synthesis of this series of isoxazoles was the optimization of the reductive amination step, which provided sub-optimal yields in the synthesis of <b>2</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">Scheme S2</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In order to improve the total yield of the synthesis, the reductive amination was substituted for a nucleophilic substitution reaction. Final compounds <b>2</b> and <b>5</b> were accessed in an efficient manner by the mesylation of alcohol <b>16</b> with methane sulfonic anhydride (monitored by NMR), the <i>in situ</i> addition of the substituted aniline, followed by the hydrolysis of the benzoate ester. In contrast, <b>8</b> (fluoro substituent) was synthesized <i>via</i> the original reductive amination route (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><div class="NLM_p last">Compounds with an ether and thioether linkage (<b>3</b>, <b>9</b>, and <b>4</b>) were synthesized from core intermediate <b>16</b><i>via</i> a Mitsunobu reaction with hydroxy- or mercaptobenzoate, respectively, furnishing the products in acceptable yields (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). For the <i>cis</i> and <i>trans</i> alkene linker (<b>6</b> and <b>7</b>), the alcohol of compound <b>16</b> was oxidized to the aldehyde, which was subsequently used in a Wittig reaction, obtaining a 3:1 mixture of the <i>cis</i>/<i>trans</i> isomers (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). These were separated <i>via</i> preparative high-performance liquid chromatography/ultraviolet (HPLC-UV) to afford <b>24</b> and <b>25</b>, and followed by ester hydrolysis, which afforded final compounds <b>6</b> (<i>trans</i>) and <b>7</b> (<i>cis</i>) (for which the stereochemistry was determined based on the relative <sup>1</sup>H NMR <i>J</i>-coupling values between the alkene protons).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">2.3.  Biochemical Assays and X-ray Crystallography Reveal a Positive Correlation between the C-4 Linker Lipophilicity and Potency</h3><div class="NLM_p">The potency of the C-4 modified compounds for RORγt was investigated in a time-resolved FRET (TR-FRET) coactivator recruitment assay (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A, see <a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">Figure S3A</a> for a schematic representation of the assay setup).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> RORγt is constitutively active, which means that it shows a basic level of transcriptional activity, thus allowing the partial recruitment of coactivators in the absence of an agonist.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Reference compounds <b>1</b> and <b>2</b> showed potent inhibition of coactivator binding, with IC<sub>50</sub> values comparable to previous studies.<a onclick="showRef(event, 'ref24 ref28'); return false;" href="javascript:void(0);" class="ref ref24 ref28">(24,28)</a> Interestingly, compound <b>3</b> (<b>FM156</b>) containing an ether linkage demonstrated a 9-fold increase in potency compared to <b>2</b> with an amine linker (IC<sub>50</sub> of 31 ± 3 nM vs 270 ± 20 nM, respectively), resulting in an IC<sub>50</sub> value in the same range as indazole <b>1</b>. The <i>trans</i>-alkene linker (<b>6</b>, <b>FM260</b>) resulted in a low nM IC<sub>50</sub> value as well (IC<sub>50</sub> of 20 ± 2 nM), in contrast to the <i>cis</i>-alkene linker (<b>7</b>) which was 25 times less potent (IC<sub>50</sub> of 490 ± 30 nM), as predicted by the docking scores. In contrast, a thioether linkage (<b>4</b>) resulted in a significantly decreased potency compared to <b>2</b> (IC<sub>50</sub> of 6.6 ± 0.8 μM), whereas a methylated amine linker (<b>5</b>) resulted in a loss of activity (IC<sub>50</sub> > 100 μM). The introduction of a fluorine substituent at the <i>ortho</i> position of the benzoic acid moiety proved detrimental to coactivator inhibition with a 7–13 fold decrease in potency compared to the compound without a substituent (<b>8</b> vs <b>2</b> and <b>9</b> vs <b>3</b>), which was also the case for an isoxazole analogue in a previous SAR study.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/medium/jm1c00475_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Biochemical analysis and X-ray crystallography data for isoxazole compounds with C-4 modifications. (A) Dose–response curves from the TR-FRET coactivator recruitment assay for <b>1</b>, <b>2</b>, <b>3</b>, and <b>6</b>; (B) dose–response curves from the ligand displacement TR-FRET assay using the AlexaFluor MRL-871 probe for <b>1</b>, <b>2</b>, <b>3</b>, and <b>6</b>; (C) melting temperatures (Δ<i>T</i><sub>m</sub> in °C), as measured in TSA for <b>1</b>, <b>2</b>, <b>3</b>, and <b>6</b>. Data were recorded in ≥3 independent experiments, each recorded in triplicate (one representative dataset shown). Error bars represent the SD of the mean; (D,G) tertiary co-crystal structure of RORγt in complex with <b>3</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NPC">7NPC</a>) (D) and <b>9</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NP5">7NP5</a>) (G) (stick representation). The final 2Fo–Fc electron density map of compounds is shown as an isomesh contoured at 1σ; (E,H) overlay of the co-crystal structure of RORγt in complex with <b>FM26</b> (<b>2</b>) (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6SAL">6SAL</a>) and RORγt bound to <b>3</b> (E), and an overlay of RORγt with <b>3</b> and <b>9</b> (H); and (F,I) enlarged view of the allosteric pocket of RORγt showing the interactions between <b>3</b> (F)/<b>9</b> (I) and the protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00475&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To prove an allosteric mode of action, the compounds were also tested in two other TR-FRET assay formats. First, a previously described AlexaFluor 647-labeled MRL-871 probe<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">Figure S1</a>) was used, which upon binding to RORγt shows FRET pairing with an anti-His terbium cryptate donor on the protein (see <a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">Figure S3B</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> All compounds showed displacement of the AlexaFluor-MRL allosteric probe, proving an allosteric binding mode (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B), with the IC<sub>50</sub> values correlating with the IC<sub>50</sub> values from the TR-FRET coactivator recruitment assay (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). In particular, ether <b>3</b> and <i>trans</i>-alkene <b>6</b> demonstrated efficient displacement of the probe, with IC<sub>50</sub> values of 12 ± 1 and 7.4 ± 0.9 nM, respectively, significantly increased as compared to <b>2</b> (IC<sub>50</sub> value of 100 ± 10 nM).</div><div class="NLM_p">The most potent ligands <b>3</b> and <b>6</b> were also measured in a competitive TR-FRET coactivator recruitment assay, where the compounds were titrated in the presence of cholesterol, which is an orthosteric agonist (activator) for RORγt<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">Figure S2</a>, see <a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">Figure S3C</a> for a schematic representation of the assay setup). The binding curves for compounds <b>3</b> and <b>6</b> show that the IC<sub>50</sub> values did not decrease upon increasing concentrations of cholesterol, demonstrating that their binding mode is independent to that of cholesterol, supporting their allosteric-binding mode. In fact, the presence of cholesterol slightly enhanced the potency of both <b>3</b> and <b>6</b>, suggesting a cooperative behavior between orthosteric and allosteric ligand binding, as was observed previously.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a></div><div class="NLM_p">A thermal shift assay (TSA) was performed as an orthogonal assay to investigate the effect of the compounds on the thermal denaturation of the RORγt protein (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C). Ligand binding typically improves the thermal stability of a protein by stabilizing the protein fold, as indicated by the change in the melting temperature Δ<i>T</i><sub>m</sub>.<a onclick="showRef(event, 'ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43">(41−43)</a> The C-4 isoxazole derivatives <b>3–9</b> showed a thermal stabilization effect according to their potency, as observed in the TR-FRET assays. The most potent compounds <b>3</b> and <b>6</b> showed particularly high Δ<i>T</i><sub>m</sub> values (4.9 and 6.4 °C resp.). These values are improved compared to that for <b>2</b>, which provides further indication that <b>3</b> and <b>6</b> have a high-binding affinity for RORγt.</div><div class="NLM_p">Crystallization studies provided the co-crystal structures of the RORγt LBD in complex with compounds <b>3</b> (ether linker) and <b>9</b> (fluoro substituent), with resolutions of 1.46 and 1.55 Å, respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">Tables S4 and S5, Figure S6</a>). The co-crystal structures of RORγt with <b>3</b> and <b>9</b> showed clear electron density for the compounds in the allosteric binding site between helices 3, 4, 11, and 12 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D,G). In <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>E, an overlay of RORγt in complex with <b>2</b> and with <b>3</b> is shown, demonstrating a common binding pose, with the C-3, C-4, and C-5 isoxazole substituents anchored at the same position. The pyrrole moiety forms a hydrogen bond interaction with the main chain carbonyls of residues Leu353 and Lys354 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>F). Additionally, the carboxylic acid moiety forms hydrogen bond interactions with the side chain of Gln329 and backbone nitrogens of Phe498 and Ala497, as is also the case for <b>1</b> and <b>2</b>. Interestingly, the electron density for <b>3</b> and <b>2</b> would allow two different conformations of the C-4 linker,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> but the preferred conformation for the ether linker in <b>3</b> is opposite to the preferred conformation for the amine linker in <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>E). For compound <b>9</b>, the electron density and binding mode are highly similar to <b>3</b>, with the same conformation for the ether linker present (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>G–I). The <i>ortho</i>-fluoro substituent on the benzoic acid ring does not significantly influence the conformation of the compound, except for the disubstituted phenyl ring at the isoxazole C-3 position, which is normally fixed at the same position but is now slightly shifted (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>H).</div><div class="NLM_p last">The increased potency of ether <b>3</b> and alkene <b>6</b> could be the result of increased hydrophobic effects of these more lipophilic compounds toward the hydrophobic allosteric-binding pocket (see the protein–ligand interaction plot in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">Figure S5</a>). The different preferred conformations of the ether linker for <b>3</b>, as seen in the co-crystal structure, might also be contributing to the potency. In contrast, the compound with a thioether linkage (<b>4</b>) shows a significantly lower potency, which might be caused by a slight change in the bond angle and length of the linker. The docking pose shows that the isoxazole core and pyrrole moiety are clearly shifted compared to the compound with ether linker (<b>3</b>) (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">Figure S4A</a>). The drop in potency for <b>5</b>, featuring a methylated amine linker, likely results from the restricted rotation of the linker. The electron density for the isoxazoles shows that two conformations of the linker are present, but when the linker is more rotationally restricted, as is the case for <b>5</b>, only one of these linker conformations will most likely be present, potentially resulting in a higher entropic penalty and in turn a decrease in the binding affinity. The introduction of an <i>ortho</i>-fluoro substituent at the benzoic acid moiety leads to a slight decrease in potency (<b>8</b> vs <b>2</b> and <b>9</b> vs <b>3</b>). The co-crystal structure in complex with <b>9</b> shows that the fluoro substituent is placed in the same plane as the carboxylic acid moiety (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>I). This unfavorable conformation is believed to be caused in order to both fit the fluoro substituent in the pocket and also allow hydrogen bond interactions between the carboxylic acid and the protein, which could lead to charge repulsion between the two moieties and a decreased potency.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">2.4.  SAR Studies Show the Necessity of a H-Bond Donor Moiety at the Isoxazole C-5 Position</h3><div class="NLM_p">The SAR was further explored at the isoxazole C-5 position to investigate the hydrogen bonding character of the pyrrole moiety of <b>2</b>. Compound <b>3</b> with the ether linkage was chosen as a core scaffold, based on the combination of its high potency, availability of the co-crystal structure, and synthetic feasibility. A focused library of C-5 derivatives (compounds <b>10–13</b>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) was designed and synthesized (the full library used for docking is shown in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">Table S2</a>). Specifically, the effect of the nitrogen position (<b>10</b>), p<i>K</i><sub>a</sub> (<b>11</b>) (p<i>K</i><sub>a</sub> = 10.17 for <b>11</b> vs 14.99 for <b>3</b>) and substitution (<b>12</b>) was investigated, as well as the hydrophobic space around the pyrrole (<b>13</b>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR Studies around the C-5 Isoxazole Position<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/medium/jm1c00475_0010.gif" alt="" id="GRAPHIC-d7e1432-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/medium/jm1c00475_0011.gif" alt="" id="gr8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Glide scores, TR-FRET IC<sub>50</sub> values (μM) from the coactivator recruitment and AlexaFluor-MRL-871 displacement assays, Δ<i>T</i><sub>m</sub> values (°C) from TSA, and fold decrease in IL-17a expression levels relative to DMSO (RT-PCR) are shown. Abbreviations: n.d., not determined. TR-FRET and TSA data are recorded in triplicate; values are representative of ≥3 repeated experiments. RT-PCR data are recorded in triplicate; values are representative of ≥2 repeated experiments.</p></div></div><div></div></div><div class="NLM_p">Compounds <b>10</b>–<b>13</b> were synthesized using an analogous synthesis route as shown previously (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Because the C-5 moiety is incorporated early in the synthesis, it was not possible to diversify from a late-stage intermediate, as for the C-4 modifications. Bromide <b>14</b> was subjected to a Suzuki reaction with the associated pinacol ester, containing a Boc-, THP-, or methyl-protected heterocycle, followed by ester hydrolysis with DIBAL to yield <b>30–33</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). For the <i>N</i>-methyl pyrrole, the original conditions were used (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">Scheme S2</a>) (the tetrakis palladium catalyst in the Suzuki reaction and LiAlH<sub>4</sub> for reduction) because no labile-protecting group was used in this synthesis route. Next, a Mitsunobu reaction with methyl 4-hydroxybenzoate and ester hydrolysis combined with heterocycle deprotection were conducted to afford the final compounds <b>10–13</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/medium/jm1c00475_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis Route for Different Trisubstituted Isoxazoles (C-5 Library)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00475&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>N</i>-Boc-pyrrole-B(pin), <i>N</i>-THP-pyrazole-B(pin) or 5-methyl <i>N</i>-Boc-pyrrole-B(pin) (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for the synthetic procedure of this pinacol ester), Pd(dppf)Cl<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, and DME, 85 °C, 8 h, 49% (<b>26</b>), 34% (<b>27</b>), and 24% (<b>29</b>); (b) <i>N</i>-methyl-pyrrole-B(pin), Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, DME, and H<sub>2</sub>O, 85 °C, 8 h, 55% (<b>28</b>); (c) DIBAL and CH<sub>2</sub>Cl<sub>2,</sub> −78 °C, 3 h, 69% (<b>30</b>), 71% (<b>31</b>), and 58% (<b>33</b>); (d) LiAlH<sub>4</sub> and THF, 0 °C → rt, 2 h, 76% (<b>32</b>); (e) (i) methyl 4-hydroxybenzoate, DIAD, PPh<sub>3</sub>, and THF, reflux, 3 h, 21%, (ii) LiOH, EtOH, and H<sub>2</sub>O, 95 °C, 3 h, 41% (<b>10</b>); (f) (i) methyl 4-hydroxybenzoate, DIAD, PPh<sub>3</sub>, Et<sub>3</sub>N, and THF, reflux, 3 h, 44–45%, (ii) LiOH, EtOH, and H<sub>2</sub>O, 95 °C, 3 h, 86% (<b>12</b>), 83% (<b>13</b>); (g) (i) methyl 4-hydroxybenzoate, DIAD, PPh<sub>3</sub>, Et<sub>3</sub>N, and THF, reflux, 3 h, 49%, (ii) TFA and CH<sub>2</sub>Cl<sub>2</sub>, 40 °C, 2 h, 87%, (iii) LiOH, EtOH, and H<sub>2</sub>O, 95 °C, 3 h, 89% (<b>11</b>).</p></p></figure><div class="NLM_p">To assess the SAR around the C-5 position, analogues <b>10–13</b> were evaluated in the TR-FRET coactivator recruitment assay (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). A nitrogen shift (2- instead of 3-position) in the pyrrole ring (<b>10</b>) resulted in a 4.5-fold decrease in potency (IC<sub>50</sub> = 140 ± 10 nM) compared to <b>3</b>. Pyrazole <b>11</b> (<b>FM257</b>) showed a slight drop in potency, with an IC<sub>50</sub> value of 110 ± 10 nM. For compound <b>12</b> (containing a methylated pyrrole) and compound <b>13</b> (methylation of the pyrrole at the 5-position), a lower activity was observed with an IC<sub>50</sub> value of 3.3 ± 0.3 and 2.9 ± 0.2 μM, respectively. Additionally, the TR-FRET AlexaFluor-MRL assay was performed, validating an allosteric binding mode for all compounds (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Analysis of the IC<sub>50</sub> values for this series showed that these were in line with the IC<sub>50</sub> values from the TR-FRET coactivator assay (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). In the TSA, compounds <b>10</b> and <b>11</b> induced thermal stabilization with Δ<i>T</i><sub>m</sub> values of 2.8 and 2.7 °C respectively, which is lower than for <b>3</b> (Δ<i>T</i><sub>m</sub> = 4.9 °C) but slightly higher than for <b>2</b> (Δ<i>T</i><sub>m</sub> = 2.4 °C). Compounds <b>12</b> and <b>13</b> did not show any response (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/medium/jm1c00475_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Biochemical analysis and X-ray crystallography data for isoxazole compounds with C-5 modifications. (A) Dose–response curves from the TR-FRET coactivator recruitment assay for <b>2</b>, <b>3</b>, <b>10</b>, and <b>11</b>; (B) dose–response curves from the ligand displacement TR-FRET assay using the AlexaFluor MRL-871 probe for <b>2</b>, <b>3</b>, <b>10</b>, and <b>11</b>; (C) melting temperatures (Δ<i>T</i><sub>m</sub> in °C), as measured in TSA for <b>2</b>, <b>3</b>, <b>10</b>, and <b>11</b>. Data were recorded in ≥3 independent experiments, each recorded in triplicate (one representative dataset shown). Error bars represent the SD of the mean. (D,G) Tertiary co-crystal structure of RORγt in complex with <b>10</b> (D) (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NEC">7NEC</a>) and <b>11</b> (G) (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NP6">7NP6</a>) (stick representation). The final 2Fo–Fc electron density map of the compounds is shown as an isomesh contoured at 1σ; (E,H) overlay of the crystal structure of RORγt in complex with <b>3</b> and RORγt bound to <b>10</b> (E) or <b>11</b> (H); and (F,I) enlarged view of the allosteric pocket of RORγt showing the interactions between <b>10</b> (F)/<b>11</b> (I) and the protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00475&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Crystallization studies provided the co-crystal structures of the RORγt LBD in complex with C-5-modified compounds <b>10</b> (2-pyrrole) and <b>11</b> (pyrazole), with resolutions of 1.95 and 1.84 Å, respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">Tables S6 and S7, Figure S6</a>). The co-crystal structure of RORγt with <b>10</b> reveals a clear ligand electron density in the allosteric site with the ether linker in the same preferred conformation as for <b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D,E). The 2-pyrrole at the C-5 position, with the nitrogen at a different position, does not establish a direct hydrogen bond interaction with the protein, as expected, potentially explaining the lower potency of the compound for RORγt. Interestingly, the NH of the pyrrole substituent of <b>10</b> forms an alternative hydrogen bond network <i>via</i> a water molecule in the binding pocket at a distance of 3.2 Å from the NH of the pyrrole (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>F) (this water molecule appears to be present in all crystal structures with an allosteric ligand, and thus has a structural role). For pyrazole <b>11</b>, the binding mode is highly similar to <b>3</b>, again establishing a hydrogen bond interaction between the NH of the pyrazole and the backbone carbonyls of RORγt (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>G–I).</div><div class="NLM_p last">These results show that small changes at the pyrrole C-5 moiety lead to relevant changes in the potency of the compounds. The 4.5-fold decrease in potency for the compound with a changed position of the nitrogen in the pyrrole ring (<b>10</b>) (compared to <b>3</b>) is most probably due to the loss of the characteristic H-bond interaction between the pyrrole ring and the backbone of the protein. The additional H-bond interaction with a water molecule explains why <b>10</b> is still active on RORγt with an IC<sub>50</sub> value < 150 nM, despite the lack of the characteristic C-5 H-bond interaction. For the pyrazole (<b>11</b>, <b>FM257</b>), the 3.5-fold lower potency indicates that the lower p<i>K</i><sub>a</sub> of the pyrazole is not beneficial for H-bond formation, although other factors might also be involved, for example, the existence of the pyrazole in two tautomeric forms for which only one can establish the hydrogen bond interaction with the protein. The much lower potency for compound <b>12</b> (methylated pyrrole) suggests that the space around the pyrrole is limited, which is also supported by the low potency of the methyl substitution of the pyrrole at the 5-positon (<b>13</b>). The docking score predicts compound <b>12</b> to be highly active, based on the docking pose where the pyrrole ring is rotated and the methyl substituent could point toward a small cavity (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">Figure S4B</a>). Together, based on the biochemical data, the methylated pyrrole does not appear to have enough space for this rotation in the allosteric pocket. Combined, these data show the need for an H-bond donor at the right position of the heterocycle at the C-5 position of the isoxazole scaffold, while additional substituents at the ring appear to be too bulky to be tolerated.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">2.5.  The New Isoxazole Series Show the Inhibition of IL-17a Expression in EL4 Cells</h3><div class="NLM_p">A selection of the novel isoxazole compounds was tested in a quantitative RT-PCR assay to investigate their functional effect. EL4 cells were treated with 10 μM of the compound or dimethyl sulfoxide (DMSO), after which the IL-17a mRNA levels were measured (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Hit compound <b>2</b> showed a 9.3-fold reduction, in accordance with our previous reports.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The optimized compounds <b>3</b> and <b>6</b> (IC<sub>50</sub> values of 31 and 20 nM, respectively) showed a 15- and 16-fold reduction of IL-17a levels compared to DMSO, which is in line with their high biochemical potency and indicates good cellular uptake and activity. Compounds <b>10</b> and <b>11</b> induced a 12- and 6.6-fold decrease in IL-17a mRNA levels, correlating with their slightly lower biochemical potency compared to <b>3</b> and <b>6</b>. Compound <b>12</b> only resulted in a 2.4-fold decrease compared to DMSO, as expected, given its significantly lower potency in the TR-FRET coactivator recruitment assay.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/medium/jm1c00475_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. IL-17a mRNA expression levels in EL4 cells treated with ligands <b>1</b>, <b>2</b>, <b>3</b>, <b>6</b>, <b>10</b>, <b>11</b>, and <b>12</b> (10 μM, 24 h) or DMSO and fold decrease of the IL-17a expression relative to DMSO. The level of IL-17a expression was normalized to that of GAPDH expression. All data are expressed as mean ± s.d. (<i>n</i> = 3). The relative gene expression was calculated by the 2<sup>–ΔΔ<i>C</i></sup><sub>t</sub> (Livak) method using DMSO control as a calibrator. Statistical analysis was performed using a one-way analysis of variance (ANOVA) compared against the DMSO control following Dunnett’s <i>post hoc</i> test; ***<i>P</i> < 0.001 and ****<i>P</i> < 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00475&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">2.6.  The Isoxazole Series Shows an Improved Selectivity Profile for RORγt</h3><div class="NLM_p">Previous studies have shown that <b>1</b> is selective for RORγt over other NRs, except for PPARγ on which it shows a significant cross-reactivity to the orthosteric binding site, as was also supported by the co-crystal structure.<a onclick="showRef(event, 'ref24 ref44'); return false;" href="javascript:void(0);" class="ref ref24 ref44">(24,44)</a> Isoxazole <b>2</b> already showed a higher selectivity for RORγt over PPARγ than <b>1</b>,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> so we were interested to establish if the novel isoxazole compounds further improved this promising selectivity profile.</div><div class="NLM_p">In a TR-FRET coactivator recruitment assay (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), <b>1</b> showed PPARγ agonism with an EC<sub>50</sub> value of 0.34 ± 0.02 μM, while the EC<sub>50</sub> value for <b>2</b> was >20-fold higher (EC<sub>50</sub> = 8.2 ± 0.3 μM).<a onclick="showRef(event, 'ref24 ref28'); return false;" href="javascript:void(0);" class="ref ref24 ref28">(24,28)</a> All novel isoxazole ligands developed in this study were at least five times less active on PPARγ than <b>1</b> (EC<sub>50</sub> values > 1.7 μM), except for compounds <b>12</b> and <b>13</b> (both bearing a methyl substituent at the pyrrole moiety), which showed a higher cross-reactivity on PPARγ (EC<sub>50</sub> values of 1.2 ± 0.1 and 0.79 ± 0.10 μM resp.). This might be due to the more bulky substitution pattern around the pyrrole C-5 substituent.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. EC<sub>50</sub> Values Observed in the TR-FRET Coactivator Recruitment Assay, IC<sub>50</sub> Values from the TR-FRET Competition Assay with PPARγ, and Δ<i>T</i><sub>m</sub> Values (°C) from TSA Assays<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">fold-selective for RORγt over PPARγ</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (μM) PPARγ</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM) PPARγ (competition rosiglitazone)</th><th class="colsep0 rowsep0" align="center" char="±">Δ<i>T</i><sub>m</sub> (°C) PPARγ</th><th class="colsep0 rowsep0" align="center" char=".">TR-FRET</th><th class="colsep0 rowsep0" align="center" char=".">TSA</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">0.34 ± 0.02</td><td class="colsep0 rowsep0" align="left">6.3 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="±">2.5 ± 0.2</td><td class="colsep0 rowsep0" align="center" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">8.2 ± 0.3</td><td class="colsep0 rowsep0" align="left">81 ± 7</td><td class="colsep0 rowsep0" align="char" char="±">0.3 ± 0.0</td><td class="colsep0 rowsep0" align="center" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">8.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">3.1 ± 0.1</td><td class="colsep0 rowsep0" align="left">63 ± 8</td><td class="colsep0 rowsep0" align="char" char="±">0.6 ± 0.0</td><td class="colsep0 rowsep0" align="center" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">8.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">18 ± 1</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="char" char="±">0.7 ± 0.0</td><td class="colsep0 rowsep0" align="center" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="char" char="±">0.0 ± 0.0</td><td class="colsep0 rowsep0" align="center" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">2.5 ± 0.1</td><td class="colsep0 rowsep0" align="left">64 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">1.1 ± 0.2</td><td class="colsep0 rowsep0" align="center" char=".">125</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">7.5 ± 0.3</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="char" char="±">0.1 ± 0.0</td><td class="colsep0 rowsep0" align="center" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">7.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">15 ± 1</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="char" char="±">0.1 ± 0.0</td><td class="colsep0 rowsep0" align="center" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">7.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">5.8 ± 0.2</td><td class="colsep0 rowsep0" align="left">67 ± 6</td><td class="colsep0 rowsep0" align="char" char="±">0.4 ± 0.0</td><td class="colsep0 rowsep0" align="center" char=".">67</td><td class="colsep0 rowsep0" align="char" char=".">7.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">1.7 ± 0.1</td><td class="colsep0 rowsep0" align="left">29 ± 4</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.0</td><td class="colsep0 rowsep0" align="center" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">3.6 ± 0.1</td><td class="colsep0 rowsep0" align="left">79 ± 11</td><td class="colsep0 rowsep0" align="char" char="±">0.7 ± 0.0</td><td class="colsep0 rowsep0" align="center" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">1.2 ± 0.1</td><td class="colsep0 rowsep0" align="left">20 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">1.5 ± 0.0</td><td class="colsep0 rowsep0" align="center" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char="."><0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">0.79 ± 0.10</td><td class="colsep0 rowsep0" align="left">19 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">1.5 ± 0.0</td><td class="colsep0 rowsep0" align="center" char=".">0.27</td><td class="colsep0 rowsep0" align="char" char="."><0.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">TR-FRET and TSA data are recorded in triplicate; values are representative of ≥3 repeated experiments.</p></div></div></div><div class="NLM_p">In order to further explore the binding site of the isoxazole compounds on PPARγ, a TR-FRET assay was performed whereby the competition between the isoxazole ligands and a known orthosteric PPARγ agonist, rosiglitazone, was measured (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).<a onclick="showRef(event, 'ref28 ref45'); return false;" href="javascript:void(0);" class="ref ref28 ref45">(28,45)</a> All compounds showed competition with rosiglitazone at high concentrations, indicating binding to the orthosteric site of PPARγ. Interestingly, at least a 3-fold lower competition with rosiglitazone was observed for the isoxazole compounds compared to <b>1</b> (i.e., at least a 3-fold increase of the IC<sub>50</sub> values compared to <b>1</b>), with most analogues demonstrating IC<sub>50</sub> values > 50 μM. Overall, a similar trend was observed for the IC<sub>50</sub> values in this competition assay as for the EC<sub>50</sub> values in the previously mentioned TR-FRET coactivator recruitment assay (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Again, compounds <b>12</b> and <b>13</b> appeared to be less selective for RORγt than the more potent RORγt-binding isoxazoles (IC<sub>50</sub> values of 20 ± 2 and 19 ± 3 μM resp.). Compound <b>10</b> showed some cross-reactivity with PPARγ as well, although with an IC<sub>50</sub> value > 20 μM.</div><div class="NLM_p">Next, the compounds were evaluated in a PPARγ TSA (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Compounds <b>10</b>, <b>12</b>, and <b>13</b> showed the highest thermal stabilization effect (Δ<i>T</i><sub>m</sub> of 1.2 and 1.5 °C), in line with the TR-FRET data, and also <b>6</b> appeared to show a significant stabilization effect (Δ<i>T</i><sub>m</sub> of 1.1 °C). Compound <b>1</b> again showed the most significant activity on PPARγ, with a Δ<i>T</i><sub>m</sub> of 2.5 °C. The selectivity of the compounds for RORγt over PPARγ was calculated (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) by comparing the data for PPARγ and RORγt for both the TR-FRET coactivator recruitment assay and TSA (see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Interestingly, compounds <b>3</b> and <b>6</b>, which are highly potent RORγt inverse agonists (IC<sub>50</sub> values < 35 nM), show a 100- and 125-fold selectivity for RORγt over PPARγ, respectively, based on the TR-FRET results, which is a significant improvement compared to <b>2</b> (30-fold). Contrastingly, <b>12</b> and <b>13</b> containing a methyl substituent at the pyrrole moiety show higher cross-reactivity toward PPARγ, in the same range as for <b>1</b>. Together, the cross-reactivity of the isoxazoles on PPARγ can be modulated by only small changes in the pyrrole substitution pattern. Gratifyingly, the most potent compounds for RORγt (<b>3</b> and <b>6</b>) also feature the highest selectivity for RORγt over PPARγ.</div><div class="NLM_p last">Lastly, the isoxazole compounds were tested on the farnesoid X receptor (FXR) to exclude cross-reactivity because trisubstituted isoxazole ligands, such as <b>GW4064</b>, have been reported as potent FXR agonists.<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46,47)</a> The most potent RORγt isoxazole ligands and <b>GW4064</b> were evaluated in a fluorescence polarization (FP) assay. <b>GW4064</b> showed a typical agonistic dose–response curve for FXR, whereas the novel isoxazole ligands did not elicit an agonistic response on FXR (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">Figure S7</a>A). Additionally, the EC<sub>50</sub> value of <b>GW4064</b> was not significantly affected by the presence of isoxazole <b>3</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">Figure S7B</a>), thus also excluding an antagonistic behavior of <b>3</b> on FXR.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">2.7.  Absorption, Distribution, Metabolism, and Excretion Profile</h3><div class="NLM_p">Previous studies on the absorption, distribution, metabolism, and excretion (ADME) parameters of the isoxazoles showed that these were promising but not optimal yet for compound <b>2</b>, most probably governed by the pyrrole moiety and the amine linker, which are both likely to be prone to oxidation.<a onclick="showRef(event, 'ref28 ref48'); return false;" href="javascript:void(0);" class="ref ref28 ref48">(28,48)</a> The ADME profiling of the novel isoxazoles (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) demonstrates that compounds <b>3</b>, <b>6</b>, <b>9</b>, and <b>10</b> in general show comparable properties to hit compound <b>2</b>, with promising values for the kinetic solubility and (passive) membrane permeability, especially because the compounds contain a carboxylic acid moiety which generally leads to lower permeability values. The metabolic stability in human liver microsomes showed that the clearance values in phase I metabolism are rather high, similar to <b>2</b>. Glucuronidation assays (as the most important phase II pathway) showed promising improved values (% remain), especially for compound <b>10</b>. The plasma stability (except for <b>6</b>) was slightly lower than for <b>1</b>, and relatively high levels of blood plasma protein binding were measured. Contrastingly, compound <b>11</b>, containing a pyrazole instead of a pyrrole substituent at the C-5 position, showed a rather different ADME profile. It demonstrated a promising stability in phase I metabolism and was highly stable in plasma, although the phase II stability (glucuronidation) and permeability were lower than for the other isoxazoles.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. ADME Properties for Compounds <b>1</b>, <b>2</b>, <b>3</b>, <b>6</b>, <b>9</b>, <b>10</b>, and <b>11</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">microsomal stability</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char=".">kinetic solubility (μM)</th><th class="colsep0 rowsep0" align="center" char=".">PAMPA (% flux)</th><th class="colsep0 rowsep0" align="center" char=".">phase 1 (Cl<sub>int</sub>, μL/min/mg)</th><th class="colsep0 rowsep0" align="center" char=".">glucuronidation <i>in vitro</i> (% remaining)</th><th class="colsep0 rowsep0" align="center" char=".">plasma stability (% remaining)</th><th class="colsep0 rowsep0" align="center" char=".">plasma protein binding (% bound)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">423</td><td class="colsep0 rowsep0" align="char" char=".">29.7</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">37.7</td><td class="colsep0 rowsep0" align="char" char=".">95.5</td><td class="colsep0 rowsep0" align="char" char=".">99.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">460</td><td class="colsep0 rowsep0" align="char" char=".">36.1</td><td class="colsep0 rowsep0" align="char" char=".">31.2</td><td class="colsep0 rowsep0" align="char" char=".">73.0</td><td class="colsep0 rowsep0" align="char" char=".">79.1</td><td class="colsep0 rowsep0" align="char" char=".">99.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">436</td><td class="colsep0 rowsep0" align="char" char=".">40.9</td><td class="colsep0 rowsep0" align="char" char=".">57.8</td><td class="colsep0 rowsep0" align="char" char=".">30.7</td><td class="colsep0 rowsep0" align="char" char=".">74.2</td><td class="colsep0 rowsep0" align="char" char=".">99.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">392</td><td class="colsep0 rowsep0" align="char" char=".">40.3</td><td class="colsep0 rowsep0" align="char" char=".">69.0</td><td class="colsep0 rowsep0" align="char" char=".">58.3</td><td class="colsep0 rowsep0" align="char" char=".">59.5</td><td class="colsep0 rowsep0" align="char" char=".">99.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char=".">445</td><td class="colsep0 rowsep0" align="char" char=".">37.3</td><td class="colsep0 rowsep0" align="char" char=".">77.0</td><td class="colsep0 rowsep0" align="char" char=".">54.6</td><td class="colsep0 rowsep0" align="char" char=".">97.1</td><td class="colsep0 rowsep0" align="char" char=".">99.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">421</td><td class="colsep0 rowsep0" align="char" char=".">50.5</td><td class="colsep0 rowsep0" align="char" char=".">68.0</td><td class="colsep0 rowsep0" align="char" char=".">68.9</td><td class="colsep0 rowsep0" align="char" char=".">89.5</td><td class="colsep0 rowsep0" align="char" char=".">99.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char=".">476</td><td class="colsep0 rowsep0" align="char" char=".">23.0</td><td class="colsep0 rowsep0" align="char" char=".">8.8</td><td class="colsep0 rowsep0" align="char" char=".">39.1</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">98.8</td></tr></tbody></table></div></div><div class="NLM_p">The open-source program OSIRIS Property Explorer<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> was used to predict the drug likeness and toxicity of the compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">Table S3</a>) to have a first indication on these aspects. All isoxazole compounds (except <b>5</b>) were predicted to have no side effects (i.e., mutagenic, tumorigenic, irritant, and reproductive effects), whereas <b>1</b> was predicted to have a potentially high risk of reproductive toxicity. Additionally, all isoxazole ligands showed higher drug scores than <b>1</b>, with pyrazole <b>11</b> showing the best properties, again highlighting its potential for further development.</div><div class="NLM_p last">Combined, the change of an amine to an ether/alkene linker (<b>2</b> vs <b>3</b> and <b>6</b>) does not significantly affect the ADME(T) properties (except for the glucuronidation of <b>3</b>), while the change of a pyrrole to a pyrazole moiety (<b>11</b>) results in a differentiated, promising profile. The C-4/C-5 isoxazole modifications thus provide valuable entry points for optimization of the ADME properties.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">3.  Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85677" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85677" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The NR RORγt has an important regulatory role in the immune system, and inhibition of RORγt <i>via</i> allosteric inverse agonists could be a promising strategy in the treatment of autoimmune disorders. Apart from indazoles, with <b>1</b> (<b>MRL-871</b>) as a prominent example, there has been little chemical diversity of allosteric RORγt modulators. Trisubstituted isoxazoles constitute a distinct novel chemotype in this matter, with <b>2</b> (<b>FM26</b>) as an exemplary potent hit compound.</div><div class="NLM_p">Here, we further optimized this isoxazole series, specifically focusing on the linker at the C-4 position and the heterocycle at the C-5 position to deliver lead compounds for further optimization. The optimization of the linker at the C-4 position revealed a clear correlation between potency and the lipophilicity and flexibility of the linker, with an ether or alkene linker resulting in the highest potency. The co-crystal structure of RORγt in complex with ether compound <b>3</b> revealed the role of hydrophobic interactions and conformation of the linker at the C-4 position. The most potent compounds <b>3</b> (<b>FM156</b>) and <b>6</b> (<b>FM260</b>) were highly selective for RORγt over PPARγ, which is a valuable improvement compared to the exemplary indazole <b>1</b>.</div><div class="NLM_p">The focused library of C-5 isoxazoles revealed several routes for chemical exploration. Changing the position of the hydrogen bond donor <i>via</i> the repositioning of the pyrrole ring (<b>10</b>) led only to a 3-fold lower potency, with the formation of another hydrogen bond interaction network <i>via</i> a water molecule in the RORγt pocket. Changing the pyrrole to a pyrazole (with a lower p<i>K</i><sub>a</sub>) in compound <b>11</b> (<b>FM257</b>) was also tolerated and resulted in a promising PK profile, opening up routes for affinity and ADME optimization.</div><div class="NLM_p last">In conclusion, by probing the effect of the linker at the C-4 position and the importance of the polar character of the C-5 moiety, this study has led to valuable leads as allosteric inverse agonists for RORγt with improved potency, increased selectivity against PPARγ and FXR, and promising initial ADME properties. The results not only provide new insights into the SAR for this specific isoxazole class of allosteric RORγt ligands but can also most probably similarly be translated to other allosteric RORγt chemotypes. Overall, the trisubstituted isoxazole class of allosteric RORγt ligands shows high potential for chemical biology approaches as well as for future development in drug discovery programs against autoimmune diseases.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">4.  Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32101" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32101" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">4.1.  <i>In Silico</i> Studies</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20">4.1.1.  Molecular Docking Studies</h4><div class="NLM_p last">The receptor–ligand complex structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YPQ">4YPQ</a>) was prepared using the Protein Preparation Wizard within Maestro (version 12.3 (2020-1), Schrödinger LLC, New York, NY, USA) (default parameters). A receptor grid centered on the bound ligand was generated using the Protein Preparation Wizard. All parameters were kept as the default. The examined ligands were drawn in ChemDraw. Energy-minimized 3D ligand conformations for each molecule to be investigated were generated using the Ligand Preparation Wizard within Maestro (default parameters). Ligands were docked using Glide in standard precision mode with flexible ligand sampling. The predicted binding modes of all ligands were ranked according to their glide score.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21">4.1.2.  <i>In Silico</i> Drug Likeness and Toxicity Predictions</h4><div class="NLM_p last">OSIRIS Property Explorer utilizes the database of traded drugs and commercially available compounds (Fluka), assumable as nondrug-like data set, to assess the occurrence frequency of each fragment in the individual structure.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The program was used to estimate the risks of side effects, such as mutagenic, tumorigenic, irritant, and reproductive effects, as well as drug likeness and overall drug score (by combining the outcome of <i>c</i>log <i>P</i>, log <i>S</i> (solubility), MW, toxicity risks, and drug likeness). The drug score is a measure of the compound’s potential to meet the criteria of a possible drug candidate.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">4.2.  General Chemistry</h3><div class="NLM_p">All nonaqueous reactions were performed under an argon atmosphere unless otherwise stated. Water-sensitive reactions were performed in oven-dried glassware, cooled under argon before use. All solvents were supplied by Biosolve or Sigma-Aldrich and used without further purification. Dry solvents were obtained from a MBRAUN solvent purification system (MB-SPS-800). Water was purified by a Millipore purification train. Deuterated solvents were obtained from Cambridge Isotope Laboratories. Solvents were removed <i>in vacuo</i> using a Büchi rotary evaporator and a diaphragm pump. Commercially available starting materials were obtained from Sigma-Aldrich, TCI Chemicals and Fluorochem. Proton (<sup>1</sup>H) NMR (400 MHz), carbon (<sup>13</sup>C) NMR (100 MHz), and 2D NMR (400 MHz) were recorded on a Bruker Avance 400 MHz NMR spectrometer. Proton spectra are referenced to tetramethyl silane (TMS). Carbon spectra are referenced to TMS or the solvent peak of the deuterated spectrum. NMR spectra are reported as follows: chemical shift (δ) in parts per million (ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, dd = doublet of doublet, td = triplet of doublets, app. = apparent), coupling constant (<i>J</i>) in Hertz (Hz) (if applicable), and integration (proton spectra only). Peak assignments are based on additional 2D NMR techniques (COSY, HMBC, and HSQC). Analytical liquid chromatography coupled with mass spectrometry (LC–MS) was performed on a C4 Jupiter SuC4300A 150 × 2.0 mm column using ultrapure water with 0.1% formic acid (FA) and acetonitrile with 0.1% FA, in general with a gradient of 5–100% acetonitrile for over 10 min, connected to a Thermo Fisher LCQ fleet ion-trap mass spectrometer. The purity of the samples was assessed using a UV detector at 254 nm. Unless otherwise stated all final compounds were >95% pure as judged by HPLC. High-resolution mass spectra (HRMS) were recorded using a Waters ACQUITY UPLC I-Class LC system coupled to a Xevo G2 quadrupole time-of-flight (Q-TOF) mass spectrometer. Preparative HP-LC was performed on a Gemini S4 110A 150 × 21.20 mm column using ultrapure water with 0.1% FA and acetonitrile with 0.1% FA with various gradients (mentioned for each compound specifically). Column chromatography was either performed manually using silica gel (60–200 μm particle size, 60 AÅ) or using an automated Grace Reveleris X2 chromatograph with pre-packed silica columns supplied by Buchi/Grace (40 μm particle size). The reaction progress was monitored by thin-layer liquid chromatography (TLC) using Merck TLC silica gel 60 F254 plates. The visualization of the plates was achieved using an ultraviolet lamp (λ<sub>max</sub> = 254 nm).</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23">4.2.1.  General Procedure for Suzuki Coupling</h4><div class="NLM_p last">Under an inert atmosphere, pinacol boronate (2.0 equiv), Cs<sub>2</sub>CO<sub>3</sub> (2.0 equiv), and Pd(dppf)Cl<sub>2</sub> (0.1 equiv) were added to a solution of bromide <b>14</b> (1.0 equiv) in degassed 1,2-dimethoxyethane (DME) (0.1 M). The reaction mixture was heated at 85 °C for 8 h, cooled to room temperature, diluted with H<sub>2</sub>O, and extracted with EtOAc (3×). The combined organic phase was washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The crude product was purified by flash column chromatography using the specified eluent to afford the desired product.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24">4.2.2.  General Procedure for the Reduction of Esters to Alcohols</h4><div class="NLM_p last">Under an inert atmosphere, DIBAL (1.23 g/mL in cyclohexane, 15.0 equiv) was added dropwise to a solution of ester (1.0 equiv) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (0.1 M) at −78 °C. The reaction mixture was followed by TLC analysis. Upon complete consumption of the starting material, the reaction mixture was warmed to room temperature, quenched by the addition of a saturated Rochelle salt (KNaC<sub>4</sub>H<sub>4</sub>O<sub>6</sub>·4H<sub>2</sub>O) solution and stirred vigorously for 60 min. Subsequently, the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×) and separated. The combined organic phase was washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i> to afford the title compound which was purified as described.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25">4.2.3.  General Procedure for Mesylation and Substitution</h4><div class="NLM_p last">Under an inert atmosphere, triethylamine (3.0 equiv) was added to a solution of alcohol compound <b>16</b> (1.0 equiv) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (0.1 M). Methanesulfonic anhydride (1.5 equiv) was added to the flask, and the reaction mixture was heated at 40 °C. The reaction was monitored using NMR analysis. Subsequently, aniline (5.0 equiv) was added, and the reaction mixture was stirred for 1 h, cooled to room temperature, and CH<sub>2</sub>Cl<sub>2</sub> was removed <i>in vacuo</i>. The crude product was purified by flash column chromatography using the specified eluent.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26">4.2.4.  General Procedure for Ester Hydrolysis and N-Boc Deprotection</h4><div class="NLM_p last">LiOH·H<sub>2</sub>O (10.0 equiv) was added to a suspension of ester (1.0 equiv) in a 4:1 mixture of EtOH/H<sub>2</sub>O (0.05 M). The reaction mixture was heated to 95 °C followed by TLC analysis. Upon complete consumption of the starting material, EtOH was removed <i>in vacuo</i>, and the resulting aqueous mixture was acidified to pH 3 using 10% v/v aqueous HCl and extracted with a 9:1 mixture of CH<sub>2</sub>Cl<sub>2</sub>/MeOH (5×). The combined organic phase was dried (MgSO<sub>4</sub>), filtered, and concentrated <i>in vacuo</i> to furnish the final compound which was purified as described.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27">4.2.5.  General Procedure for Mitsunobu Coupling</h4><div class="NLM_p last">Under an inert atmosphere, triphenylphosphine (2.0 equiv) and DIAD (2.0 equiv) were dissolved in anhydrous tetrahydrofuran (THF) (0.05 M) and stirred for 15 min at 0 °C. Subsequently, the alcohol compound (1.0 equiv), the benzoate (1.1 equiv), and triethylamine (1.0 equiv) were added, and the reaction mixture was heated at 80 °C for 3 h, cooled to room temperature, and THF was removed <i>in vacuo</i>. The crude product was purified by flash column chromatography using the specified eluent.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28">4.2.6.  4-(((3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(1<i>H</i>-pyrrol-3-yl)isoxazol-4-yl)methyl) amino) Benzoic Acid (<b>2</b>)</h4><div class="NLM_p last">According to the general procedure for ester hydrolysis and <i>N</i>-Boc deprotection, ester <b>17</b> (0.035 g, 0.067 mmol) was hydrolyzed with a concomitant loss of the Boc protecting group. The crude product was purified by column chromatography, eluted with 1.5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>, to furnish carboxylic acid <b>2</b> (10.3 mg, 33%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 11.98 (1H, br s, CO<sub>2</sub><i>H</i>), 11.52 (1H, s, pyrrole-N<i>H</i>), 7.90 (1H, d, <i>J</i> = 8.0 Hz, ArH-3), 7.84 (1H, d, <i>J</i> = 7.8 Hz, ArH-5), 7.72 (1H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 7.53 (2H, d, <i>J</i> = 8.7 Hz, benzoate C-2), 7.39 (1H, m, pyrrole H-2), 6.98 (1H, m, pyrrole H-5), 6.55 (1H, m, pyrrole H-4), 6.41 (2H, d, <i>J</i> = 8.7 Hz, benzoate H-3), 6.34 (1H, app. t, <i>J</i> = 4.4 Hz, CH<sub>2</sub>N<i>H</i>), 4.07 (1H, dd, <i>J</i> = 14.4, 5.0 Hz, C<i>H</i><sub>a</sub>NH), 4.02 (1H, dd, <i>J</i> = 14.5, 4.5 Hz, C<i>H</i><sub>b</sub>NH); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 167.9 (<i>C</i>O<sub>2</sub>H), 165.7 (C-5), 159.2 (C-3), 152.3 (benzoate C-4), 136.0 (ArC-2), 134.1 (ArC-3), 132.4 (ArC-4), 131.3 (benzoate C-2), 130.9 (q, <i>J</i> = 30.4 Hz, ArC-6), 126.8 (ArC-1), 125.8 (q, <i>J</i> = 5.0 Hz, ArC-5), 122.0 (q, <i>J</i> = 274.3 Hz, <i>C</i>F<sub>3</sub>), 120.5 (pyrrole C-5), 119.2 (pyrrole C-2), 117.8 (benzoate C-1), 111.2 (benzoate C-3), 110.5 (pyrrole C-3), 109.2 (C-4), 106.7 (pyrrole C-4), 36.2 (<i>C</i>H<sub>2</sub>NH). LC–MS (ESI): calcd for C<sub>22</sub>H<sub>15</sub>ClF<sub>3</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 462.08; observed, 462.17 (<i>R</i><sub>t</sub> = 6.13 min). HRMS (ESI): calcd for C<sub>22</sub>H<sub>15</sub>ClF<sub>3</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 462.0832; observed, 462.0835.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29">4.2.7.  4-((3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(1<i>H</i>-pyrrol-3-yl)isoxazol-4-yl)methoxy) Benzoic Acid (<b>3</b>)</h4><div class="NLM_p last">According to the general procedure for ester hydrolysis and <i>N</i>-Boc deprotection, ester <b>20</b> (0.020 g, 0.035 mmol) was hydrolyzed with a concomitant loss of the Boc-protecting group. The crude product was purified by column chromatography, eluting with 1.5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>, to furnish carboxylic acid <b>3</b> (12.0 mg, 75%) as a white solid. <sup>1</sup>H NMR (400 MHz, acetone-<i>d</i><sub>6</sub>): δ (ppm) 10.78 (1H, br s, CO<sub>2</sub><i>H</i>), 7.92 (4H, m, ArH-3, ArH-5 and benzoate C-2), 7.77 (1H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 7.47 (1H, m, pyrrole H-2), 7.03 (1H, m, pyrrole H-5), 6.94 (2H, d, <i>J</i> = 8.8 Hz, benzoate H-3), 6.64 (1H, m, pyrrole H-4), 5.04 (2H, s, C<i>H</i><sub>2</sub>O); <sup>13</sup>C NMR (100 MHz, acetone-<i>d</i><sub>6</sub>): δ (ppm) 167.6 (C-5), 167.3 (benzoate C-4), 163.1 (<i>C</i>O<sub>2</sub>H), 159.8 (C-3), 137.2 (ArC-2), 134.4 (ArC-3), 132.8 (q, <i>J</i> = 30.4 Hz, ArC-6), 132.6 (benzoate C-2), 132.5 (ArC-4), 127.9 (ArC-1), 126.1 (q, <i>J</i> = 5.0 Hz, ArC-5), 124.2 (benzoate C-1), 122.7 (q, <i>J</i> = 274.3 Hz, <i>C</i>F<sub>3</sub>), 121.0 (pyrrole C-5), 120.0 (pyrrole C-2), 115.1 (benzoate C-3), 111.6 (pyrrole C-3), 108.3 (C-4), 107.4 (pyrrole C-4), 60.8 (<i>C</i>H<sub>2</sub>O). LC–MS (ESI): calcd for C<sub>22</sub>H<sub>14</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 463.06; observed, 463.25 (<i>R</i><sub>t</sub> = 4.62 min). HRMS (ESI): calcd for C<sub>22</sub>H<sub>14</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 463.0672; observed, 463.0650.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30">4.2.8.  4-(((3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(1<i>H</i>-pyrrol-3-yl)isoxazol-4-yl)methyl)thio) Benzoic Acid (<b>4</b>)</h4><div class="NLM_p last">According to the general procedure for ester hydrolysis and <i>N</i>-Boc deprotection, ester <b>22</b> (0.020 g, 0.034 mmol) was hydrolyzed with a concomitant loss of the Boc protecting group. The crude product was purified by column chromatography, eluting with 2% MeOH in CH<sub>2</sub>Cl<sub>2</sub>, to furnish carboxylic acid <b>4</b> (8.00 mg, 49%) as a white solid. <sup>1</sup>H NMR (400 MHz, acetone-<i>d</i><sub>6</sub>): δ (ppm) 10.77 (1H, br s, CO<sub>2</sub><i>H</i>), 7.89 (4H, m, ArH-3, ArH-5 and benzoate C-2), 7.79 (1H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 7.52 (1H, m, pyrrole H-2), 7.31 (2H, d, <i>J</i> = 8.5 Hz, benzoate H-3), 7.03 (1H, m, pyrrole H-5), 6.68 (1H, m, pyrrole H-4), 4.22 (2H, s, C<i>H</i><sub>2</sub>S); <sup>13</sup>C NMR (100 MHz, acetone-<i>d</i><sub>6</sub>): δ (ppm) 167.2 (<i>C</i>O<sub>2</sub>H), 166.8 (C-5), 159.8 (C-3), 144.6 (benzoate C-4), 137.2 (ArC-2), 134.5 (ArC-3), 132.7 (ArC-4), 132.5 (q, <i>J</i> = 30.4 Hz, ArC-6), 131.4 (benzoate C-1), 130.9 (benzoate C-2), 128.3 (ArC-1), 127.3 (benzoate C-3), 126.3 (q, <i>J</i> = 5.0 Hz, ArC-5), 122.7 (q, <i>J</i> = 274.3 Hz, <i>C</i>F<sub>3</sub>), 120.9 (pyrrole C-5), 119.7 (pyrrole C-2), 111.6 (pyrrole C-3), 107.3 (C-4), 107.3 (pyrrole C-4), 26.2 (<i>C</i>H<sub>2</sub>S). LC–MS (ESI): calcd for C<sub>22</sub>H<sub>14</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup>, 479.04; observed, 479.25 (<i>R</i><sub>t</sub> = 4.86 min). HRMS (ESI): calcd for C<sub>22</sub>H<sub>14</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>3</sub>S [M + H]<sup>+</sup>, 479.0444; observed, 479.0438.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31">4.2.9.  4-(((3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(1<i>H</i>-pyrrol-3-yl)isoxazol-4-yl)methyl) (methyl)amino) Benzoic Acid (<b>5</b>)</h4><div class="NLM_p last">According to the general procedure for ester hydrolysis and <i>N</i>-Boc deprotection, ester <b>18</b> (0.040 g, 0.068 mmol) was hydrolyzed with a concomitant loss of the Boc protecting group. The crude product was purified by column chromatography, eluting with 2% MeOH in CH<sub>2</sub>Cl<sub>2</sub>, to furnish carboxylic acid <b>5</b> (19.3 mg, 60%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 12.08 (1H, br s, CO<sub>2</sub><i>H</i>), 11.60 (1H, s, pyrrole-N<i>H</i>), 7.80 (1H, d, <i>J</i> = 8.1 Hz, ArH-3), 7.76 (1H, d, <i>J</i> = 7.8 Hz, ArH-5), 7.64 (1H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 7.53 (1H, m, pyrrole H-2), 7.49 (2H, d, <i>J</i> = 8.9 Hz, benzoate C-2), 7.02 (1H, m, pyrrole H-5), 6.63 (1H, m, pyrrole H-4), 6.33 (2H, d, <i>J</i> = 8.9 Hz, benzoate H-3), 4.48 (2H, s, C<i>H</i><sub>2</sub>NCH<sub>3</sub>), 2.54 (3H, s, CH<sub>2</sub>NC<i>H</i><sub>3</sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ (ppm) 167.3 (<i>C</i>O<sub>2</sub>H), 165.0 (C-5), 158.5 (C-3), 151.7 (benzoate C-4), 135.5 (ArC-2), 133.6 (ArC-3), 131.8 (ArC-4), 130.5 (benzoate C-2), 130.1 (q, <i>J</i> = 30.4 Hz, ArC-6), 126.5 (ArC-1), 125.4 (q, <i>J</i> = 5.0 Hz, ArC-5), 124.2 (q, <i>J</i> = 274.3 Hz, <i>C</i>F<sub>3</sub>), 120.2 (pyrrole C-5), 118.8 (pyrrole C-2), 117.3 (benzoate C-1), 110.5 (benzoate C-3), 109.7 (pyrrole C-3), 109.0 (C-4), 106.3 (pyrrole C-4), 43.9 (<i>C</i>H<sub>2</sub>NCH<sub>3</sub>), 37.0 (CH<sub>2</sub>N<i>C</i>H<sub>3</sub>). LC–MS (ESI): calcd for C<sub>23</sub>H<sub>17</sub>ClF<sub>3</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 476.09; observed, 476.17 (<i>R</i><sub>t</sub> = 6.33 min). HRMS (ESI): calcd for C<sub>23</sub>H<sub>17</sub>ClF<sub>3</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 476.0989; observed, 476.0971.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32">4.2.10.  (<i>E</i>)-4-(2-(3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(1<i>H</i>-pyrrol-3-yl)isoxazol-4-yl) vinyl) Benzoic Acid (<b>6</b>)</h4><div class="NLM_p last">According to the general procedure for ester hydrolysis and <i>N</i>-Boc deprotection, ester <b>24</b> (0.012 g, 0.021 mmol) was hydrolyzed with a concomitant loss of the Boc protecting group. The crude product was purified via preparative HPLC (gradient of 70–73% acetonitrile in H<sub>2</sub>O) to furnish carboxylic acid <b>6</b> (6.1 mg, 63%) as a white solid. <sup>1</sup>H NMR (400 MHz, acetone-<i>d</i><sub>6</sub>): δ (ppm) 10.85 (1H, br s, CO<sub>2</sub><i>H</i>), 8.00 (2H, ArH-3 and ArH-5), 7.92 (3H, m, benzoate C-2 and ArH-4), 7.62 (1H, m, pyrrole H-2), 7.39 (3H, m, benzoate H-3 and C4-<i>H</i>C═CH), 7.08 (1H, m, pyrrole H-5), 6.74 (1H, m, pyrrole H-4), 6.15 (1H, s, benzoate C4-<i>H</i>C═CH); <sup>13</sup>C NMR (100 MHz, acetone-<i>d</i><sub>6</sub>): δ (ppm) 166.3 (<i>C</i>O<sub>2</sub>H), 165.2 (C-5), 156.8 (C-3), 141.5 (benzoate C-4), 136.1 (ArC-2), 133.8 (ArC-3), 131.9 (ArC-4), 131.4 (q, <i>J</i> = 30.4 Hz, ArC-6), 130.0 (benzoate C-2), 129.4 (benzoate C-1), 128.1 (benzoate C4-H<i>C</i>═CH), 128.0 (ArC-1), 126.0 (benzoate C-3), 125.6 (q, <i>J</i> = 5.0 Hz, ArC-5), 121.9 (q, <i>J</i> = 274.3 Hz, <i>C</i>F<sub>3</sub>), 120.2 (pyrrole C-5), 119.3 (pyrrole C-2), 118.8 (C4-H<i>C</i>═C<i>H</i>), 110.9 (pyrrole C-3), 110.3 (C-4), 106.7 (pyrrole C-4). LC–MS (ESI): calcd for C<sub>23</sub>H<sub>14</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 459.06; observed, 459.25 (<i>R</i><sub>t</sub> = 4.90 min). HRMS (ESI): calcd for C<sub>23</sub>H<sub>14</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 459.0723; observed, 459.0726.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33">4.2.11.  (<i>Z</i>)-4-(2-(3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(1<i>H</i>-pyrrol-3-yl)isoxazol-4-yl) vinyl) Benzoic Acid (<b>7</b>)</h4><div class="NLM_p last">According to the general procedure for ester hydrolysis and <i>N</i>-Boc deprotection, ester <b>25</b> (0.040 g, 0.070 mmol) was hydrolyzed with a concomitant loss of the Boc-protecting group. The crude product was purified via preparative HPLC (gradient of 70–73% acetonitrile in H<sub>2</sub>O) to furnish carboxylic acid <b>7</b> (26.0 mg, 81%) as a white solid. <sup>1</sup>H NMR (400 MHz, acetone-<i>d</i><sub>6</sub>): δ (ppm) 10.50 (1H, br s, CO<sub>2</sub><i>H</i>), 7.80 (5H, m, ArH-3, ArH-5, ArH-4 and benzoate C-2), 7.36 (2H, d, <i>J</i> = 8.2 Hz, benzoate H-3), 7.21 (1H, m, pyrrole H-2), 6.79 (1H, m, pyrrole H-5), 6.74 (1H, d, <i>J</i> = 12.2 Hz, benzoate C4-<i>H</i>C═CH), 6.49 (1H, m, pyrrole H-4), 6.29 (1H, d, <i>J</i> = 12.2 Hz, C4-<i>H</i>C═CH); <sup>13</sup>C NMR (100 MHz, acetone-<i>d</i><sub>6</sub>): δ (ppm) 166.3 (<i>C</i>O<sub>2</sub>H), 163.7 (C-5), 158.4 (C-3), 141.1 (benzoate C-4), 136.1 (ArC-2), 133.5 (benzoate C4-H<i>C</i>═CH), 133.5 (ArC-3), 131.6 (ArC-4), 131.3 (q, <i>J</i> = 30.4 Hz, ArC-6), 129.4 (benzoate C-2), 128.4 (benzoate C-3), 127.2 (benzoate C-1), 125.3 (q, <i>J</i> = 5.0 Hz, ArC-5), 124.5 (ArC-1), 121.8 (q, <i>J</i> = 274.3 Hz, <i>C</i>F<sub>3</sub>), 119.3 (pyrrole C-5), 118.8 (pyrrole C-2), 118.7 (C4-H<i>C</i>═CH), 111.2 (pyrrole C-3), 108.6 (C-4), 106.3 (pyrrole C-4). LC–MS (ESI): calcd for C<sub>23</sub>H<sub>14</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 459.06; observed, 459.25 (<i>R</i><sub>t</sub> = 4.87 min). HRMS (ESI): calcd for C<sub>23</sub>H<sub>14</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 459.0723; observed, 459.0715.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34">4.2.12.  4-(((3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(1<i>H</i>-pyrrol-3-yl)isoxazol-4-yl)methyl) amino)-2-fluorobenzoic Acid (<b>8</b>)</h4><div class="NLM_p last">According to the general procedure for ester hydrolysis and <i>N</i>-Boc deprotection, ester <b>19</b> (0.008 g, 0.016 mmol) was hydrolyzed. The crude product was purified by column chromatography, eluting with 1.5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>, to furnish carboxylic acid <b>8</b> (2.2 mg, 29%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.09 (1H, br s, CO<sub>2</sub><i>H</i>), 11.5 (1H, s, pyrrole-N<i>H</i>), 7.87 (1H, d, <i>J</i> = 8.0 Hz, ArH-3), 7.82 (1H, d, <i>J</i> = 7.9 Hz, ArH-5), 7.72 (1H, app. t, <i>J</i> = 7.9 Hz, ArH-4), 7.47 (1H, app. t, <i>J</i> = 8.8 Hz, benzoate H-2), 7.38 (1H, m, pyrrole H-2), 6.97 (1H, m, pyrrole H-5), 6.64 (1H, app. t, <i>J</i> = 4.8 Hz, CH<sub>2</sub>N<i>H</i>), 6.55 (1H, m, pyrrole H-4), 6.24 (1H, dd, <i>J</i> = 8.8, 2.1 Hz, benzoate H-3<sub>a</sub>), 6.10 (1H, dd, <i>J</i> = 14.4, 1.8 Hz, benzoate H-3<sub>b</sub>), 4.06 (2H, m, C<i>H</i><sub>2</sub>NH). LC–MS (ESI): calcd for C<sub>22</sub>H<sub>14</sub>ClF<sub>4</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 480.07; observed, 480.25 (<i>R</i><sub>t</sub> = 6.21 min). HRMS (ESI): calcd for C<sub>22</sub>H<sub>14</sub>ClF<sub>4</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 480.0738; observed, 480.0759.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35">4.2.13.  4-((3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(1<i>H</i>-pyrrol-3-yl)isoxazol-4-yl)methoxy)-2-fluorobenzoic Acid (<b>9</b>)</h4><div class="NLM_p last">According to the general procedure for ester hydrolysis and <i>N</i>-Boc deprotection, ester <b>21</b> (0.017 mg, 0.029 mmol) was hydrolyzed with a concomitant loss of the Boc protecting group. The crude product was purified by column chromatography, eluting with 1.5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>, to furnish carboxylic acid <b>9</b> (8.0 mg, 57%) as a white solid. <sup>1</sup>H NMR (400 MHz, acetone-<i>d</i><sub>6</sub>): δ (ppm) 10.81 (1H, br s, CO<sub>2</sub><i>H</i>), 7.98 (3H, m, ArH-3, ArH-5 and benzoate C-2), 7.78 (1H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 7.48 (1H, m, pyrrole H-2), 7.02 (1H, m, pyrrole H-5), 6.73 (2H, m, benzoate H-3), 6.64 (1H, m, pyrrole H-4), 5.06 (2H, s, C<i>H</i><sub>2</sub>O); <sup>13</sup>C NMR (100 MHz, acetone-<i>d</i><sub>6</sub>): δ (ppm) 167.4 (C-5), 165.5 (<i>C</i>O<sub>2</sub>H), 164.0 (benzoate C-4), 162.9 (benzoate <i>C</i>–F), 159.7 (C-3), 137.2 (ArC-2), 134.4 (ArC-3), 132.7 (q, <i>J</i> = 30.4 Hz, ArC-6), 132.6 (Ar C-4), 132.4 (benzoate C-2), 127.8 (ArC-1), 126.1 (q, <i>J</i> = 5.0 Hz, ArC-5), 125.4 (benzoate C-1), 122.7 (q, <i>J</i> = 274.3 Hz, <i>C</i>F<sub>3</sub>), 121.0 (pyrrole C-5), 120.0 (pyrrole C-2), 111.7 (benzoate C-3<sub>a</sub>), 111.5 (pyrrole C-3), 108.0 (C-4), 107.4 (pyrrole C-4), 103.7 (benzoate C-3<sub>b</sub>), 61.3 (<i>C</i>H<sub>2</sub>O). LC–MS (ESI): calcd for C<sub>22</sub>H<sub>13</sub>ClF<sub>4</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 481.05; observed, 481.25 (<i>R</i><sub>t</sub> = 4.92 min). HRMS (ESI): calcd for C<sub>22</sub>H<sub>13</sub>ClF<sub>4</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 481.0578; observed, 481.0572.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36">4.2.14.  4-((3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(1<i>H</i>-pyrrol-2-yl)isoxazol-4-yl)methoxy) Benzoic Acid (<b>10</b>)</h4><div class="NLM_p last">According to the general procedure for Mitsunobu coupling (without the addition of triethylamine), alcohol <b>30</b> (0.080 g, 0.180 mmol) was reacted with methyl 4-hydroxybenzoate (0.030 g, 0.200 mmol). The crude product was purified by column chromatography, eluting with a gradient of 5–25% EtOAc in <i>n</i>-heptane, to furnish the ether compound (22.0 mg, 21%). The resulting product (0.012 g, 0.021 mmol) was subject to ester hydrolysis with a concomitant loss of the Boc protecting group according to the general procedure for ester hydrolysis and <i>N</i>-Boc deprotection. The crude product was purified by column chromatography, eluting with 1.5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>, to furnish carboxylic acid <b>10</b> (4.0 mg, 41%) as a white solid. <sup>1</sup>H NMR (400 MHz, acetone-<i>d</i><sub>6</sub>): δ (ppm) 11.13 (1H, br s, CO<sub>2</sub><i>H</i>), 7.91 (4H, m, ArH-3, ArH-5 and benzoate C-2), 7.80 (1H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 7.19 (1H, m, pyrrole H-5), 6.93 (2H, d, <i>J</i> = 8.4 Hz, benzoate H-3), 6.79 (1H, m, pyrrole H-3), 6.34 (1H, m, pyrrole H-4), 5.09 (2H, s, C<i>H</i><sub>2</sub>O); <sup>13</sup>C NMR (100 MHz, acetone-<i>d</i><sub>6</sub>): δ (ppm) 162.4 (C-5), 162.0 (<i>C</i>O<sub>2</sub>H), 161.2 (benzoate C-4), 159.1 (C-3), 136.2 (ArC-2), 133.5 (ArC-3), 131.9 (benzoate C-2), 131.6 (ArC-4), 131.5 (q, <i>J</i> = 30.4 Hz, ArC-6), 126.5 (ArC-1), 125.3 (q, <i>J</i> = 5.0 Hz, ArC-5), 123.2 (benzoate C-1), 122.7 (pyrrole C-5), 121.8 (q, <i>J</i> = 274.3 Hz, <i>C</i>F<sub>3</sub>), 118.7 (pyrrole C-2), 114.2 (benzoate C-3), 111.6 (pyrrole C-3), 111.3 (pyrrole C-4), 107.6 (C-4), 59.8 (<i>C</i>H<sub>2</sub>O). LC–MS (ESI): calcd for C<sub>22</sub>H<sub>14</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 463.06; observed, 463.17 (<i>R</i><sub>t</sub> = 4.87 min). HRMS (ESI): calcd for C<sub>22</sub>H<sub>14</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 463.0672; observed, 463.0665.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37">4.2.15.  4-((3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(1<i>H</i>-pyrazol-4-yl)isoxazol-4-yl) methoxy) Benzoic Acid (<b>11</b>)</h4><div class="NLM_p last">According to the general procedure for Mitsunobu coupling, alcohol <b>31</b> (0.100 g, 0.234 mmol) was reacted with methyl 4-hydroxybenzoate (0.039 g, 0.257 mmol). The crude product was purified by column chromatography, eluting with a gradient of 10–25% EtOAc in <i>n</i>-heptane, to furnish the ether compound (65.0 mg, 49%). The ether compound (0.045 g, 0.080 mmol), containing a THP-protected pyrazole, was diluted in a mixture of TFA/CH<sub>2</sub>Cl<sub>2</sub> (50/50) (0.05 M), and the reaction mixture was stirred at 40 °C for 2 h. Afterward, it was cooled to room temperature, and the solvent was removed <i>in vacuo</i>. The crude product was purified by column chromatography, eluting with 25–40% EtOAc in <i>n</i>-heptane, to furnish the pyrazole product (28.0 mg, 88%). The resulting product was subjected to ester hydrolysis according to the general procedure for ester hydrolysis and <i>N</i>-Boc deprotection. The crude product was purified via preparative HPLC (gradient of 62–67% acetonitrile in H<sub>2</sub>O) to furnish carboxylic acid <b>11</b> (26.0 mg, 89%) as a white solid. <sup>1</sup>H NMR (400 MHz, acetone-<i>d</i><sub>6</sub>): δ (ppm) 8.24 (2H, s, pyrazole H-3 and H-5), 7.92 (4H, m, ArH-3, ArH-5 and benzoate C-2), 7.80 (1H, app. t, <i>J</i> = 7.9 Hz, ArH-4), 6.94 (2H, d, <i>J</i> = 8.1 Hz, benzoate H-3), 5.12 (2H, s, C<i>H</i><sub>2</sub>O); <sup>13</sup>C NMR (100 MHz, acetone-<i>d</i><sub>6</sub>): δ (ppm) 167.2 (<i>C</i>O<sub>2</sub>H), 164.6 (C-5), 162.9 (benzoate C-4), 159.9 (C-3), 137.1 (ArC-2), 134.4 (ArC-3), 133.6 (pyrazole C-3 and C-5), 133.0 (q, <i>J</i> = 30.4 Hz, ArC-6), 132.8 (ArC-4), 132.4 (benzoate C-2), 127.4 (ArC-1), 126.2 (q, <i>J</i> = 5.0 Hz, ArC-5), 124.3 (benzoate C-1), 122.7 (q, <i>J</i> = 274.3 Hz, <i>C</i>F<sub>3</sub>), 115.1 (benzoate C-3), 110.2 (C-4), 109.6 (pyrrole C-4). LC–MS (ESI): calcd for C<sub>21</sub>H<sub>13</sub>ClF<sub>3</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 464.05; observed, 464.08 (<i>R</i><sub>t</sub> = 4.45 min). HRMS (ESI): calcd for C<sub>21</sub>H<sub>13</sub>ClF<sub>3</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 464.0625; observed, 464.0610.</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38">4.2.16.  4-((3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(1-methyl-1<i>H</i>-pyrrol-3-yl)isoxazol-4-yl)methoxy) Benzoic Acid (<b>12</b>)</h4><div class="NLM_p last">According to the general procedure for Mitsunobu coupling, alcohol <b>32</b> (0.175 g, 0.490 mmol) was reacted with methyl 4-hydroxybenzoate (0.082 g, 0.540 mmol). The crude product was purified by column chromatography, eluting with a gradient of 5–20% EtOAc in <i>n</i>-heptane, to furnish the ether compound (109 mg, 45%). The resulting product (0.060 g, 0.122 mmol) was subjected to ester hydrolysis according to the general procedure for ester hydrolysis and <i>N</i>-Boc deprotection. The crude product was purified by column chromatography, eluting with 1.5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>, to furnish carboxylic acid <b>12</b> (50.0 mg, 86%) as a white solid. <sup>1</sup>H NMR (400 MHz, acetone-<i>d</i><sub>6</sub>): δ (ppm) 7.92 (4H, m, ArH-3, ArH-5 and benzoate C-2), 7.76 (1H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 7.38 (1H, m, pyrrole H-2), 6.92 (2H, d, <i>J</i> = 8.8 Hz, benzoate H-3), 6.88 (1H, m, pyrrole H-5), 6.56 (1H, m, pyrrole H-4), 5.04 (2H, s, C<i>H</i><sub>2</sub>O), 3.78 (3H, s, NC<i>H</i><sub>3</sub>); <sup>13</sup>C NMR (100 MHz, acetone-<i>d</i><sub>6</sub>): δ (ppm) 167.3 (C-5), 167.1 (<i>C</i>O<sub>2</sub>H), 163.1 (benzoate C-4), 159.7 (C-3), 137.1 (ArC-2), 134.3 (ArC-3), 132.7 (q, <i>J</i> = 30.4 Hz, ArC-6), 132.5 (ArC-4), 132.4 (benzoate C-2), 127.9 (ArC-1), 126.1 (q, <i>J</i> = 5.1 Hz, ArC-5), 124.8 (pyrrole C-5), 124.1 (benzoate C-1), 123.3 (pyrrole C-2), 122.7 (q, <i>J</i> = 274.0 Hz, <i>C</i>F<sub>3</sub>), 115.1 (benzoate C-3), 111.6 (pyrrole C-3), 108.2 (C-4), 107.8 (pyrrole C-4), 60.8 (<i>C</i>H<sub>2</sub>O), 36.7 (N<i>C</i>H<sub>3</sub>). LC–MS (ESI): calcd for C<sub>23</sub>H<sub>16</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 477.08; observed, 477.33 (<i>R</i><sub>t</sub> = 5.06 min). HRMS (ESI): calcd for C<sub>23</sub>H<sub>16</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 477.0829; observed, 477.0813.</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39">4.2.17.  4-((3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(5-methyl-1<i>H</i>-pyrrol-3-yl)isoxazol-4-yl)methoxy) Benzoic Acid (<b>13</b>)</h4><div class="NLM_p last">According to the general procedure for Mitsunobu coupling, alcohol <b>33</b> (0.175 g, 0.383 mmol) was reacted with methyl 4-hydroxybenzoate (0.064 g, 0.421 mmol). The crude product was purified by column chromatography, eluting with a gradient of 10–40% EtOAc in <i>n</i>-heptane, to furnish the ether compound (100 mg, 44%). The resulting product (0.030 g, 0.051 mmol) was subjected to ester hydrolysis with a concomitant loss of the Boc protecting group according to the general procedure for ester hydrolysis and <i>N</i>-Boc deprotection. The crude product was purified via preparative HPLC (gradient of 65–70% acetonitrile in H<sub>2</sub>O) to furnish carboxylic acid <b>13</b> (20.0 mg, 83%) as a white solid. <sup>1</sup>H NMR (400 MHz, acetone-<i>d</i><sub>6</sub>): δ (ppm) 10.47 (1H, br s, CO<sub>2</sub><i>H</i>), 7.90 (4H, m, ArH-3, ArH-5 and benzoate C-2), 7.77 (1H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 7.29 (1H, m, pyrrole H-2), 6.93 (2H, d, <i>J</i> = 8.5 Hz, benzoate H-3), 6.44 (1H, m, pyrrole H-4), 5.02 (2H, s, C<i>H</i><sub>2</sub>O), 2.29 (3H, s, NCC<i>H</i><sub>3</sub>); <sup>13</sup>C NMR (100 MHz, acetone-<i>d</i><sub>6</sub>): δ (ppm) 167.7 (C-5), 167.3 (benzoate C-4), 163.1 (<i>C</i>O<sub>2</sub>H), 159.7 (C-3), 137.2 (ArC-2), 134.4 (ArC-3), 132.7 (q, <i>J</i> = 30.4 Hz, ArC-6), 132.5 (benzoate C-2), 132.4 (ArC-4), 130.7 (pyrrole C-5), 128.0 (ArC-1), 126.1 (q, <i>J</i> = 5.0 Hz, ArC-5), 124.2 (benzoate C-1), 122.7 (q, <i>J</i> = 274.3 Hz, <i>C</i>F<sub>3</sub>), 119.7 (pyrrole C-2), 115.1 (benzoate C-3), 111.7 (pyrrole C-3), 108.0 (C-4), 105.2 (pyrrole C-4), 60.8 (<i>C</i>H<sub>2</sub>O), 12.6 (NC<i>C</i>H<sub>3</sub>). LC–MS (ESI): calcd for C<sub>23</sub>H<sub>16</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 477.08; observed, 477.25 (<i>R</i><sub>t</sub> = 4.88 min). HRMS (ESI): calcd for C<sub>23</sub>H<sub>16</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 477.0829; observed, 477.0830.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40">4.2.18.  Methyl 5-Bromo-3-(2-chloro-6-(trifluoromethyl)phenyl)isoxazole-4-carboxylate (<b>15</b>)</h4><div class="NLM_p last">According to the general procedure for Suzuki coupling, bromide <b>14</b> (0.900 g, 2.34 mmol) was reacted with <i>tert</i>-butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrole-1-carboxylate (1.37 g, 4.68 mmol). The crude product was purified by flash column chromatography, eluting with a gradient of 5–10% EtOAc in <i>n</i>-heptane, to furnish <b>15</b> (0.553 g, 50%) as colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 8.44 (1H, app. t, <i>J</i> = 2.0 Hz, pyrrole H-2), 7.76–7.65 (2H, m, ArH-3 and ArH-5), 7.55 (1H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 7.36 (1H, dd, <i>J</i> = 3.4, 2.2 Hz, pyrrole H-5), 6.99 (1H, dd, <i>J</i> = 3.4, 1.6 Hz, pyrrole H-4), 3.61 (3H, s, CO<sub>2</sub>C<i>H</i><sub>3</sub>), 1.64 (9H, s, C(C<i>H</i><sub>3</sub>)<sub>3</sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ (ppm) 168.9 (C-5), 161.5 (<i>C</i>O<sub>2</sub>CH<sub>3</sub>), 158.9 (C-3), 148.1 (N<i>C</i>O<sub>2</sub>), 136.2 (ArC-2), 132.7 (ArC-3), 131.4 (q, <i>J</i> = 31.4 Hz, ArC-6), 130.5 (ArC-4), 127.7 (ArC-1), 124.6 (q, <i>J</i> = 5.0 Hz, ArC-5), 124.1 (pyrrole C-2), 121.6 (q, <i>J</i> = 274.4 Hz, <i>C</i>F<sub>3</sub>), 120.9 (pyrrole C-5), 113.7 (pyrrole C-3), 111.5 (pyrrole C-4), 107.1 (C-4), 85.1 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 51.6 (CO<sub>2</sub><i>C</i>H<sub>3</sub>), 27.9 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>). LC–MS (ESI): calcd for C<sub>21</sub>H<sub>18</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 471.09; observed, 470.92 (<i>R</i><sub>t</sub> = 6.04 min).</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41">4.2.19.  <i>tert</i>-Butyl 3-(3-(2-Chloro-6-(trifluoromethyl)phenyl)-4-(hydroxymethyl)isoxazol-5-yl)-1<i>H</i>-pyrrole-1-carboxylate (<b>16</b>)</h4><div class="NLM_p last">Ester <b>15</b> (0.100 g, 0.212 mmol) was treated according to the general procedure for the reduction of esters to alcohols. The crude product was purified by flash column chromatography, eluting with a gradient of 10–20% EtOAc in <i>n</i>-heptane, to furnish alcohol <b>16</b> (0.075 g, 80%) as colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 7.88 (1H, s, pyrrole H-2), 7.78–7.68 (2H, m, ArH-3 and ArH-5), 7.57 (1H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 7.37–7.33 (1H, m, pyrrole H-5), 6.79–6.73 (1H, m, pyrrole H-4), 4.42 (2H, br s, C<i>H</i><sub>2</sub>OH), 1.63 (9H, s, C(C<i>H</i><sub>3</sub>)<sub>3</sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ (ppm) 164.6 (C-5), 158.7 (C-3), 148.2 (N<i>C</i>O<sub>2</sub>), 136.5 (ArC-2), 133.1 (ArC-3), 132.2 (q, <i>J</i> = 31.2 Hz, ArC-6), 131.0 (ArC-4), 126.7 (ArC-1), 124.9 (q, <i>J</i> = 5.1 Hz, ArC-5), 121.5 (q, <i>J</i> = 274.5 Hz, <i>C</i>F<sub>3</sub>), 121.4 (pyrrole C-5), 120.0 (pyrrole C-2), 114.5 (pyrrole C-3), 113.1 (C-4), 110.3 (pyrrole C-4), 84.9 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 53.8 (<i>C</i>H<sub>2</sub>OH), 27.9 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>). LC–MS (ESI): calcd for C<sub>20</sub>H<sub>18</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 443.09; observed, 443.08 (<i>R</i><sub>t</sub> = 7.23 min).</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42">4.2.20.  <i>tert</i>-Butyl 3-(3-(2-Chloro-6-(trifluoromethyl)phenyl)-4-(((4-(methoxycarbonyl) phenyl)amino)methyl)isoxazol-5-yl)-1<i>H</i>-pyrrole-1-carboxylate (<b>17</b>)</h4><div class="NLM_p last">According to the general procedure for mesylation and substitution, alcohol <b>16</b> (0.072 g, 0.163 mmol) was mesylated and reacted with methyl 4-aminobenzoate (0.122 g, 0.805 mmol) <i>in situ</i>. The crude product was purified by column chromatography, eluting with a gradient of 5–20% EtOAc in <i>n</i>-heptane, to furnish <b>17</b> (32.2 mg, 36%) as colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.83 (2H, d, <i>J</i> = 8.2 Hz, benzoate H-2), 7.69 (3H, m, ArH-3, ArH-5 and pyrrole H-2), 7.53 (1 H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 7.34 (1H, m, pyrrole H-5), 6.65 (1H, m, pyrrole H-4), 6.51 (2H, d, <i>J</i> = 8.6 Hz, benzoate H-3), 4.09 (2H, m, C<i>H</i><sub>2</sub>NH), 4.06 (1H, m, CH<sub>2</sub>N<i>H</i>), 3.84 (3H, s, OC<i>H</i><sub>3</sub>), 1.52 (9H, s, (C(C<i>H</i><sub>3</sub>)<sub>3</sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ (ppm) 167.1 (<i>C</i>OOCH<sub>3</sub>), 164.3 (C-5), 159.1 (C-3), 150.9 (benzoate C-4), 148.0 (N<i>C</i>O<sub>2</sub>), 136.5 (ArC-2), 133.2 (ArC-3), 132.1 (q, <i>J</i> = 31.2 Hz, ArC-6), 131.5 (benzoate C-2), 131.2 (ArC-4), 126.4 (ArC-1), 125.0 (q, <i>J</i> = 5.0 Hz, ArC-5), 121.6 (pyrrole C-5), 121.5 (q, <i>J</i> = 274.5 Hz, <i>C</i>F<sub>3</sub>), 119.7 (pyrrole C-2), 119.2 (benzoate C-1), 114.2 (pyrrole C-3), 110.3 (C-4), 111.5 (benzoate C-3), 109.9 (pyrrole C-4), 85.0 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 51.6 (O<i>C</i>H<sub>3</sub>), 36.5 (<i>C</i>H<sub>2</sub>NH), 27.8 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>). LC–MS (ESI): calcd for C<sub>28</sub>H<sub>25</sub>ClF<sub>3</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 576.14; observed, 576.08 (<i>R</i><sub>t</sub> = 8.23 min).</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43">4.2.21.  <i>tert</i>-Butyl 3-(3-(2-Chloro-6-(trifluoromethyl)phenyl)-4-(((4-(methoxycarbonyl) phenyl) (methyl)amino)methyl)isoxazol-5-yl)-1<i>H</i>-pyrrole-1-carboxylate (<b>18</b>)</h4><div class="NLM_p last">According to the general procedure for mesylation and substitution, alcohol <b>16</b> (0.120 g, 0.271 mmol) was mesylated and reacted with methyl 4-(methylamino)benzoate (0.190 g, 1.15 mmol) <i>in situ</i>. The crude product was purified by column chromatography, eluting with a gradient of 5–20% EtOAc in <i>n</i>-heptane, to furnish <b>18</b> (70.3 mg, 52%) as colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.70 (3H, m, benzoate H-2 and pyrrole H-2), 7.60 (1H, d, <i>J</i> = 7.8 Hz, ArH-5), 7.50 (1 H, d, <i>J</i> = 8.0 Hz, ArH-3), 7.41 (1H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 7.38 (1H, m, pyrrole H-4), 6.68 (1H, m, pyrrole H-5), 6.39 (2H, d, <i>J</i> = 8.8 Hz, benzoate H-3), 4.42 (2H, m, C<i>H</i><sub>2</sub>NCH<sub>3</sub>), 3.84 (3H, s, OC<i>H</i><sub>3</sub>), 2.66 (3H, s, CH<sub>2</sub>NC<i>H</i><sub>3</sub>), 1.52 (9H, s, (C(C<i>H</i><sub>3</sub>)<sub>3</sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ (ppm) 167.2 (<i>C</i>OOCH<sub>3</sub>), 163.3 (C-5), 159.0 (C-3), 152.2 (benzoate C-4), 148.1 (N<i>C</i>O<sub>2</sub>), 136.7 (ArC-2), 133.0 (ArC-3), 131.7 (q, <i>J</i> = 31.2 Hz, ArC-6), 131.0 (benzoate C-2), 130.8 (ArC-4), 126.9 (ArC-1), 124.9 (q, <i>J</i> = 5.0 Hz, ArC-5), 121.6 (q, <i>J</i> = 274.5 Hz, <i>C</i>F<sub>3</sub>), 121.5 (pyrrole C-5), 119.5 (pyrrole C-2), 117.8 (benzoate C-1), 114.3 (pyrrole C-3), 111.5 (C-4), 110.9 (benzoate C-3), 110.2 (pyrrole C-4), 85.1 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 51.5 (O<i>C</i>H<sub>3</sub>), 44.2 (<i>C</i>H<sub>2</sub>NCH<sub>3</sub>), 36.8 (CH<sub>2</sub>N<i>C</i>H<sub>3</sub>), 27.9 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>). LC–MS (ESI): calcd for C<sub>29</sub>H<sub>27</sub>ClF<sub>3</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 590.16; observed, 590.00 (<i>R</i><sub>t</sub> = 8.64 min).</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44">4.2.22.  Methyl 4-(((3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(1<i>H</i>-pyrrol-3-yl)isoxazol-4-yl) methyl)amino)-2-fluorobenzoate (<b>19</b>)</h4><div class="NLM_p last">Alcohol compound <b>16</b> (0.256 g, 0.580 mmol) was dissolved in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (8 mL). To this was added Dess–Martin periodinane (0.369 mg, 0.870 mmol), and the reaction mixture was stirred at room temperature for 3 h. The reaction mixture was quenched by the addition of 10% aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The combined organic phase was washed with saturated aqueous NaHCO<sub>3</sub> and H<sub>2</sub>O, dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The crude product was purified by column chromatography, eluting with a gradient of 20–30% EtOAc in <i>n</i>-heptane, to furnish the aldehyde (112.0 mg, 44%). Methyl 4-amino-2-fluorobenzoate (0.052 g, 0.310 mmol) was added to a solution of the aldehyde (0.112 g, 0.250 mmol) and AcOH (1.43 μL, 0.025 mmol) in MeOH (2 mL). The reaction mixture was heated at the reflux for 24 h and then concentrated <i>in vacuo</i>. The intermediate imine was isolated by flash column chromatography, eluting with a gradient of 10–30% EtOAc in <i>n</i>-heptane (62.3 mg, 42%), and then dissolved in EtOH (1 mL), cooled to 0 °C (ice), and treated with NaBH<sub>4</sub> (0.020 mg, 0.526 mmol). The reaction mixture was stirred at 86 °C for 4 h. The solvent was removed <i>in vacuo</i>, and the mixture was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and washed with water. The aqueous phase was further extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×), dried (MgSO<sub>4</sub>), filtered, and concentrated <i>in vacuo</i>. The crude product was purified by flash column chromatography, eluting with a gradient of 30–40% EtOAc in <i>n</i>-heptane, to furnish compound <b>19</b> (10.5 mg, 17%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.4 (1H, s, pyrrole-N<i>H</i>), 7.89 (1H, d, <i>J</i> = 8.0 Hz, ArH-5), 7.84 (1H, d, <i>J</i> = 7.5 Hz, ArH-3), 7.72 (1H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 7.47 (1H, app. t, <i>J</i> = 8.7 Hz, benzoate H-2), 7.40 (1H, m, pyrrole H-2), 6.99 (1H, m, pyrrole H-5), 6.76 (1H, app. t, <i>J</i> = 4.6 Hz, CH<sub>2</sub>N<i>H</i>), 6.55 (1H, m, pyrrole H-4), 6.25 (1H, dd, <i>J</i> = 8.9, 1.9 Hz, benzoate H-3<sub>a</sub>), 6.10 (1H, d, <i>J</i> = 14.6 Hz, benzoate H-3<sub>b</sub>), 4.17 (2H, m, C<i>H</i><sub>2</sub>NH). LC–MS (ESI): calcd for C<sub>23</sub>H<sub>16</sub>ClF<sub>4</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 494.08; observed, 494.25 (<i>R</i><sub>t</sub> = 7.14 min).</div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45">4.2.23.  <i>tert</i>-Butyl 3-(3-(2-Chloro-6-(trifluoromethyl)phenyl)-4-((4-(methoxycarbonyl) phenoxy)methyl)isoxazol-5-yl)-1<i>H</i>-pyrrole-1-carboxylate (<b>20</b>)</h4><div class="NLM_p last">According to the general procedure for Mitsunobu coupling, alcohol <b>16</b> (0.023 g, 0.053 mmol) was reacted with methyl 4-hydroxybenzoate (0.010 g, 0.058 mmol). The crude product was purified by column chromatography, eluting with a gradient of 5–25% EtOAc in <i>n</i>-heptane, to furnish <b>20</b> (16.6 mg, 55%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.92 (2H, d, <i>J</i> = 8.9 Hz, benzoate H-2), 7.71 (3H, m, ArH-3, ArH-5 and pyrrole H-2), 7.56 (1 H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 7.35 (1H, m, pyrrole H-5), 6.82 (2H, d, <i>J</i> = 8.9 Hz, benzoate H-3), 6.66 (1H, m, pyrrole H-4), 4.83 (2H, s, C<i>H</i><sub>2</sub>O), 3.87 (3H, s, OC<i>H</i><sub>3</sub>), 1.55 (9H, s, (C(C<i>H</i><sub>3</sub>)<sub>3</sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ (ppm) 166.7 (<i>C</i>OOCH<sub>3</sub>), 165.1 (C-5), 161.8 (benzoate C-4), 158.9 (C-3), 148.1 (N<i>C</i>O<sub>2</sub>), 136.7 (ArC-2), 133.1 (ArC-3), 132.3 (q, <i>J</i> = 31.2 Hz, ArC-6), 131.6 (benzoate C-2), 131.1 (ArC-4), 126.4 (ArC-1), 124.9 (q, <i>J</i> = 5.0 Hz, ArC-5), 123.2 (benzoate C-1), 121.6 (pyrrole C-5), 121.4 (q, <i>J</i> = 274.5 Hz, <i>C</i>F<sub>3</sub>), 120.0 (pyrrole C-2), 114.2 (pyrrole C-3), 114.1 (benzoate C-3), 110.2 (pyrrole C-4), 109.3 (C-4), 85.0 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 59.4 (<i>C</i>H<sub>2</sub>O), 51.9 (O<i>C</i>H<sub>3</sub>), 27.8 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>). LC–MS (ESI): calcd for C<sub>28</sub>H<sub>24</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 577.13; observed, 577.17 (<i>R</i><sub>t</sub> = 8.57 min).</div></div><div id="sec4_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46">4.2.24.  <i>tert</i>-Butyl 3-(3-(2-Chloro-6-(trifluoromethyl)phenyl)-4-((3-fluoro-4-(methoxy carbonyl)phenoxy)methyl)isoxazol-5-yl)-1<i>H</i>-pyrrole-1-carboxylate (<b>21</b>)</h4><div class="NLM_p last">According to the general procedure for Mitsunobu coupling, alcohol <b>16</b> (0.050 g, 0.113 mmol) was reacted with methyl 2-fluoro-4-hydroxybenzoate (0.021 g, 0.124 mmol). The crude product was purified by column chromatography, eluting with a gradient of 5–25% EtOAc in <i>n</i>-heptane, to furnish <b>21</b> (17.0 mg, 25%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.85 (1H, app. t, <i>J</i> = 8.6 Hz, benzoate H-2), 7.73 (3H, m, ArH-3, ArH-5 and pyrrole H-2), 7.57 (1 H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 7.36 (1H, m, pyrrole H-5), 6.65 (2H, m, pyrrole H-4 and benzoate H-3<sub>a</sub>), 6.52 (1H, dd, <i>J</i> = 12.4, 2.3 Hz, benzoate H-3<sub>b</sub>), 4.82 (2H, s, C<i>H</i><sub>2</sub>O), 3.89 (3H, s, OC<i>H</i><sub>3</sub>), 1.57 (9H, s, (C(C<i>H</i><sub>3</sub>)<sub>3</sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ (ppm) 165.2 (C-5), 164.5 (<i>C</i>OOCH<sub>3</sub>), 162.9 (benzoate <i>C</i>–F), 161.9 (benzoate C-4), 158.9 (C-3), 148.0 (N<i>C</i>O<sub>2</sub>), 136.7 (ArC-2), 133.6 (benzoate C-2), 133.2 (ArC-3), 132.3 (q, <i>J</i> = 31.2 Hz, ArC-6), 131.2 (ArC-4), 126.2 (ArC-1), 125.0 (q, <i>J</i> = 5.0 Hz, ArC-5), 121.7 (pyrrole C-5), 121.4 (q, <i>J</i> = 274.5 Hz, <i>C</i>F<sub>3</sub>), 120.0 (pyrrole C-2), 114.1 (pyrrole C-3), 111.6 (benzoate C-3<sub>a</sub>), 110.4 (benzoate C-1), 110.2 (pyrrole C-4), 108.8 (C-4), 103.1 (benzoate C-3<sub>b</sub>), 85.1 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 59.9 (<i>C</i>H<sub>2</sub>O), 52.0 (O<i>C</i>H<sub>3</sub>), 27.8 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>). LC–MS (ESI): calcd for C<sub>28</sub>H<sub>23</sub>ClF<sub>4</sub>N<sub>2</sub>O<sub>6</sub> [M + H]<sup>+</sup>, 595.12; observed, 595.00 (<i>R</i><sub>t</sub> = 6.14 min).</div></div><div id="sec4_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47">4.2.25.  <i>tert</i>-Butyl 3-(3-(2-Chloro-6-(trifluoromethyl)phenyl)-4-(((4-(methoxycarbonyl) phenyl)thio)methyl)isoxazol-5-yl)-1<i>H</i>-pyrrole-1-carboxylate (<b>22</b>)</h4><div class="NLM_p last">According to the general procedure for Mitsunobu coupling, alcohol <b>16</b> (0.055 g, 0.124 mmol) was reacted with methyl 4-mercaptobenzoate (0.024 g, 0.137 mmol). The crude product was purified by column chromatography, eluting with a gradient of 0–20% EtOAc in <i>n</i>-heptane, to furnish <b>21</b> (20.0 mg, 27%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.84 (2H, d, <i>J</i> = 8.5 Hz, benzoate H-2), 7.72 (3H, m, ArH-3, ArH-5 and pyrrole H-2), 7.57 (1 H, app. t, <i>J</i> = 8.5 Hz, ArH-4), 7.34 (1H, m, pyrrole H-5), 7.18 (2H, d, <i>J</i> = 8.9 Hz, benzoate H-3), 6.68 (1H, m, pyrrole H-4), 4.01 (2H, s, C<i>H</i><sub>2</sub>O), 3.89 (3H, s, OC<i>H</i><sub>3</sub>), 1.58 (9H, s, (C(C<i>H</i><sub>3</sub>)<sub>3</sub>). LC–MS (ESI): calcd for C<sub>28</sub>H<sub>24</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>5</sub>S [M + H]<sup>+</sup>, 593.10; observed, 592.92 (<i>R</i><sub>t</sub> = 6.28 min).</div></div><div id="sec4_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48">4.2.26.  <i>tert</i>-Butyl 3-(3-(2-Chloro-6-(trifluoromethyl)phenyl)-4-formylisoxazol-5-yl)-1<i>H</i>-pyrrole-1-carboxylate (<b>23</b>)</h4><div class="NLM_p last">Alcohol compound <b>16</b> (0.150 g, 0.407 mmol) was dissolved in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (5 mL). To this was added Dess–Martin periodinane (0.216 mg, 0.610 mmol), and the reaction mixture was stirred at room temperature for 3 h. The reaction mixture was quenched by the addition of 10% aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The combined organic phase was washed with saturated aqueous NaHCO<sub>3</sub> and H<sub>2</sub>O, dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The crude product was purified by column chromatography, eluting with a gradient of 15–30% EtOAc in <i>n</i>-heptane, to furnish <b>21</b> (150 mg, 100%) as colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 9.67 (1H, s, C<i>H</i>O), 8.54 (1H, s, pyrrole H-2), 7.81–7.73 (2H, m, ArH-3 and ArH-5), 7.63 (1H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 7.43–7.38 (1H, m, pyrrole H-5), 6.97–6.92 (1H, m, pyrrole H-4), 1.66 (9H, s, C(C<i>H</i><sub>3</sub>)<sub>3</sub>). LC–MS (ESI): calcd for C<sub>20</sub>H<sub>16</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 441.08; observed, 440.92 (<i>R</i><sub>t</sub> = 5.87 min).</div></div><div id="sec4_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49">4.2.27.  <i>tert</i>-Butyl (<i>E</i>) or (<i>Z</i>)-3-(3-(2-Chloro-6-(trifluoromethyl)phenyl)-4-(4-(methoxy carbonyl)styryl)isoxazol-5-yl)-1<i>H</i>-pyrrole-1-carboxylate (<b>24</b> and <b>25</b>)</h4><div class="NLM_p">Under an inert atmosphere, triphenylphosphine (0.890 g, 3.39 mmol) and methyl 4-(bromomethyl)benzoate (0.519 g, 2.27 mmol) were dissolved in acetonitrile (20 mL). The reaction mixture was stirred at 82 °C for 3 h, when TLC indicated the full conversion of the starting material. The reaction mixture was cooled to room temperature and precipitated in toluene (150 mL). The solid was filtered, collected, and dried under reduced pressure to yield (4-(methoxycarbonyl)benzyl) triphenylphosphonium as a crystalline white solid (930 mg, 100%). The resulting product (0.152 g, 0.369 mmol) was dissolved in anhydrous THF (2 mL) under an inert atmosphere. The solution was cooled to −78 °C, LiHMDS (0.4 mL, 1 M in hexane) was added and the solution was stirred at −78 °C for 2 h. Aldehyde <b>23</b> (0.125 g, 0.284 mmol), dissolved in anhydrous THF (2 mL), was added dropwise. The reaction mixture was slowly warmed to room temperature and stirred for 24 h. The reaction was quenched with H<sub>2</sub>O (10 mL) and extracted with EtOAc (3×). The combined organic phase was washed with H<sub>2</sub>O and brine, dried over MgSO<sub>4</sub>, filtrated, and concentrated <i>in vacuo</i>. The crude product was purified by column chromatography, eluting with a gradient of 5–20% EtOAc in <i>n</i>-heptane, to furnish a mixture of cis/trans isomers (3:1) (70 mg). The mixture of cis/trans isomers was separated via preparative HPLC (gradient of 80–100% acetonitrile in H<sub>2</sub>O) to furnish <b>24</b> (trans isomer, 12.0 mg, 7%) and <b>25</b> (cis isomer, 44.0 mg, 27%), both as white solids. Trans isomer (<b>24</b>): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.92 (2H, d, <i>J</i> = 7.9 Hz, benzoate H-2), 7.80 (3H, m, ArH-3, ArH-5 and pyrrole H-2), 7.63 (1 H, app. t, <i>J</i> = 7.8 Hz, ArH-4), 7.39 (1H, m, pyrrole H-5), 7.24 (2H, d, <i>J</i> = 7.9 Hz, benzoate H-3), 7.03 (1H, d, <i>J</i> = 16.5 Hz, C4-<i>H</i>C═CH), 6.73 (1H, m, pyrrole H-4), 6.17 (1H, d, <i>J</i> = 16.4 Hz, benzoate C4-<i>H</i>C═CH), 3.90 (3H, s, OC<i>H</i><sub>3</sub>), 1.64 (9H, s, (C(C<i>H</i><sub>3</sub>)<sub>3</sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ (ppm) 166.7 (<i>C</i>OOCH<sub>3</sub>), 162.7 (C-5), 157.1 (C-3), 148.1 (N<i>C</i>O<sub>2</sub>), 141.3 (benzoate C-4), 136.7 (ArC-2), 133.2 (ArC-3), 132.2 (q, <i>J</i> = 31.5 Hz, ArC-6), 131.1 (ArC-4), 129.9 (benzoate C-2), 129.8 (benzoate C4-H<i>C</i>═CH), 129.2 (benzoate C-1), 127.6 (ArC-1), 126.0 (benzoate C-3), 125.1 (q, <i>J</i> = 5.0 Hz, ArC-5), 121.5 (pyrrole C-5), 121.4 (q, <i>J</i> = 274.5 Hz, <i>C</i>F<sub>3</sub>), 119.7 (pyrrole C-2), 118.0 (C4-H<i>C</i>═CH), 114.6 (pyrrole C-3), 112.6 (C-4), 110.4 (pyrrole C-4), 85.1 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 52.1 (O<i>C</i>H<sub>3</sub>), 27.9 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>). LC–MS (ESI): calcd for C<sub>29</sub>H<sub>24</sub>ClF<sub>3</sub>IN<sub>2</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 573.13; observed, 573.00 (<i>R</i><sub>t</sub> = 6.44 min).</div><div class="NLM_p last">Cis isomer (<b>25</b>): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.77 (2H, d, <i>J</i> = 8.0 Hz, benzoate H-2), 7.68 (2H, m, ArH-3 and ArH-5), 7.53 (1 H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 7.38 (1H, br s, pyrrole H-2), 7.28 (2H, d, <i>J</i> = 8.0 Hz, benzoate H-3), 7.08 (1H, br s, pyrrole H-5), 6.62 (1H, d, <i>J</i> = 12.1 Hz, C4-<i>H</i>C═CH), 6.50 (1H, br s, pyrrole H-4), 6.18 (1H, d, <i>J</i> = 12.1 Hz, benzoate C4-<i>H</i>C═CH), 3.87 (3H, s, OC<i>H</i><sub>3</sub>), 1.57 (9H, s, (C(C<i>H</i><sub>3</sub>)<sub>3</sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ (ppm) 166.7 (<i>C</i>OOCH<sub>3</sub>), 161.3 (C-5), 159.0 (C-3), 148.1 (N<i>C</i>O<sub>2</sub>), 140.8 (benzoate C-4), 136.6 (ArC-2), 133.9 (C4-H<i>C</i>═CH), 133.1 (ArC-3), 132.0 (q, <i>J</i> = 31.5 Hz, ArC-6), 130.8 (ArC-4), 129.5 (benzoate C-2), 129.1 (benzoate C-1), 128.2 (benzoate C-3), 126.8 (ArC-1), 124.9 (q, <i>J</i> = 5.0 Hz, ArC-5), 121.5 (q, <i>J</i> = 274.5 Hz, <i>C</i>F<sub>3</sub>), 120.6 (pyrrole C-5), 119.7 (pyrrole C-2), 118.2 (benzoate C4-H<i>C</i>═CH), 114.6 (pyrrole C-3), 110.8 (C-4), 110.0 (pyrrole C-4), 84.7 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 52.1 (O<i>C</i>H<sub>3</sub>), 27.9 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>). LC–MS (ESI): calcd for C<sub>29</sub>H<sub>24</sub>ClF<sub>3</sub>IN<sub>2</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 573.13; observed, 573.00 (<i>R</i><sub>t</sub> = 6.26 min).</div></div><div id="sec4_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50">4.2.28.  Methyl 3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(1<i>H</i>-pyrrol-2-yl)isoxazole-4-carboxylate (<b>26</b>)</h4><div class="NLM_p last">According to the general procedure for Suzuki coupling, bromide <b>14</b> (0.500 g, 1.30 mmol) was coupled to <i>tert</i>-butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrole-1-carboxylate (0.762 g, 2.60 mmol). The crude product was purified by flash column chromatography, eluting with a gradient of 5–10% EtOAc in <i>n</i>-heptane, to furnish <b>26</b> (0.298 g, 49%) as colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 7.77–7.67 (2H, m, ArH-3 and ArH-5), 7.60–7.55 (2H, m, ArH-4 and pyrrole H-5), 6.88 (1H, dd, <i>J</i> = 3.6, 1.7 Hz, pyrrole H-3), 6.36 (1H, app. t, <i>J</i> = 3.4 Hz, pyrrole H-4), 3.57 (3H, s, CO<sub>2</sub>C<i>H</i><sub>3</sub>), 1.52 (9H, s, C(C<i>H</i><sub>3</sub>)<sub>3</sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ (ppm) 166.7 (C-5), 161.1 (<i>C</i>O<sub>2</sub>CH<sub>3</sub>), 158.4 (C-3), 148.3 (N<i>C</i>O<sub>2</sub>), 136.3 (ArC-2), 132.8 (ArC-3), 131.5 (q, <i>J</i> = 31.4 Hz, ArC-6), 130.7 (ArC-4), 127.1 (ArC-1), 126.2 (pyrrole C-5), 124.6 (q, <i>J</i> = 5.0 Hz, ArC-5), 121.6 (q, <i>J</i> = 274.4 Hz, <i>C</i>F<sub>3</sub>), 121.2 (pyrrole C-3), 118.5 (pyrrole C-2), 111.1 (pyrrole C-4), 110.2 (C-4), 85.3 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 51.7 (CO<sub>2</sub><i>C</i>H<sub>3</sub>), 27.7 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>). LC–MS (ESI): calcd for C<sub>21</sub>H<sub>18</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 471.09; observed, 470.92 (<i>R</i><sub>t</sub> = 5.73 min).</div></div><div id="sec4_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51">4.2.29.  Methyl 3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(1<i>H</i>-pyrazol-4-yl)isoxazole-4-carboxylate (<b>27</b>)</h4><div class="NLM_p last">According to the general procedure for Suzuki coupling, bromide <b>14</b> (0.500 g, 1.30 mmol) was reacted with <i>tert</i>-butyl 1-(3,4-dihydro-2<i>H</i>-pyran-6-yl)-4-(4,4,5-trimethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (0.723 g, 2.60 mmol). The crude product was purified by flash column chromatography, eluting with a gradient of 5–10% EtOAc in <i>n</i>-heptane, to furnish <b>27</b> (0.203 g, 34%) as colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 8.78 (1H, s, pyrazole H-5), 8.34 (1H, s, pyrazole H-3), 7.75–7.67 (2H, app. t, <i>J</i> = 9.2 Hz, ArH-3 and ArH-5), 7.56 (1H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 5.51–5.46 (1H, m, NC<i>H</i>CO), 4.14–4.04 (1H, m, THP-H), 3.78–3.72 (1H, m, THP-H), 3.60 (3H, s, CO<sub>2</sub>C<i>H</i><sub>3</sub>), 2.20–2.12 (2H, m, THP-H), 1.75–1.62 (4H, m, THP-H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ (ppm) 167.8 (C-5), 161.6 (<i>C</i>O<sub>2</sub>CH<sub>3</sub>), 158.6 (C-3), 139.7 (pyrazole C-3), 136.2 (ArC-2), 132.7 (ArC-3), 131.4 (q, <i>J</i> = 31.3 Hz, ArC-6), 130.6 (ArC-4), 130.6 (pyrazole C-5), 127.5 (ArC-1), 124.6 (q, <i>J</i> = 4.9 Hz, ArC-5), 121.6 (q, <i>J</i> = 274.4 Hz, <i>C</i>F<sub>3</sub>), 109.6 (pyrazole C-4), 106.8 (C-4), 88.0 (N<i>C</i>HCO), 67.8 (THP-C), 51.7 (CO<sub>2</sub><i>C</i>H<sub>3</sub>), 30.6 (THP-C), 24.8 (THP-C), 20.1 (THP-C). LC–MS (ESI): calcd for C<sub>20</sub>H<sub>17</sub>ClF<sub>3</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 456.09; observed, 456.08 (<i>R</i><sub>t</sub> = 5.37 min).</div></div><div id="sec4_2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52">4.2.30.  Methyl 3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(1-methyl-1<i>H</i>-pyrrol-3-yl)isoxazole-4-carboxylate (<b>28</b>)</h4><div class="NLM_p last">Under an inert atmosphere 1-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrole (0.404 g, 1.95 mmol), Na<sub>2</sub>CO<sub>3</sub> (0.276 g, 2.6 mmol)), and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.150 g, 0.13 mmol) were added to a solution of bromide <b>14</b> (0.500 g, 1.3 mmol) in de-gassed DME/H<sub>2</sub>O (4:1) (15 mL). The reaction mixture was heated at 85 °C for 8 h, cooled to room temperature, diluted with H<sub>2</sub>O, and extracted with EtOAc (3×). The combined organic phase was dried (MgSO<sub>4</sub>), filtered, and concentrated <i>in vacuo</i>. The crude product was purified by column chromatography, eluting with 5–15% EtOH in <i>n</i>-heptane, to furnish <b>28</b> (0.275 g, 55%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 7.97 (1H, s, pyrrole H-2), 7.75–7.64 (2H, m, ArH-3 and ArH-5), 7.52 (1H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 6.92 (1H, br s, pyrrole H-5), 6.69 (1H, br s, pyrrole H-4), 3.74 (3H, s, NC<i>H</i><sub>3</sub>), 3.56 (3H, s, CO<sub>2</sub>C<i>H</i><sub>3</sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ (ppm) 170.4 (C-5), 162.1 (<i>C</i>O<sub>2</sub>CH<sub>3</sub>), 158.6 (C-3), 136.2 (ArC-2), 132.6 (ArC-3), 131.3 (q, <i>J</i> = 31.3 Hz, ArC-6), 130.3 (ArC-4), 128.2 (ArC-1), 126.8 (pyrrole C-2), 124.5 (q, <i>J</i> = 5.0 Hz, ArC-5), 123.1 (pyrrole C-5), 121.6 (q, <i>J</i> = 274.4 Hz, <i>C</i>F<sub>3</sub>), 110.6 (pyrrole C-3), 109.4 (pyrrole C-4), 104.9 (C-4), 51.4 (CO<sub>2</sub><i>C</i>H<sub>3</sub>), 36.7 (N<i>C</i>H<sub>3</sub>). LC–MS (ESI): calcd for C<sub>17</sub>H<sub>12</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 385.05; observed, 385.17 (<i>R</i><sub>t</sub> = 5.27 min).</div></div><div id="sec4_2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53">4.2.31.  Methyl 3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(5-methyl-1<i>H</i>-pyrrol-3-yl)isoxazole-4-carboxylate (<b>29</b>)</h4><div class="NLM_p">Under an inert atmosphere, a Schlenk tube was charged with <i>tert</i>-butyl 2,4-dimethyl-1<i>H</i>-pyrrole-1-carboxylate (1.10 g, 6.05 mmol). Two separate flasks under argon were charged with [Ir(OMe)(COD)]<sub>2</sub> (0.060 g, 0.091 mmol) and dtbpy (0.049 g, 0.182 mmol). HBPin (1.16 g, 9.08 mmol) was added to the [Ir(OMe)(COD)]<sub>2</sub> containing flask. Anhydrous THF (18 mL) was added to the dtbpy-containing flask, and the solution was mixed with the [Ir(OMe)(COD)]<sub>2</sub> and HBPin mixture. The resulting solution was transferred to the Schlenk flask, and the reaction mixture was stirred at 60 °C for 6 h. Afterward, the reaction mixture was cooled to room temperature and THF was removed <i>in vacuo</i>. The crude product was purified by flash column chromatography, eluting with a gradient of 0–5% EtOAc in <i>n</i>-heptane, to furnish <i>tert</i>-butyl 2-methyl-4-(4,4,5-trimethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrrole-1-carboxylate (1.30 g, 70%).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p last">Subsequently, according to the general procedure for Suzuki coupling, bromide <b>14</b> (1.09 g, 2.82 mmol) was reacted with the synthesized pinacol boronate (1.30 g, 4.23 mmol). The crude product was purified by flash column chromatography, eluting with a gradient of 30–60% CH<sub>2</sub>Cl<sub>2</sub> in <i>n</i>-heptane, to furnish <b>29</b> (0.325 g, 24%) as colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 8.39 (1H, s, pyrrole H-2), 7.74–7.65 (2H, m, ArH-3 and ArH-5), 7.54 (1H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 6.70 (1H, s, pyrrole H-4), 3.61 (3H, s, CO<sub>2</sub>C<i>H</i><sub>3</sub>), 2.51 (3H, s, NCC<i>H</i><sub>3</sub>), 1.64 (9H, s, C(C<i>H</i><sub>3</sub>)<sub>3</sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ (ppm) 169.0 (C-5), 161.6 (<i>C</i>O<sub>2</sub>CH<sub>3</sub>), 158.9 (C-3), 148.9 (N<i>C</i>O<sub>2</sub>), 136.2 (ArC-2), 132.8 (pyrrole C-5), 132.6 (ArC-3), 131.3 (q, <i>J</i> = 31.4 Hz, ArC-6), 130.5 (ArC-4), 127.7 (ArC-1), 124.9 (pyrrole C-2), 124.5 (q, <i>J</i> = 4.9 Hz, ArC-5), 121.6 (q, <i>J</i> = 274.4 Hz, <i>C</i>F<sub>3</sub>), 111.6 (pyrrole C-3), 110.9 (pyrrole C-4), 106.9 (C-4), 84.7 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 51.6 (CO<sub>2</sub><i>C</i>H<sub>3</sub>), 28.0 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>), 15.3 (NC<i>C</i>H<sub>3</sub>). LC–MS (ESI): calcd for C<sub>22</sub>H<sub>20</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>5</sub> [M + H]<sup>+</sup>, 485.10; observed, 485.00 (<i>R</i><sub>t</sub> = 6.22 min).</div></div><div id="sec4_2_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54">4.2.32.  (3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(1<i>H</i>-pyrrol-2-yl)isoxazol-4-yl)methanol (<b>30</b>)</h4><div class="NLM_p last">Ester <b>26</b> (0.260 g, 0.552 mmol) was treated according to the general procedure for the reduction of esters to alcohols. The crude product was purified by flash column chromatography, eluting with a gradient of 10–20% EtOAc in <i>n</i>-heptane, to furnish alcohol <b>30</b> (169 mg, 69%) as colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 7.77–7.69 (2H, m, ArH-3 and ArH-5), 7.57 (1H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 7.51 (1H, dd, <i>J</i> = 3.2, 1.7 Hz, pyrrole H-5), 6.70 (1H, dd, <i>J</i> = 3.4, 1.7 Hz, pyrrole H-3), 6.34 (1H, app. t, <i>J</i> = 3.4 Hz, pyrrole H-4), 4.34 (2H, br s, C<i>H</i><sub>2</sub>OH), 1.53 (9H, s, C(C<i>H</i><sub>3</sub>)<sub>3</sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ (ppm) 161.9 (C-5), 158.6 (C-3), 148.7 (N<i>C</i>O<sub>2</sub>), 136.5 (ArC-2), 133.2 (ArC-3), 132.1 (q, <i>J</i> = 31.2 Hz, ArC-6), 131.0 (ArC-4), 126.8 (ArC-1), 125.5 (pyrrole C-5), 125.0 (q, <i>J</i> = 5.1 Hz, ArC-5), 121.5 (q, <i>J</i> = 274.5 Hz, <i>C</i>F<sub>3</sub>), 119.9 (pyrrole C-3), 118.7 (pyrrole C-2), 116.9 (C-4), 111.3 (pyrrole C-4), 85.5 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 54.1 (<i>C</i>H<sub>2</sub>OH), 27.8 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>). LC–MS (ESI): calcd for C<sub>20</sub>H<sub>18</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 443.09; observed, 443.00 (<i>R</i><sub>t</sub> = 5.27 min).</div></div><div id="sec4_2_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55">4.2.33.  (3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(1<i>H</i>-pyrazol-4-yl)isoxazol-4-yl)methanol (<b>31</b>)</h4><div class="NLM_p last">Ester <b>27</b> (0.200 g, 0.434 mmol) was treated according to the general procedure for the reduction of esters to alcohols. The crude product was purified by flash column chromatography, eluting with a gradient of 30–50% EtOAc in <i>n</i>-heptane, to furnish alcohol <b>31</b> (0.100 g, 71%) as colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 8.25 (1H, s, pyrazole H-5), 8.09 (1H, s, pyrazole H-3), 7.80–7.69 (2H, m, ArH-3 and ArH-5), 7.59 (1H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 5.47 (1H, t, <i>J</i> = 6.1 Hz, NC<i>H</i>CO), 4.41 (1H, br s, C<i>H</i><sub>2</sub>OH), 4.14–3.98 (1H, m, THP-H), 3.76–3.71 (1H, m, THP-H), 2.17–1.98 (3H, m, THP-H), 1.78–1.58 (3H, m, THP-H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ (ppm) 163.3 (C-5), 158.6 (C-3), 137.9 (pyrazole C-3), 136.5 (ArC-2), 133.2 (ArC-3), 132.2 (q, <i>J</i> = 31.2 Hz, ArC-6), 131.1 (ArC-4), 127.5 (pyrazole C-5), 126.6 (ArC-1), 125.0 (q, <i>J</i> = 5.1 Hz, ArC-5), 121.5 (q, <i>J</i> = 274.4 Hz, <i>C</i>F<sub>3</sub>), 112.8 (C-4), 110.2 (pyrazole C-4), 87.9 (N<i>C</i>HCO), 67.8 (THP-C), 53.9 (<i>C</i>H<sub>2</sub>OH), 30.7 (THP-C), 24.9 (THP-C), 22.1 (THP-C). LC–MS (ESI): calcd for C<sub>19</sub>H<sub>17</sub>ClF<sub>3</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 428.09; observed, 428.08 (<i>R</i><sub>t</sub> = 4.64 min).</div></div><div id="sec4_2_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56">4.2.34.  (3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(1-methyl-1<i>H</i>-pyrrol-3-yl)isoxazol-4-yl) Methanol (<b>32</b>)</h4><div class="NLM_p last">Under an inert atmosphere, LiAlH<sub>4</sub> (1 M in THF, 1.07 mL, 1.01 mmol) was added dropwise to a solution of ester <b>28</b> (0.275 g, 0.710 mmol) in anhydrous THF (6 mL) at 0 °C. The reaction mixture was warmed to room temperature and stirred for 2 h. The reaction mixture was quenched by the addition of saturated aqueous NH<sub>4</sub>Cl solution and stirred vigorously for 60 min. Subsequently, the mixture was extracted with EtOAc (3×). The combined organic phase was washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated <i>in vacuo</i>. The crude product was purified by flash column chromatography, eluting with a gradient of 10–20% EtOAc in <i>n</i>-heptane, to furnish alcohol <b>32</b> (0.192 g, 76%) as colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 7.76–7.68 (2H, m, ArH-3 and ArH-5), 7.56 (1H, app. t, <i>J</i> = 8.3 Hz, ArH-4), 7.30 (1H, app. t, <i>J</i> = 1.9 Hz, pyrrole H-2), 6.70 (1H, app. t, <i>J</i> = 2.5 Hz, pyrrole H-5), 6.68 (1H, app. t, <i>J</i> = 2.5 Hz, pyrrole H-4), 4.38 (2H, br s, C<i>H</i><sub>2</sub>OH), 3.73 (3H, s, NC<i>H</i><sub>3</sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ (ppm) 166.3 (C-5), 158.6 (C-3), 136.6 (ArC-2), 133.1 (ArC-3), 132.2 (q, <i>J</i> = 31.3 Hz, ArC-6), 130.9 (ArC-4), 127.1 (ArC-1), 124.9 (q, <i>J</i> = 5.0 Hz, ArC-5), 123.4 (pyrrole C-5), 122.5 (pyrrole C-2), 121.5 (q, <i>J</i> = 274.4 Hz, <i>C</i>F<sub>3</sub>), 111.3 (pyrrole C-3), 110.9 (C-4), 107.5 (pyrrole C-4), 54.2 (C<i>H</i><sub>2</sub>OH), 36.6 (N<i>C</i>H<sub>3</sub>). LC–MS (ESI): calcd for C<sub>16</sub>H<sub>12</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup>, 357.05; observed, 357.17 (<i>R</i><sub>t</sub> = 4.63 min).</div></div><div id="sec4_2_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57">4.2.35.  (3-(2-Chloro-6-(trifluoromethyl)phenyl)-5-(5-methyl-1<i>H</i>-pyrrol-3-yl)isoxazol-4-yl) Methanol (<b>33</b>)</h4><div class="NLM_p last">Ester <b>29</b> (0.400 g, 0.825 mmol) was treated according to the general procedure for the reduction of esters to alcohols. The crude product was purified by flash column chromatography, eluting with a gradient of 10–25% EtOAc in <i>n</i>-heptane, to furnish alcohol <b>33</b> (0.220 g, 58%) as colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 7.83 (1H, s, pyrrole H-2), 7.77–7.58 (2H, m, ArH-3 and ArH-5), 7.58 (1H, app. t, <i>J</i> = 8.0 Hz, ArH-4), 6.48 (1H, s, pyrrole H-4), 4.42 (2H, br s, C<i>H</i><sub>2</sub>OH), 2.50 (3H, s, NCC<i>H</i><sub>3</sub>), 1.63 (9H, s, C(C<i>H</i><sub>3</sub>)<sub>3</sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ (ppm) 164.8 (C-5), 158.7 (C-3), 149.1 (N<i>C</i>O<sub>2</sub>), 136.5 (ArC-2), 133.4 (pyrrole C-5), 133.1 (ArC-3), 132.2 (q, <i>J</i> = 31.4 Hz, ArC-6), 131.0 (ArC-4), 126.8 (ArC-1), 124.9 (q, <i>J</i> = 4.9 Hz, ArC-5), 121.5 (q, <i>J</i> = 274.4 Hz, <i>C</i>F<sub>3</sub>), 120.7 (pyrrole C-2), 112.9 (C-4), 112.3 (pyrrole C-3), 109.9 (pyrrole C-4), 84.6 (<i>C</i>(CH<sub>3</sub>)<sub>3</sub>), 53.9 (<i>C</i>H<sub>2</sub>OH), 28.0 (C(<i>C</i>H<sub>3</sub>)<sub>3</sub>), 15.4 (NC<i>C</i>H<sub>3</sub>). LC–MS (ESI): calcd for C<sub>21</sub>H<sub>20</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 457.11; observed, 456.92 (<i>R</i><sub>t</sub> = 5.53 min).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58">4.3.  Biophysical Assays</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59">4.3.1.  RORγt-LBD Expression and Purification</h4><div class="NLM_p last">His-tagged RORγt LBD was expressed and purified as described in previous studies.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60">4.3.2.  TR-FRET Coactivator Recruitment Assay</h4><div class="NLM_p last">Assays were conducted using 100 nM <i>N</i>-terminal biotinylated SRC-1 box2 coactivator peptide (Biotin-N-PSSHSSLTARHKILHRLLQEGSPSD-CONH<sub>2</sub>) and 20 nM His<sub>6</sub>-RORγt-LBD in buffer containing 10 mM HEPES (pH 7.5), 150 mM NaCl, 5 mM dithiothreitol (DTT), 0.1% bovine serum albumin (BSA) (w/v), and 0.1 mM CHAPS. A terbium-labeled anti-His antibody (CisBio Bioassays, 61HISTLA) and D2-labeled streptavidin (CisBio Bioassays, 610SADLA) were used at the concentrations recommended by the supplier. Compounds (dissolved in DMSO) were titrated using a 2× dilution series in Corning white low volume, low binding, 384-well plates at a final volume of 10 μL. The final DMSO concentration was 1% v/v throughout. The plate was directly measured and centrifuged before reading (excitation = 340 nm; emission = 665 and 620 nm) on a Tecan infinite F500 plate reader using the parameters recommended by CisBio Bioassays. The data were analyzed with GraphPad Prism 7.0 software. The dose–response curve was fitted represented by<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/medium/jm1c00475_m001.gif" alt="" id="_i61" /></img></span>where <i>y</i> is the FRET ratio ((acceptor/donor) × 1000), <i>A</i><sub>1</sub> is the bottom asymptote, <i>A</i><sub>2</sub> is the top asymptote, <i>p</i> is the Hill slope, <i>x</i> is the ligand concentration in μM, and <i>x</i><sub>0</sub> is the IC<sub>50</sub> value in μM. Where dose–response curves did not reach a bottom asymptote, this was fixed at the value of the negative control. The data were recorded in triplicate in three independent experiments (one representative data set shown). Error bars represent the SD of the mean.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62">4.3.3.  Competition TR-FRET Coactivator Recruitment Assay</h4><div class="NLM_p last">Competition assays were performed in an analogous fashion to that described above, only in the presence of fixed concentrations of cholesterol: 0 μM (DMSO), 0.25 μM, and 1.0 μM such that the final concentration of DMSO remained at 1.2% v/v.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63">4.3.4.  TR-FRET AlexaFluor-MRL-871 Recruitment Assay</h4><div class="NLM_p last">Assays were conducted using 100 nM AlexaFluor647-labeled MRL-871 and 20 nM His<sub>6</sub>-RORγt-LBD in buffer as described above. A terbium-labeled anti-His antibody (CisBio Bioassays, 61HISTLA) was used at the concentrations recommended by the supplier. The assay was carried out in the same manner as described above.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64">4.3.5.  Thermal Shift Assay</h4><div class="NLM_p last">TSA were performed using 40 μL samples containing 5 μM RORγt-LBD, 10 μM compound, and 2.5x SYPRO Orange (Sigma) in buffer containing 150 mM NaCl, 10 mM HEPES (pH 7.5), and 1% DMSO. Hard-Shell 96-well PCR plates (low profile, thin wall, skirted, green/white #hsp9645) were used. The samples were heated from 25 to 80 °C at a rate of 0.5 °C per 5 s in a CFX96 touch real-time PCR detection system (Bio-Rad). After each increment, Sypro Orange intensity was measured using the plate read option in Bio-Rad CFX Manager 3.1. Melting temperatures were determined by Bio-Rad CFX Manager 3.1 software in negative mode. The data were recorded in triplicate in three independent experiments (one representative data set shown). Error bars represent the SD of the mean.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65">4.4.  Quantitative IL-17a mRNA RT-PCR Assay</h3><div class="NLM_p last">Cell culture, RT-PCR experiments, and data analysis were performed as described in previous studies.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Statistical analysis was performed using a one-way ANOVA, comparing against the DMSO control following the Dunnett’s <i>post hoc</i> test (GraphPad Prism 7.0 software). A <i>P</i> value < 0.05 was considered statistically significant. (Data recorded in triplicate from two independent experiments. Data shown are representative of two independent experiments. Error bars represent the SD of the mean.)</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66">4.5.  Protein X-ray Crystallography</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67">4.5.1.  RORγt-LBD Expression and Purification (Used for Crystallography)</h4><div class="NLM_p last">His-tagged RORγt LBD containing a C455H mutation was expressed and purified as described in previous studies.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68">4.5.2.  X-ray Crystallography</h4><div class="NLM_p last">X-ray crystallography experiments and data analysis were performed as described in previous studies.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Diffraction data were collected at the P11 beamline of the PETRA III facility at DESY (Hamburg, Germany), the ID30B beamline of ESRF (Grenola, France), and the i04 beamline of Diamond Light Source (Didcot, UK). The structures of RORγtC455H in complex with <b>3</b>, <b>9</b>, <b>10</b>, and <b>11</b> were deposited in the Protein Data Bank (PDB) under codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NPC">7NPC</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NP5">7NP5</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NEC">7NEC</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NP6">7NP6</a>.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69">4.6.  Selectivity TR-FRET Coactivator Recruitment Assays</h3><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70">4.6.1.  TR-FRET Coactivator Recruitment Assays on PPARγ</h4><div class="NLM_p last">TR-FRET competition assays were performed in an analogous fashion to that described above, only using 10 nM His<sub>6</sub>-PPARγ LBD instead of 20 nM His<sub>6</sub>-RORγt LBD and 200 nM <i>N</i>-terminal biotinylated PGC1a coactivator peptide (Biotin-N-GTPPPQEAEEPSLLKLLLAPANTQ-CONH<sub>2</sub>) instead of 100 nM SRC-1 box 2 coactivator peptide.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71">4.6.2.  Competition TR-FRET Coactivator Recruitment Assays on PPARγ</h4><div class="NLM_p last">TR-FRET competition assays were performed in an analogous fashion to that described above, only using 100 nM His<sub>6</sub>-PPARγ LBD instead of 20 nM His<sub>6</sub>-RORγt LBD. The assay was performed in the presence of 1 μM rosiglitazone, in order to initially activate PPARγ.</div></div><div id="sec4_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72">4.6.3.  TSA on PPARγ</h4><div class="NLM_p last">TSA were performed in an analogous fashion to that described above, only using PPARγ LBD instead of RORγt LBD.</div></div><div id="sec4_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73">4.6.4.  FP Assays on FXR</h4><div class="NLM_p last">Assays were conducted using 100 nM <i>N</i>-terminal FITC-labeled SRC-1 box2 coactivator peptide (FITC-N-PSSHSSLTARHKILHRLLQEGSPSD-CONH<sub>2</sub>) and 1 μM GST-tagged FXR-LBD in buffer containing 10 mM HEPES (pH 7.5), 150 mM NaCl, 5 mM DTT, 0.1% BSA (w/v), and 0.1 mM CHAPS. For the competition assay, the assay was performed in the presence of 0, 1, 10, or 50 μM of ligand <b>3</b>. Compounds (dissolved in DMSO) were titrated using a 2× dilution series in Corning black round-bottom, low-volume, low-binding, 384-well plates at a final volume of 10 μL. The final DMSO concentration was 1% v/v throughout. The plate was directly measured (excitation = 485 nm; emission = 535 nm) on a Tecan infinite F500 plate reader. The data were analyzed with GraphPad Prism 7.0 software. The dose–response curve was fitted in the same way as described for the TR-FRET data on RORγt. The data were recorded in triplicate in three independent experiments (one representative data set shown). Error bars represent the SD of the mean.</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74">4.7.  ADME Experiments</h3><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75">4.7.1.  Kinetic Solubility</h4><div class="NLM_p last">Aqueous solubility of compounds was determined by the spectrophotometrical measurement of the kinetic solubility of a 500 μM compound solution in HEPES buffer pH 7.4 compared to a solution containing 50% of the organic solvent acetonitrile. To this end, saturated samples of the compounds in buffer were prepared starting from DMSO stocks, and samples were shaken for 90 min at room temperature. The precipitated material was removed by filtration and samples were further diluted with the same volume of acetonitrile. Absorbance spectra (250–500 nm) were recorded and relative solubility was calculated in comparison to the acetonitrile–buffer solution of the compounds using absorbance ratios.</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76">4.7.2.  Parallel Artificial Membrane Permeability Assay</h4><div class="NLM_p last">Permeability through artificial membranes [parallel artificial membrane permeability assay (PAMPA)] was performed at an initial concentration of 500 μM of the compound in the donor compartment. After an incubation period of 20 h, the absorption of the receiver wells was measured by spectrophotometry and permeation was calculated by the normalization of the compound flux across a blank filter.</div></div><div id="sec4_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77">4.7.3.  Microsomal Stability—Phase I</h4><div class="NLM_p last">Metabolic stability under oxidative conditions was measured using NADPH-supplemented human liver microsomes. Compound depletion was analyzed by liquid chromatography with tandem mass spectrometry (LC–MS/MS) at a concentration of 1 μM over a time up to 50 min at 37 °C. Based on compound half-life <i>t</i><sub>1/2</sub>, in vitro intrinsic clearance Cl<sub>int</sub> was calculated. <span class="NLM_inline-formula"><img class="imgWithoutFigViewer inline-formula-styles" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/medium/jm1c00475_m002.gif" alt="" id="_i78" /></img></span>, with <i>V</i> = assay volume and mg = amount of microsomal protein.</div></div><div id="sec4_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79">4.7.4.  Microsomal Stability—<i>In Vitro</i> Glucuronidation</h4><div class="NLM_p last">Metabolic stability under conjugative conditions was measured in the glucuronidation assay by the LC–MS-based determination of % remaining of selected compounds. Prior to the assay, human liver microsomes were activated using alamethicin and further supplemented with 5 mM of the cofactor UDPGA. 5 μM compound was added to the reaction mixture, and it was incubated for 1 h at 37 °C.</div></div><div id="sec4_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80">4.7.5.  Plasma Stability</h4><div class="NLM_p last">Plasma stability was measured by the LC–MS-based determination of % remaining of selected compounds at a concentration of 5 μM after incubation in 50% plasma in phosphate-buffered saline (obtained from humans) for 1 h at 37 °C.</div></div><div id="sec4_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81">4.7.6.  Plasma Protein Binding</h4><div class="NLM_p last">Plasma protein binding was determined by equilibrium dialysis. Plasma containing 5 μM of test compound was allowed to equilibrate with the buffer compartment for 6 h at 37 °C. Compound concentrations on both sides of the semipermeable membrane were analyzed by LC–MS/MS and % bound was calculated.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82"><a href="/doi/suppl/10.1021/acs.jmedchem.1c00475" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21354" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21354" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.1c00475?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00475</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Chemical structure of AlexaFluor-MRL probe; dose–response curves; schematic representation of TR-FRET assays; docking poses of <b>4</b> and <b>12</b> in overlay with <b>3</b>; protein–ligand interaction plot for <b>3</b>; electron density around compounds <b>3</b>, <b>9</b>, <b>10</b>, and <b>11</b>; fluorescence polarization assay; synthesis route for isoxazole scaffold <b>14</b>; original synthesis route for isoxazole compound <b>FM26</b>; library of compounds used in docking studies; toxicity risks, drug likeness, and drug score for all compounds; data collection and refinement statistics (molecular replacement) of <b>3</b>, <b>9</b>, <b>10</b>, and <b>11</b>; synthesis, biochemical assays, and docking experiments; NMR and LC–UV spectra for assayed compounds; and details on crystallography experiments (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf">jm1c00475_si_001.pdf (3.9 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_002.csv">jm1c00475_si_002.csv (1.13 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors for the RORγt bound to compounds <b>3</b>, <b>9</b>, <b>10</b>, and <b>11</b> have been deposited in the Protein Data Bank under accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NPC">7NPC</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NP5">7NP5</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NEC">7NEC</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NP6">7NP6</a>. The authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.1c00475" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12576" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12576" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luc Brunsveld</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Chemical Biology, Department of Biomedical Engineering and Institute
for Complex Molecular Systems, Technische Universiteit Eindhoven, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-5675-511X" title="Orcid link">https://orcid.org/0000-0001-5675-511X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7f13511d0d0a110c091a131b3f0b0a1a511113"><span class="__cf_email__" data-cfemail="e08cce8292958e9396858c84a0949585ce8e8c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Femke A. Meijer</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Chemical Biology, Department of Biomedical Engineering and Institute
for Complex Molecular Systems, Technische Universiteit Eindhoven, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0003-4412-9968" title="Orcid link">https://orcid.org/0000-0003-4412-9968</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Annet O.W.M. Saris</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Chemical Biology, Department of Biomedical Engineering and Institute
for Complex Molecular Systems, Technische Universiteit Eindhoven, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard G. Doveston</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Chemical Biology, Department of Biomedical Engineering and Institute
for Complex Molecular Systems, Technische Universiteit Eindhoven, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands</span>; 
    <span class="hlFld-Affiliation affiliation">Leicester
Institute of Structural and Chemical Biology and School of Chemistry, University of Leicester, University Road, LE1 7RH Leicester, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guido J.M. Oerlemans</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Chemical Biology, Department of Biomedical Engineering and Institute
for Complex Molecular Systems, Technische Universiteit Eindhoven, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-7562-2654" title="Orcid link">https://orcid.org/0000-0001-7562-2654</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rens M.J.M. de Vries</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Chemical Biology, Department of Biomedical Engineering and Institute
for Complex Molecular Systems, Technische Universiteit Eindhoven, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bente A. Somsen</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Chemical Biology, Department of Biomedical Engineering and Institute
for Complex Molecular Systems, Technische Universiteit Eindhoven, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anke Unger</span> - <span class="hlFld-Affiliation affiliation">Lead
Discovery Center GmbH, 44227 Dortmund, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bert Klebl</span> - <span class="hlFld-Affiliation affiliation">Lead
Discovery Center GmbH, 44227 Dortmund, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Ottmann</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Chemical Biology, Department of Biomedical Engineering and Institute
for Complex Molecular Systems, Technische Universiteit Eindhoven, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0001-7315-0315" title="Orcid link">https://orcid.org/0000-0001-7315-0315</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter J. Cossar</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Chemical Biology, Department of Biomedical Engineering and Institute
for Complex Molecular Systems, Technische Universiteit Eindhoven, Den Dolech 2, 5612 AZ Eindhoven, The Netherlands</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all the authors. F.A.M. and A.O.W.M.S. performed synthesis; F.A.M. performed biochemical studies; G.J.M.O., R.M.J.M.d.V., and B.A.S. performed crystallography studies; G.J.M.O. performed the expression of the FXR protein; AU performed ADME measurements; F.A.M., R.G.D., B.K., C.O., P.J.C., and L.B. designed the studies. All the authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This work was supported by the Netherlands Organization for Scientific Research through Gravity program 024.001.035, Vici grant 016.150.366, ECHO grants 711.018.003 and 711.017.014, the European Union through a Marie Skłodowska-Curie Actions (MSCA) Individual Fellowship (R.G.D., H2020-MSCA-IEF-2016, grant no. 705188) and Eurotech Postdoctoral Fellow program (grant no. 754462).</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): F.A.M., R.G.D., C.O. and L.B. are coinventors of patent WO2020149740: Substituted heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-t inhibitors.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i85">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22330" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22330" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Iris A. Leijten-van de Gevel for expression of the RORγt protein used for biophysical assays, Auke A. Koops for the expression of the PPARγ protein, and Joost L.J. van Dongen for performing HRMS measurements. Additionally, we thank Saskia W.C. van Mil for providing the plasmid for FXR expression and for providing GW4064 (FXR agonist). We also thank the DLS-CCP4 Data Collection and Structure Solution Workshop 2021 at Diamond Light Source (Oxfordshire, UK).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">FP</td><td class="NLM_def"><p class="first last">fluorescence polarization</p></td></tr><tr><td class="NLM_term">FXR</td><td class="NLM_def"><p class="first last">farnesoid X receptor</p></td></tr><tr><td class="NLM_term">H12</td><td class="NLM_def"><p class="first last">helix 12</p></td></tr><tr><td class="NLM_term">HPLC–UV</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography/ultraviolet</p></td></tr><tr><td class="NLM_term">IPTG</td><td class="NLM_def"><p class="first last">isopropyl-β-<span class="smallcaps smallerCapital">d</span>-thiogalactoside</p></td></tr><tr><td class="NLM_term">LBD</td><td class="NLM_def"><p class="first last">ligand-binding domain</p></td></tr><tr><td class="NLM_term">LC–MS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">NR</td><td class="NLM_def"><p class="first last">nuclear receptor</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeability assay</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">PPARγ</td><td class="NLM_def"><p class="first last">peroxisome proliferated-activated receptor γ</p></td></tr><tr><td class="NLM_term">Q-TOF</td><td class="NLM_def"><p class="first last">quadrupole time-of-flight</p></td></tr><tr><td class="NLM_term">RORγt</td><td class="NLM_def"><p class="first last">retinoic-acid-receptor-related orphan receptor γt</p></td></tr><tr><td class="NLM_term">RT-PCR</td><td class="NLM_def"><p class="first last">reverse transcriptase PCR</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">Th17</td><td class="NLM_def"><p class="first last">T helper 17</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>m</sub></td><td class="NLM_def"><p class="first last">melting temperature</p></td></tr><tr><td class="NLM_term">TR-FRET</td><td class="NLM_def"><p class="first last">time-resolved FRET</p></td></tr><tr><td class="NLM_term">TSA</td><td class="NLM_def"><p class="first last">thermal shift assay</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24286" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24286" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 50 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robinson-Rechavi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laudet, V.</span></span> <span> </span><span class="NLM_article-title">The nuclear receptor superfamily</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">585</span>– <span class="NLM_lpage">586</span>, <span class="refDoi"> DOI: 10.1242/jcs.00247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1242%2Fjcs.00247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=12538758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252FjtFamuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2003&pages=585-586&author=M.+Robinson-Rechaviauthor=H.+E.+Garciaauthor=V.+Laudet&title=The+nuclear+receptor+superfamily&doi=10.1242%2Fjcs.00247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The nuclear receptor superfamily</span></div><div class="casAuthors">Robinson-Rechavi Marc; Escriva Garcia Hector; Laudet Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cell science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">Pt 4</span>),
    <span class="NLM_cas:pages">585-6</span>
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSISsSnWMCNWGxpATR2EQURfW6udTcc2ebxQVdlHQ2nY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252FjtFamuw%253D%253D&md5=ac244dd3bf3de2a5ff92fd43fe8f5959</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1242%2Fjcs.00247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.00247%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson-Rechavi%26aufirst%3DM.%26aulast%3DGarcia%26aufirst%3DH.%2BE.%26aulast%3DLaudet%26aufirst%3DV.%26atitle%3DThe%2520nuclear%2520receptor%2520superfamily%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2003%26volume%3D116%26spage%3D585%26epage%3D586%26doi%3D10.1242%2Fjcs.00247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastinejad, F.</span></span> <span> </span><span class="NLM_article-title">Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics</span>. <i>Annu. Rev. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1146/annurev-physiol-021909-135917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1146%2Fannurev-physiol-021909-135917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=20148675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktFKkt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2010&pages=247-272&author=P.+Huangauthor=V.+Chandraauthor=F.+Rastinejad&title=Structural+overview+of+the+nuclear+receptor+superfamily%3A+insights+into+physiology+and+therapeutics&doi=10.1146%2Fannurev-physiol-021909-135917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics</span></div><div class="casAuthors">Huang, Pengxiang; Chandra, Vikas; Rastinejad, Fraydoon</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Physiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">247-272</span>CODEN:
                <span class="NLM_cas:coden">ARPHAD</span>;
        ISSN:<span class="NLM_cas:issn">0066-4278</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  As ligand-regulated transcription factors, the nuclear hormone receptors are nearly ideal drug targets, with internal pockets that bind to hydrophobic, drug-like mols. and well-characterized ligand-induced conformational changes that recruit transcriptional coregulators to promoter elements.  Yet, due to the multitude of genes under the control of a single receptor, the major challenge was the identification of ligands with gene-selective actions, impacting disease outcomes through a narrow subset of target genes and not across their entire gene-regulatory repertoire.  Here, we summarize the concepts and work to date underlying the development of steroidal and nonsteroidal receptor ligands, including the use of crystal structures, high-throughput screens, and rational design approaches for finding useful therapeutic mols.  Difficulties in finding selective receptor modulators require a more complete understanding of receptor interdomain communications, posttranslational modifications, and receptor-protein interactions that could be exploited for target gene selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU31gr_40ZoLVg90H21EOLACvtfcHk0ljO4ctZldRPCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktFKkt7o%253D&md5=3764fd1b044297f2e3145924fbc7e1f7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev-physiol-021909-135917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-physiol-021909-135917%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DChandra%26aufirst%3DV.%26aulast%3DRastinejad%26aufirst%3DF.%26atitle%3DStructural%2520overview%2520of%2520the%2520nuclear%2520receptor%2520superfamily%253A%2520insights%2520into%2520physiology%2520and%2520therapeutics%26jtitle%3DAnnu.%2520Rev.%2520Physiol.%26date%3D2010%26volume%3D72%26spage%3D247%26epage%3D272%26doi%3D10.1146%2Fannurev-physiol-021909-135917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gronemeyer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laudet, V.</span></span> <span> </span><span class="NLM_article-title">Principles for modulation of the nuclear receptor superfamily</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">950</span>– <span class="NLM_lpage">964</span>, <span class="refDoi"> DOI: 10.1038/nrd1551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1038%2Fnrd1551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=15520817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFemtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=950-964&author=H.+Gronemeyerauthor=J.-A.+Gustafssonauthor=V.+Laudet&title=Principles+for+modulation+of+the+nuclear+receptor+superfamily&doi=10.1038%2Fnrd1551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Principles for modulation of the nuclear receptor superfamily</span></div><div class="casAuthors">Gronemeyer, Hinrich; Gustafsson, Jan-A.; Laudet, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">950-964</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors are major targets for drug discovery and have key roles in development and homeostasis, as well as in many diseases such as obesity, diabetes and cancer.  This review provides a general overview of the mechanism of action of nuclear receptors and explores the various factors that are instrumental in modulating their pharmacol.  In most cases, the response of a given receptor to a particular ligand in a specific tissue will be dictated by the set of proteins with which the receptor is able to interact.  One of the most promising aspects of nuclear receptor pharmacol. is that it is now possible to develop ligands with a large spectrum of full, partial or inverse agonist or antagonist activities, but also compds., called selective nuclear receptor modulators, that activate only a subset of the functions induced by the cognate ligand or that act in a cell-type-selective manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSWL9yf1CceLVg90H21EOLACvtfcHk0lh55ht28EXVEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFemtrY%253D&md5=aedb60785c235bf44cb5f0ea34236090</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrd1551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1551%26sid%3Dliteratum%253Aachs%26aulast%3DGronemeyer%26aufirst%3DH.%26aulast%3DGustafsson%26aufirst%3DJ.-A.%26aulast%3DLaudet%26aufirst%3DV.%26atitle%3DPrinciples%2520for%2520modulation%2520of%2520the%2520nuclear%2520receptor%2520superfamily%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D950%26epage%3D964%26doi%3D10.1038%2Fnrd1551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaulton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bento, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donadi, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bologa, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Lazikani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oprea, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span> <span> </span><span class="NLM_article-title">A comprehensive map of molecular drug targets</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1038%2Fnrd.2016.230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=27910877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVSms7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=19-34&author=R.+Santosauthor=O.+Ursuauthor=A.+Gaultonauthor=A.+P.+Bentoauthor=R.+S.+Donadiauthor=C.+G.+Bologaauthor=A.+Karlssonauthor=B.+Al-Lazikaniauthor=A.+Herseyauthor=T.+I.+Opreaauthor=J.+P.+Overington&title=A+comprehensive+map+of+molecular+drug+targets&doi=10.1038%2Fnrd.2016.230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive map of molecular drug targets</span></div><div class="casAuthors">Santos, Rita; Ursu, Oleg; Gaulton, Anna; Bento, A. Patricia; Donadi, Ramesh S.; Bologa, Cristian G.; Karlsson, Anneli; Al-Lazikani, Bissan; Hersey, Anne; Oprea, Tudor I.; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-34</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The success of mechanism-based drug discovery depends on the definition of the drug target.  This definition becomes even more important as we try to link drug response to genetic variation, understand stratified clin. efficacy and safety, rationalize the differences between drugs in the same therapeutic class and predict drug utility in patient subgroups.  However, drug targets are often poorly defined in the literature, both for launched drugs and for potential therapeutic agents in discovery and development.  Here, we present an updated comprehensive map of mol. targets of approved drugs.  We curate a total of 893 human and pathogen-derived biomols. through which 1,578 US FDA-approved drugs act.  These biomols. include 667 human-genome-derived proteins targeted by drugs for human disease.  Anal. of these drug targets indicates the continued dominance of privileged target families across disease areas, but also the growth of novel first-in-class mechanisms, particularly in oncol.  We explore the relationships between bioactivity class and clin. success, as well as the presence of orthologues between human and animal models and between pathogen and human genomes.  Through the collaboration of three independent teams, we highlight some of the ongoing challenges in accurately defining the targets of mol. therapeutics and present conventions for deconvoluting the complexities of mol. pharmacol. and drug efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTfWwWkoZnbrVg90H21EOLACvtfcHk0lh55ht28EXVEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVSms7rK&md5=7437d4b678ac75dac0a5e3248df98761</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.230%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DR.%26aulast%3DUrsu%26aufirst%3DO.%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DDonadi%26aufirst%3DR.%2BS.%26aulast%3DBologa%26aufirst%3DC.%2BG.%26aulast%3DKarlsson%26aufirst%3DA.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DOprea%26aufirst%3DT.%2BI.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DA%2520comprehensive%2520map%2520of%2520molecular%2520drug%2520targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D19%26epage%3D34%26doi%3D10.1038%2Fnrd.2016.230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solt, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span> <span> </span><span class="NLM_article-title">Action of RORs and their ligands in (patho)physiology</span>. <i>Trends Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">619</span>– <span class="NLM_lpage">627</span>, <span class="refDoi"> DOI: 10.1016/j.tem.2012.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.tem.2012.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=22789990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWgur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=619-627&author=L.+A.+Soltauthor=T.+P.+Burris&title=Action+of+RORs+and+their+ligands+in+%28patho%29physiology&doi=10.1016%2Fj.tem.2012.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Action of RORs and their ligands in (patho)physiology</span></div><div class="casAuthors">Solt, Laura A.; Burris, Thomas P.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">619-627</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The retinoic-acid-receptor-related orphan receptors (RORs) are members of the nuclear receptor (NR) superfamily whose activity has been implicated in several physiol. and pathol. processes.  The RORs, specifically RORα and RORγ, are considered to be master regulators of TH17 cells, a recently described subset of CD4+ T helper cells that have been demonstrated to have a pathol. role in autoimmune disease.  As with most members of the NR superfamily, RORs are ligand-regulated, suggesting that their activity can be modulated by synthetic ligands.  Recent advances in the field have established that selective inhibition of the RORs is a viable therapeutic approach for not only the treatment of autoimmune disorders but also ROR-mediated metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU_NvOEtj6cbVg90H21EOLACvtfcHk0lh55ht28EXVEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWgur%252FJ&md5=a1d5b61ffa1b224265d1cd90d60e9620</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2012.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2012.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DSolt%26aufirst%3DL.%2BA.%26aulast%3DBurris%26aufirst%3DT.%2BP.%26atitle%3DAction%2520of%2520RORs%2520and%2520their%2520ligands%2520in%2520%2528patho%2529physiology%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2012%26volume%3D23%26spage%3D619%26epage%3D627%26doi%3D10.1016%2Fj.tem.2012.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, I. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadokoro, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepelley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafaille, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cua, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">1121</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.07.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.cell.2006.07.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=16990136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCnsrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2006&pages=1121-1133&author=I.+I.+Ivanovauthor=B.+S.+McKenzieauthor=L.+Zhouauthor=C.+E.+Tadokoroauthor=A.+Lepelleyauthor=J.+J.+Lafailleauthor=D.+J.+Cuaauthor=D.+R.+Littman&title=The+Orphan+Nuclear+Receptor+ROR%CE%B3t+Directs+the+Differentiation+Program+of+Proinflammatory+IL-17%2B+T+Helper+Cells&doi=10.1016%2Fj.cell.2006.07.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells</span></div><div class="casAuthors">Ivanov, Ivaylo I.; McKenzie, Brent S.; Zhou, Liang; Tadokoro, Carlos E.; Lepelley, Alice; Lafaille, Juan J.; Cua, Daniel J.; Littman, Dan R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1121-1133</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">IL-17-producing T lymphocytes have been recently shown to comprise a distinct lineage of proinflammatory T helper cells, termed Th17 cells, that are major contributors to autoimmune disease.  The authors show here that the orphan nuclear receptor RORγt is the key transcription factor that orchestrates the differentiation of this effector cell lineage.  RORγt induces transcription of the genes encoding IL-17 and the related cytokine IL-17F in naive CD4+ T helper cells and is required for their expression in response to IL-6 and TGF-β, the cytokines known to induce IL-17.  Th17 cells are constitutively present throughout the intestinal lamina propria, express RORγt, and are absent in mice deficient for RORγt or IL-6.  Mice with RORγt-deficient T cells have attenuated autoimmune disease and lack tissue-infiltrating Th17 cells.  Together, these studies suggest that RORγt is a key regulator of immune homeostasis and highlight its potential as a therapeutic target in inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYsJd6RyFqWrVg90H21EOLACvtfcHk0liT6nlqT3fo2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCnsrrE&md5=4f5693603c30dca4f6a2d0994aeaf9b0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.07.035%26sid%3Dliteratum%253Aachs%26aulast%3DIvanov%26aufirst%3DI.%2BI.%26aulast%3DMcKenzie%26aufirst%3DB.%2BS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DTadokoro%26aufirst%3DC.%2BE.%26aulast%3DLepelley%26aufirst%3DA.%26aulast%3DLafaille%26aufirst%3DJ.%2BJ.%26aulast%3DCua%26aufirst%3DD.%2BJ.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DThe%2520Orphan%2520Nuclear%2520Receptor%2520ROR%25CE%25B3t%2520Directs%2520the%2520Differentiation%2520Program%2520of%2520Proinflammatory%2520IL-17%252B%2520T%2520Helper%2520Cells%26jtitle%3DCell%26date%3D2006%26volume%3D126%26spage%3D1121%26epage%3D1133%26doi%3D10.1016%2Fj.cell.2006.07.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unutmaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">641</span>– <span class="NLM_lpage">649</span>, <span class="refDoi"> DOI: 10.1038/ni.1610</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1038%2Fni.1610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=18454151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVWqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=641-649&author=N.+Manelauthor=D.+Unutmazauthor=D.+R.+Littman&title=The+differentiation+of+human+TH-17+cells+requires+transforming+growth+factor-%CE%B2+and+induction+of+the+nuclear+receptor+ROR%CE%B3t&doi=10.1038%2Fni.1610"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt</span></div><div class="casAuthors">Manel, Nicolas; Unutmaz, Derya; Littman, Dan R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">641-649</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">TH-17 cells are interleukin 17 (IL-17)-secreting CD4+ T helper cells involved in autoimmune disease and mucosal immunity.  In naive CD4+ T cells from mice, IL-17 is expressed in response to a combination of IL-6 or IL-21 and transforming growth factor-β (TGF-β) and requires induction of the nuclear receptor RORγt.  It has been suggested that the differentiation of human TH-17 cells is independent of TGF-β and thus differs fundamentally from that in mice.  The authors show here that TGF-β, IL-1β and IL-6, IL-21 or IL-23 in serum-free conditions were necessary and sufficient to induce IL-17 expression in naive human CD4+ T cells from cord blood.  TGF-β upregulated RORγt expression but simultaneously inhibited its ability to induce IL-17 expression.  Inflammatory cytokines relieved this inhibition and increased RORγt-directed IL-17 expression.  Other gene products detected in TH-17 cells after RORγt induction included the chemokine receptor CCR6, the IL-23 receptor, IL-17F and IL-26.  The authors' studies identify RORγt as having a central function in the differentiation of human TH-17 cells from naive CD4+ T cells and suggest that similar cytokine pathways are involved in this process in mice and humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZBHk62Mj3R7Vg90H21EOLACvtfcHk0liT6nlqT3fo2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVWqurg%253D&md5=9c1406dfd60902657b1bd5231618cc70</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fni.1610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1610%26sid%3Dliteratum%253Aachs%26aulast%3DManel%26aufirst%3DN.%26aulast%3DUnutmaz%26aufirst%3DD.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DThe%2520differentiation%2520of%2520human%2520TH-17%2520cells%2520requires%2520transforming%2520growth%2520factor-%25CE%25B2%2520and%2520induction%2520of%2520the%2520nuclear%2520receptor%2520ROR%25CE%25B3t%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D641%26epage%3D649%26doi%3D10.1038%2Fni.1610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miossec, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolls, J. K.</span></span> <span> </span><span class="NLM_article-title">Targeting IL-17 and TH17 cells in chronic inflammation</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">763</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.1038/nrd3794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1038%2Fnrd3794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=23023676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVaqsb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=763-776&author=P.+Miossecauthor=J.+K.+Kolls&title=Targeting+IL-17+and+TH17+cells+in+chronic+inflammation&doi=10.1038%2Fnrd3794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting IL-17 and TH17 cells in chronic inflammation</span></div><div class="casAuthors">Miossec, Pierre; Kolls, Jay K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">763-776</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The key role of interleukin-17 (IL-17) and T helper 17 (TH17) cells in tissue inflammation, autoimmunity and host defense led to the exptl. targeting of these mols. in mouse models of diseases as well as in clin. settings.  Moreover, the demonstration that IL-17 and TH17 cells contribute to local and systemic aspects of disease pathogenesis, as well as the finding that the IL-17-TH17 cell pathway is regulated by IL-23, prompted the identification of inhibitors.  These inhibitors include biotechnol. products that target IL-23 as well as the leading member of the IL-17 family, IL-17A, and one of its receptors, IL-17 receptor A.  Several clin. trials of these inhibitors are underway, and pos. results have been obtained in psoriasis, rheumatoid arthritis and ankylosing spondylitis.  This Review focuses on the current knowledge of the IL-17-TH17 cell pathway to better understand the pos. as well as potential neg. consequences of targeting them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLAiqCF66JHrVg90H21EOLACvtfcHk0liT6nlqT3fo2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVaqsb7L&md5=0627e4086ae6e50881cc3de52f1a2752</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrd3794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3794%26sid%3Dliteratum%253Aachs%26aulast%3DMiossec%26aufirst%3DP.%26aulast%3DKolls%26aufirst%3DJ.%2BK.%26atitle%3DTargeting%2520IL-17%2520and%2520TH17%2520cells%2520in%2520chronic%2520inflammation%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D763%26epage%3D776%26doi%3D10.1038%2Fnrd3794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundrud, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skepner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamagata, T.</span></span> <span> </span><span class="NLM_article-title">Targeting Th17 cells in autoimmune diseases</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">500</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2014.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.tips.2014.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=25131183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12mtrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=493-500&author=J.+Yangauthor=M.+S.+Sundrudauthor=J.+Skepnerauthor=T.+Yamagata&title=Targeting+Th17+cells+in+autoimmune+diseases&doi=10.1016%2Fj.tips.2014.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Th17 cells in autoimmune diseases</span></div><div class="casAuthors">Yang, Jianfei; Sundrud, Mark S.; Skepner, Jill; Yamagata, Tetsuya</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">493-500</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  T helper 17 (Th17) cells have been implicated in the pathogenesis of most common autoimmune diseases, including psoriasis, rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and multiple sclerosis (MS).  Although anti-interleukin-17 (IL-17) antibodies show marked clin. efficacy in psoriasis, targeting IL-17 alone is not sufficient to improve clin. end points in other autoimmune conditions, namely RA and Crohn's disease.  Given that Th17 cells express IL-17 together with many other proinflammatory cytokines [IL-17F, IL-22, IL-26, and granulocyte-macrophage colony-stimulating factor (GM-CSF)], targeting the Th17 cell lineage may be superior to blocking a single effector cytokine.  Here, we discuss the rationale for targeting two checkpoints in the development and inflammatory function of Th17 cells, retinoid-related orphan receptor-γt (RORγt) and IL-23, and we review recent progress in the development of both RORγt small mol. inhibitors and IL-23 neutralizing antibodies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIqpQyNCHuJ7Vg90H21EOLACvtfcHk0liT6nlqT3fo2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12mtrfI&md5=85bf5039611c1730cc7194c7558d144e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DSundrud%26aufirst%3DM.%2BS.%26aulast%3DSkepner%26aufirst%3DJ.%26aulast%3DYamagata%26aufirst%3DT.%26atitle%3DTargeting%2520Th17%2520cells%2520in%2520autoimmune%2520diseases%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D35%26spage%3D493%26epage%3D500%26doi%3D10.1016%2Fj.tips.2014.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burkett, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchroo, V. K.</span></span> <span> </span><span class="NLM_article-title">IL-17 Blockade in Psoriasis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">1669</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.11.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.cell.2016.11.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=27984714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFWlsrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2016&pages=1669&author=P.+R.+Burkettauthor=V.+K.+Kuchroo&title=IL-17+Blockade+in+Psoriasis&doi=10.1016%2Fj.cell.2016.11.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">IL-17 Blockade in Psoriasis</span></div><div class="casAuthors">Burkett, Patrick R.; Kuchroo, Vijay K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1669</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">IL-17A both directly induces and synergizes with other cytokines to promote autoimmune tissue inflammation.  Secukinumab and ixekizumab are monoclonal antibodies (mAb) that inhibit interleukin-17A.  These two agents were recently approved for treatment of psoriasis, and secukinumab is also approved for treatment of two spondyloarthropathies, psoriatic arthritis and ankylosing spondylitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobNyijIUaJ-rVg90H21EOLACvtfcHk0liXDpCZISpggA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFWlsrrE&md5=e2d2918a30d5bf98cd5b405e51f171d4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.11.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.11.044%26sid%3Dliteratum%253Aachs%26aulast%3DBurkett%26aufirst%3DP.%2BR.%26aulast%3DKuchroo%26aufirst%3DV.%2BK.%26atitle%3DIL-17%2520Blockade%2520in%2520Psoriasis%26jtitle%3DCell%26date%3D2016%26volume%3D167%26spage%3D1669%26doi%3D10.1016%2Fj.cell.2016.11.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lock, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermans, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedotti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brendolan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schadt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garren, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer-Gould, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strober, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannella, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klonowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lad, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaminski, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oksenberg, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raine, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinman, L.</span></span> <span> </span><span class="NLM_article-title">Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">500</span>– <span class="NLM_lpage">508</span>, <span class="refDoi"> DOI: 10.1038/nm0502-500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1038%2Fnm0502-500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=11984595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1Kgur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=500-508&author=C.+Lockauthor=G.+Hermansauthor=R.+Pedottiauthor=A.+Brendolanauthor=E.+Schadtauthor=H.+Garrenauthor=A.+Langer-Gouldauthor=S.+Stroberauthor=B.+Cannellaauthor=J.+Allardauthor=P.+Klonowskiauthor=A.+Austinauthor=N.+Ladauthor=N.+Kaminskiauthor=S.+J.+Galliauthor=J.+R.+Oksenbergauthor=C.+S.+Raineauthor=R.+Hellerauthor=L.+Steinman&title=Gene-microarray+analysis+of+multiple+sclerosis+lesions+yields+new+targets+validated+in+autoimmune+encephalomyelitis&doi=10.1038%2Fnm0502-500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis</span></div><div class="casAuthors">Lock, C.; Hermans, G.; Pedotti, R.; Brendolan, A.; Schadt, E.; Garren, H.; Langer-Gould, A.; Strober, S.; Cannella, B.; Allard, J.; Klonowski, P.; Austin, A.; Lad, N.; Kaminski, N.; Galli, S. J.; Oksenberg, J. R.; Raine, C. S.; Heller, R.; Steinman, L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">500-508</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Microarray anal. of multiple sclerosis (MS) lesions obtained at autopsy revealed increased transcripts of genes encoding inflammatory cytokines, particularly interleukin-6 and -17, interferon-γ and assocd. downstream pathways.  Comparison of two poles of MS pathol.-acute lesions with inflammation vs. 'silent' lesions without inflammation-revealed differentially transcribed genes.  Some products of these genes were chosen as targets for therapy of exptl. autoimmune encephalomyelitis (EAE) in mice.  Granulocyte colony-stimulating factor is upregulated in acute, but not in chronic, MS lesions, and the effect on ameliorating EAE is more pronounced in the acute phase, in contrast to knocking out the Ig Fc receptor common γ chain where the effect is greatest on chronic disease.  These results in EAE corroborate the microarray studies on MS lesions.  Large-scale anal. of transcripts in MS lesions elucidates new aspects of pathol. and opens possibilities for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPWj6FNx8JZ7Vg90H21EOLACvtfcHk0liXDpCZISpggA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1Kgur8%253D&md5=1e50114f238ec03ff0d534966273f245</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnm0502-500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0502-500%26sid%3Dliteratum%253Aachs%26aulast%3DLock%26aufirst%3DC.%26aulast%3DHermans%26aufirst%3DG.%26aulast%3DPedotti%26aufirst%3DR.%26aulast%3DBrendolan%26aufirst%3DA.%26aulast%3DSchadt%26aufirst%3DE.%26aulast%3DGarren%26aufirst%3DH.%26aulast%3DLanger-Gould%26aufirst%3DA.%26aulast%3DStrober%26aufirst%3DS.%26aulast%3DCannella%26aufirst%3DB.%26aulast%3DAllard%26aufirst%3DJ.%26aulast%3DKlonowski%26aufirst%3DP.%26aulast%3DAustin%26aufirst%3DA.%26aulast%3DLad%26aufirst%3DN.%26aulast%3DKaminski%26aufirst%3DN.%26aulast%3DGalli%26aufirst%3DS.%2BJ.%26aulast%3DOksenberg%26aufirst%3DJ.%2BR.%26aulast%3DRaine%26aufirst%3DC.%2BS.%26aulast%3DHeller%26aufirst%3DR.%26aulast%3DSteinman%26aufirst%3DL.%26atitle%3DGene-microarray%2520analysis%2520of%2520multiple%2520sclerosis%2520lesions%2520yields%2520new%2520targets%2520validated%2520in%2520autoimmune%2520encephalomyelitis%26jtitle%3DNat.%2520Med.%26date%3D2002%26volume%3D8%26spage%3D500%26epage%3D508%26doi%3D10.1038%2Fnm0502-500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Isono, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita-Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, S.</span></span> <span> </span><span class="NLM_article-title">Inhibiting RORγt/Th17 axis for autoimmune disorders</span>. <i>Drug Discov. Today</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1205</span>– <span class="NLM_lpage">1211</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2014.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.drudis.2014.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=24792721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVeitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1205-1211&author=F.+Isonoauthor=S.+Fujita-Satoauthor=S.+Ito&title=Inhibiting+ROR%CE%B3t%2FTh17+axis+for+autoimmune+disorders&doi=10.1016%2Fj.drudis.2014.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting RORγt/Th17 axis for autoimmune disorders</span></div><div class="casAuthors">Isono, Fujio; Fujita-Sato, Saori; Ito, Shuichiro</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1205-1211</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The recent success reported in late-stage clin. trials for the treatment of psoriasis by antibodies directed against interleukin (IL)-17 or its receptor has validated and strongly supports the development of inhibitors of the IL-17 pathway as a new therapeutic modality in chronic inflammation and autoimmunity.  These results also encourage the drug discovery of orally available small mols. that can modulate down the prodn. of IL-17 by Th17 cells (the major IL-17 producers) or the downstream signaling of the IL-17 receptor.  Here, we review these strategies with an emphasis on inhibiting the retinoic-acid-related orphan nuclear receptor RORγt, which is the master regulator of Th17 cells and a promising therapeutic target for the treatment of multiple autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQi4K-X9vSobVg90H21EOLACvtfcHk0liXDpCZISpggA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVeitbc%253D&md5=aaa82e8d21bcd0c879b0219a7b84e126</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DIsono%26aufirst%3DF.%26aulast%3DFujita-Sato%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DS.%26atitle%3DInhibiting%2520ROR%25CE%25B3t%252FTh17%2520axis%2520for%2520autoimmune%2520disorders%26jtitle%3DDrug%2520Discov.%2520Today%26date%3D2014%26volume%3D19%26spage%3D1205%26epage%3D1211%26doi%3D10.1016%2Fj.drudis.2014.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hueber, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dryja, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koroleva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antoni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draelos, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tak, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Reino, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samson, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falk, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callanan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haider, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Padova, F.</span></span> <span> </span><span class="NLM_article-title">Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">52ra72</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3001107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1126%2Fscitranslmed.3001107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=20926833" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=52ra72&author=W.+Hueberauthor=D.+D.+Patelauthor=T.+Dryjaauthor=A.+M.+Wrightauthor=I.+Korolevaauthor=G.+Bruinauthor=C.+Antoniauthor=Z.+Draelosauthor=M.+H.+Goldauthor=P.+Durezauthor=P.+P.+Takauthor=J.+J.+Gomez-Reinoauthor=C.+S.+Fosterauthor=R.+Y.+Kimauthor=C.+M.+Samsonauthor=N.+S.+Falkauthor=D.+S.+Chuauthor=D.+Callananauthor=Q.+D.+Nguyenauthor=K.+Roseauthor=A.+Haiderauthor=F.+Di+Padova&title=Effects+of+AIN457%2C+a+fully+human+antibody+to+interleukin-17A%2C+on+psoriasis%2C+rheumatoid+arthritis%2C+and+uveitis&doi=10.1126%2Fscitranslmed.3001107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3001107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3001107%26sid%3Dliteratum%253Aachs%26aulast%3DHueber%26aufirst%3DW.%26aulast%3DPatel%26aufirst%3DD.%2BD.%26aulast%3DDryja%26aufirst%3DT.%26aulast%3DWright%26aufirst%3DA.%2BM.%26aulast%3DKoroleva%26aufirst%3DI.%26aulast%3DBruin%26aufirst%3DG.%26aulast%3DAntoni%26aufirst%3DC.%26aulast%3DDraelos%26aufirst%3DZ.%26aulast%3DGold%26aufirst%3DM.%2BH.%26aulast%3DDurez%26aufirst%3DP.%26aulast%3DTak%26aufirst%3DP.%2BP.%26aulast%3DGomez-Reino%26aufirst%3DJ.%2BJ.%26aulast%3DFoster%26aufirst%3DC.%2BS.%26aulast%3DKim%26aufirst%3DR.%2BY.%26aulast%3DSamson%26aufirst%3DC.%2BM.%26aulast%3DFalk%26aufirst%3DN.%2BS.%26aulast%3DChu%26aufirst%3DD.%2BS.%26aulast%3DCallanan%26aufirst%3DD.%26aulast%3DNguyen%26aufirst%3DQ.%2BD.%26aulast%3DRose%26aufirst%3DK.%26aulast%3DHaider%26aufirst%3DA.%26aulast%3DDi%2BPadova%26aufirst%3DF.%26atitle%3DEffects%2520of%2520AIN457%252C%2520a%2520fully%2520human%2520antibody%2520to%2520interleukin-17A%252C%2520on%2520psoriasis%252C%2520rheumatoid%2520arthritis%252C%2520and%2520uveitis%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2010%26volume%3D2%26spage%3D52ra72%26doi%3D10.1126%2Fscitranslmed.3001107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, S.</span></span> <span> </span><span class="NLM_article-title">Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-γ (RORγ or RORc)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5871</span>– <span class="NLM_lpage">5892</span>, <span class="refDoi"> DOI: 10.1021/jm401901d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401901d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVartbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5871-5892&author=B.+P.+Fauberauthor=S.+Magnuson&title=Modulators+of+the+nuclear+receptor+retinoic+acid+receptor-related+orphan+receptor-%CE%B3+%28ROR%CE%B3+or+RORc%29&doi=10.1021%2Fjm401901d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)</span></div><div class="casAuthors">Fauber, Benjamin P.; Magnuson, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5871-5892</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  As the biol. surrounding the nuclear receptor retinoic acid receptor-related orphan receptor-gamma (RORγ or RORc) continues to evolve, significant effort has been invested in discovering modulators of this potentially important target for the treatment of metabolic and immunol. diseases.  Several major pharmaceutical and biotechnol. companies have disclosed RORc inhibitors or partnered with other players in the field.  In this perspective, we discuss both the biol. and the underlying structural biol. of RORc, and summarize the RORc modulators disclosed in the scientific and patent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXhzxefrY4hLVg90H21EOLACvtfcHk0liwa3gNeMcMrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVartbo%253D&md5=42b350bff7776d4b5689275eab214d86</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm401901d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401901d%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DMagnuson%26aufirst%3DS.%26atitle%3DModulators%2520of%2520the%2520nuclear%2520receptor%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor-%25CE%25B3%2520%2528ROR%25CE%25B3%2520or%2520RORc%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5871%26epage%3D5892%26doi%3D10.1021%2Fjm401901d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cyr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronner, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span> <span> </span><span class="NLM_article-title">Recent progress on nuclear receptor RORγ modulators</span>. <i>Bioorg. Med. Chem. Lett</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4387</span>– <span class="NLM_lpage">4393</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.bmcl.2016.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=27542308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4387-4393&author=P.+Cyrauthor=S.+M.+Bronnerauthor=J.+J.+Crawford&title=Recent+progress+on+nuclear+receptor+ROR%CE%B3+modulators&doi=10.1016%2Fj.bmcl.2016.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress on nuclear receptor RORγ modulators</span></div><div class="casAuthors">Cyr, Patrick; Bronner, Sarah M.; Crawford, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4387-4393</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The retinoic acid receptor-related orphan receptor RORγ plays key roles in the development and differentiation of TH17 cells, and thus in IL-17 expression, thymocyte development and regulation of metab.  With the recent progression into phase 2 clin. trials of both oral and topically administered inverse agonists, and with others close behind, there is significant interest in the discovery of RORγ modulators.  This digest covers key developments around RORγ agonists, antagonists and inverse agonists; orthosteric and allosteric binders; and aims to summarize the available information concerning the potential utility of RORγ modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD6nrse0GiBLVg90H21EOLACvtfcHk0lixriqbsIXWog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7rL&md5=688885fc5c71ce01b86df6c9703b51ec</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DCyr%26aufirst%3DP.%26aulast%3DBronner%26aufirst%3DS.%2BM.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26atitle%3DRecent%2520progress%2520on%2520nuclear%2520receptor%2520ROR%25CE%25B3%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett%26date%3D2016%26volume%3D26%26spage%3D4387%26epage%3D4393%26doi%3D10.1016%2Fj.bmcl.2016.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pandya, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachchidanand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, R. C.</span></span> <span> </span><span class="NLM_article-title">Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">10976</span>– <span class="NLM_lpage">10995</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00588</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00588" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlWrtL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=10976-10995&author=V.+B.+Pandyaauthor=S.+Kumarauthor=S.+Sachchidanandauthor=R.+Sharmaauthor=R.+C.+Desai&title=Combating+Autoimmune+Diseases+With+Retinoic+Acid+Receptor-Related+Orphan+Receptor-%CE%B3+%28ROR%CE%B3+or+RORc%29+Inhibitors%3A+Hits+and+Misses&doi=10.1021%2Facs.jmedchem.8b00588"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses</span></div><div class="casAuthors">Pandya, Vrajesh B.; Kumar, Sanjay; Sachchidanand; Sharma, Rajiv; Desai, Ranjit C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10976-10995</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The nuclear receptor retinoic acid receptor-related orphan receptor gamma (RORγ or RORc) is a key transcription factor for the prodn. of pro-inflammatory cytokines implicated in the pathogenesis of autoimmune diseases.  Recently, small mol. inhibitors of RORc drew the enormous attention of the research community worldwide as a possible therapy for autoimmune diseases, mediated by the IL-17 cytokine.  With the clin. proof-of-concept inferred from a small mol. inhibitor VTP-43742 for psoriasis and recent inflow of several RORc inhibitors into the clinic for therapeutic interventions in autoimmune diseases, this field continues to evolve.  This review briefly summarizes the RORc inhibitors disclosed in the literature and discusses the progress made by these inhibitors in combating autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKGqZl3bPbtLVg90H21EOLACvtfcHk0lixriqbsIXWog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlWrtL7E&md5=4113d22f73ab2911535eef053801994d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00588%26sid%3Dliteratum%253Aachs%26aulast%3DPandya%26aufirst%3DV.%2BB.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DSachchidanand%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DDesai%26aufirst%3DR.%2BC.%26atitle%3DCombating%2520Autoimmune%2520Diseases%2520With%2520Retinoic%2520Acid%2520Receptor-Related%2520Orphan%2520Receptor-%25CE%25B3%2520%2528ROR%25CE%25B3%2520or%2520RORc%2529%2520Inhibitors%253A%2520Hits%2520and%2520Misses%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D10976%26epage%3D10995%26doi%3D10.1021%2Facs.jmedchem.8b00588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bronner, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zbieg, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span> <span> </span><span class="NLM_article-title">RORgamma antagonists and inverse agonists: a patent review</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1080/13543776.2017.1236918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1080%2F13543776.2017.1236918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=27629281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsF2nsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=101-112&author=S.+M.+Bronnerauthor=J.+R.+Zbiegauthor=J.+J.+Crawford&title=RORgamma+antagonists+and+inverse+agonists%3A+a+patent+review&doi=10.1080%2F13543776.2017.1236918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">RORγ antagonists and inverse agonists: a patent review</span></div><div class="casAuthors">Bronner, Sarah M.; Zbieg, Jason R.; Crawford, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-112</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The transcription factor RORγ plays a crit. role in the expression of pro-inflammatory cytokine interleukin IL-17 and is therefore an attractive target for the treatment of inflammatory diseases.  Interest in this mol. target has been heightened by the advancement of orally and topically administered RORγ modulators into clin. trials.  The present review seeks to summarize published patent applications from assignee companies that have disclosed Investigational New Drug (IND) filings for small mol. RORγ/RORγt antagonists and inverse agonists.  The field of RORγ research is extremely competitive, with the majority of companies targeting psoriasis as the primary disease indication.  Vitae Pharmaceuticals is currently the most advanced, with a potential first-in-class oral RORγ-modulator for the treatment of psoriasis.  Future efforts will likely expand into potential applications of RORγ-modulators in the lesser explored immune-related areas of rheumatoid arthritis, type 1 diabetes, lupus, and irritable bowel disorder, as well as cancer immunotherapy and castration-resistant prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj8lMzWsYVA7Vg90H21EOLACvtfcHk0lixriqbsIXWog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsF2nsbzP&md5=d80db6c4c948bc12c5d0ce4b41edd2fb</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1080%2F13543776.2017.1236918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2017.1236918%26sid%3Dliteratum%253Aachs%26aulast%3DBronner%26aufirst%3DS.%2BM.%26aulast%3DZbieg%26aufirst%3DJ.%2BR.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26atitle%3DRORgamma%2520antagonists%2520and%2520inverse%2520agonists%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2017%26volume%3D27%26spage%3D101%26epage%3D112%26doi%3D10.1080%2F13543776.2017.1236918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Retinoic acid receptor-related orphan receptor gamma-t (RORγt) inhibitors in clinical development for the treatment of autoimmune diseases: a patent review (2016-present)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1080/13543776.2019.1655541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1080%2F13543776.2019.1655541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=31403347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A280%3ADC%252BB3MvntVGnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=663-674&author=N.+Sunauthor=H.+Guoauthor=Y.+Wang&title=Retinoic+acid+receptor-related+orphan+receptor+gamma-t+%28ROR%CE%B3t%29+inhibitors+in+clinical+development+for+the+treatment+of+autoimmune+diseases%3A+a+patent+review+%282016-present%29&doi=10.1080%2F13543776.2019.1655541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoic acid receptor-related orphan receptor gamma-t (RORγt) inhibitors in clinical development for the treatment of autoimmune diseases: a patent review (2016-present)</span></div><div class="casAuthors">Sun Nannan; Guo Huimin; Wang Yonghui</div><div class="citationInfo"><span class="NLM_cas:title">Expert opinion on therapeutic patents</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">663-674</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Introduction: RORγt is critical for the differentiation of Th17 cells and the production of IL-17.  Inhibition of RORγt is considered as a promising strategy to treat Th17-mediated autoimmune diseases.  Quite a number of RORγt inhibitors have been progressed into clinical trials, besides much biological interests in this attractive target.  Areas covered: This article reviews the progress of RORγt inhibitors (antagonists and inverse agonists) that are active in clinical development based on an analysis of the related patents published by the corresponding companies in the period of January 2016 through May 2019.  Expert opinion: The development of RORγt inhibitors has gone through a boom period in the past three years.  However, with a little bit frustration, some of the frontrunner clinical compounds were either discontinued or suspended for further development possibly due to some safety concerns or lack of efficacy in humans.  There is a need to probe deeply into these concerns in the on-going pre-clinical and clinical studies.  Given the effectiveness of a few recently FDA-approved anti-IL-17(R) antibodies on psoriasis, the discovery of RORγt inhibitors continues to be an exciting field for the development of novel treatment approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9_8Bn0AMJVtFxYDaSSP8XfW6udTcc2eb6leBfZitWPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MvntVGnsg%253D%253D&md5=7ff7335975148b7ee7fd28d23f89b6c9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1080%2F13543776.2019.1655541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2019.1655541%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DN.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DRetinoic%2520acid%2520receptor-related%2520orphan%2520receptor%2520gamma-t%2520%2528ROR%25CE%25B3t%2529%2520inhibitors%2520in%2520clinical%2520development%2520for%2520the%2520treatment%2520of%2520autoimmune%2520diseases%253A%2520a%2520patent%2520review%2520%25282016-present%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2019%26volume%3D29%26spage%3D663%26epage%3D674%26doi%3D10.1080%2F13543776.2019.1655541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dulubova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reisman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotema, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevino, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eken, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigley, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visnick, M.</span></span> <span> </span><span class="NLM_article-title">A novel series of cysteine-dependent, allosteric inverse agonists of the nuclear receptor RORγt</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">126967</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2020.126967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.bmcl.2020.126967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=32005415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVGksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2020&pages=126967&author=X.+Jiangauthor=I.+Dulubovaauthor=S.+A.+Reismanauthor=M.+Hotemaauthor=C.+I.+Leeauthor=L.+Liuauthor=L.+McCauleyauthor=I.+Trevinoauthor=D.+A.+Fergusonauthor=Y.+Ekenauthor=A.+K.+Wilsonauthor=W.+C.+Wigleyauthor=M.+Visnick&title=A+novel+series+of+cysteine-dependent%2C+allosteric+inverse+agonists+of+the+nuclear+receptor+ROR%CE%B3t&doi=10.1016%2Fj.bmcl.2020.126967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A novel series of cysteine-dependent, allosteric inverse agonists of the nuclear receptor RORγt</span></div><div class="casAuthors">Jiang, Xin; Dulubova, Irina; Reisman, Scott A.; Hotema, Martha; Lee, Chun-Yue I.; Liu, Liping; McCauley, Lyndsey; Trevino, Isaac; Ferguson, Deborah A.; Eken, Yigitcan; Wilson, Angela K.; Wigley, W. Christian; Visnick, Melean</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">126967</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibition of the nuclear receptor Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) is a promising strategy for the treatment of autoimmune diseases.  In this paper, we describe a series of allosteric, cysteine-dependent, inverse agonists of RORγt.  Site-directed mutagenesis and mol. dynamics simulations are supportive of a mechanism of action through specific binding to Cys476 on alpha helix 11 of the ligand binding domain (LBD).  Representative compds. in the series selectively inhibit RORγt, potently suppress interleukin-17A (IL-17A) prodn. by human CD4+ T cells, and inhibit T helper 17 (Th17) differentiation from human naive CD4+ T cells.  The advanced compd. 13 is orally bioavailable and active at a dose of 3 mg/kg in a murine collagen-induced model of rheumatoid arthritis.  Collectively, these data are supportive of the development of compd. 13 in autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTWstjHsgufrVg90H21EOLACvtfcHk0lgE1vFNgBz9Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVGksbs%253D&md5=d135fd96abe54ce513507132dcdedc26</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2020.126967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2020.126967%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DDulubova%26aufirst%3DI.%26aulast%3DReisman%26aufirst%3DS.%2BA.%26aulast%3DHotema%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DC.%2BI.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMcCauley%26aufirst%3DL.%26aulast%3DTrevino%26aufirst%3DI.%26aulast%3DFerguson%26aufirst%3DD.%2BA.%26aulast%3DEken%26aufirst%3DY.%26aulast%3DWilson%26aufirst%3DA.%2BK.%26aulast%3DWigley%26aufirst%3DW.%2BC.%26aulast%3DVisnick%26aufirst%3DM.%26atitle%3DA%2520novel%2520series%2520of%2520cysteine-dependent%252C%2520allosteric%2520inverse%2520agonists%2520of%2520the%2520nuclear%2520receptor%2520ROR%25CE%25B3t%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D30%26spage%3D126967%26doi%3D10.1016%2Fj.bmcl.2020.126967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leijten-van de Gevel, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, R. M. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunsveld, L.</span></span> <span> </span><span class="NLM_article-title">Allosteric small molecule modulators of nuclear receptors</span>. <i>Mol. Cell. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>485</i></span>,  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.mce.2019.01.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.mce.2019.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=30703487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtVWhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2019&pages=20-34&author=F.+A.+Meijerauthor=I.+A.+Leijten-van+de+Gevelauthor=R.+M.+J.+M.+de+Vriesauthor=L.+Brunsveld&title=Allosteric+small+molecule+modulators+of+nuclear+receptors&doi=10.1016%2Fj.mce.2019.01.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric small molecule modulators of nuclear receptors</span></div><div class="casAuthors">Meijer, Femke A.; Leijten-van de Gevel, Iris A.; de Vries, Rens M. J. M.; Brunsveld, Luc</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">20-34</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Nuclear Receptors (NRs) are multi-domain proteins, whose natural regulation occurs via ligands for a classical, orthosteric, binding pocket and via intra- and inter-domain allosteric mechanisms.  Allosteric modulation of NRs via synthetic small mols. has recently emerged as an interesting entry to address the need for small mols. targeting NRs in pathol., via novel modes of action and with beneficial profiles.  In this review the general concept of allosteric modulation in drug discovery is first discussed, serving as a background and inspiration for NRs.  Subsequently, the review focuses on examples of small mols. that allosterically modulate NRs, with a strong focus on structural information and the ligand binding domain.  Recently discovered nanomolar potent allosteric site NR modulators are catapulting allosteric targeting of NRs to the center of attention.  The obtained insights serve as a basis for recommendations for the next steps to take in allosteric small mol. targeting of NRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsuqvFC3-gY7Vg90H21EOLACvtfcHk0lgE1vFNgBz9Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtVWhs7k%253D&md5=a76ceb455cdf901bb7d7dae77686afc9</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2019.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2019.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DF.%2BA.%26aulast%3DLeijten-van%2Bde%2BGevel%26aufirst%3DI.%2BA.%26aulast%3Dde%2BVries%26aufirst%3DR.%2BM.%2BJ.%2BM.%26aulast%3DBrunsveld%26aufirst%3DL.%26atitle%3DAllosteric%2520small%2520molecule%2520modulators%2520of%2520nuclear%2520receptors%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2019%26volume%3D485%26spage%3D20%26epage%3D34%26doi%3D10.1016%2Fj.mce.2019.01.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moore, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayne, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katzenellenbogen, J. A.</span></span> <span> </span><span class="NLM_article-title">Minireview: Not picking pockets: nuclear receptor alternate-site modulators (NRAMs)</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">683</span>– <span class="NLM_lpage">695</span>, <span class="refDoi"> DOI: 10.1210/me.2009-0362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1210%2Fme.2009-0362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=19933380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVOhsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=683-695&author=T.+W.+Mooreauthor=C.+G.+Mayneauthor=J.+A.+Katzenellenbogen&title=Minireview%3A+Not+picking+pockets%3A+nuclear+receptor+alternate-site+modulators+%28NRAMs%29&doi=10.1210%2Fme.2009-0362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Not picking pockets: nuclear receptor alternate-site modulators (NRAMs)</span></div><div class="casAuthors">Moore, Terry W.; Mayne, Christopher G.; Katzenellenbogen, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">683-695</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Because of their central importance in gene regulation and mediating the actions of many hormones, the nuclear receptors (NRs) have long been recognized as very important biol. and pharmaceutical targets.  Of all the surfaces available on a given NR, the singular site for regulation of receptor activity has almost invariably been the ligand-binding pocket of the receptor, the site where agonists, antagonists, and selective NR modulators interact.  With our increasing understanding of the multiple mol. components involved in NR action, researchers have recently begun to look to addnl. interaction sites on NRs for regulating their activities by novel mechanisms.  The alternate NR-assocd. interaction sites that have been targeted include the coactivator-binding groove and allosteric sites in the ligand-binding domain, the zinc fingers of the DNA-binding domain, and the NR response element in DNA.  The studies thus far have been performed with the estrogen receptors, the androgen receptor (AR), the thyroid hormone receptors, and the pregnane X receptor.  Phenotypic and conformation-based screens have also identified small mol. modulators that are believed to function through the NRs but have, as yet, unknown sites and mechanisms of action.  The rewards from investigation of these NR alternate-site modulators should be the discovery of new therapeutic approaches and novel agents for regulating the activities of these important NR proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVtxERmnC5SLVg90H21EOLACvtfcHk0lgE1vFNgBz9Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVOhsb4%253D&md5=cd35a2ad9714316347764e692455cf65</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1210%2Fme.2009-0362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2009-0362%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DT.%2BW.%26aulast%3DMayne%26aufirst%3DC.%2BG.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26atitle%3DMinireview%253A%2520Not%2520picking%2520pockets%253A%2520nuclear%2520receptor%2520alternate-site%2520modulators%2520%2528NRAMs%2529%26jtitle%3DMol.%2520Endocrinol.%26date%3D2010%26volume%3D24%26spage%3D683%26epage%3D695%26doi%3D10.1210%2Fme.2009-0362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caboni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, D. G.</span></span> <span> </span><span class="NLM_article-title">Beyond the ligand-binding pocket: targeting alternate sites in nuclear receptors</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1118</span>, <span class="refDoi"> DOI: 10.1002/med.21275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1002%2Fmed.21275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=23344935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1ChtbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=1081-1118&author=L.+Caboniauthor=D.+G.+Lloyd&title=Beyond+the+ligand-binding+pocket%3A+targeting+alternate+sites+in+nuclear+receptors&doi=10.1002%2Fmed.21275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond the Ligand-Binding Pocket: Targeting Alternate Sites in Nuclear Receptors</span></div><div class="casAuthors">Caboni, Laura; Lloyd, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1081-1118</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors (NRs) are a family of ligand-modulated transcription factors with significant therapeutic relevance from metabolic disorders and inflammation to cancer, neurodegenerative, and psychiatric disorders.  Drug discovery efforts are typically concd. on modulating the natural ligand action within the ligand-binding pocket (LBP) in the C-terminal ligand-binding domain (LBD).  Drawbacks of LBP-based strategies include physiol. alterations due to disruption of ligand binding and difficulties in achieving tissue specificity.  Furthermore, the lack of a "pure" and predictable mechanism of action predisposes such intervention toward drug resistance.  Recent outstanding progress in our understanding of NR biol. has shifted the focus of drug discovery efforts from inside to outside the LBP, affording consideration to the interaction between NRs and coactivator proteins, the interaction between NRs and DNA and the NRs' ligand-independent functions.  This review encompasses such currently available NR non-LBP-based interventions and their potential application in therapy or as specific tools to probe NR biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAhSzBdWcj87Vg90H21EOLACvtfcHk0lgETu6s_Rm44g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1ChtbrK&md5=e30fa7f4b5df11580ad77c9dcbabcd03</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fmed.21275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21275%26sid%3Dliteratum%253Aachs%26aulast%3DCaboni%26aufirst%3DL.%26aulast%3DLloyd%26aufirst%3DD.%2BG.%26atitle%3DBeyond%2520the%2520ligand-binding%2520pocket%253A%2520targeting%2520alternate%2520sites%2520in%2520nuclear%2520receptors%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D1081%26epage%3D1118%26doi%3D10.1002%2Fmed.21275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tice, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.-J.</span></span> <span> </span><span class="NLM_article-title">Non-canonical modulators of nuclear receptors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4157</span>– <span class="NLM_lpage">4164</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.07.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.bmcl.2016.07.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=27503683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlaju7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4157-4164&author=C.+M.+Ticeauthor=Y.-J.+Zheng&title=Non-canonical+modulators+of+nuclear+receptors&doi=10.1016%2Fj.bmcl.2016.07.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Non-canonical modulators of nuclear receptors</span></div><div class="casAuthors">Tice, Colin M.; Zheng, Ya-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4157-4164</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Like G protein-coupled receptors (GPCRs) and protein kinases, nuclear receptors (NRs) are a rich source of pharmaceutical targets.  Over 80 NR-targeting drugs have been approved for 18 NRs.  The focus of drug discovery in NRs has hitherto been on identifying ligands that bind to the canonical ligand binding pockets of the C-terminal ligand binding domains (LBDs).  Due to the development of drug resistance and selectivity concerns, there has been considerable interest in exploring other, non-canonical ligand binding sites.  Unfortunately, the potencies of compds. binding at other sites have generally not been sufficient for clin. development.  However, the situation has changed dramatically over the last 3 years, as compds. with sufficient potency have been reported for several NR targets.  Here we review recent developments in this area from a medicinal chem. point of view in the hope of stimulating further interest in this area of research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopu9N4QDGsXrVg90H21EOLACvtfcHk0lgETu6s_Rm44g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlaju7bN&md5=5677a03f0e607260d148c48e24d49110</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.07.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.07.067%26sid%3Dliteratum%253Aachs%26aulast%3DTice%26aufirst%3DC.%2BM.%26aulast%3DZheng%26aufirst%3DY.-J.%26atitle%3DNon-canonical%2520modulators%2520of%2520nuclear%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D4157%26epage%3D4164%26doi%3D10.1016%2Fj.bmcl.2016.07.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheepstra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leysen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Almen, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piesvaux, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutilek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Eenennaam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagpal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soisson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornienko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correll, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trotter, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Stelt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oubrie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parthasarathy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunsveld, L.</span></span> <span> </span><span class="NLM_article-title">Identification of an allosteric binding site for RORγt inhibition</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e8833</span> <span class="refDoi"> DOI: 10.1038/ncomms9833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1038%2Fncomms9833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=26640126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKit7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&author=M.+Scheepstraauthor=S.+Leysenauthor=G.+C.+van+Almenauthor=J.+R.+Millerauthor=J.+Piesvauxauthor=V.+Kutilekauthor=H.+van+Eenennaamauthor=H.+Zhangauthor=K.+Barrauthor=S.+Nagpalauthor=S.+M.+Soissonauthor=M.+Kornienkoauthor=K.+Wileyauthor=N.+Elsenauthor=S.+Sharmaauthor=C.+C.+Correllauthor=B.+W.+Trotterauthor=M.+van+der+Steltauthor=A.+Oubrieauthor=C.+Ottmannauthor=G.+Parthasarathyauthor=L.+Brunsveld&title=Identification+of+an+allosteric+binding+site+for+ROR%CE%B3t+inhibition&doi=10.1038%2Fncomms9833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an allosteric binding site for RORγt inhibition</span></div><div class="casAuthors">Scheepstra, Marcel; Leysen, Seppe; van Almen, Geert C.; Miller, J. Richard; Piesvaux, Jennifer; Kutilek, Victoria; van Eenennaam, Hans; Zhang, Hongjun; Barr, Kenneth; Nagpal, Sunil; Soisson, Stephen M.; Kornienko, Maria; Wiley, Kristen; Elsen, Nathaniel; Sharma, Sujata; Correll, Craig C.; Trotter, B. Wesley; van der Stelt, Mario; Oubrie, Arthur; Ottmann, Christian; Parthasarathy, Gopal; Brunsveld, Luc</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8833/1-8833/10</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">RORγt is crit. for the differentiation and proliferation of Th17 cells assocd. with several chronic autoimmune diseases.  We report the discovery of a novel allosteric binding site on the nuclear receptor RORγt.  Co-crystn. of the ligand binding domain (LBD) of RORγt with a series of small-mol. antagonists demonstrates occupancy of a previously unreported allosteric binding pocket.  Binding at this non-canonical site induces an unprecedented conformational reorientation of helix 12 in the RORγt LBD, which blocks cofactor binding.  The functional consequence of this allosteric ligand-mediated conformation is inhibition of function as evidenced by both biochem. and cellular studies.  RORγt function is thus antagonized in a manner molecularly distinct from that of previously described orthosteric RORγt ligands.  This brings forward an approach to target RORγt for the treatment of Th17-mediated autoimmune diseases.  The elucidation of an unprecedented modality of pharmacol. antagonism establishes a mechanism for modulation of nuclear receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNcktcUUFl77Vg90H21EOLACvtfcHk0lgETu6s_Rm44g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKit7zL&md5=409b08232ecdd3f3e82fa660585c989d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fncomms9833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9833%26sid%3Dliteratum%253Aachs%26aulast%3DScheepstra%26aufirst%3DM.%26aulast%3DLeysen%26aufirst%3DS.%26aulast%3Dvan%2BAlmen%26aufirst%3DG.%2BC.%26aulast%3DMiller%26aufirst%3DJ.%2BR.%26aulast%3DPiesvaux%26aufirst%3DJ.%26aulast%3DKutilek%26aufirst%3DV.%26aulast%3Dvan%2BEenennaam%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBarr%26aufirst%3DK.%26aulast%3DNagpal%26aufirst%3DS.%26aulast%3DSoisson%26aufirst%3DS.%2BM.%26aulast%3DKornienko%26aufirst%3DM.%26aulast%3DWiley%26aufirst%3DK.%26aulast%3DElsen%26aufirst%3DN.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DCorrell%26aufirst%3DC.%2BC.%26aulast%3DTrotter%26aufirst%3DB.%2BW.%26aulast%3Dvan%2Bder%2BStelt%26aufirst%3DM.%26aulast%3DOubrie%26aufirst%3DA.%26aulast%3DOttmann%26aufirst%3DC.%26aulast%3DParthasarathy%26aufirst%3DG.%26aulast%3DBrunsveld%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520an%2520allosteric%2520binding%2520site%2520for%2520ROR%25CE%25B3t%2520inhibition%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26doi%3D10.1038%2Fncomms9833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karstens, W. F. J.</span>; <span class="NLM_string-name">van der Stelt, M.</span>; <span class="NLM_string-name">Cals, J.</span>; <span class="NLM_string-name">Azevedo, R. C. R. G.</span>; <span class="NLM_string-name">Barr, K. J.</span>; <span class="NLM_string-name">Zhang, H.</span>; <span class="NLM_string-name">Beresis, R. T.</span>; <span class="NLM_string-name">Zhang, D.</span>; <span class="NLM_string-name">Duan, X.</span></span> <span> </span><span class="NLM_article-title">RORgammaT Inhibitors</span>. PCT Int. Appl. <span class="NLM_patent">WO 2012106995 A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=W.+F.+J.+Karstens&author=M.+van+der+Stelt&author=J.+Cals&author=R.+C.+R.+G.+Azevedo&author=K.+J.+Barr&author=H.+Zhang&author=R.+T.+Beresis&author=D.+Zhang&author=X.+Duan&title=RORgammaT+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKarstens%26aufirst%3DW.%2BF.%2BJ.%26atitle%3DRORgammaT%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leijten-van
de Gevel, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunsveld, L.</span></span> <span> </span><span class="NLM_article-title">Delineation of the molecular determinants of the unique allosteric binding site of the orphan nuclear receptor RORγt</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>295</i></span>,  <span class="NLM_fpage">9183</span>– <span class="NLM_lpage">9191</span>, <span class="refDoi"> DOI: 10.1074/jbc.ra120.013581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1074%2Fjbc.RA120.013581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=32439807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFWktLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2020&pages=9183-9191&author=I.+A.+Leijten-van%0Ade+Gevelauthor=L.+Brunsveld&title=Delineation+of+the+molecular+determinants+of+the+unique+allosteric+binding+site+of+the+orphan+nuclear+receptor+ROR%CE%B3t&doi=10.1074%2Fjbc.ra120.013581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Delineation of the molecular determinants of the unique allosteric binding site of the orphan nuclear receptor RORγt</span></div><div class="casAuthors">Leijten-van de Gevel, Iris A.; Brunsveld, Luc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">9183-9192</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">1083-351X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nuclear receptors (NRs) are high-interest targets in drug discovery because of their involvement in numerous biol. processes and diseases.  Classically, NRs are targeted via their hydrophobic, orthosteric pocket.  Although successful, this approach comes with challenges, including off-target effects due to lack of selectivity.  Allosteric modulation of NR activity constitutes a promising pharmacol. strategy.  The retinoic acid receptor-related orphan receptor-γt (RORγt) is a constitutively active NR that pos. regulates the expression of interleukin-17 in T helper 17 cells.  Inhibiting this process is an emerging strategy for managing autoimmune diseases.  Recently, an allosteric binding pocket in the C-terminal region of the ligand-binding domain (LBD) of RORγt was discovered that is amenable to small-mol. drug discovery.  Compds. binding this pocket induce a reorientation of helix 12, thereby preventing coactivator recruitment.  Therefore, inverse agonists binding this site with high affinity are actively being pursued.  To elucidate the pocket formation mechanism, verify the uniqueness of this pocket, and substantiate the relevance of targeting this site, here we identified the key characteristics of the RORγt allosteric region.  We evaluated the effects of substitutions in the LBD on coactivator, orthosteric, and allosteric ligand binding.  We found that two mol. elements unique to RORγt, the length of helix 119 and a Gln-487 residue, are crucial for the formation of the allosteric pocket.  The unique combination of elements present in RORγt suggests a high potential for subtype-selective targeting of this NR to more effectively treat patients with autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptob_4Lxg5orVg90H21EOLACvtfcHk0lhtmtZe73y0Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFWktLfF&md5=1ff65a2cf0a09633bd9f05848698a837</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA120.013581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA120.013581%26sid%3Dliteratum%253Aachs%26aulast%3DLeijten-van%2Bde%2BGevel%26aufirst%3DI.%2BA.%26aulast%3DBrunsveld%26aufirst%3DL.%26atitle%3DDelineation%2520of%2520the%2520molecular%2520determinants%2520of%2520the%2520unique%2520allosteric%2520binding%2520site%2520of%2520the%2520orphan%2520nuclear%2520receptor%2520ROR%25CE%25B3t%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2020%26volume%3D295%26spage%3D9183%26epage%3D9191%26doi%3D10.1074%2Fjbc.ra120.013581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Vries, R. M. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doveston, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leijten-van
de Gevel, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunsveld, L.</span></span> <span> </span><span class="NLM_article-title">Cooperativity between the Orthosteric and Allosteric Ligand Binding Sites of RORγt</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>118</i></span>, <span class="NLM_elocation-id">e2021287118</span> <span class="refDoi"> DOI: 10.1073/pnas.2021287118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1073%2Fpnas.2021287118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=33536342" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2021&author=R.+M.+J.+M.+de%0AVriesauthor=F.+A.+Meijerauthor=R.+G.+Dovestonauthor=I.+A.+Leijten-van%0Ade+Gevelauthor=L.+Brunsveld&title=Cooperativity+between+the+Orthosteric+and+Allosteric+Ligand+Binding+Sites+of+ROR%CE%B3t&doi=10.1073%2Fpnas.2021287118"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1073%2Fpnas.2021287118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.2021287118%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BVries%26aufirst%3DR.%2BM.%2BJ.%2BM.%26aulast%3DMeijer%26aufirst%3DF.%2BA.%26aulast%3DDoveston%26aufirst%3DR.%2BG.%26aulast%3DLeijten-van%2Bde%2BGevel%26aufirst%3DI.%2BA.%26aulast%3DBrunsveld%26aufirst%3DL.%26atitle%3DCooperativity%2520between%2520the%2520Orthosteric%2520and%2520Allosteric%2520Ligand%2520Binding%2520Sites%2520of%2520ROR%25CE%25B3t%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2021%26volume%3D118%26doi%3D10.1073%2Fpnas.2021287118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doveston, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vries, R. M. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, A. A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leysen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheepstra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milroy, L.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunsveld, L.</span></span> <span> </span><span class="NLM_article-title">Ligand-Based Design of Allosteric Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Inverse Agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">241</span>– <span class="NLM_lpage">259</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01372</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01372" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlOhtrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=241-259&author=F.+A.+Meijerauthor=R.+G.+Dovestonauthor=R.+M.+J.+M.+De+Vriesauthor=G.+M.+Vosauthor=A.+A.+A.+Vosauthor=S.+Leysenauthor=M.+Scheepstraauthor=C.+Ottmannauthor=L.-G.+Milroyauthor=L.+Brunsveld&title=Ligand-Based+Design+of+Allosteric+Retinoic+Acid+Receptor-Related+Orphan+Receptor+%CE%B3t+%28ROR%CE%B3t%29+Inverse+Agonists&doi=10.1021%2Facs.jmedchem.9b01372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-Based Design of Allosteric Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Inverse Agonists</span></div><div class="casAuthors">Meijer, Femke A.; Doveston, Richard G.; de Vries, Rens M. J. M.; Vos, Gael M.; Vos, Alex A. A.; Leysen, Seppe; Scheepstra, Marcel; Ottmann, Christian; Milroy, Lech-Gustav; Brunsveld, Luc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">241-259</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Retinoic acid receptor-related orphan receptor γt (RORγt) is a nuclear receptor assocd. with the pathogenesis of autoimmune diseases.  Allosteric inhibition of RORγt is conceptually new, unique for this specific nuclear receptor, and offers advantages over traditional orthosteric inhibition.  Here, we report a highly efficient in silico-guided approach that led to the discovery of novel allosteric RORγt inverse agonists with a distinct isoxazole chemotype.  The the most potent compd., I (FM26), displayed submicromolar inhibition in a coactivator recruitment assay and effectively reduced IL-17a mRNA prodn. in EL4 cells, a marker of RORγt activity.  The projected allosteric mode of action of I was confirmed by biochem. expts. and cocrystn. with the RORγt ligand binding domain.  The isoxazole compds. have promising pharmacokinetic properties comparable to other allosteric ligands but with a more diverse chemotype.  The efficient ligand-based design approach adopted demonstrates its versatility in generating chem. diversity for allosteric targeting of RORγt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolfmtpPwH8IbVg90H21EOLACvtfcHk0lhtmtZe73y0Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlOhtrbF&md5=db24c8aba88c9d59d93167cd8212236e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01372%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DF.%2BA.%26aulast%3DDoveston%26aufirst%3DR.%2BG.%26aulast%3DDe%2BVries%26aufirst%3DR.%2BM.%2BJ.%2BM.%26aulast%3DVos%26aufirst%3DG.%2BM.%26aulast%3DVos%26aufirst%3DA.%2BA.%2BA.%26aulast%3DLeysen%26aufirst%3DS.%26aulast%3DScheepstra%26aufirst%3DM.%26aulast%3DOttmann%26aufirst%3DC.%26aulast%3DMilroy%26aufirst%3DL.-G.%26aulast%3DBrunsveld%26aufirst%3DL.%26atitle%3DLigand-Based%2520Design%2520of%2520Allosteric%2520Retinoic%2520Acid%2520Receptor-Related%2520Orphan%2520Receptor%2520%25CE%25B3t%2520%2528ROR%25CE%25B3t%2529%2520Inverse%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D241%26epage%3D259%26doi%3D10.1021%2Facs.jmedchem.9b01372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robarge, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerhill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists</span>. <i>Bioorg. Med. Chem. Lett</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2907</span>– <span class="NLM_lpage">2912</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.05.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.bmcl.2015.05.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=26048793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpt1yrtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2907-2912&author=B.+P.+Fauberauthor=A.+Gobbiauthor=K.+Robargeauthor=A.+Zhouauthor=A.+Barnardauthor=J.+Caoauthor=Y.+Dengauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Ganguliauthor=J.+Hawkinsauthor=A.+R.+Johnsonauthor=H.+Laauthor=M.+Normanauthor=G.+Salmonauthor=S.+Summerhillauthor=W.+Ouyangauthor=W.+Tangauthor=H.+Wong&title=Discovery+of+imidazo%5B1%2C5-a%5Dpyridines+and+-pyrimidines+as+potent+and+selective+RORc+inverse+agonists&doi=10.1016%2Fj.bmcl.2015.05.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists</span></div><div class="casAuthors">Fauber, Benjamin P.; Gobbi, Alberto; Robarge, Kirk; Zhou, Aihe; Barnard, Adrian; Cao, Jianhua; Deng, Yuzhong; Eidenschenk, Celine; Everett, Christine; Ganguli, Arunima; Hawkins, Julie; Johnson, Adam R.; La, Hank; Norman, Maxine; Salmon, Gary; Summerhill, Susan; Ouyang, Wenjun; Tang, Wei; Wong, Harvey</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2907-2912</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The nuclear receptor (NR) retinoic acid receptor-related orphan receptor gamma (RORγ, RORc, or NR1F3) is a promising target for the treatment of autoimmune diseases.  RORc is a crit. regulator in the prodn. of the pro-inflammatory cytokine interleukin-17.  We discovered a series of potent and selective imidazo[1,5-a]pyridine and -pyrimidine RORc inverse agonists.  The most potent compds. displayed >300-fold selectivity for RORc over the other ROR family members, PPARγ, and NRs in our cellular selectivity panel.  The favorable potency, selectivity, and physiochem. properties of GNE-0946 (9) and GNE-6468 (28), in addn. to their potent suppression of IL-17 prodn. in human primary cells, support their use as chem. biol. tools to further explore the role of RORc in human biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIQTYB5nafXLVg90H21EOLACvtfcHk0lhdojWKEonBqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpt1yrtb0%253D&md5=d0e89e186488a9db8f7629fd86ed7ea0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.05.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.05.055%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DRobarge%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DA.%26aulast%3DBarnard%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGanguli%26aufirst%3DA.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DSalmon%26aufirst%3DG.%26aulast%3DSummerhill%26aufirst%3DS.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520imidazo%255B1%252C5-a%255Dpyridines%2520and%2520-pyrimidines%2520as%2520potent%2520and%2520selective%2520RORc%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett%26date%3D2015%26volume%3D25%26spage%3D2907%26epage%3D2912%26doi%3D10.1016%2Fj.bmcl.2015.05.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ouvry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouix-Peter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciesielski, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantalat, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duvert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feret, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzy, A.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musicki, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orfila, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parnet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polge, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raffin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rival, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taquet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoreau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennequin, L. F.</span></span> <span> </span><span class="NLM_article-title">Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonists</span>. <i>Bioorg. Med. Chem. Lett</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5802</span>– <span class="NLM_lpage">5808</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.bmcl.2016.10.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=27815118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslynsr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5802-5808&author=G.+Ouvryauthor=C.+Bouix-Peterauthor=F.+Ciesielskiauthor=L.+Chantalatauthor=O.+Christinauthor=C.+Cominoauthor=D.+Duvertauthor=C.+Feretauthor=C.+S.+Harrisauthor=L.+Lamyauthor=A.-P.+Luzyauthor=B.+Musickiauthor=D.+Orfilaauthor=J.+Pascauauthor=V.+Parnetauthor=A.+Perrinauthor=R.+Pierreauthor=G.+Polgeauthor=C.+Raffinauthor=Y.+Rivalauthor=N.+Taquetauthor=E.+Thoreauauthor=L.+F.+Hennequin&title=Discovery+of+phenoxyindazoles+and+phenylthioindazoles+as+ROR%CE%B3+inverse+agonists&doi=10.1016%2Fj.bmcl.2016.10.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonists</span></div><div class="casAuthors">Ouvry, Gilles; Bouix-Peter, Claire; Ciesielski, Fabrice; Chantalat, Laurent; Christin, Olivier; Comino, Catherine; Duvert, Denis; Feret, Christophe; Harris, Craig S.; Lamy, Laurent; Luzy, Anne-Pascale; Musicki, Branislav; Orfila, Danielle; Pascau, Jonathan; Parnet, Veronique; Perrin, Agnes; Pierre, Romain; Polge, Gaelle; Raffin, Catherine; Rival, Yves; Taquet, Nathalie; Thoreau, Etienne; Hennequin, Laurent F.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5802-5808</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Targeting the IL17 pathway and more specifically the nuclear receptor RORγ is thought to be beneficial in multiple skin disorders.  The Letter describes the discovery of phenoxyindazoles and thiophenoxy indazoles as potent RORγ inverse agonists.  Optimization of the potency and efforts to mitigate the phototoxic liability of the series are presented.  Finally, crystn. of the lead compd. revealed that the series bound to an allosteric site of the nuclear receptor.  Such compds. could be useful as tool compds. for understanding the impact of topical treatment on skin disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX7Dguvi_h8LVg90H21EOLACvtfcHk0lhdojWKEonBqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslynsr%252FM&md5=cd3aa2c246cfa35c98306096d823dccc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.023%26sid%3Dliteratum%253Aachs%26aulast%3DOuvry%26aufirst%3DG.%26aulast%3DBouix-Peter%26aufirst%3DC.%26aulast%3DCiesielski%26aufirst%3DF.%26aulast%3DChantalat%26aufirst%3DL.%26aulast%3DChristin%26aufirst%3DO.%26aulast%3DComino%26aufirst%3DC.%26aulast%3DDuvert%26aufirst%3DD.%26aulast%3DFeret%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DC.%2BS.%26aulast%3DLamy%26aufirst%3DL.%26aulast%3DLuzy%26aufirst%3DA.-P.%26aulast%3DMusicki%26aufirst%3DB.%26aulast%3DOrfila%26aufirst%3DD.%26aulast%3DPascau%26aufirst%3DJ.%26aulast%3DParnet%26aufirst%3DV.%26aulast%3DPerrin%26aufirst%3DA.%26aulast%3DPierre%26aufirst%3DR.%26aulast%3DPolge%26aufirst%3DG.%26aulast%3DRaffin%26aufirst%3DC.%26aulast%3DRival%26aufirst%3DY.%26aulast%3DTaquet%26aufirst%3DN.%26aulast%3DThoreau%26aufirst%3DE.%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DDiscovery%2520of%2520phenoxyindazoles%2520and%2520phenylthioindazoles%2520as%2520ROR%25CE%25B3%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett%26date%3D2016%26volume%3D26%26spage%3D5802%26epage%3D5808%26doi%3D10.1016%2Fj.bmcl.2016.10.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shaikh, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munot, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raje, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagaraj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamdar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavhane, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohote, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherkar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bala, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umrani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouduri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandikere, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhuniya, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mookhtiar, K. A.</span></span> <span> </span><span class="NLM_article-title">Discovery and pharmacological evaluation of indole derivatives as potent and selective RORγt inverse agonist for multiple autoimmune conditions</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">2208</span>– <span class="NLM_lpage">2217</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.06.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.bmcl.2019.06.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=31272795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlaqt7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=2208-2217&author=N.+S.+Shaikhauthor=J.+P.+Iyerauthor=Y.+S.+Munotauthor=P.+P.+Mukhopadhyayauthor=A.+A.+Rajeauthor=R.+Nagarajauthor=V.+Jamdarauthor=R.+Gavhaneauthor=M.+Lohoteauthor=P.+Sherkarauthor=M.+Balaauthor=R.+Petlaauthor=A.+Meruauthor=D.+Umraniauthor=S.+Rouduriauthor=S.+Joshiauthor=S.+Reddyauthor=V.+Kandikereauthor=D.+Bhuniyaauthor=B.+Kulkarniauthor=K.+A.+Mookhtiar&title=Discovery+and+pharmacological+evaluation+of+indole+derivatives+as+potent+and+selective+ROR%CE%B3t+inverse+agonist+for+multiple+autoimmune+conditions&doi=10.1016%2Fj.bmcl.2019.06.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and pharmacological evaluation of indole derivatives as potent and selective RORγt inverse agonist for multiple autoimmune conditions</span></div><div class="casAuthors">Shaikh, Nadim S.; Iyer, Jitesh P.; Munot, Yogesh S.; Mukhopadhyay, Partha P.; Raje, Amol A.; Nagaraj, Ranganayaki; Jamdar, Vijay; Gavhane, Ravindra; Lohote, Mahendra; Sherkar, Prasad; Bala, Madhu; Petla, Rajkanth; Meru, Ashwinkumar; Umrani, Dhananjay; Rouduri, Sreekanth; Joshi, Sachin; Reddy, Satyanarayan; Kandikere, Vishwottam; Bhuniya, Debnath; Kulkarni, Bheemashankar; Mookhtiar, Kasim A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2208-2217</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Targeting nuclear receptor RORγ is recognized to be beneficial in multiple autoimmune disorders.  We disclosed new indole analogs as potent RORγ inverse agonists.  RO-2 as one of the potent and orally bioavailable compds. was evaluated in various models of autoimmune disorder.  It showed potent suppression of downstream markers of RORγt activity in murine and human primary cells, ex vivo PD assay and in multiple animal models of autoimmune diseases.  The results indicate the potential of these indole analogs as orally bioavailable small mol. inverse agonists of RORγt, efficacious in various Th17 driven models of autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTZNKPrT6CpbVg90H21EOLACvtfcHk0lhdojWKEonBqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlaqt7fN&md5=c74da1da9ce3fc636a60aac9fd02f627</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.06.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.06.044%26sid%3Dliteratum%253Aachs%26aulast%3DShaikh%26aufirst%3DN.%2BS.%26aulast%3DIyer%26aufirst%3DJ.%2BP.%26aulast%3DMunot%26aufirst%3DY.%2BS.%26aulast%3DMukhopadhyay%26aufirst%3DP.%2BP.%26aulast%3DRaje%26aufirst%3DA.%2BA.%26aulast%3DNagaraj%26aufirst%3DR.%26aulast%3DJamdar%26aufirst%3DV.%26aulast%3DGavhane%26aufirst%3DR.%26aulast%3DLohote%26aufirst%3DM.%26aulast%3DSherkar%26aufirst%3DP.%26aulast%3DBala%26aufirst%3DM.%26aulast%3DPetla%26aufirst%3DR.%26aulast%3DMeru%26aufirst%3DA.%26aulast%3DUmrani%26aufirst%3DD.%26aulast%3DRouduri%26aufirst%3DS.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DReddy%26aufirst%3DS.%26aulast%3DKandikere%26aufirst%3DV.%26aulast%3DBhuniya%26aufirst%3DD.%26aulast%3DKulkarni%26aufirst%3DB.%26aulast%3DMookhtiar%26aufirst%3DK.%2BA.%26atitle%3DDiscovery%2520and%2520pharmacological%2520evaluation%2520of%2520indole%2520derivatives%2520as%2520potent%2520and%2520selective%2520ROR%25CE%25B3t%2520inverse%2520agonist%2520for%2520multiple%2520autoimmune%2520conditions%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D2208%26epage%3D2217%26doi%3D10.1016%2Fj.bmcl.2019.06.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapointe, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azevedo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cals, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correll, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Eenenaam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karstens, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maclean, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moy, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagpal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oubrie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palte, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parthasarathy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciammetta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Stelt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodhouse, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trotter, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, K.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune Diseases</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00431</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00431" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtVGnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=114-119&author=H.+Zhangauthor=B.+T.+Lapointeauthor=N.+Anthonyauthor=R.+Azevedoauthor=J.+Calsauthor=C.+C.+Correllauthor=M.+Danielsauthor=S.+Deshmukhauthor=H.+van+Eenenaamauthor=H.+Fergusonauthor=L.+G.+Hegdeauthor=W.+J.+Karstensauthor=J.+Macleanauthor=J.+R.+Millerauthor=L.+Y.+Moyauthor=V.+Simovauthor=S.+Nagpalauthor=A.+Oubrieauthor=R.+L.+Palteauthor=G.+Parthasarathyauthor=N.+Sciammettaauthor=M.+van+der+Steltauthor=J.+D.+Woodhouseauthor=B.+W.+Trotterauthor=K.+Barr&title=Discovery+of+N-%28Indazol-3-yl%29piperidine-4-carboxylic+Acids+as+ROR%CE%B3t+Allosteric+Inhibitors+for+Autoimmune+Diseases&doi=10.1021%2Facsmedchemlett.9b00431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune Diseases</span></div><div class="casAuthors">Zhang, Hongjun; Lapointe, Blair T.; Anthony, Neville; Azevedo, Rita; Cals, Jos; Correll, Craig C.; Daniels, Matthew; Deshmukh, Sujal; van Eenenaam, Hans; Ferguson, Heidi; Hegde, Laxminarayan G.; Karstens, Willem Jan; MacLean, John; Miller, J. Richard; Moy, Lily Y.; Simov, Vladimir; Nagpal, Sunil; Oubrie, Arthur; Palte, Rachel L.; Parthasarathy, Gopal; Sciammetta, Nunzio; van der Stelt, Mario; Woodhouse, Janice D.; Trotter, B. Wesley; Barr, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">114-119</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The clin. success of anti-IL-17 monoclonal antibodies (i.e., Cosentyx and Taltz) has validated Th17 pathway modulation for the treatment of autoimmune diseases.  The nuclear hormone receptor RORγt is a master regulator of Th17 cells and affects the prodn. of a host of cytokines, including IL-17A, IL-17F, IL-22, IL-26, and GM-CSF.  Substantial interest has been spurred across both academia and industry to seek small mols. suitable for RORγt inhibition.  A variety of RORγt inhibitors have been reported in the past few years, the majority of which are orthosteric binders.  Here the authors disclose the discovery and optimization of a class of inhibitors, which bind differently to an allosteric binding pocket.  Starting from a weakly active hit 1, a tool compd. 14 was quickly identified that demonstrated superior potency, selectivity, and off-target profile.  Further optimization focused on improving metabolic stability.  Replacing the benzoic acid moiety with piperidinyl carboxylate, modifying the 4-aza-indazole core in 14 to 4-F-indazole, and incorporating a key hydroxyl group led to the discovery of I, which possesses exquisite potency and selectivity, as well as an improved pharmacokinetic profile suitable for oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXx2w5vE5C97Vg90H21EOLACvtfcHk0ljvb1Cw6LoUIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtVGnuw%253D%253D&md5=701fad0e447fda063dc61a0ca2197d67</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00431%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLapointe%26aufirst%3DB.%2BT.%26aulast%3DAnthony%26aufirst%3DN.%26aulast%3DAzevedo%26aufirst%3DR.%26aulast%3DCals%26aufirst%3DJ.%26aulast%3DCorrell%26aufirst%3DC.%2BC.%26aulast%3DDaniels%26aufirst%3DM.%26aulast%3DDeshmukh%26aufirst%3DS.%26aulast%3Dvan%2BEenenaam%26aufirst%3DH.%26aulast%3DFerguson%26aufirst%3DH.%26aulast%3DHegde%26aufirst%3DL.%2BG.%26aulast%3DKarstens%26aufirst%3DW.%2BJ.%26aulast%3DMaclean%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DJ.%2BR.%26aulast%3DMoy%26aufirst%3DL.%2BY.%26aulast%3DSimov%26aufirst%3DV.%26aulast%3DNagpal%26aufirst%3DS.%26aulast%3DOubrie%26aufirst%3DA.%26aulast%3DPalte%26aufirst%3DR.%2BL.%26aulast%3DParthasarathy%26aufirst%3DG.%26aulast%3DSciammetta%26aufirst%3DN.%26aulast%3Dvan%2Bder%2BStelt%26aufirst%3DM.%26aulast%3DWoodhouse%26aufirst%3DJ.%2BD.%26aulast%3DTrotter%26aufirst%3DB.%2BW.%26aulast%3DBarr%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520N-%2528Indazol-3-yl%2529piperidine-4-carboxylic%2520Acids%2520as%2520ROR%25CE%25B3t%2520Allosteric%2520Inhibitors%2520for%2520Autoimmune%2520Diseases%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D11%26spage%3D114%26epage%3D119%26doi%3D10.1021%2Facsmedchemlett.9b00431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaudari, S. S.</span>; <span class="NLM_string-name">Thomas, A.</span>; <span class="NLM_string-name">Dhone, S. V.</span>; <span class="NLM_string-name">Khairatkar-Joshi, N.</span>; <span class="NLM_string-name">Bajpai, M.</span></span> <span> </span><span class="NLM_article-title">Bicyclic Heterocyclic Compounds as ROR gamma Modulators</span>. PCT Int. Appl. <span class="NLM_patent">WO 2015008234 A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+S.+Chaudari&author=A.+Thomas&author=S.+V.+Dhone&author=N.+Khairatkar-Joshi&author=M.+Bajpai&title=Bicyclic+Heterocyclic+Compounds+as+ROR+gamma+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChaudari%26aufirst%3DS.%2BS.%26atitle%3DBicyclic%2520Heterocyclic%2520Compounds%2520as%2520ROR%2520gamma%2520Modulators%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vries, R. M. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doveston, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunsveld, L.</span></span> <span> </span><span class="NLM_article-title">Elucidation of an Allosteric Mode of Action for a Thienopyrazole RORγt Inverse Agonist</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">565</span>, <span class="refDoi"> DOI: 10.1002/cmdc.202000044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1002%2Fcmdc.202000044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=32053744" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=561-565&author=R.+M.+J.+M.+Vriesauthor=R.+G.+Dovestonauthor=F.+A.+Meijerauthor=L.+Brunsveld&title=Elucidation+of+an+Allosteric+Mode+of+Action+for+a+Thienopyrazole+ROR%CE%B3t+Inverse+Agonist&doi=10.1002%2Fcmdc.202000044"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.202000044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.202000044%26sid%3Dliteratum%253Aachs%26aulast%3DVries%26aufirst%3DR.%2BM.%2BJ.%2BM.%26aulast%3DDoveston%26aufirst%3DR.%2BG.%26aulast%3DMeijer%26aufirst%3DF.%2BA.%26aulast%3DBrunsveld%26aufirst%3DL.%26atitle%3DElucidation%2520of%2520an%2520Allosteric%2520Mode%2520of%2520Action%2520for%2520a%2520Thienopyrazole%2520ROR%25CE%25B3t%2520Inverse%2520Agonist%26jtitle%3DChemMedChem%26date%3D2020%26volume%3D15%26spage%3D561%26epage%3D565%26doi%3D10.1002%2Fcmdc.202000044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brunsveld, L.</span>; <span class="NLM_string-name">Doveston, R. G.</span>; <span class="NLM_string-name">Leysen, S. F. R.</span>; <span class="NLM_string-name">Milroy, L.-G.</span>; <span class="NLM_string-name">Meijer, F. A.</span>; <span class="NLM_string-name">Scheepstra, M.</span>; <span class="NLM_string-name">Ottmann, C.</span></span> <span> </span><span class="NLM_article-title">Substituted heterocyclic compounds and their use as retinoic acid receptor-related orphan receptor (ROR) gamma-t inhibitors</span>. PCT Int. Appl. <span class="NLM_patent">WO 2020149740 A1</span>, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=L.+Brunsveld&author=R.+G.+Doveston&author=S.+F.+R.+Leysen&author=L.-G.+Milroy&author=F.+A.+Meijer&author=M.+Scheepstra&author=C.+Ottmann&title=Substituted+heterocyclic+compounds+and+their+use+as+retinoic+acid+receptor-related+orphan+receptor+%28ROR%29+gamma-t+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrunsveld%26aufirst%3DL.%26atitle%3DSubstituted%2520heterocyclic%2520compounds%2520and%2520their%2520use%2520as%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor%2520%2528ROR%2529%2520gamma-t%2520inhibitors%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klicic, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenkin, P. S.</span></span> <span> </span><span class="NLM_article-title">Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1749</span>, <span class="refDoi"> DOI: 10.1021/jm0306430</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+A+New+Approach+for+Rapid%2C+Accurate+Docking+and+Scoring.+1.+Method+and+Assessment+of+Docking+Accuracy&doi=10.1021%2Fjm0306430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0lhrYadJJH_ziQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520A%2520New%2520Approach%2520for%2520Rapid%252C%2520Accurate%2520Docking%2520and%2520Scoring.%25201.%2520Method%2520and%2520Assessment%2520of%2520Docking%2520Accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749%26doi%3D10.1021%2Fjm0306430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beard, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span> <span> </span><span class="NLM_article-title">Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1750</span>– <span class="NLM_lpage">1759</span>, <span class="refDoi"> DOI: 10.1021/jm030644s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030644s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1750-1759&author=T.+A.+Halgrenauthor=R.+B.+Murphyauthor=R.+A.+Friesnerauthor=H.+S.+Beardauthor=L.+L.+Fryeauthor=W.+T.+Pollardauthor=J.+L.+Banks&title=Glide%3A+A+New+Approach+for+Rapid%2C+Accurate+Docking+and+Scoring.+2.+Enrichment+Factors+in+Database+Screening&doi=10.1021%2Fjm030644s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span></div><div class="casAuthors">Halgren, Thomas A.; Murphy, Robert B.; Friesner, Richard A.; Beard, Hege S.; Frye, Leah L.; Pollard, W. Thomas; Banks, Jay L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1750-1759</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Glide's ability to identify active compds. in a database screen is characterized by applying Glide to a diverse set of nine protein receptors.  In many cases, two, or even three, protein sites are employed to probe the sensitivity of the results to the site geometry.  To make the database screens as realistic as possible, the screens use sets of "druglike" decoy ligands that have been selected to be representative of what we believe is likely to be found in the compd. collection of a pharmaceutical or biotechnol. company.  Results are presented for releases 1.8, 2.0, and 2.5 of Glide.  The comparisons show that av. measures for both "early" and "global" enrichment for Glide 2.5 are 3 times higher than for Glide 1.8 and more than 2 times higher than for Glide 2.0 because of better results for the least well-handled screens.  This improvement in enrichment stems largely from the better balance of the more widely parametrized GlideScore 2.5 function and the inclusion of terms that penalize ligand-protein interactions that violate established principles of phys. chem., particularly as it concerns the exposure to solvent of charged protein and ligand groups.  Comparisons to results for the thymidine kinase and estrogen receptors published by Rognan and co-workers (J. Med. Chem. 2000, 43, 4759-4767) show that Glide 2.5 performs better than GOLD 1.1, FlexX 1.8, or DOCK 4.01.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT2ptubbKbvLVg90H21EOLACvtfcHk0lhrYadJJH_ziQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D&md5=33d68dd968e65626b449df61e44e37be</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm030644s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030644s%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DPollard%26aufirst%3DW.%2BT.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26atitle%3DGlide%253A%2520A%2520New%2520Approach%2520for%2520Rapid%252C%2520Accurate%2520Docking%2520and%2520Scoring.%25202.%2520Enrichment%2520Factors%2520in%2520Database%2520Screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1750%26epage%3D1759%26doi%3D10.1021%2Fjm030644s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degorce, F.</span></span> <span> </span><span class="NLM_article-title">HTRF: A Technology Tailored for Drug Discovery - A Review of Theoretical Aspects and Recent Applications</span>. <i>Curr. Chem. Genom.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.2174/1875397300903010022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.2174%2F1875397300903010022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=20161833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFWnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2009&pages=22-32&author=F.+Degorce&title=HTRF%3A+A+Technology+Tailored+for+Drug+Discovery+-+A+Review+of+Theoretical+Aspects+and+Recent+Applications&doi=10.2174%2F1875397300903010022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">HTRF: a technology tailored for drug discovery - a review of theoretical aspects and recent applications</span></div><div class="casAuthors">Degorce, Francois; Card, Amy; Soh, Sharon; Trinquet, Eric; Knapik, Glenn P.; Xie, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Current Chemical Genomics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22-32</span>CODEN:
                <span class="NLM_cas:coden">CCGUAQ</span>;
        ISSN:<span class="NLM_cas:issn">1875-3973</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  HTRF (Homogeneous Time Resolved Fluorescence) is the most frequently used generic assay technol. to measure analytes in a homogenous format, which is the ideal platform used for drug target studies in high-throughput screening (HTS).  This technol. combines fluorescence resonance energy transfer technol. (FRET) with time-resolved measurement (TR).  In TR-FRET assays, a signal is generated through fluorescent resonance energy transfer between a donor and an acceptor mol. when in close proximity to each other.  Buffer and media interference is dramatically reduced by dual-wavelength detection, and the final signal is proportional to the extent of product formation.  The HTRF assay is usually sensitive and robust that can be miniaturized into the 384 and 1536-well plate formats.  This assay technol. has been applied to many antibody-based assays including GPCR signaling (cAMP and IP-One), kinases, cytokines and biomarkers, bioprocess (antibody and protein prodn.), as well as the assays for protein-protein, protein-peptide, and protein-DNA/RNA interactions.  Since its introduction to the drug-screening world over ten years ago, researchers have used HTRF to expedite the study of GPCRs, kinases, new biomarkers, protein-protein interactions, and other targets of interest.  HTRF has also been utilized as an alternative method for bioprocess monitoring.  The first-generation HTRF technol., which uses Europium cryptate as a fluorescence donor to monitor reactions between biomols., was extended in 2008 through the introduction of a second-generation donor, Terbium cryptate (Tb), enhancing screening performance.  Terbium cryptate possesses different photophys. properties compared to Europium, including increased quantum yield and a higher molar extinction coeff.  In addn. to being compatible with the same acceptor fluorophors used with Europium, it can serve as a donor fluorophore to green-emitting fluors because it has multiple emission peaks including one at 490 nm.  Moreover, all Terbium HTRF assays can be read on the same HTRF-compatible instruments as Europium HTRF assays.  Overall, HTRF is a highly sensitive, robust technol. for the detection of mol. interactions in vitro and is widely used for primary and secondary screening phases of drug development.  This review addresses the general principles of HTRF and its current applications in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKDP8Vd8k247Vg90H21EOLACvtfcHk0lhrYadJJH_ziQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFWnsr4%253D&md5=9590149ceeed17ce424522ef85aa32f9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2174%2F1875397300903010022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1875397300903010022%26sid%3Dliteratum%253Aachs%26aulast%3DDegorce%26aufirst%3DF.%26atitle%3DHTRF%253A%2520A%2520Technology%2520Tailored%2520for%2520Drug%2520Discovery%2520-%2520A%2520Review%2520of%2520Theoretical%2520Aspects%2520and%2520Recent%2520Applications%26jtitle%3DCurr.%2520Chem.%2520Genom.%26date%3D2009%26volume%3D3%26spage%3D22%26epage%3D32%26doi%3D10.2174%2F1875397300903010022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muegge, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terenzio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labadia, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrow, N. A.</span></span> <span> </span><span class="NLM_article-title">Structural studies unravel the active conformation of apo RORγt nuclear receptor and a common inverse agonism of two diverse classes of RORγt inhibitors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">11618</span>– <span class="NLM_lpage">11630</span>, <span class="refDoi"> DOI: 10.1074/jbc.m117.789024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1074%2Fjbc.M117.789024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=28546429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFOjtbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=11618-11630&author=X.+Liauthor=M.+Andersonauthor=D.+Collinauthor=I.+Mueggeauthor=J.+Wanauthor=D.+Brennanauthor=S.+Kuglerauthor=D.+Terenzioauthor=C.+Kennedyauthor=S.+Linauthor=M.+E.+Labadiaauthor=B.+Cookauthor=R.+Hughesauthor=N.+A.+Farrow&title=Structural+studies+unravel+the+active+conformation+of+apo+ROR%CE%B3t+nuclear+receptor+and+a+common+inverse+agonism+of+two+diverse+classes+of+ROR%CE%B3t+inhibitors&doi=10.1074%2Fjbc.m117.789024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structural studies unravel the active conformation of apo RORγt nuclear receptor and a common inverse agonism of two diverse classes of RORγt inhibitors</span></div><div class="casAuthors">Li, Xiang; Anderson, Marie; Collin, Delphine; Muegge, Ingo; Wan, John; Brennan, Debra; Kugler, Stanley; Terenzio, Donna; Kennedy, Charles; Lin, Siqi; Labadia, Mark E.; Cook, Brian; Hughes, Robert; Farrow, Neil A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">11618-11630</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The nuclear receptor retinoid acid receptor-related orphan receptor γt (RORγt) is a master regulator of the Th17/IL-17 pathway that plays crucial roles in the pathogenesis of autoimmunity.  RORγt has recently emerged as a highly promising target for treatment of a no. of autoimmune diseases.  Through high-throughput screening, we previously identified several classes of inverse agonists for RORγt.  Here, we report the crystal structures for the ligand-binding domain of RORγt in both apo and ligand-bound states.  We show that apo RORγt adopts an active conformation capable of recruiting coactivator peptides and present a detailed anal. of the structural determinants that stabilize helix 12 (H12) of RORγt in the active state in the absence of a ligand.  The structures of ligand-bound RORγt revealed that binding of the inverse agonists disrupted crit. interactions that stabilized H12.  This destabilizing effect was supported by ab initio calcns. and exptl. by a normalized crystallog. B-factor anal.  Of note, the H12 destabilization in the active state shifted the conformational equil. of RORγt toward an inactive state, which underlies the mol. mechanism of action for the inverse agonists reported here.  These findings highlight that nuclear receptor structure and function are dictated by a dynamic conformational equil. and that subtle changes in ligand structures can shift this equil. in opposite directions, leading to a functional switch from agonists to inverse agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzicB5efbjf7Vg90H21EOLACvtfcHk0ljaykdUoFnVJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFOjtbjJ&md5=8224bb328772787a2e1df0aec43566d6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.789024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.789024%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DCollin%26aufirst%3DD.%26aulast%3DMuegge%26aufirst%3DI.%26aulast%3DWan%26aufirst%3DJ.%26aulast%3DBrennan%26aufirst%3DD.%26aulast%3DKugler%26aufirst%3DS.%26aulast%3DTerenzio%26aufirst%3DD.%26aulast%3DKennedy%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DLabadia%26aufirst%3DM.%2BE.%26aulast%3DCook%26aufirst%3DB.%26aulast%3DHughes%26aufirst%3DR.%26aulast%3DFarrow%26aufirst%3DN.%2BA.%26atitle%3DStructural%2520studies%2520unravel%2520the%2520active%2520conformation%2520of%2520apo%2520ROR%25CE%25B3t%2520nuclear%2520receptor%2520and%2520a%2520common%2520inverse%2520agonism%2520of%2520two%2520diverse%2520classes%2520of%2520ROR%25CE%25B3t%2520inhibitors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D11618%26epage%3D11630%26doi%3D10.1074%2Fjbc.m117.789024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soroosh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sablad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelen, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dandridge, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tootoonchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenkrants, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung-Leung, W.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Leon-Tabaldo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blevitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milla, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span> <span> </span><span class="NLM_article-title">Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiation</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">12163</span>– <span class="NLM_lpage">12168</span>, <span class="refDoi"> DOI: 10.1073/pnas.1322807111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1073%2Fpnas.1322807111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=25092323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1GqtLnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=12163-12168&author=P.+Sorooshauthor=J.+Wuauthor=X.+Xueauthor=J.+Songauthor=S.+W.+Suttonauthor=M.+Sabladauthor=J.+Yuauthor=M.+I.+Nelenauthor=X.+Liuauthor=G.+Castroauthor=R.+Lunaauthor=S.+Crawfordauthor=H.+Banieauthor=R.+A.+Dandridgeauthor=X.+Dengauthor=A.+Bittnerauthor=C.+Kueiauthor=M.+Tootoonchiauthor=N.+Rozenkrantsauthor=K.+Hermanauthor=J.+Gaoauthor=X.+V.+Yangauthor=K.+Sachenauthor=K.+Ngoauthor=W.-P.+Fung-Leungauthor=S.+Nguyenauthor=A.+de+Leon-Tabaldoauthor=J.+Blevittauthor=Y.+Zhangauthor=M.+D.+Cummingsauthor=T.+Raoauthor=N.+S.+Maniauthor=C.+Liuauthor=M.+McKinnonauthor=M.+E.+Millaauthor=A.+M.+Fourieauthor=S.+Sun&title=Oxysterols+are+agonist+ligands+of+ROR%CE%B3t+and+drive+Th17+cell+differentiation&doi=10.1073%2Fpnas.1322807111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiation</span></div><div class="casAuthors">Soroosh, Pejman; Wu, Jiejun; Xue, Xiaohua; Song, Jiao; Sutton, Steven W.; Sablad, Marciano; Yu, Jingxue; Nelen, Marina I.; Liu, Xuejun; Castro, Glenda; Luna, Rosa; Crawford, Shelby; Banie, Homayon; Dandridge, Rose A.; Deng, Xiaohu; Bittner, Anton; Kuei, Chester; Tootoonchi, Mandana; Rozenkrants, Natasha; Herman, Krystal; Gao, Jingjin; Yang, Xia V.; Sachen, Kacey; Ngo, Karen; Fung-Leung, Wai-Ping; Nguyen, Steven; de Leon-Tabaldo, Aimee; Blevitt, Jonathan; Zhang, Yan; Cummings, Maxwell D.; Rao, Tadimeti; Mani, Neelakandha S.; Liu, Changlu; McKinnon, Murray; Milla, Marcos E.; Fourie, Anne M.; Sun, Siquan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">12163-12168</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The RAR-related orphan receptor gamma t (RORγt) is a nuclear receptor required for generating IL-17-producing CD4+ Th17 T cells, which are essential in host defense and may play key pathogenic roles in autoimmune diseases.  Oxysterols elicit profound effects on immune and inflammatory responses as well as on cholesterol and lipid metab.  Here, we describe the identification of several naturally occurring oxysterols as RORγt agonists.  The most potent and selective activator for RORγt is 7β,27-dihydroxycholesterol (7β, 27-OHC).  We show that these oxysterols reverse the inhibitory effect of an RORγt antagonist, ursolic acid, in RORγ- or RORγt-dependent cell-based reporter assays.  These ligands bind directly to recombinant RORγ ligand binding domain (LBD), promote recruitment of a coactivator peptide, and reduce binding of a corepressor peptide to RORγ LBD.  In primary cells, 7β,27-OHC and 7α,27-OHC enhance the differentiation of murine and human IL-17-producing Th17 cells in an RORγt-dependent manner.  Importantly, we showed that Th17, but not Th1 cells, preferentially produce these two oxysterols.  In vivo, administration of 7β,27-OHC in mice enhanced IL-17 prodn.  Mice deficient in CYP27A1, a key enzyme in generating these oxysterols, showed significant redn. of IL-17-producing cells, including CD4+ and γδ+ T cells, similar to the deficiency obsd. in RORγt knockout mice.  Our results reveal a previously unknown mechanism for selected oxysterols as immune modulators and a direct role for CYP27A1 in generating these RORγt agonist ligands, which we propose as RORγt endogenous ligands, driving both innate and adaptive IL-17-dependent immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopdx3pchXTabVg90H21EOLACvtfcHk0ljaykdUoFnVJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1GqtLnF&md5=4070bdf42ff542d3cf75e7a712dec298</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1322807111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1322807111%26sid%3Dliteratum%253Aachs%26aulast%3DSoroosh%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DSutton%26aufirst%3DS.%2BW.%26aulast%3DSablad%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DNelen%26aufirst%3DM.%2BI.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DCastro%26aufirst%3DG.%26aulast%3DLuna%26aufirst%3DR.%26aulast%3DCrawford%26aufirst%3DS.%26aulast%3DBanie%26aufirst%3DH.%26aulast%3DDandridge%26aufirst%3DR.%2BA.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DBittner%26aufirst%3DA.%26aulast%3DKuei%26aufirst%3DC.%26aulast%3DTootoonchi%26aufirst%3DM.%26aulast%3DRozenkrants%26aufirst%3DN.%26aulast%3DHerman%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%2BV.%26aulast%3DSachen%26aufirst%3DK.%26aulast%3DNgo%26aufirst%3DK.%26aulast%3DFung-Leung%26aufirst%3DW.-P.%26aulast%3DNguyen%26aufirst%3DS.%26aulast%3Dde%2BLeon-Tabaldo%26aufirst%3DA.%26aulast%3DBlevitt%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DRao%26aufirst%3DT.%26aulast%3DMani%26aufirst%3DN.%2BS.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DMilla%26aufirst%3DM.%2BE.%26aulast%3DFourie%26aufirst%3DA.%2BM.%26aulast%3DSun%26aufirst%3DS.%26atitle%3DOxysterols%2520are%2520agonist%2520ligands%2520of%2520ROR%25CE%25B3t%2520and%2520drive%2520Th17%2520cell%2520differentiation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2014%26volume%3D111%26spage%3D12163%26epage%3D12168%26doi%3D10.1073%2Fpnas.1322807111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeSantis, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinking, J. L.</span></span> <span> </span><span class="NLM_article-title">Use of Differential Scanning Fluorimetry to Identify Nuclear Receptor Ligands</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1443</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-3724-0_3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1007%2F978-1-4939-3724-0_3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=27246332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFKjtrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1443&publication_year=2016&pages=21-30&author=K.+A.+DeSantisauthor=J.+L.+Reinking&title=Use+of+Differential+Scanning+Fluorimetry+to+Identify+Nuclear+Receptor+Ligands&doi=10.1007%2F978-1-4939-3724-0_3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Use of differential scanning fluorimetry to identify nuclear receptor ligands</span></div><div class="casAuthors">DeSantis, Kara A.; Reinking, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1443</span>
        (<span class="NLM_cas:issue">Nuclear Receptor Superfamily</span>),
    <span class="NLM_cas:pages">21-30</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Identification of small mols. that interact specifically with the ligand-binding domains (LBDs) of nuclear receptors (NRs) can be accomplished using a variety of methodologies.  Here, we describe the use of differential scanning fluorimetry to identify these ligands, a technique that requires no modification or derivatization of either the protein or the ligand, and uses an instrument that is becoming increasingly affordable and common in modern mol. biol. labs., the quant., or real-time, PCR machine.  Upon being introduced to specific ligands, nuclear receptors undergo structural and dynamic changes that tend to increase mol. stability, which can be measured by the resistance of the protein to heat denaturation.  Differential scanning fluorimetry (DSF) uses a dielec. sensitive fluorescent dye to measure the thermal denaturation, or "melting" point (Tm) of a protein under different conditions, in this case in the absence and presence of a candidate ligand.  Using DSF, multiple candidates can be screened at once, in nos. corresponding to plate size of the instrument used (e.g., 96- or 384-well), allowing significant throughput if a modest library of compds. needs to be tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIzidMgIwKsbVg90H21EOLACvtfcHk0ljQoMfNgHp5lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFKjtrjM&md5=3b6c8fbebe013880cfe974b0f6f498a4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-3724-0_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-3724-0_3%26sid%3Dliteratum%253Aachs%26aulast%3DDeSantis%26aufirst%3DK.%2BA.%26aulast%3DReinking%26aufirst%3DJ.%2BL.%26atitle%3DUse%2520of%2520Differential%2520Scanning%2520Fluorimetry%2520to%2520Identify%2520Nuclear%2520Receptor%2520Ligands%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2016%26volume%3D1443%26spage%3D21%26epage%3D30%26doi%3D10.1007%2F978-1-4939-3724-0_3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niesen, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berglund, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedadi, M.</span></span> <span> </span><span class="NLM_article-title">The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">2212</span>– <span class="NLM_lpage">2221</span>, <span class="refDoi"> DOI: 10.1038/nprot.2007.321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1038%2Fnprot.2007.321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=17853878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFagsb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=2212-2221&author=F.+H.+Niesenauthor=H.+Berglundauthor=M.+Vedadi&title=The+use+of+differential+scanning+fluorimetry+to+detect+ligand+interactions+that+promote+protein+stability&doi=10.1038%2Fnprot.2007.321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability</span></div><div class="casAuthors">Niesen, Frank H.; Berglund, Helena; Vedadi, Masoud</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2212-2221</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Differential scanning fluorometry (DSF) is a rapid and inexpensive screening method to identify low-mol.-wt. ligands that bind and stabilize purified proteins.  The temp. at which a protein unfolds is measured by an increase in the fluorescence of a dye with affinity for hydrophobic parts of the protein, which are exposed as the protein unfolds.  A simple fitting procedure allows quick calcn. of the transition midpoint; the difference in the temp. of this midpoint in the presence and absence of ligand is related to the binding affinity of the small mol., which can be a low-mol.-wt. compd., a peptide or a nucleic acid.  DSF is best performed using a conventional real-time PCR instrument.  Ligand solns. from a storage plate are added to a soln. of protein and dye, distributed into the wells of the PCR plate and fluorescence intensity measured as the temp. is raised gradually.  Results can be obtained in a single day.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomViqp6Tq7krVg90H21EOLACvtfcHk0ljQoMfNgHp5lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFagsb7N&md5=8a74dbb348ab81179614ab4ae5797d94</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2007.321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2007.321%26sid%3Dliteratum%253Aachs%26aulast%3DNiesen%26aufirst%3DF.%2BH.%26aulast%3DBerglund%26aufirst%3DH.%26aulast%3DVedadi%26aufirst%3DM.%26atitle%3DThe%2520use%2520of%2520differential%2520scanning%2520fluorimetry%2520to%2520detect%2520ligand%2520interactions%2520that%2520promote%2520protein%2520stability%26jtitle%3DNat.%2520Protoc.%26date%3D2007%26volume%3D2%26spage%3D2212%26epage%3D2221%26doi%3D10.1038%2Fnprot.2007.321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oerlemans, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groves, M. R.</span></span> <span> </span><span class="NLM_article-title">Theory and applications of differential scanning fluorimetry in early-stage drug discovery</span>. <i>Biophys. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1007/s12551-020-00619-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1007%2Fs12551-020-00619-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=32006251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtFyltbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=85-104&author=K.+Gaoauthor=R.+Oerlemansauthor=M.+R.+Groves&title=Theory+and+applications+of+differential+scanning+fluorimetry+in+early-stage+drug+discovery&doi=10.1007%2Fs12551-020-00619-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Theory and applications of differential scanning fluorimetry in early-stage drug discovery</span></div><div class="casAuthors">Gao, Kai; Oerlemans, Rick; Groves, Matthew R.</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Reviews</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-104</span>CODEN:
                <span class="NLM_cas:coden">BRIECG</span>;
        ISSN:<span class="NLM_cas:issn">1867-2450</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Abstr.: Differential scanning fluorimetry (DSF) is an accessible, rapid, and economical biophys. technique that has seen many applications over the years, ranging from protein folding state detection to the identification of ligands that bind to the target protein.  In this review, we discuss the theory, applications, and limitations of DSF, including the latest applications of DSF by ourselves and other researchers.  We show that DSF is a powerful high-throughput tool in early drug discovery efforts.  We place DSF in the context of other biophys. methods frequently used in drug discovery and highlight their benefits and downsides.  We illustrate the uses of DSF in protein buffer optimization for stability, refolding, and crystn. purposes and provide several examples of each.  We also show the use of DSF in a more downstream application, where it is used as an in vivo validation tool of ligand-target interaction in cell assays.  Although DSF is a potent tool in buffer optimization and large chem. library screens when it comes to ligand-binding validation and optimization, orthogonal techniques are recommended as DSF is prone to false positives and negatives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUrggrBr-7BLVg90H21EOLACvtfcHk0ljQoMfNgHp5lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtFyltbs%253D&md5=e6b941952c4cd97537f12b744d5ebf5c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2Fs12551-020-00619-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12551-020-00619-2%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DK.%26aulast%3DOerlemans%26aufirst%3DR.%26aulast%3DGroves%26aufirst%3DM.%2BR.%26atitle%3DTheory%2520and%2520applications%2520of%2520differential%2520scanning%2520fluorimetry%2520in%2520early-stage%2520drug%2520discovery%26jtitle%3DBiophys.%2520Rev.%26date%3D2020%26volume%3D12%26spage%3D85%26epage%3D104%26doi%3D10.1007%2Fs12551-020-00619-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leijten-van de Gevel, I. A.</span>; <span class="NLM_string-name">van Herk, K. H. N.</span>; <span class="NLM_string-name">de Vries, R. M. J. M.</span>; <span class="NLM_string-name">Brunsveld, L.</span></span> <i>PDB ID: 6TDC. PPAR gamma ligand binding domain in complex with MRL-871</i>; <span class="NLM_publisher-name">National Center for Biotechnology Information</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=I.+A.+Leijten-van+de+Gevel&author=K.+H.+N.+van+Herk&author=R.+M.+J.+M.+de+Vries&author=L.+Brunsveld&title=PDB+ID%3A+6TDC.+PPAR+gamma+ligand+binding+domain+in+complex+with+MRL-871"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3DLeijten-van%2Bde%2BGevel%26aufirst%3DI.%2BA.%26jtitle%3DPDB%2520ID%253A%25206TDC.%2520PPAR%2520gamma%2520ligand%2520binding%2520domain%2520in%2520complex%2520with%2520MRL-871%26pub%3DNational%2520Center%2520for%2520Biotechnology%2520Information%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ianaro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maffia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di
Paola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ialenti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genovese, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Rosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caputi, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiemermann, C.</span></span> <span> </span><span class="NLM_article-title">Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>483</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2003.10.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.ejphar.2003.10.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=14709329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpt1ei" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2004&pages=79-93&author=S.+Cuzzocreaauthor=B.+Pisanoauthor=L.+Dugoauthor=A.+Ianaroauthor=P.+Maffiaauthor=N.+S.+A.+Patelauthor=R.+Di%0APaolaauthor=A.+Ialentiauthor=T.+Genoveseauthor=P.+K.+Chatterjeeauthor=M.+Di+Rosaauthor=A.+P.+Caputiauthor=C.+Thiemermann&title=Rosiglitazone%2C+a+ligand+of+the+peroxisome+proliferator-activated+receptor-gamma%2C+reduces+acute+inflammation&doi=10.1016%2Fj.ejphar.2003.10.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-γ, reduces acute inflammation</span></div><div class="casAuthors">Cuzzocrea, Salvatore; Pisano, Barbara; Dugo, Laura; Ianaro, Angela; Maffia, Pasquale; Patel, Nimesh S. A.; Di Paola, Rosanna; Ialenti, Armando; Genovese, Tiziana; Chatterjee, Prabal K.; Di Rosa, Massimo; Caputi, Achille P.; Thiemermann, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">483</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-93</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone receptor superfamily of ligand-activated transcription factors that are related to retinoid, steroid and thyroid hormone receptors.  The PPAR-γ receptor subtype appears to play a pivotal role in the regulation of cellular proliferation and inflammation.  The thiazolidinedione rosiglitazone (Avandia) is a peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist, that was recently approved by the Food and Drug Administration for treatment of type II diabetes mellitus.  In the present study, we have investigated the effects of rosiglitazone in animal models of acute inflammation (carrageenan-induced paw edema and carrageenan-induced pleurisy).  We report here for the first time that rosiglitazone (given at 1, 3 or 10 mg/kg i.p. concomitantly with carrageenan injection in the paw edema model, or at 3, 10 or 30 mg/kg i.p. 15 min before carrageenan administration in the pleurisy model) exerts potent anti-inflammatory effects (e.g. inhibition of paw edema, pleural exudate formation, mononuclear cell infiltration and histol. injury) in vivo.  Furthermore, rosiglitazone reduced: (1) the increase in the staining (immunohistochem.) for nitrotyrosine and poly (ADP-ribose) polymerase (PARP), (2) the expression of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), intercellular adhesion mols.-1 (ICAM-1) and P-selectin in the lungs of carrageenan-treated rats.  In order to elucidate whether the protective effect of rosiglitazone is related to activation of the PPAR-γ receptor, we also investigated the effect of a PPAR-γ antagonist, bisphenol A diglycidyl ether (BADGE), on the protective effects of rosiglitazone.  BADGE (30 mg/kg i.p.) administered 30 min prior to treatment with rosiglitazone significantly antagonized the effect of the PPAR-γ agonist and thus abolished the anti-inflammatory effects of rosiglitazone.  We propose that rosiglitazone and other potent PPAR-γ agonists may be useful in the therapy of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoskKXJ_92uWbVg90H21EOLACvtfcHk0lhpa-IRw5ckqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpt1ei&md5=50dd379c9346a616db914bb55a52b833</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2003.10.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2003.10.056%26sid%3Dliteratum%253Aachs%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DPisano%26aufirst%3DB.%26aulast%3DDugo%26aufirst%3DL.%26aulast%3DIanaro%26aufirst%3DA.%26aulast%3DMaffia%26aufirst%3DP.%26aulast%3DPatel%26aufirst%3DN.%2BS.%2BA.%26aulast%3DDi%2BPaola%26aufirst%3DR.%26aulast%3DIalenti%26aufirst%3DA.%26aulast%3DGenovese%26aufirst%3DT.%26aulast%3DChatterjee%26aufirst%3DP.%2BK.%26aulast%3DDi%2BRosa%26aufirst%3DM.%26aulast%3DCaputi%26aufirst%3DA.%2BP.%26aulast%3DThiemermann%26aufirst%3DC.%26atitle%3DRosiglitazone%252C%2520a%2520ligand%2520of%2520the%2520peroxisome%2520proliferator-activated%2520receptor-gamma%252C%2520reduces%2520acute%2520inflammation%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D483%26spage%3D79%26epage%3D93%26doi%3D10.1016%2Fj.ejphar.2003.10.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bass, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caravella, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creech, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deaton, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madauss, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marr, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFadyen, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parks, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisely, G. B.</span></span> <span> </span><span class="NLM_article-title">Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2969</span>– <span class="NLM_lpage">2973</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.04.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.bmcl.2009.04.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=19410460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVeku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2969-2973&author=J.+Y.+Bassauthor=R.+D.+Caldwellauthor=J.+A.+Caravellaauthor=L.+Chenauthor=K.+L.+Creechauthor=D.+N.+Deatonauthor=K.+P.+Madaussauthor=H.+B.+Marrauthor=R.+B.+McFadyenauthor=A.+B.+Millerauthor=D.+J.+Parksauthor=D.+Toddauthor=S.+P.+Williamsauthor=G.+B.+Wisely&title=Substituted+isoxazole+analogs+of+farnesoid+X+receptor+%28FXR%29+agonist+GW4064&doi=10.1016%2Fj.bmcl.2009.04.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064</span></div><div class="casAuthors">Bass, Jonathan Y.; Caldwell, Richard D.; Caravella, Justin A.; Chen, Lihong; Creech, Katrina L.; Deaton, David N.; Madauss, Kevin P.; Marr, Harry B.; McFadyen, Robert B.; Miller, Aaron B.; Parks, Derek J.; Todd, Dan; Williams, Shawn P.; Wisely, G. Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2969-2973</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Starting from the known FXR agonist GW 4064 (I) (R1 = i-Pr, R2 = 2,6-Cl2C6H3), a series of alternately 3,5-substituted isoxazoles was prepd.  A subset of this series, with a tether between the isoxazole ring and the 3-position aryl substituent, were equipotent FXR agonists to GW 4064, with the analog I (R1 = i-Pr, R2 = 2,6-Me2C6H3OCH2) having greater FRET FXR potency than GW 4064.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmilCrO1yO1LVg90H21EOLACvtfcHk0lhpa-IRw5ckqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVeku70%253D&md5=38b2a1b54be6ef8a3d58f6550a1ff16f</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.04.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.04.047%26sid%3Dliteratum%253Aachs%26aulast%3DBass%26aufirst%3DJ.%2BY.%26aulast%3DCaldwell%26aufirst%3DR.%2BD.%26aulast%3DCaravella%26aufirst%3DJ.%2BA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DCreech%26aufirst%3DK.%2BL.%26aulast%3DDeaton%26aufirst%3DD.%2BN.%26aulast%3DMadauss%26aufirst%3DK.%2BP.%26aulast%3DMarr%26aufirst%3DH.%2BB.%26aulast%3DMcFadyen%26aufirst%3DR.%2BB.%26aulast%3DMiller%26aufirst%3DA.%2BB.%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DTodd%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DS.%2BP.%26aulast%3DWisely%26aufirst%3DG.%2BB.%26atitle%3DSubstituted%2520isoxazole%2520analogs%2520of%2520farnesoid%2520X%2520receptor%2520%2528FXR%2529%2520agonist%2520GW4064%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2969%26epage%3D2973%26doi%3D10.1016%2Fj.bmcl.2009.04.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sepe, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchianò, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finamore, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baronissi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Leva, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biagioli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorucci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassiano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Gaudio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limongelli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorucci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zampella, A.</span></span> <span> </span><span class="NLM_article-title">Novel Isoxazole Derivatives with Potent FXR Agonistic Activity Prevent Acetaminophen-Induced Liver Injury</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">412</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00423</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00423" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVegu7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=407-412&author=V.+Sepeauthor=S.+Marchian%C3%B2author=C.+Finamoreauthor=G.+Baronissiauthor=F.+S.+Di+Levaauthor=A.+Carinoauthor=M.+Biagioliauthor=C.+Fiorucciauthor=C.+Cassianoauthor=M.+C.+Montiauthor=F.+del+Gaudioauthor=E.+Novellinoauthor=V.+Limongelliauthor=S.+Fiorucciauthor=A.+Zampella&title=Novel+Isoxazole+Derivatives+with+Potent+FXR+Agonistic+Activity+Prevent+Acetaminophen-Induced+Liver+Injury&doi=10.1021%2Facsmedchemlett.8b00423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Isoxazole Derivatives with Potent FXR Agonistic Activity Prevent Acetaminophen-Induced Liver Injury</span></div><div class="casAuthors">Sepe, Valentina; Marchiano, Silvia; Finamore, Claudia; Baronissi, Giuliana; Di Leva, Francesco Saverio; Carino, Adriana; Biagioli, Michele; Fiorucci, Chiara; Cassiano, Chiara; Monti, Maria Chiara; del Gaudio, Federica; Novellino, Ettore; Limongelli, Vittorio; Fiorucci, Stefano; Zampella, Angela</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">407-412</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acetaminophen misuse is a leading cause of acute liver failure and liver transplantation for which therapy is poorly effective.  FXR ligands have shown effective in reducing liver injury in several exptl. and clin. settings.  In this Letter, we have elaborated on the structure of GW4064, the first nonsteroidal agonist for FXR, to identify novel isoxazoles endowed with FXR agonistic activity and improved ADME properties.  The pharmacol. characterization and mol. docking studies for the structure-activity rationalization allowed the identification of several FXR agonists with nanomolar potency in transactivation and SRC-1 recruitment assays.  This characterization resulted in the identification of a potent FXR agonist, compd. I that was orally active, and rescued mice from acute liver failure caused by acetaminophen overdose in a FXR-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQmzVjonQgsrVg90H21EOLACvtfcHk0liNq24Ijo4M8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVegu7zK&md5=a5a1905bc917c8cf240bfdbb53a944f1</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00423%26sid%3Dliteratum%253Aachs%26aulast%3DSepe%26aufirst%3DV.%26aulast%3DMarchian%25C3%25B2%26aufirst%3DS.%26aulast%3DFinamore%26aufirst%3DC.%26aulast%3DBaronissi%26aufirst%3DG.%26aulast%3DDi%2BLeva%26aufirst%3DF.%2BS.%26aulast%3DCarino%26aufirst%3DA.%26aulast%3DBiagioli%26aufirst%3DM.%26aulast%3DFiorucci%26aufirst%3DC.%26aulast%3DCassiano%26aufirst%3DC.%26aulast%3DMonti%26aufirst%3DM.%2BC.%26aulast%3Ddel%2BGaudio%26aufirst%3DF.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DLimongelli%26aufirst%3DV.%26aulast%3DFiorucci%26aufirst%3DS.%26aulast%3DZampella%26aufirst%3DA.%26atitle%3DNovel%2520Isoxazole%2520Derivatives%2520with%2520Potent%2520FXR%2520Agonistic%2520Activity%2520Prevent%2520Acetaminophen-Induced%2520Liver%2520Injury%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D407%26epage%3D412%26doi%3D10.1021%2Facsmedchemlett.8b00423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khojasteh-Bakht, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J. P.</span></span> <span> </span><span class="NLM_article-title">Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1021/tx015574b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx015574b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=269-299&author=D.+K.+Dalvieauthor=A.+S.+Kalgutkarauthor=S.+C.+Khojasteh-Bakhtauthor=R.+S.+Obachauthor=J.+P.+O%E2%80%99Donnell&title=Biotransformation+Reactions+of+Five-Membered+Aromatic+Heterocyclic+Rings&doi=10.1021%2Ftx015574b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings</span></div><div class="casAuthors">Dalvie, Deepak K.; Kalgutkar, Amit S.; Khojasteh-Bakht, S. Cyrus; Obach, R. Scott; O'Donnell, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">269-299</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 278 refs. is given on the biotransformation pathways of most commonly used 5-membered arom. heterocyclic rings.  The effect of physicochem. properties such as the electronic effects of heteroatoms, aromaticity, and acidity/basicity (pKa) of the rings are correlated on their biotransformation.  The generation of reactive metabolites following oxidn. or redn. of these heterocycles and the subsequent toxicol. consequences are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpNaEz19aehbVg90H21EOLACvtfcHk0liNq24Ijo4M8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D&md5=e8e2dfd12772f9ff2289b173bdefa590</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Ftx015574b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx015574b%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKhojasteh-Bakht%26aufirst%3DS.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26atitle%3DBiotransformation%2520Reactions%2520of%2520Five-Membered%2520Aromatic%2520Heterocyclic%2520Rings%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2002%26volume%3D15%26spage%3D269%26epage%3D299%26doi%3D10.1021%2Ftx015574b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span> </span><span class="NLM_article-title">Molecular property explorer OSIRIS</span>. <span class="NLM_year">2021</span>, Available from: <a href="http://www.organic-chemistry.org/prog/peo/drugScore" class="extLink">http://www.organic-chemistry.org/prog/peo/drugScore</a> (accessed Feb 26, 2021).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular+property+explorer+OSIRIS.+2021%2C+Available+from%3A+http%3A%2F%2Fwww.organic-chemistry.org%2Fprog%2Fpeo%2FdrugScore+%28accessed+Feb+26%2C+2021%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DMolecular%2520property%2520explorer%2520OSIRIS%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kallepalli, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onyeozili, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maleczka, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. R.</span></span> <span> </span><span class="NLM_article-title">Boc Groups as Protectors and Directors for Ir-Catalyzed C–H Borylation of Heterocycles</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">9199</span>– <span class="NLM_lpage">9201</span>, <span class="refDoi"> DOI: 10.1021/jo901822b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo901822b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOksrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=9199-9201&author=V.+A.+Kallepalliauthor=F.+Shiauthor=S.+Paulauthor=E.+N.+Onyeoziliauthor=R.+E.+Maleczkaauthor=M.+R.+Smith&title=Boc+Groups+as+Protectors+and+Directors+for+Ir-Catalyzed+C%E2%80%93H+Borylation+of+Heterocycles&doi=10.1021%2Fjo901822b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Boc Groups as Protectors and Directors for Ir-Catalyzed C-H Borylation of Heterocycles</span></div><div class="casAuthors">Kallepalli, Venkata A.; Shi, Feng; Paul, Sulagna; Onyeozili, Edith N.; Maleczka, Robert E.; Smith, Milton R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9199-9201</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ir-catalyzed C-H borylation is found to be compatible with Boc protecting groups.  Thus, pyrroles, indoles, and azaindoles can be selectively functionalized at C-H positions β to N.  The Boc group can be removed on thermolysis or left intact during subsequent transformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodzdE1QRfDHLVg90H21EOLACvtfcHk0liNq24Ijo4M8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOksrjM&md5=d3e4927fdc04ca35db39a05469289d2c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjo901822b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo901822b%26sid%3Dliteratum%253Aachs%26aulast%3DKallepalli%26aufirst%3DV.%2BA.%26aulast%3DShi%26aufirst%3DF.%26aulast%3DPaul%26aufirst%3DS.%26aulast%3DOnyeozili%26aufirst%3DE.%2BN.%26aulast%3DMaleczka%26aufirst%3DR.%2BE.%26aulast%3DSmith%26aufirst%3DM.%2BR.%26atitle%3DBoc%2520Groups%2520as%2520Protectors%2520and%2520Directors%2520for%2520Ir-Catalyzed%2520C%25E2%2580%2593H%2520Borylation%2520of%2520Heterocycles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D9199%26epage%3D9201%26doi%3D10.1021%2Fjo901822b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/medium/jm1c00475_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00475&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/medium/jm1c00475_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Co-crystal structure of the RORγt LBD in complex with allosteric ligand <b>FM26</b> (shown as orange sticks) (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6SAL">6SAL</a>),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> where the allosteric site (orange circle) and the orthosteric site (blue circle) are indicated; (B) enlarged view of <b>FM26</b> (shown as orange sticks) in the allosteric pocket, where H-bond interactions are indicated with orange dashes; (C) chemical structures of allosteric RORγt ligands <b>FM26</b> (<b>2</b>), <b>MRL-871</b> (<b>1</b>), and <b>RTA-1701</b>; and (D) exploration of the hit-to-lead SAR profile of <b>FM26</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00475&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/medium/jm1c00475_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis Route for Different Trisubstituted Isoxazoles (C-4 Library)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00475&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>N</i>-Boc-pyrrole-B(pin), Pd(dppf)Cl<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, and DME, 85 °C, 8 h, 50%; (b) DIBAL and CH<sub>2</sub>Cl<sub>2</sub>, −78 °C, 3 h, 80%; (c) (i) (MeSO<sub>2</sub>)<sub>2</sub>O, Et<sub>3</sub>N, and CH<sub>2</sub>Cl<sub>2</sub>, 0 °C → rt, 3 h, (ii) aniline or <i>N</i>-methylaniline, rt, 3 h, 36% (<b>17</b>) and 52% (<b>18</b>); (d) (i) DMP and CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 h, 44%, (ii) methyl 4-amino benzoate, MeOH, and AcOH, reflux, 24 h, 42%, (iii) NaBH<sub>4</sub> and EtOH, reflux, 3 h, 17% (<b>19</b>); (e) LiOH, EtOH, and H<sub>2</sub>O, 95 °C, 3 h, 29–81%; (f) methyl 4-hydroxybenzoate or methyl 2-fluoro-4-hydroxybenzoate, DIAD, PPh<sub>3</sub>, Et<sub>3</sub>N, and THF, reflux, 3 h, 55% (<b>20</b>), 25% (<b>21</b>); (g) methyl 4-mercaptobenzoate, DIAD, PPh<sub>3</sub>, Et<sub>3</sub>N, and THF, reflux, 3 h, 27%; (h) DMP and CH<sub>2</sub>Cl<sub>2</sub>, rt, 3 h, quant.; (i) (4-(methoxycarbonyl)benzyl)triphenylphosphonium (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for the synthetic procedure of the triphenylphosphonium), LiHMDS, and THF, −78 °C → rt, 24 h, 7% (<b>24</b>), 27% (<b>25</b>).</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/medium/jm1c00475_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Biochemical analysis and X-ray crystallography data for isoxazole compounds with C-4 modifications. (A) Dose–response curves from the TR-FRET coactivator recruitment assay for <b>1</b>, <b>2</b>, <b>3</b>, and <b>6</b>; (B) dose–response curves from the ligand displacement TR-FRET assay using the AlexaFluor MRL-871 probe for <b>1</b>, <b>2</b>, <b>3</b>, and <b>6</b>; (C) melting temperatures (Δ<i>T</i><sub>m</sub> in °C), as measured in TSA for <b>1</b>, <b>2</b>, <b>3</b>, and <b>6</b>. Data were recorded in ≥3 independent experiments, each recorded in triplicate (one representative dataset shown). Error bars represent the SD of the mean; (D,G) tertiary co-crystal structure of RORγt in complex with <b>3</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NPC">7NPC</a>) (D) and <b>9</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NP5">7NP5</a>) (G) (stick representation). The final 2Fo–Fc electron density map of compounds is shown as an isomesh contoured at 1σ; (E,H) overlay of the co-crystal structure of RORγt in complex with <b>FM26</b> (<b>2</b>) (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6SAL">6SAL</a>) and RORγt bound to <b>3</b> (E), and an overlay of RORγt with <b>3</b> and <b>9</b> (H); and (F,I) enlarged view of the allosteric pocket of RORγt showing the interactions between <b>3</b> (F)/<b>9</b> (I) and the protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00475&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/medium/jm1c00475_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis Route for Different Trisubstituted Isoxazoles (C-5 Library)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00475&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>N</i>-Boc-pyrrole-B(pin), <i>N</i>-THP-pyrazole-B(pin) or 5-methyl <i>N</i>-Boc-pyrrole-B(pin) (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for the synthetic procedure of this pinacol ester), Pd(dppf)Cl<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, and DME, 85 °C, 8 h, 49% (<b>26</b>), 34% (<b>27</b>), and 24% (<b>29</b>); (b) <i>N</i>-methyl-pyrrole-B(pin), Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, DME, and H<sub>2</sub>O, 85 °C, 8 h, 55% (<b>28</b>); (c) DIBAL and CH<sub>2</sub>Cl<sub>2,</sub> −78 °C, 3 h, 69% (<b>30</b>), 71% (<b>31</b>), and 58% (<b>33</b>); (d) LiAlH<sub>4</sub> and THF, 0 °C → rt, 2 h, 76% (<b>32</b>); (e) (i) methyl 4-hydroxybenzoate, DIAD, PPh<sub>3</sub>, and THF, reflux, 3 h, 21%, (ii) LiOH, EtOH, and H<sub>2</sub>O, 95 °C, 3 h, 41% (<b>10</b>); (f) (i) methyl 4-hydroxybenzoate, DIAD, PPh<sub>3</sub>, Et<sub>3</sub>N, and THF, reflux, 3 h, 44–45%, (ii) LiOH, EtOH, and H<sub>2</sub>O, 95 °C, 3 h, 86% (<b>12</b>), 83% (<b>13</b>); (g) (i) methyl 4-hydroxybenzoate, DIAD, PPh<sub>3</sub>, Et<sub>3</sub>N, and THF, reflux, 3 h, 49%, (ii) TFA and CH<sub>2</sub>Cl<sub>2</sub>, 40 °C, 2 h, 87%, (iii) LiOH, EtOH, and H<sub>2</sub>O, 95 °C, 3 h, 89% (<b>11</b>).</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/medium/jm1c00475_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Biochemical analysis and X-ray crystallography data for isoxazole compounds with C-5 modifications. (A) Dose–response curves from the TR-FRET coactivator recruitment assay for <b>2</b>, <b>3</b>, <b>10</b>, and <b>11</b>; (B) dose–response curves from the ligand displacement TR-FRET assay using the AlexaFluor MRL-871 probe for <b>2</b>, <b>3</b>, <b>10</b>, and <b>11</b>; (C) melting temperatures (Δ<i>T</i><sub>m</sub> in °C), as measured in TSA for <b>2</b>, <b>3</b>, <b>10</b>, and <b>11</b>. Data were recorded in ≥3 independent experiments, each recorded in triplicate (one representative dataset shown). Error bars represent the SD of the mean. (D,G) Tertiary co-crystal structure of RORγt in complex with <b>10</b> (D) (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NEC">7NEC</a>) and <b>11</b> (G) (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NP6">7NP6</a>) (stick representation). The final 2Fo–Fc electron density map of the compounds is shown as an isomesh contoured at 1σ; (E,H) overlay of the crystal structure of RORγt in complex with <b>3</b> and RORγt bound to <b>10</b> (E) or <b>11</b> (H); and (F,I) enlarged view of the allosteric pocket of RORγt showing the interactions between <b>10</b> (F)/<b>11</b> (I) and the protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00475&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/medium/jm1c00475_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. IL-17a mRNA expression levels in EL4 cells treated with ligands <b>1</b>, <b>2</b>, <b>3</b>, <b>6</b>, <b>10</b>, <b>11</b>, and <b>12</b> (10 μM, 24 h) or DMSO and fold decrease of the IL-17a expression relative to DMSO. The level of IL-17a expression was normalized to that of GAPDH expression. All data are expressed as mean ± s.d. (<i>n</i> = 3). The relative gene expression was calculated by the 2<sup>–ΔΔ<i>C</i></sup><sub>t</sub> (Livak) method using DMSO control as a calibrator. Statistical analysis was performed using a one-way analysis of variance (ANOVA) compared against the DMSO control following Dunnett’s <i>post hoc</i> test; ***<i>P</i> < 0.001 and ****<i>P</i> < 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/acs.jmedchem.1c00475/20210629/images/large/jm1c00475_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00475&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i87">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23784" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23784" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 50 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robinson-Rechavi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laudet, V.</span></span> <span> </span><span class="NLM_article-title">The nuclear receptor superfamily</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">585</span>– <span class="NLM_lpage">586</span>, <span class="refDoi"> DOI: 10.1242/jcs.00247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1242%2Fjcs.00247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=12538758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252FjtFamuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2003&pages=585-586&author=M.+Robinson-Rechaviauthor=H.+E.+Garciaauthor=V.+Laudet&title=The+nuclear+receptor+superfamily&doi=10.1242%2Fjcs.00247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The nuclear receptor superfamily</span></div><div class="casAuthors">Robinson-Rechavi Marc; Escriva Garcia Hector; Laudet Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cell science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">Pt 4</span>),
    <span class="NLM_cas:pages">585-6</span>
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSISsSnWMCNWGxpATR2EQURfW6udTcc2eYG2-QUav9oxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252FjtFamuw%253D%253D&md5=ac244dd3bf3de2a5ff92fd43fe8f5959</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1242%2Fjcs.00247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.00247%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson-Rechavi%26aufirst%3DM.%26aulast%3DGarcia%26aufirst%3DH.%2BE.%26aulast%3DLaudet%26aufirst%3DV.%26atitle%3DThe%2520nuclear%2520receptor%2520superfamily%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2003%26volume%3D116%26spage%3D585%26epage%3D586%26doi%3D10.1242%2Fjcs.00247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastinejad, F.</span></span> <span> </span><span class="NLM_article-title">Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics</span>. <i>Annu. Rev. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">247</span>– <span class="NLM_lpage">272</span>, <span class="refDoi"> DOI: 10.1146/annurev-physiol-021909-135917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1146%2Fannurev-physiol-021909-135917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=20148675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktFKkt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2010&pages=247-272&author=P.+Huangauthor=V.+Chandraauthor=F.+Rastinejad&title=Structural+overview+of+the+nuclear+receptor+superfamily%3A+insights+into+physiology+and+therapeutics&doi=10.1146%2Fannurev-physiol-021909-135917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics</span></div><div class="casAuthors">Huang, Pengxiang; Chandra, Vikas; Rastinejad, Fraydoon</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Physiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">247-272</span>CODEN:
                <span class="NLM_cas:coden">ARPHAD</span>;
        ISSN:<span class="NLM_cas:issn">0066-4278</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  As ligand-regulated transcription factors, the nuclear hormone receptors are nearly ideal drug targets, with internal pockets that bind to hydrophobic, drug-like mols. and well-characterized ligand-induced conformational changes that recruit transcriptional coregulators to promoter elements.  Yet, due to the multitude of genes under the control of a single receptor, the major challenge was the identification of ligands with gene-selective actions, impacting disease outcomes through a narrow subset of target genes and not across their entire gene-regulatory repertoire.  Here, we summarize the concepts and work to date underlying the development of steroidal and nonsteroidal receptor ligands, including the use of crystal structures, high-throughput screens, and rational design approaches for finding useful therapeutic mols.  Difficulties in finding selective receptor modulators require a more complete understanding of receptor interdomain communications, posttranslational modifications, and receptor-protein interactions that could be exploited for target gene selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU31gr_40ZoLVg90H21EOLACvtfcHk0lgEFBH2CKpWIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktFKkt7o%253D&md5=3764fd1b044297f2e3145924fbc7e1f7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev-physiol-021909-135917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-physiol-021909-135917%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DChandra%26aufirst%3DV.%26aulast%3DRastinejad%26aufirst%3DF.%26atitle%3DStructural%2520overview%2520of%2520the%2520nuclear%2520receptor%2520superfamily%253A%2520insights%2520into%2520physiology%2520and%2520therapeutics%26jtitle%3DAnnu.%2520Rev.%2520Physiol.%26date%3D2010%26volume%3D72%26spage%3D247%26epage%3D272%26doi%3D10.1146%2Fannurev-physiol-021909-135917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gronemeyer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafsson, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laudet, V.</span></span> <span> </span><span class="NLM_article-title">Principles for modulation of the nuclear receptor superfamily</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">950</span>– <span class="NLM_lpage">964</span>, <span class="refDoi"> DOI: 10.1038/nrd1551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1038%2Fnrd1551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=15520817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFemtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=950-964&author=H.+Gronemeyerauthor=J.-A.+Gustafssonauthor=V.+Laudet&title=Principles+for+modulation+of+the+nuclear+receptor+superfamily&doi=10.1038%2Fnrd1551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Principles for modulation of the nuclear receptor superfamily</span></div><div class="casAuthors">Gronemeyer, Hinrich; Gustafsson, Jan-A.; Laudet, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">950-964</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors are major targets for drug discovery and have key roles in development and homeostasis, as well as in many diseases such as obesity, diabetes and cancer.  This review provides a general overview of the mechanism of action of nuclear receptors and explores the various factors that are instrumental in modulating their pharmacol.  In most cases, the response of a given receptor to a particular ligand in a specific tissue will be dictated by the set of proteins with which the receptor is able to interact.  One of the most promising aspects of nuclear receptor pharmacol. is that it is now possible to develop ligands with a large spectrum of full, partial or inverse agonist or antagonist activities, but also compds., called selective nuclear receptor modulators, that activate only a subset of the functions induced by the cognate ligand or that act in a cell-type-selective manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSWL9yf1CceLVg90H21EOLACvtfcHk0lgEFBH2CKpWIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFemtrY%253D&md5=aedb60785c235bf44cb5f0ea34236090</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrd1551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1551%26sid%3Dliteratum%253Aachs%26aulast%3DGronemeyer%26aufirst%3DH.%26aulast%3DGustafsson%26aufirst%3DJ.-A.%26aulast%3DLaudet%26aufirst%3DV.%26atitle%3DPrinciples%2520for%2520modulation%2520of%2520the%2520nuclear%2520receptor%2520superfamily%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D950%26epage%3D964%26doi%3D10.1038%2Fnrd1551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaulton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bento, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donadi, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bologa, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Lazikani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oprea, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span> <span> </span><span class="NLM_article-title">A comprehensive map of molecular drug targets</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1038%2Fnrd.2016.230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=27910877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVSms7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=19-34&author=R.+Santosauthor=O.+Ursuauthor=A.+Gaultonauthor=A.+P.+Bentoauthor=R.+S.+Donadiauthor=C.+G.+Bologaauthor=A.+Karlssonauthor=B.+Al-Lazikaniauthor=A.+Herseyauthor=T.+I.+Opreaauthor=J.+P.+Overington&title=A+comprehensive+map+of+molecular+drug+targets&doi=10.1038%2Fnrd.2016.230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive map of molecular drug targets</span></div><div class="casAuthors">Santos, Rita; Ursu, Oleg; Gaulton, Anna; Bento, A. Patricia; Donadi, Ramesh S.; Bologa, Cristian G.; Karlsson, Anneli; Al-Lazikani, Bissan; Hersey, Anne; Oprea, Tudor I.; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-34</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The success of mechanism-based drug discovery depends on the definition of the drug target.  This definition becomes even more important as we try to link drug response to genetic variation, understand stratified clin. efficacy and safety, rationalize the differences between drugs in the same therapeutic class and predict drug utility in patient subgroups.  However, drug targets are often poorly defined in the literature, both for launched drugs and for potential therapeutic agents in discovery and development.  Here, we present an updated comprehensive map of mol. targets of approved drugs.  We curate a total of 893 human and pathogen-derived biomols. through which 1,578 US FDA-approved drugs act.  These biomols. include 667 human-genome-derived proteins targeted by drugs for human disease.  Anal. of these drug targets indicates the continued dominance of privileged target families across disease areas, but also the growth of novel first-in-class mechanisms, particularly in oncol.  We explore the relationships between bioactivity class and clin. success, as well as the presence of orthologues between human and animal models and between pathogen and human genomes.  Through the collaboration of three independent teams, we highlight some of the ongoing challenges in accurately defining the targets of mol. therapeutics and present conventions for deconvoluting the complexities of mol. pharmacol. and drug efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTfWwWkoZnbrVg90H21EOLACvtfcHk0lgEFBH2CKpWIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVSms7rK&md5=7437d4b678ac75dac0a5e3248df98761</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.230%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DR.%26aulast%3DUrsu%26aufirst%3DO.%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DDonadi%26aufirst%3DR.%2BS.%26aulast%3DBologa%26aufirst%3DC.%2BG.%26aulast%3DKarlsson%26aufirst%3DA.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DOprea%26aufirst%3DT.%2BI.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DA%2520comprehensive%2520map%2520of%2520molecular%2520drug%2520targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D19%26epage%3D34%26doi%3D10.1038%2Fnrd.2016.230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solt, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span> <span> </span><span class="NLM_article-title">Action of RORs and their ligands in (patho)physiology</span>. <i>Trends Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">619</span>– <span class="NLM_lpage">627</span>, <span class="refDoi"> DOI: 10.1016/j.tem.2012.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.tem.2012.05.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=22789990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWgur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=619-627&author=L.+A.+Soltauthor=T.+P.+Burris&title=Action+of+RORs+and+their+ligands+in+%28patho%29physiology&doi=10.1016%2Fj.tem.2012.05.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Action of RORs and their ligands in (patho)physiology</span></div><div class="casAuthors">Solt, Laura A.; Burris, Thomas P.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">619-627</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The retinoic-acid-receptor-related orphan receptors (RORs) are members of the nuclear receptor (NR) superfamily whose activity has been implicated in several physiol. and pathol. processes.  The RORs, specifically RORα and RORγ, are considered to be master regulators of TH17 cells, a recently described subset of CD4+ T helper cells that have been demonstrated to have a pathol. role in autoimmune disease.  As with most members of the NR superfamily, RORs are ligand-regulated, suggesting that their activity can be modulated by synthetic ligands.  Recent advances in the field have established that selective inhibition of the RORs is a viable therapeutic approach for not only the treatment of autoimmune disorders but also ROR-mediated metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU_NvOEtj6cbVg90H21EOLACvtfcHk0lhA_wmsSUANCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWgur%252FJ&md5=a1d5b61ffa1b224265d1cd90d60e9620</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2012.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2012.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DSolt%26aufirst%3DL.%2BA.%26aulast%3DBurris%26aufirst%3DT.%2BP.%26atitle%3DAction%2520of%2520RORs%2520and%2520their%2520ligands%2520in%2520%2528patho%2529physiology%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2012%26volume%3D23%26spage%3D619%26epage%3D627%26doi%3D10.1016%2Fj.tem.2012.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, I. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadokoro, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepelley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafaille, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cua, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">1121</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.07.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.cell.2006.07.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=16990136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCnsrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2006&pages=1121-1133&author=I.+I.+Ivanovauthor=B.+S.+McKenzieauthor=L.+Zhouauthor=C.+E.+Tadokoroauthor=A.+Lepelleyauthor=J.+J.+Lafailleauthor=D.+J.+Cuaauthor=D.+R.+Littman&title=The+Orphan+Nuclear+Receptor+ROR%CE%B3t+Directs+the+Differentiation+Program+of+Proinflammatory+IL-17%2B+T+Helper+Cells&doi=10.1016%2Fj.cell.2006.07.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells</span></div><div class="casAuthors">Ivanov, Ivaylo I.; McKenzie, Brent S.; Zhou, Liang; Tadokoro, Carlos E.; Lepelley, Alice; Lafaille, Juan J.; Cua, Daniel J.; Littman, Dan R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1121-1133</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">IL-17-producing T lymphocytes have been recently shown to comprise a distinct lineage of proinflammatory T helper cells, termed Th17 cells, that are major contributors to autoimmune disease.  The authors show here that the orphan nuclear receptor RORγt is the key transcription factor that orchestrates the differentiation of this effector cell lineage.  RORγt induces transcription of the genes encoding IL-17 and the related cytokine IL-17F in naive CD4+ T helper cells and is required for their expression in response to IL-6 and TGF-β, the cytokines known to induce IL-17.  Th17 cells are constitutively present throughout the intestinal lamina propria, express RORγt, and are absent in mice deficient for RORγt or IL-6.  Mice with RORγt-deficient T cells have attenuated autoimmune disease and lack tissue-infiltrating Th17 cells.  Together, these studies suggest that RORγt is a key regulator of immune homeostasis and highlight its potential as a therapeutic target in inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYsJd6RyFqWrVg90H21EOLACvtfcHk0lhA_wmsSUANCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCnsrrE&md5=4f5693603c30dca4f6a2d0994aeaf9b0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.07.035%26sid%3Dliteratum%253Aachs%26aulast%3DIvanov%26aufirst%3DI.%2BI.%26aulast%3DMcKenzie%26aufirst%3DB.%2BS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DTadokoro%26aufirst%3DC.%2BE.%26aulast%3DLepelley%26aufirst%3DA.%26aulast%3DLafaille%26aufirst%3DJ.%2BJ.%26aulast%3DCua%26aufirst%3DD.%2BJ.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DThe%2520Orphan%2520Nuclear%2520Receptor%2520ROR%25CE%25B3t%2520Directs%2520the%2520Differentiation%2520Program%2520of%2520Proinflammatory%2520IL-17%252B%2520T%2520Helper%2520Cells%26jtitle%3DCell%26date%3D2006%26volume%3D126%26spage%3D1121%26epage%3D1133%26doi%3D10.1016%2Fj.cell.2006.07.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unutmaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">641</span>– <span class="NLM_lpage">649</span>, <span class="refDoi"> DOI: 10.1038/ni.1610</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1038%2Fni.1610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=18454151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVWqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=641-649&author=N.+Manelauthor=D.+Unutmazauthor=D.+R.+Littman&title=The+differentiation+of+human+TH-17+cells+requires+transforming+growth+factor-%CE%B2+and+induction+of+the+nuclear+receptor+ROR%CE%B3t&doi=10.1038%2Fni.1610"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt</span></div><div class="casAuthors">Manel, Nicolas; Unutmaz, Derya; Littman, Dan R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">641-649</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">TH-17 cells are interleukin 17 (IL-17)-secreting CD4+ T helper cells involved in autoimmune disease and mucosal immunity.  In naive CD4+ T cells from mice, IL-17 is expressed in response to a combination of IL-6 or IL-21 and transforming growth factor-β (TGF-β) and requires induction of the nuclear receptor RORγt.  It has been suggested that the differentiation of human TH-17 cells is independent of TGF-β and thus differs fundamentally from that in mice.  The authors show here that TGF-β, IL-1β and IL-6, IL-21 or IL-23 in serum-free conditions were necessary and sufficient to induce IL-17 expression in naive human CD4+ T cells from cord blood.  TGF-β upregulated RORγt expression but simultaneously inhibited its ability to induce IL-17 expression.  Inflammatory cytokines relieved this inhibition and increased RORγt-directed IL-17 expression.  Other gene products detected in TH-17 cells after RORγt induction included the chemokine receptor CCR6, the IL-23 receptor, IL-17F and IL-26.  The authors' studies identify RORγt as having a central function in the differentiation of human TH-17 cells from naive CD4+ T cells and suggest that similar cytokine pathways are involved in this process in mice and humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZBHk62Mj3R7Vg90H21EOLACvtfcHk0lhA_wmsSUANCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVWqurg%253D&md5=9c1406dfd60902657b1bd5231618cc70</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fni.1610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1610%26sid%3Dliteratum%253Aachs%26aulast%3DManel%26aufirst%3DN.%26aulast%3DUnutmaz%26aufirst%3DD.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DThe%2520differentiation%2520of%2520human%2520TH-17%2520cells%2520requires%2520transforming%2520growth%2520factor-%25CE%25B2%2520and%2520induction%2520of%2520the%2520nuclear%2520receptor%2520ROR%25CE%25B3t%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D641%26epage%3D649%26doi%3D10.1038%2Fni.1610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miossec, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolls, J. K.</span></span> <span> </span><span class="NLM_article-title">Targeting IL-17 and TH17 cells in chronic inflammation</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">763</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.1038/nrd3794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1038%2Fnrd3794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=23023676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVaqsb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=763-776&author=P.+Miossecauthor=J.+K.+Kolls&title=Targeting+IL-17+and+TH17+cells+in+chronic+inflammation&doi=10.1038%2Fnrd3794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting IL-17 and TH17 cells in chronic inflammation</span></div><div class="casAuthors">Miossec, Pierre; Kolls, Jay K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">763-776</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The key role of interleukin-17 (IL-17) and T helper 17 (TH17) cells in tissue inflammation, autoimmunity and host defense led to the exptl. targeting of these mols. in mouse models of diseases as well as in clin. settings.  Moreover, the demonstration that IL-17 and TH17 cells contribute to local and systemic aspects of disease pathogenesis, as well as the finding that the IL-17-TH17 cell pathway is regulated by IL-23, prompted the identification of inhibitors.  These inhibitors include biotechnol. products that target IL-23 as well as the leading member of the IL-17 family, IL-17A, and one of its receptors, IL-17 receptor A.  Several clin. trials of these inhibitors are underway, and pos. results have been obtained in psoriasis, rheumatoid arthritis and ankylosing spondylitis.  This Review focuses on the current knowledge of the IL-17-TH17 cell pathway to better understand the pos. as well as potential neg. consequences of targeting them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLAiqCF66JHrVg90H21EOLACvtfcHk0lip6erU5-zc2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVaqsb7L&md5=0627e4086ae6e50881cc3de52f1a2752</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrd3794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3794%26sid%3Dliteratum%253Aachs%26aulast%3DMiossec%26aufirst%3DP.%26aulast%3DKolls%26aufirst%3DJ.%2BK.%26atitle%3DTargeting%2520IL-17%2520and%2520TH17%2520cells%2520in%2520chronic%2520inflammation%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D763%26epage%3D776%26doi%3D10.1038%2Fnrd3794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundrud, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skepner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamagata, T.</span></span> <span> </span><span class="NLM_article-title">Targeting Th17 cells in autoimmune diseases</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">500</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2014.07.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.tips.2014.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=25131183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12mtrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=493-500&author=J.+Yangauthor=M.+S.+Sundrudauthor=J.+Skepnerauthor=T.+Yamagata&title=Targeting+Th17+cells+in+autoimmune+diseases&doi=10.1016%2Fj.tips.2014.07.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Th17 cells in autoimmune diseases</span></div><div class="casAuthors">Yang, Jianfei; Sundrud, Mark S.; Skepner, Jill; Yamagata, Tetsuya</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">493-500</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  T helper 17 (Th17) cells have been implicated in the pathogenesis of most common autoimmune diseases, including psoriasis, rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and multiple sclerosis (MS).  Although anti-interleukin-17 (IL-17) antibodies show marked clin. efficacy in psoriasis, targeting IL-17 alone is not sufficient to improve clin. end points in other autoimmune conditions, namely RA and Crohn's disease.  Given that Th17 cells express IL-17 together with many other proinflammatory cytokines [IL-17F, IL-22, IL-26, and granulocyte-macrophage colony-stimulating factor (GM-CSF)], targeting the Th17 cell lineage may be superior to blocking a single effector cytokine.  Here, we discuss the rationale for targeting two checkpoints in the development and inflammatory function of Th17 cells, retinoid-related orphan receptor-γt (RORγt) and IL-23, and we review recent progress in the development of both RORγt small mol. inhibitors and IL-23 neutralizing antibodies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIqpQyNCHuJ7Vg90H21EOLACvtfcHk0lip6erU5-zc2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12mtrfI&md5=85bf5039611c1730cc7194c7558d144e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2014.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2014.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DSundrud%26aufirst%3DM.%2BS.%26aulast%3DSkepner%26aufirst%3DJ.%26aulast%3DYamagata%26aufirst%3DT.%26atitle%3DTargeting%2520Th17%2520cells%2520in%2520autoimmune%2520diseases%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2014%26volume%3D35%26spage%3D493%26epage%3D500%26doi%3D10.1016%2Fj.tips.2014.07.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burkett, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchroo, V. K.</span></span> <span> </span><span class="NLM_article-title">IL-17 Blockade in Psoriasis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>167</i></span>,  <span class="NLM_fpage">1669</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.11.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.cell.2016.11.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=27984714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFWlsrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2016&pages=1669&author=P.+R.+Burkettauthor=V.+K.+Kuchroo&title=IL-17+Blockade+in+Psoriasis&doi=10.1016%2Fj.cell.2016.11.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">IL-17 Blockade in Psoriasis</span></div><div class="casAuthors">Burkett, Patrick R.; Kuchroo, Vijay K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1669</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">IL-17A both directly induces and synergizes with other cytokines to promote autoimmune tissue inflammation.  Secukinumab and ixekizumab are monoclonal antibodies (mAb) that inhibit interleukin-17A.  These two agents were recently approved for treatment of psoriasis, and secukinumab is also approved for treatment of two spondyloarthropathies, psoriatic arthritis and ankylosing spondylitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobNyijIUaJ-rVg90H21EOLACvtfcHk0lip6erU5-zc2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFWlsrrE&md5=e2d2918a30d5bf98cd5b405e51f171d4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.11.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.11.044%26sid%3Dliteratum%253Aachs%26aulast%3DBurkett%26aufirst%3DP.%2BR.%26aulast%3DKuchroo%26aufirst%3DV.%2BK.%26atitle%3DIL-17%2520Blockade%2520in%2520Psoriasis%26jtitle%3DCell%26date%3D2016%26volume%3D167%26spage%3D1669%26doi%3D10.1016%2Fj.cell.2016.11.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lock, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermans, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedotti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brendolan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schadt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garren, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer-Gould, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strober, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannella, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klonowski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lad, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaminski, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galli, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oksenberg, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raine, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinman, L.</span></span> <span> </span><span class="NLM_article-title">Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">500</span>– <span class="NLM_lpage">508</span>, <span class="refDoi"> DOI: 10.1038/nm0502-500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1038%2Fnm0502-500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=11984595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjt1Kgur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=500-508&author=C.+Lockauthor=G.+Hermansauthor=R.+Pedottiauthor=A.+Brendolanauthor=E.+Schadtauthor=H.+Garrenauthor=A.+Langer-Gouldauthor=S.+Stroberauthor=B.+Cannellaauthor=J.+Allardauthor=P.+Klonowskiauthor=A.+Austinauthor=N.+Ladauthor=N.+Kaminskiauthor=S.+J.+Galliauthor=J.+R.+Oksenbergauthor=C.+S.+Raineauthor=R.+Hellerauthor=L.+Steinman&title=Gene-microarray+analysis+of+multiple+sclerosis+lesions+yields+new+targets+validated+in+autoimmune+encephalomyelitis&doi=10.1038%2Fnm0502-500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis</span></div><div class="casAuthors">Lock, C.; Hermans, G.; Pedotti, R.; Brendolan, A.; Schadt, E.; Garren, H.; Langer-Gould, A.; Strober, S.; Cannella, B.; Allard, J.; Klonowski, P.; Austin, A.; Lad, N.; Kaminski, N.; Galli, S. J.; Oksenberg, J. R.; Raine, C. S.; Heller, R.; Steinman, L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">500-508</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Microarray anal. of multiple sclerosis (MS) lesions obtained at autopsy revealed increased transcripts of genes encoding inflammatory cytokines, particularly interleukin-6 and -17, interferon-γ and assocd. downstream pathways.  Comparison of two poles of MS pathol.-acute lesions with inflammation vs. 'silent' lesions without inflammation-revealed differentially transcribed genes.  Some products of these genes were chosen as targets for therapy of exptl. autoimmune encephalomyelitis (EAE) in mice.  Granulocyte colony-stimulating factor is upregulated in acute, but not in chronic, MS lesions, and the effect on ameliorating EAE is more pronounced in the acute phase, in contrast to knocking out the Ig Fc receptor common γ chain where the effect is greatest on chronic disease.  These results in EAE corroborate the microarray studies on MS lesions.  Large-scale anal. of transcripts in MS lesions elucidates new aspects of pathol. and opens possibilities for therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPWj6FNx8JZ7Vg90H21EOLACvtfcHk0lg2t8A3-cGWNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjt1Kgur8%253D&md5=1e50114f238ec03ff0d534966273f245</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnm0502-500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0502-500%26sid%3Dliteratum%253Aachs%26aulast%3DLock%26aufirst%3DC.%26aulast%3DHermans%26aufirst%3DG.%26aulast%3DPedotti%26aufirst%3DR.%26aulast%3DBrendolan%26aufirst%3DA.%26aulast%3DSchadt%26aufirst%3DE.%26aulast%3DGarren%26aufirst%3DH.%26aulast%3DLanger-Gould%26aufirst%3DA.%26aulast%3DStrober%26aufirst%3DS.%26aulast%3DCannella%26aufirst%3DB.%26aulast%3DAllard%26aufirst%3DJ.%26aulast%3DKlonowski%26aufirst%3DP.%26aulast%3DAustin%26aufirst%3DA.%26aulast%3DLad%26aufirst%3DN.%26aulast%3DKaminski%26aufirst%3DN.%26aulast%3DGalli%26aufirst%3DS.%2BJ.%26aulast%3DOksenberg%26aufirst%3DJ.%2BR.%26aulast%3DRaine%26aufirst%3DC.%2BS.%26aulast%3DHeller%26aufirst%3DR.%26aulast%3DSteinman%26aufirst%3DL.%26atitle%3DGene-microarray%2520analysis%2520of%2520multiple%2520sclerosis%2520lesions%2520yields%2520new%2520targets%2520validated%2520in%2520autoimmune%2520encephalomyelitis%26jtitle%3DNat.%2520Med.%26date%3D2002%26volume%3D8%26spage%3D500%26epage%3D508%26doi%3D10.1038%2Fnm0502-500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Isono, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita-Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, S.</span></span> <span> </span><span class="NLM_article-title">Inhibiting RORγt/Th17 axis for autoimmune disorders</span>. <i>Drug Discov. Today</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1205</span>– <span class="NLM_lpage">1211</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2014.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.drudis.2014.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=24792721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVeitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1205-1211&author=F.+Isonoauthor=S.+Fujita-Satoauthor=S.+Ito&title=Inhibiting+ROR%CE%B3t%2FTh17+axis+for+autoimmune+disorders&doi=10.1016%2Fj.drudis.2014.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting RORγt/Th17 axis for autoimmune disorders</span></div><div class="casAuthors">Isono, Fujio; Fujita-Sato, Saori; Ito, Shuichiro</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1205-1211</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The recent success reported in late-stage clin. trials for the treatment of psoriasis by antibodies directed against interleukin (IL)-17 or its receptor has validated and strongly supports the development of inhibitors of the IL-17 pathway as a new therapeutic modality in chronic inflammation and autoimmunity.  These results also encourage the drug discovery of orally available small mols. that can modulate down the prodn. of IL-17 by Th17 cells (the major IL-17 producers) or the downstream signaling of the IL-17 receptor.  Here, we review these strategies with an emphasis on inhibiting the retinoic-acid-related orphan nuclear receptor RORγt, which is the master regulator of Th17 cells and a promising therapeutic target for the treatment of multiple autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQi4K-X9vSobVg90H21EOLACvtfcHk0lg2t8A3-cGWNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVeitbc%253D&md5=aaa82e8d21bcd0c879b0219a7b84e126</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DIsono%26aufirst%3DF.%26aulast%3DFujita-Sato%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DS.%26atitle%3DInhibiting%2520ROR%25CE%25B3t%252FTh17%2520axis%2520for%2520autoimmune%2520disorders%26jtitle%3DDrug%2520Discov.%2520Today%26date%3D2014%26volume%3D19%26spage%3D1205%26epage%3D1211%26doi%3D10.1016%2Fj.drudis.2014.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hueber, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dryja, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koroleva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antoni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draelos, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gold, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tak, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Reino, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samson, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falk, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callanan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, Q. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haider, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Padova, F.</span></span> <span> </span><span class="NLM_article-title">Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">52ra72</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3001107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1126%2Fscitranslmed.3001107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=20926833" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=52ra72&author=W.+Hueberauthor=D.+D.+Patelauthor=T.+Dryjaauthor=A.+M.+Wrightauthor=I.+Korolevaauthor=G.+Bruinauthor=C.+Antoniauthor=Z.+Draelosauthor=M.+H.+Goldauthor=P.+Durezauthor=P.+P.+Takauthor=J.+J.+Gomez-Reinoauthor=C.+S.+Fosterauthor=R.+Y.+Kimauthor=C.+M.+Samsonauthor=N.+S.+Falkauthor=D.+S.+Chuauthor=D.+Callananauthor=Q.+D.+Nguyenauthor=K.+Roseauthor=A.+Haiderauthor=F.+Di+Padova&title=Effects+of+AIN457%2C+a+fully+human+antibody+to+interleukin-17A%2C+on+psoriasis%2C+rheumatoid+arthritis%2C+and+uveitis&doi=10.1126%2Fscitranslmed.3001107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3001107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3001107%26sid%3Dliteratum%253Aachs%26aulast%3DHueber%26aufirst%3DW.%26aulast%3DPatel%26aufirst%3DD.%2BD.%26aulast%3DDryja%26aufirst%3DT.%26aulast%3DWright%26aufirst%3DA.%2BM.%26aulast%3DKoroleva%26aufirst%3DI.%26aulast%3DBruin%26aufirst%3DG.%26aulast%3DAntoni%26aufirst%3DC.%26aulast%3DDraelos%26aufirst%3DZ.%26aulast%3DGold%26aufirst%3DM.%2BH.%26aulast%3DDurez%26aufirst%3DP.%26aulast%3DTak%26aufirst%3DP.%2BP.%26aulast%3DGomez-Reino%26aufirst%3DJ.%2BJ.%26aulast%3DFoster%26aufirst%3DC.%2BS.%26aulast%3DKim%26aufirst%3DR.%2BY.%26aulast%3DSamson%26aufirst%3DC.%2BM.%26aulast%3DFalk%26aufirst%3DN.%2BS.%26aulast%3DChu%26aufirst%3DD.%2BS.%26aulast%3DCallanan%26aufirst%3DD.%26aulast%3DNguyen%26aufirst%3DQ.%2BD.%26aulast%3DRose%26aufirst%3DK.%26aulast%3DHaider%26aufirst%3DA.%26aulast%3DDi%2BPadova%26aufirst%3DF.%26atitle%3DEffects%2520of%2520AIN457%252C%2520a%2520fully%2520human%2520antibody%2520to%2520interleukin-17A%252C%2520on%2520psoriasis%252C%2520rheumatoid%2520arthritis%252C%2520and%2520uveitis%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2010%26volume%3D2%26spage%3D52ra72%26doi%3D10.1126%2Fscitranslmed.3001107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, S.</span></span> <span> </span><span class="NLM_article-title">Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-γ (RORγ or RORc)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5871</span>– <span class="NLM_lpage">5892</span>, <span class="refDoi"> DOI: 10.1021/jm401901d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401901d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVartbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5871-5892&author=B.+P.+Fauberauthor=S.+Magnuson&title=Modulators+of+the+nuclear+receptor+retinoic+acid+receptor-related+orphan+receptor-%CE%B3+%28ROR%CE%B3+or+RORc%29&doi=10.1021%2Fjm401901d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)</span></div><div class="casAuthors">Fauber, Benjamin P.; Magnuson, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5871-5892</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  As the biol. surrounding the nuclear receptor retinoic acid receptor-related orphan receptor-gamma (RORγ or RORc) continues to evolve, significant effort has been invested in discovering modulators of this potentially important target for the treatment of metabolic and immunol. diseases.  Several major pharmaceutical and biotechnol. companies have disclosed RORc inhibitors or partnered with other players in the field.  In this perspective, we discuss both the biol. and the underlying structural biol. of RORc, and summarize the RORc modulators disclosed in the scientific and patent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXhzxefrY4hLVg90H21EOLACvtfcHk0lhAx4D8HTcZ4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVartbo%253D&md5=42b350bff7776d4b5689275eab214d86</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm401901d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401901d%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DMagnuson%26aufirst%3DS.%26atitle%3DModulators%2520of%2520the%2520nuclear%2520receptor%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor-%25CE%25B3%2520%2528ROR%25CE%25B3%2520or%2520RORc%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5871%26epage%3D5892%26doi%3D10.1021%2Fjm401901d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cyr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronner, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span> <span> </span><span class="NLM_article-title">Recent progress on nuclear receptor RORγ modulators</span>. <i>Bioorg. Med. Chem. Lett</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4387</span>– <span class="NLM_lpage">4393</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.bmcl.2016.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=27542308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4387-4393&author=P.+Cyrauthor=S.+M.+Bronnerauthor=J.+J.+Crawford&title=Recent+progress+on+nuclear+receptor+ROR%CE%B3+modulators&doi=10.1016%2Fj.bmcl.2016.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress on nuclear receptor RORγ modulators</span></div><div class="casAuthors">Cyr, Patrick; Bronner, Sarah M.; Crawford, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4387-4393</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The retinoic acid receptor-related orphan receptor RORγ plays key roles in the development and differentiation of TH17 cells, and thus in IL-17 expression, thymocyte development and regulation of metab.  With the recent progression into phase 2 clin. trials of both oral and topically administered inverse agonists, and with others close behind, there is significant interest in the discovery of RORγ modulators.  This digest covers key developments around RORγ agonists, antagonists and inverse agonists; orthosteric and allosteric binders; and aims to summarize the available information concerning the potential utility of RORγ modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD6nrse0GiBLVg90H21EOLACvtfcHk0lj1uOhvdPeAYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7rL&md5=688885fc5c71ce01b86df6c9703b51ec</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DCyr%26aufirst%3DP.%26aulast%3DBronner%26aufirst%3DS.%2BM.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26atitle%3DRecent%2520progress%2520on%2520nuclear%2520receptor%2520ROR%25CE%25B3%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett%26date%3D2016%26volume%3D26%26spage%3D4387%26epage%3D4393%26doi%3D10.1016%2Fj.bmcl.2016.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pandya, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachchidanand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, R. C.</span></span> <span> </span><span class="NLM_article-title">Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">10976</span>– <span class="NLM_lpage">10995</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00588</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00588" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlWrtL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=10976-10995&author=V.+B.+Pandyaauthor=S.+Kumarauthor=S.+Sachchidanandauthor=R.+Sharmaauthor=R.+C.+Desai&title=Combating+Autoimmune+Diseases+With+Retinoic+Acid+Receptor-Related+Orphan+Receptor-%CE%B3+%28ROR%CE%B3+or+RORc%29+Inhibitors%3A+Hits+and+Misses&doi=10.1021%2Facs.jmedchem.8b00588"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses</span></div><div class="casAuthors">Pandya, Vrajesh B.; Kumar, Sanjay; Sachchidanand; Sharma, Rajiv; Desai, Ranjit C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10976-10995</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The nuclear receptor retinoic acid receptor-related orphan receptor gamma (RORγ or RORc) is a key transcription factor for the prodn. of pro-inflammatory cytokines implicated in the pathogenesis of autoimmune diseases.  Recently, small mol. inhibitors of RORc drew the enormous attention of the research community worldwide as a possible therapy for autoimmune diseases, mediated by the IL-17 cytokine.  With the clin. proof-of-concept inferred from a small mol. inhibitor VTP-43742 for psoriasis and recent inflow of several RORc inhibitors into the clinic for therapeutic interventions in autoimmune diseases, this field continues to evolve.  This review briefly summarizes the RORc inhibitors disclosed in the literature and discusses the progress made by these inhibitors in combating autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKGqZl3bPbtLVg90H21EOLACvtfcHk0lj1uOhvdPeAYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlWrtL7E&md5=4113d22f73ab2911535eef053801994d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00588%26sid%3Dliteratum%253Aachs%26aulast%3DPandya%26aufirst%3DV.%2BB.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DSachchidanand%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DDesai%26aufirst%3DR.%2BC.%26atitle%3DCombating%2520Autoimmune%2520Diseases%2520With%2520Retinoic%2520Acid%2520Receptor-Related%2520Orphan%2520Receptor-%25CE%25B3%2520%2528ROR%25CE%25B3%2520or%2520RORc%2529%2520Inhibitors%253A%2520Hits%2520and%2520Misses%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D10976%26epage%3D10995%26doi%3D10.1021%2Facs.jmedchem.8b00588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bronner, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zbieg, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span> <span> </span><span class="NLM_article-title">RORgamma antagonists and inverse agonists: a patent review</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1080/13543776.2017.1236918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1080%2F13543776.2017.1236918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=27629281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsF2nsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=101-112&author=S.+M.+Bronnerauthor=J.+R.+Zbiegauthor=J.+J.+Crawford&title=RORgamma+antagonists+and+inverse+agonists%3A+a+patent+review&doi=10.1080%2F13543776.2017.1236918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">RORγ antagonists and inverse agonists: a patent review</span></div><div class="casAuthors">Bronner, Sarah M.; Zbieg, Jason R.; Crawford, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-112</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The transcription factor RORγ plays a crit. role in the expression of pro-inflammatory cytokine interleukin IL-17 and is therefore an attractive target for the treatment of inflammatory diseases.  Interest in this mol. target has been heightened by the advancement of orally and topically administered RORγ modulators into clin. trials.  The present review seeks to summarize published patent applications from assignee companies that have disclosed Investigational New Drug (IND) filings for small mol. RORγ/RORγt antagonists and inverse agonists.  The field of RORγ research is extremely competitive, with the majority of companies targeting psoriasis as the primary disease indication.  Vitae Pharmaceuticals is currently the most advanced, with a potential first-in-class oral RORγ-modulator for the treatment of psoriasis.  Future efforts will likely expand into potential applications of RORγ-modulators in the lesser explored immune-related areas of rheumatoid arthritis, type 1 diabetes, lupus, and irritable bowel disorder, as well as cancer immunotherapy and castration-resistant prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj8lMzWsYVA7Vg90H21EOLACvtfcHk0lj1uOhvdPeAYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsF2nsbzP&md5=d80db6c4c948bc12c5d0ce4b41edd2fb</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1080%2F13543776.2017.1236918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2017.1236918%26sid%3Dliteratum%253Aachs%26aulast%3DBronner%26aufirst%3DS.%2BM.%26aulast%3DZbieg%26aufirst%3DJ.%2BR.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26atitle%3DRORgamma%2520antagonists%2520and%2520inverse%2520agonists%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2017%26volume%3D27%26spage%3D101%26epage%3D112%26doi%3D10.1080%2F13543776.2017.1236918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Retinoic acid receptor-related orphan receptor gamma-t (RORγt) inhibitors in clinical development for the treatment of autoimmune diseases: a patent review (2016-present)</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1080/13543776.2019.1655541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1080%2F13543776.2019.1655541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=31403347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A280%3ADC%252BB3MvntVGnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=663-674&author=N.+Sunauthor=H.+Guoauthor=Y.+Wang&title=Retinoic+acid+receptor-related+orphan+receptor+gamma-t+%28ROR%CE%B3t%29+inhibitors+in+clinical+development+for+the+treatment+of+autoimmune+diseases%3A+a+patent+review+%282016-present%29&doi=10.1080%2F13543776.2019.1655541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoic acid receptor-related orphan receptor gamma-t (RORγt) inhibitors in clinical development for the treatment of autoimmune diseases: a patent review (2016-present)</span></div><div class="casAuthors">Sun Nannan; Guo Huimin; Wang Yonghui</div><div class="citationInfo"><span class="NLM_cas:title">Expert opinion on therapeutic patents</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">663-674</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Introduction: RORγt is critical for the differentiation of Th17 cells and the production of IL-17.  Inhibition of RORγt is considered as a promising strategy to treat Th17-mediated autoimmune diseases.  Quite a number of RORγt inhibitors have been progressed into clinical trials, besides much biological interests in this attractive target.  Areas covered: This article reviews the progress of RORγt inhibitors (antagonists and inverse agonists) that are active in clinical development based on an analysis of the related patents published by the corresponding companies in the period of January 2016 through May 2019.  Expert opinion: The development of RORγt inhibitors has gone through a boom period in the past three years.  However, with a little bit frustration, some of the frontrunner clinical compounds were either discontinued or suspended for further development possibly due to some safety concerns or lack of efficacy in humans.  There is a need to probe deeply into these concerns in the on-going pre-clinical and clinical studies.  Given the effectiveness of a few recently FDA-approved anti-IL-17(R) antibodies on psoriasis, the discovery of RORγt inhibitors continues to be an exciting field for the development of novel treatment approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9_8Bn0AMJVtFxYDaSSP8XfW6udTcc2eb-hIgU7PZN4bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MvntVGnsg%253D%253D&md5=7ff7335975148b7ee7fd28d23f89b6c9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1080%2F13543776.2019.1655541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2019.1655541%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DN.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DRetinoic%2520acid%2520receptor-related%2520orphan%2520receptor%2520gamma-t%2520%2528ROR%25CE%25B3t%2529%2520inhibitors%2520in%2520clinical%2520development%2520for%2520the%2520treatment%2520of%2520autoimmune%2520diseases%253A%2520a%2520patent%2520review%2520%25282016-present%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2019%26volume%3D29%26spage%3D663%26epage%3D674%26doi%3D10.1080%2F13543776.2019.1655541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dulubova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reisman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotema, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevino, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eken, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigley, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visnick, M.</span></span> <span> </span><span class="NLM_article-title">A novel series of cysteine-dependent, allosteric inverse agonists of the nuclear receptor RORγt</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">126967</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2020.126967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.bmcl.2020.126967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=32005415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVGksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2020&pages=126967&author=X.+Jiangauthor=I.+Dulubovaauthor=S.+A.+Reismanauthor=M.+Hotemaauthor=C.+I.+Leeauthor=L.+Liuauthor=L.+McCauleyauthor=I.+Trevinoauthor=D.+A.+Fergusonauthor=Y.+Ekenauthor=A.+K.+Wilsonauthor=W.+C.+Wigleyauthor=M.+Visnick&title=A+novel+series+of+cysteine-dependent%2C+allosteric+inverse+agonists+of+the+nuclear+receptor+ROR%CE%B3t&doi=10.1016%2Fj.bmcl.2020.126967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A novel series of cysteine-dependent, allosteric inverse agonists of the nuclear receptor RORγt</span></div><div class="casAuthors">Jiang, Xin; Dulubova, Irina; Reisman, Scott A.; Hotema, Martha; Lee, Chun-Yue I.; Liu, Liping; McCauley, Lyndsey; Trevino, Isaac; Ferguson, Deborah A.; Eken, Yigitcan; Wilson, Angela K.; Wigley, W. Christian; Visnick, Melean</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">126967</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibition of the nuclear receptor Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) is a promising strategy for the treatment of autoimmune diseases.  In this paper, we describe a series of allosteric, cysteine-dependent, inverse agonists of RORγt.  Site-directed mutagenesis and mol. dynamics simulations are supportive of a mechanism of action through specific binding to Cys476 on alpha helix 11 of the ligand binding domain (LBD).  Representative compds. in the series selectively inhibit RORγt, potently suppress interleukin-17A (IL-17A) prodn. by human CD4+ T cells, and inhibit T helper 17 (Th17) differentiation from human naive CD4+ T cells.  The advanced compd. 13 is orally bioavailable and active at a dose of 3 mg/kg in a murine collagen-induced model of rheumatoid arthritis.  Collectively, these data are supportive of the development of compd. 13 in autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTWstjHsgufrVg90H21EOLACvtfcHk0ljPVbWNjwgtAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVGksbs%253D&md5=d135fd96abe54ce513507132dcdedc26</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2020.126967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2020.126967%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DDulubova%26aufirst%3DI.%26aulast%3DReisman%26aufirst%3DS.%2BA.%26aulast%3DHotema%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DC.%2BI.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMcCauley%26aufirst%3DL.%26aulast%3DTrevino%26aufirst%3DI.%26aulast%3DFerguson%26aufirst%3DD.%2BA.%26aulast%3DEken%26aufirst%3DY.%26aulast%3DWilson%26aufirst%3DA.%2BK.%26aulast%3DWigley%26aufirst%3DW.%2BC.%26aulast%3DVisnick%26aufirst%3DM.%26atitle%3DA%2520novel%2520series%2520of%2520cysteine-dependent%252C%2520allosteric%2520inverse%2520agonists%2520of%2520the%2520nuclear%2520receptor%2520ROR%25CE%25B3t%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D30%26spage%3D126967%26doi%3D10.1016%2Fj.bmcl.2020.126967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leijten-van de Gevel, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, R. M. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunsveld, L.</span></span> <span> </span><span class="NLM_article-title">Allosteric small molecule modulators of nuclear receptors</span>. <i>Mol. Cell. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>485</i></span>,  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.mce.2019.01.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.mce.2019.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=30703487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtVWhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2019&pages=20-34&author=F.+A.+Meijerauthor=I.+A.+Leijten-van+de+Gevelauthor=R.+M.+J.+M.+de+Vriesauthor=L.+Brunsveld&title=Allosteric+small+molecule+modulators+of+nuclear+receptors&doi=10.1016%2Fj.mce.2019.01.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric small molecule modulators of nuclear receptors</span></div><div class="casAuthors">Meijer, Femke A.; Leijten-van de Gevel, Iris A.; de Vries, Rens M. J. M.; Brunsveld, Luc</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">20-34</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Nuclear Receptors (NRs) are multi-domain proteins, whose natural regulation occurs via ligands for a classical, orthosteric, binding pocket and via intra- and inter-domain allosteric mechanisms.  Allosteric modulation of NRs via synthetic small mols. has recently emerged as an interesting entry to address the need for small mols. targeting NRs in pathol., via novel modes of action and with beneficial profiles.  In this review the general concept of allosteric modulation in drug discovery is first discussed, serving as a background and inspiration for NRs.  Subsequently, the review focuses on examples of small mols. that allosterically modulate NRs, with a strong focus on structural information and the ligand binding domain.  Recently discovered nanomolar potent allosteric site NR modulators are catapulting allosteric targeting of NRs to the center of attention.  The obtained insights serve as a basis for recommendations for the next steps to take in allosteric small mol. targeting of NRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsuqvFC3-gY7Vg90H21EOLACvtfcHk0ljPVbWNjwgtAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtVWhs7k%253D&md5=a76ceb455cdf901bb7d7dae77686afc9</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2019.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2019.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DF.%2BA.%26aulast%3DLeijten-van%2Bde%2BGevel%26aufirst%3DI.%2BA.%26aulast%3Dde%2BVries%26aufirst%3DR.%2BM.%2BJ.%2BM.%26aulast%3DBrunsveld%26aufirst%3DL.%26atitle%3DAllosteric%2520small%2520molecule%2520modulators%2520of%2520nuclear%2520receptors%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2019%26volume%3D485%26spage%3D20%26epage%3D34%26doi%3D10.1016%2Fj.mce.2019.01.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moore, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayne, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katzenellenbogen, J. A.</span></span> <span> </span><span class="NLM_article-title">Minireview: Not picking pockets: nuclear receptor alternate-site modulators (NRAMs)</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">683</span>– <span class="NLM_lpage">695</span>, <span class="refDoi"> DOI: 10.1210/me.2009-0362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1210%2Fme.2009-0362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=19933380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVOhsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=683-695&author=T.+W.+Mooreauthor=C.+G.+Mayneauthor=J.+A.+Katzenellenbogen&title=Minireview%3A+Not+picking+pockets%3A+nuclear+receptor+alternate-site+modulators+%28NRAMs%29&doi=10.1210%2Fme.2009-0362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Not picking pockets: nuclear receptor alternate-site modulators (NRAMs)</span></div><div class="casAuthors">Moore, Terry W.; Mayne, Christopher G.; Katzenellenbogen, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">683-695</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Because of their central importance in gene regulation and mediating the actions of many hormones, the nuclear receptors (NRs) have long been recognized as very important biol. and pharmaceutical targets.  Of all the surfaces available on a given NR, the singular site for regulation of receptor activity has almost invariably been the ligand-binding pocket of the receptor, the site where agonists, antagonists, and selective NR modulators interact.  With our increasing understanding of the multiple mol. components involved in NR action, researchers have recently begun to look to addnl. interaction sites on NRs for regulating their activities by novel mechanisms.  The alternate NR-assocd. interaction sites that have been targeted include the coactivator-binding groove and allosteric sites in the ligand-binding domain, the zinc fingers of the DNA-binding domain, and the NR response element in DNA.  The studies thus far have been performed with the estrogen receptors, the androgen receptor (AR), the thyroid hormone receptors, and the pregnane X receptor.  Phenotypic and conformation-based screens have also identified small mol. modulators that are believed to function through the NRs but have, as yet, unknown sites and mechanisms of action.  The rewards from investigation of these NR alternate-site modulators should be the discovery of new therapeutic approaches and novel agents for regulating the activities of these important NR proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVtxERmnC5SLVg90H21EOLACvtfcHk0lha0G7i62hcGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVOhsb4%253D&md5=cd35a2ad9714316347764e692455cf65</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1210%2Fme.2009-0362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2009-0362%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DT.%2BW.%26aulast%3DMayne%26aufirst%3DC.%2BG.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26atitle%3DMinireview%253A%2520Not%2520picking%2520pockets%253A%2520nuclear%2520receptor%2520alternate-site%2520modulators%2520%2528NRAMs%2529%26jtitle%3DMol.%2520Endocrinol.%26date%3D2010%26volume%3D24%26spage%3D683%26epage%3D695%26doi%3D10.1210%2Fme.2009-0362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caboni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, D. G.</span></span> <span> </span><span class="NLM_article-title">Beyond the ligand-binding pocket: targeting alternate sites in nuclear receptors</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1118</span>, <span class="refDoi"> DOI: 10.1002/med.21275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1002%2Fmed.21275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=23344935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1ChtbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=1081-1118&author=L.+Caboniauthor=D.+G.+Lloyd&title=Beyond+the+ligand-binding+pocket%3A+targeting+alternate+sites+in+nuclear+receptors&doi=10.1002%2Fmed.21275"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond the Ligand-Binding Pocket: Targeting Alternate Sites in Nuclear Receptors</span></div><div class="casAuthors">Caboni, Laura; Lloyd, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1081-1118</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors (NRs) are a family of ligand-modulated transcription factors with significant therapeutic relevance from metabolic disorders and inflammation to cancer, neurodegenerative, and psychiatric disorders.  Drug discovery efforts are typically concd. on modulating the natural ligand action within the ligand-binding pocket (LBP) in the C-terminal ligand-binding domain (LBD).  Drawbacks of LBP-based strategies include physiol. alterations due to disruption of ligand binding and difficulties in achieving tissue specificity.  Furthermore, the lack of a "pure" and predictable mechanism of action predisposes such intervention toward drug resistance.  Recent outstanding progress in our understanding of NR biol. has shifted the focus of drug discovery efforts from inside to outside the LBP, affording consideration to the interaction between NRs and coactivator proteins, the interaction between NRs and DNA and the NRs' ligand-independent functions.  This review encompasses such currently available NR non-LBP-based interventions and their potential application in therapy or as specific tools to probe NR biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAhSzBdWcj87Vg90H21EOLACvtfcHk0lha0G7i62hcGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1ChtbrK&md5=e30fa7f4b5df11580ad77c9dcbabcd03</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fmed.21275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21275%26sid%3Dliteratum%253Aachs%26aulast%3DCaboni%26aufirst%3DL.%26aulast%3DLloyd%26aufirst%3DD.%2BG.%26atitle%3DBeyond%2520the%2520ligand-binding%2520pocket%253A%2520targeting%2520alternate%2520sites%2520in%2520nuclear%2520receptors%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D1081%26epage%3D1118%26doi%3D10.1002%2Fmed.21275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tice, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y.-J.</span></span> <span> </span><span class="NLM_article-title">Non-canonical modulators of nuclear receptors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4157</span>– <span class="NLM_lpage">4164</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.07.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.bmcl.2016.07.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=27503683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlaju7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4157-4164&author=C.+M.+Ticeauthor=Y.-J.+Zheng&title=Non-canonical+modulators+of+nuclear+receptors&doi=10.1016%2Fj.bmcl.2016.07.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Non-canonical modulators of nuclear receptors</span></div><div class="casAuthors">Tice, Colin M.; Zheng, Ya-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4157-4164</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Like G protein-coupled receptors (GPCRs) and protein kinases, nuclear receptors (NRs) are a rich source of pharmaceutical targets.  Over 80 NR-targeting drugs have been approved for 18 NRs.  The focus of drug discovery in NRs has hitherto been on identifying ligands that bind to the canonical ligand binding pockets of the C-terminal ligand binding domains (LBDs).  Due to the development of drug resistance and selectivity concerns, there has been considerable interest in exploring other, non-canonical ligand binding sites.  Unfortunately, the potencies of compds. binding at other sites have generally not been sufficient for clin. development.  However, the situation has changed dramatically over the last 3 years, as compds. with sufficient potency have been reported for several NR targets.  Here we review recent developments in this area from a medicinal chem. point of view in the hope of stimulating further interest in this area of research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopu9N4QDGsXrVg90H21EOLACvtfcHk0lha0G7i62hcGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlaju7bN&md5=5677a03f0e607260d148c48e24d49110</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.07.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.07.067%26sid%3Dliteratum%253Aachs%26aulast%3DTice%26aufirst%3DC.%2BM.%26aulast%3DZheng%26aufirst%3DY.-J.%26atitle%3DNon-canonical%2520modulators%2520of%2520nuclear%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D4157%26epage%3D4164%26doi%3D10.1016%2Fj.bmcl.2016.07.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheepstra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leysen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Almen, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piesvaux, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutilek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Eenennaam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagpal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soisson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornienko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correll, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trotter, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Stelt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oubrie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parthasarathy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunsveld, L.</span></span> <span> </span><span class="NLM_article-title">Identification of an allosteric binding site for RORγt inhibition</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e8833</span> <span class="refDoi"> DOI: 10.1038/ncomms9833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1038%2Fncomms9833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=26640126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKit7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&author=M.+Scheepstraauthor=S.+Leysenauthor=G.+C.+van+Almenauthor=J.+R.+Millerauthor=J.+Piesvauxauthor=V.+Kutilekauthor=H.+van+Eenennaamauthor=H.+Zhangauthor=K.+Barrauthor=S.+Nagpalauthor=S.+M.+Soissonauthor=M.+Kornienkoauthor=K.+Wileyauthor=N.+Elsenauthor=S.+Sharmaauthor=C.+C.+Correllauthor=B.+W.+Trotterauthor=M.+van+der+Steltauthor=A.+Oubrieauthor=C.+Ottmannauthor=G.+Parthasarathyauthor=L.+Brunsveld&title=Identification+of+an+allosteric+binding+site+for+ROR%CE%B3t+inhibition&doi=10.1038%2Fncomms9833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an allosteric binding site for RORγt inhibition</span></div><div class="casAuthors">Scheepstra, Marcel; Leysen, Seppe; van Almen, Geert C.; Miller, J. Richard; Piesvaux, Jennifer; Kutilek, Victoria; van Eenennaam, Hans; Zhang, Hongjun; Barr, Kenneth; Nagpal, Sunil; Soisson, Stephen M.; Kornienko, Maria; Wiley, Kristen; Elsen, Nathaniel; Sharma, Sujata; Correll, Craig C.; Trotter, B. Wesley; van der Stelt, Mario; Oubrie, Arthur; Ottmann, Christian; Parthasarathy, Gopal; Brunsveld, Luc</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8833/1-8833/10</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">RORγt is crit. for the differentiation and proliferation of Th17 cells assocd. with several chronic autoimmune diseases.  We report the discovery of a novel allosteric binding site on the nuclear receptor RORγt.  Co-crystn. of the ligand binding domain (LBD) of RORγt with a series of small-mol. antagonists demonstrates occupancy of a previously unreported allosteric binding pocket.  Binding at this non-canonical site induces an unprecedented conformational reorientation of helix 12 in the RORγt LBD, which blocks cofactor binding.  The functional consequence of this allosteric ligand-mediated conformation is inhibition of function as evidenced by both biochem. and cellular studies.  RORγt function is thus antagonized in a manner molecularly distinct from that of previously described orthosteric RORγt ligands.  This brings forward an approach to target RORγt for the treatment of Th17-mediated autoimmune diseases.  The elucidation of an unprecedented modality of pharmacol. antagonism establishes a mechanism for modulation of nuclear receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNcktcUUFl77Vg90H21EOLACvtfcHk0lhvEFDMno2zTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKit7zL&md5=409b08232ecdd3f3e82fa660585c989d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fncomms9833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9833%26sid%3Dliteratum%253Aachs%26aulast%3DScheepstra%26aufirst%3DM.%26aulast%3DLeysen%26aufirst%3DS.%26aulast%3Dvan%2BAlmen%26aufirst%3DG.%2BC.%26aulast%3DMiller%26aufirst%3DJ.%2BR.%26aulast%3DPiesvaux%26aufirst%3DJ.%26aulast%3DKutilek%26aufirst%3DV.%26aulast%3Dvan%2BEenennaam%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBarr%26aufirst%3DK.%26aulast%3DNagpal%26aufirst%3DS.%26aulast%3DSoisson%26aufirst%3DS.%2BM.%26aulast%3DKornienko%26aufirst%3DM.%26aulast%3DWiley%26aufirst%3DK.%26aulast%3DElsen%26aufirst%3DN.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DCorrell%26aufirst%3DC.%2BC.%26aulast%3DTrotter%26aufirst%3DB.%2BW.%26aulast%3Dvan%2Bder%2BStelt%26aufirst%3DM.%26aulast%3DOubrie%26aufirst%3DA.%26aulast%3DOttmann%26aufirst%3DC.%26aulast%3DParthasarathy%26aufirst%3DG.%26aulast%3DBrunsveld%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520an%2520allosteric%2520binding%2520site%2520for%2520ROR%25CE%25B3t%2520inhibition%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26doi%3D10.1038%2Fncomms9833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karstens, W. F. J.</span>; <span class="NLM_string-name">van der Stelt, M.</span>; <span class="NLM_string-name">Cals, J.</span>; <span class="NLM_string-name">Azevedo, R. C. R. G.</span>; <span class="NLM_string-name">Barr, K. J.</span>; <span class="NLM_string-name">Zhang, H.</span>; <span class="NLM_string-name">Beresis, R. T.</span>; <span class="NLM_string-name">Zhang, D.</span>; <span class="NLM_string-name">Duan, X.</span></span> <span> </span><span class="NLM_article-title">RORgammaT Inhibitors</span>. PCT Int. Appl. <span class="NLM_patent">WO 2012106995 A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=W.+F.+J.+Karstens&author=M.+van+der+Stelt&author=J.+Cals&author=R.+C.+R.+G.+Azevedo&author=K.+J.+Barr&author=H.+Zhang&author=R.+T.+Beresis&author=D.+Zhang&author=X.+Duan&title=RORgammaT+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKarstens%26aufirst%3DW.%2BF.%2BJ.%26atitle%3DRORgammaT%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leijten-van
de Gevel, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunsveld, L.</span></span> <span> </span><span class="NLM_article-title">Delineation of the molecular determinants of the unique allosteric binding site of the orphan nuclear receptor RORγt</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>295</i></span>,  <span class="NLM_fpage">9183</span>– <span class="NLM_lpage">9191</span>, <span class="refDoi"> DOI: 10.1074/jbc.ra120.013581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1074%2Fjbc.RA120.013581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=32439807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFWktLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2020&pages=9183-9191&author=I.+A.+Leijten-van%0Ade+Gevelauthor=L.+Brunsveld&title=Delineation+of+the+molecular+determinants+of+the+unique+allosteric+binding+site+of+the+orphan+nuclear+receptor+ROR%CE%B3t&doi=10.1074%2Fjbc.ra120.013581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Delineation of the molecular determinants of the unique allosteric binding site of the orphan nuclear receptor RORγt</span></div><div class="casAuthors">Leijten-van de Gevel, Iris A.; Brunsveld, Luc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">9183-9192</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">1083-351X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nuclear receptors (NRs) are high-interest targets in drug discovery because of their involvement in numerous biol. processes and diseases.  Classically, NRs are targeted via their hydrophobic, orthosteric pocket.  Although successful, this approach comes with challenges, including off-target effects due to lack of selectivity.  Allosteric modulation of NR activity constitutes a promising pharmacol. strategy.  The retinoic acid receptor-related orphan receptor-γt (RORγt) is a constitutively active NR that pos. regulates the expression of interleukin-17 in T helper 17 cells.  Inhibiting this process is an emerging strategy for managing autoimmune diseases.  Recently, an allosteric binding pocket in the C-terminal region of the ligand-binding domain (LBD) of RORγt was discovered that is amenable to small-mol. drug discovery.  Compds. binding this pocket induce a reorientation of helix 12, thereby preventing coactivator recruitment.  Therefore, inverse agonists binding this site with high affinity are actively being pursued.  To elucidate the pocket formation mechanism, verify the uniqueness of this pocket, and substantiate the relevance of targeting this site, here we identified the key characteristics of the RORγt allosteric region.  We evaluated the effects of substitutions in the LBD on coactivator, orthosteric, and allosteric ligand binding.  We found that two mol. elements unique to RORγt, the length of helix 119 and a Gln-487 residue, are crucial for the formation of the allosteric pocket.  The unique combination of elements present in RORγt suggests a high potential for subtype-selective targeting of this NR to more effectively treat patients with autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptob_4Lxg5orVg90H21EOLACvtfcHk0lhvEFDMno2zTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFWktLfF&md5=1ff65a2cf0a09633bd9f05848698a837</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA120.013581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA120.013581%26sid%3Dliteratum%253Aachs%26aulast%3DLeijten-van%2Bde%2BGevel%26aufirst%3DI.%2BA.%26aulast%3DBrunsveld%26aufirst%3DL.%26atitle%3DDelineation%2520of%2520the%2520molecular%2520determinants%2520of%2520the%2520unique%2520allosteric%2520binding%2520site%2520of%2520the%2520orphan%2520nuclear%2520receptor%2520ROR%25CE%25B3t%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2020%26volume%3D295%26spage%3D9183%26epage%3D9191%26doi%3D10.1074%2Fjbc.ra120.013581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Vries, R. M. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doveston, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leijten-van
de Gevel, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunsveld, L.</span></span> <span> </span><span class="NLM_article-title">Cooperativity between the Orthosteric and Allosteric Ligand Binding Sites of RORγt</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>118</i></span>, <span class="NLM_elocation-id">e2021287118</span> <span class="refDoi"> DOI: 10.1073/pnas.2021287118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1073%2Fpnas.2021287118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=33536342" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2021&author=R.+M.+J.+M.+de%0AVriesauthor=F.+A.+Meijerauthor=R.+G.+Dovestonauthor=I.+A.+Leijten-van%0Ade+Gevelauthor=L.+Brunsveld&title=Cooperativity+between+the+Orthosteric+and+Allosteric+Ligand+Binding+Sites+of+ROR%CE%B3t&doi=10.1073%2Fpnas.2021287118"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1073%2Fpnas.2021287118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.2021287118%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BVries%26aufirst%3DR.%2BM.%2BJ.%2BM.%26aulast%3DMeijer%26aufirst%3DF.%2BA.%26aulast%3DDoveston%26aufirst%3DR.%2BG.%26aulast%3DLeijten-van%2Bde%2BGevel%26aufirst%3DI.%2BA.%26aulast%3DBrunsveld%26aufirst%3DL.%26atitle%3DCooperativity%2520between%2520the%2520Orthosteric%2520and%2520Allosteric%2520Ligand%2520Binding%2520Sites%2520of%2520ROR%25CE%25B3t%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2021%26volume%3D118%26doi%3D10.1073%2Fpnas.2021287118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doveston, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vries, R. M. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, A. A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leysen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheepstra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milroy, L.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunsveld, L.</span></span> <span> </span><span class="NLM_article-title">Ligand-Based Design of Allosteric Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Inverse Agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">241</span>– <span class="NLM_lpage">259</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01372</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01372" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlOhtrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=241-259&author=F.+A.+Meijerauthor=R.+G.+Dovestonauthor=R.+M.+J.+M.+De+Vriesauthor=G.+M.+Vosauthor=A.+A.+A.+Vosauthor=S.+Leysenauthor=M.+Scheepstraauthor=C.+Ottmannauthor=L.-G.+Milroyauthor=L.+Brunsveld&title=Ligand-Based+Design+of+Allosteric+Retinoic+Acid+Receptor-Related+Orphan+Receptor+%CE%B3t+%28ROR%CE%B3t%29+Inverse+Agonists&doi=10.1021%2Facs.jmedchem.9b01372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-Based Design of Allosteric Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Inverse Agonists</span></div><div class="casAuthors">Meijer, Femke A.; Doveston, Richard G.; de Vries, Rens M. J. M.; Vos, Gael M.; Vos, Alex A. A.; Leysen, Seppe; Scheepstra, Marcel; Ottmann, Christian; Milroy, Lech-Gustav; Brunsveld, Luc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">241-259</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Retinoic acid receptor-related orphan receptor γt (RORγt) is a nuclear receptor assocd. with the pathogenesis of autoimmune diseases.  Allosteric inhibition of RORγt is conceptually new, unique for this specific nuclear receptor, and offers advantages over traditional orthosteric inhibition.  Here, we report a highly efficient in silico-guided approach that led to the discovery of novel allosteric RORγt inverse agonists with a distinct isoxazole chemotype.  The the most potent compd., I (FM26), displayed submicromolar inhibition in a coactivator recruitment assay and effectively reduced IL-17a mRNA prodn. in EL4 cells, a marker of RORγt activity.  The projected allosteric mode of action of I was confirmed by biochem. expts. and cocrystn. with the RORγt ligand binding domain.  The isoxazole compds. have promising pharmacokinetic properties comparable to other allosteric ligands but with a more diverse chemotype.  The efficient ligand-based design approach adopted demonstrates its versatility in generating chem. diversity for allosteric targeting of RORγt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolfmtpPwH8IbVg90H21EOLACvtfcHk0lgzkBqRc2ddYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlOhtrbF&md5=db24c8aba88c9d59d93167cd8212236e</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01372%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DF.%2BA.%26aulast%3DDoveston%26aufirst%3DR.%2BG.%26aulast%3DDe%2BVries%26aufirst%3DR.%2BM.%2BJ.%2BM.%26aulast%3DVos%26aufirst%3DG.%2BM.%26aulast%3DVos%26aufirst%3DA.%2BA.%2BA.%26aulast%3DLeysen%26aufirst%3DS.%26aulast%3DScheepstra%26aufirst%3DM.%26aulast%3DOttmann%26aufirst%3DC.%26aulast%3DMilroy%26aufirst%3DL.-G.%26aulast%3DBrunsveld%26aufirst%3DL.%26atitle%3DLigand-Based%2520Design%2520of%2520Allosteric%2520Retinoic%2520Acid%2520Receptor-Related%2520Orphan%2520Receptor%2520%25CE%25B3t%2520%2528ROR%25CE%25B3t%2529%2520Inverse%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D241%26epage%3D259%26doi%3D10.1021%2Facs.jmedchem.9b01372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robarge, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerhill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists</span>. <i>Bioorg. Med. Chem. Lett</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2907</span>– <span class="NLM_lpage">2912</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.05.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.bmcl.2015.05.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=26048793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpt1yrtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2907-2912&author=B.+P.+Fauberauthor=A.+Gobbiauthor=K.+Robargeauthor=A.+Zhouauthor=A.+Barnardauthor=J.+Caoauthor=Y.+Dengauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Ganguliauthor=J.+Hawkinsauthor=A.+R.+Johnsonauthor=H.+Laauthor=M.+Normanauthor=G.+Salmonauthor=S.+Summerhillauthor=W.+Ouyangauthor=W.+Tangauthor=H.+Wong&title=Discovery+of+imidazo%5B1%2C5-a%5Dpyridines+and+-pyrimidines+as+potent+and+selective+RORc+inverse+agonists&doi=10.1016%2Fj.bmcl.2015.05.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists</span></div><div class="casAuthors">Fauber, Benjamin P.; Gobbi, Alberto; Robarge, Kirk; Zhou, Aihe; Barnard, Adrian; Cao, Jianhua; Deng, Yuzhong; Eidenschenk, Celine; Everett, Christine; Ganguli, Arunima; Hawkins, Julie; Johnson, Adam R.; La, Hank; Norman, Maxine; Salmon, Gary; Summerhill, Susan; Ouyang, Wenjun; Tang, Wei; Wong, Harvey</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2907-2912</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The nuclear receptor (NR) retinoic acid receptor-related orphan receptor gamma (RORγ, RORc, or NR1F3) is a promising target for the treatment of autoimmune diseases.  RORc is a crit. regulator in the prodn. of the pro-inflammatory cytokine interleukin-17.  We discovered a series of potent and selective imidazo[1,5-a]pyridine and -pyrimidine RORc inverse agonists.  The most potent compds. displayed >300-fold selectivity for RORc over the other ROR family members, PPARγ, and NRs in our cellular selectivity panel.  The favorable potency, selectivity, and physiochem. properties of GNE-0946 (9) and GNE-6468 (28), in addn. to their potent suppression of IL-17 prodn. in human primary cells, support their use as chem. biol. tools to further explore the role of RORc in human biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIQTYB5nafXLVg90H21EOLACvtfcHk0lgzkBqRc2ddYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpt1yrtb0%253D&md5=d0e89e186488a9db8f7629fd86ed7ea0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.05.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.05.055%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DRobarge%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DA.%26aulast%3DBarnard%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGanguli%26aufirst%3DA.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DSalmon%26aufirst%3DG.%26aulast%3DSummerhill%26aufirst%3DS.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520imidazo%255B1%252C5-a%255Dpyridines%2520and%2520-pyrimidines%2520as%2520potent%2520and%2520selective%2520RORc%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett%26date%3D2015%26volume%3D25%26spage%3D2907%26epage%3D2912%26doi%3D10.1016%2Fj.bmcl.2015.05.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ouvry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouix-Peter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciesielski, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantalat, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duvert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feret, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzy, A.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musicki, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orfila, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parnet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polge, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raffin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rival, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taquet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoreau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennequin, L. F.</span></span> <span> </span><span class="NLM_article-title">Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonists</span>. <i>Bioorg. Med. Chem. Lett</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5802</span>– <span class="NLM_lpage">5808</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.bmcl.2016.10.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=27815118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslynsr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5802-5808&author=G.+Ouvryauthor=C.+Bouix-Peterauthor=F.+Ciesielskiauthor=L.+Chantalatauthor=O.+Christinauthor=C.+Cominoauthor=D.+Duvertauthor=C.+Feretauthor=C.+S.+Harrisauthor=L.+Lamyauthor=A.-P.+Luzyauthor=B.+Musickiauthor=D.+Orfilaauthor=J.+Pascauauthor=V.+Parnetauthor=A.+Perrinauthor=R.+Pierreauthor=G.+Polgeauthor=C.+Raffinauthor=Y.+Rivalauthor=N.+Taquetauthor=E.+Thoreauauthor=L.+F.+Hennequin&title=Discovery+of+phenoxyindazoles+and+phenylthioindazoles+as+ROR%CE%B3+inverse+agonists&doi=10.1016%2Fj.bmcl.2016.10.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonists</span></div><div class="casAuthors">Ouvry, Gilles; Bouix-Peter, Claire; Ciesielski, Fabrice; Chantalat, Laurent; Christin, Olivier; Comino, Catherine; Duvert, Denis; Feret, Christophe; Harris, Craig S.; Lamy, Laurent; Luzy, Anne-Pascale; Musicki, Branislav; Orfila, Danielle; Pascau, Jonathan; Parnet, Veronique; Perrin, Agnes; Pierre, Romain; Polge, Gaelle; Raffin, Catherine; Rival, Yves; Taquet, Nathalie; Thoreau, Etienne; Hennequin, Laurent F.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5802-5808</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Targeting the IL17 pathway and more specifically the nuclear receptor RORγ is thought to be beneficial in multiple skin disorders.  The Letter describes the discovery of phenoxyindazoles and thiophenoxy indazoles as potent RORγ inverse agonists.  Optimization of the potency and efforts to mitigate the phototoxic liability of the series are presented.  Finally, crystn. of the lead compd. revealed that the series bound to an allosteric site of the nuclear receptor.  Such compds. could be useful as tool compds. for understanding the impact of topical treatment on skin disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX7Dguvi_h8LVg90H21EOLACvtfcHk0lj1CmwpjSPi4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslynsr%252FM&md5=cd3aa2c246cfa35c98306096d823dccc</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.023%26sid%3Dliteratum%253Aachs%26aulast%3DOuvry%26aufirst%3DG.%26aulast%3DBouix-Peter%26aufirst%3DC.%26aulast%3DCiesielski%26aufirst%3DF.%26aulast%3DChantalat%26aufirst%3DL.%26aulast%3DChristin%26aufirst%3DO.%26aulast%3DComino%26aufirst%3DC.%26aulast%3DDuvert%26aufirst%3DD.%26aulast%3DFeret%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DC.%2BS.%26aulast%3DLamy%26aufirst%3DL.%26aulast%3DLuzy%26aufirst%3DA.-P.%26aulast%3DMusicki%26aufirst%3DB.%26aulast%3DOrfila%26aufirst%3DD.%26aulast%3DPascau%26aufirst%3DJ.%26aulast%3DParnet%26aufirst%3DV.%26aulast%3DPerrin%26aufirst%3DA.%26aulast%3DPierre%26aufirst%3DR.%26aulast%3DPolge%26aufirst%3DG.%26aulast%3DRaffin%26aufirst%3DC.%26aulast%3DRival%26aufirst%3DY.%26aulast%3DTaquet%26aufirst%3DN.%26aulast%3DThoreau%26aufirst%3DE.%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DDiscovery%2520of%2520phenoxyindazoles%2520and%2520phenylthioindazoles%2520as%2520ROR%25CE%25B3%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett%26date%3D2016%26volume%3D26%26spage%3D5802%26epage%3D5808%26doi%3D10.1016%2Fj.bmcl.2016.10.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shaikh, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munot, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukhopadhyay, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raje, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagaraj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamdar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavhane, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohote, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherkar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bala, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umrani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouduri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandikere, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhuniya, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mookhtiar, K. A.</span></span> <span> </span><span class="NLM_article-title">Discovery and pharmacological evaluation of indole derivatives as potent and selective RORγt inverse agonist for multiple autoimmune conditions</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">2208</span>– <span class="NLM_lpage">2217</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.06.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.bmcl.2019.06.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=31272795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlaqt7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=2208-2217&author=N.+S.+Shaikhauthor=J.+P.+Iyerauthor=Y.+S.+Munotauthor=P.+P.+Mukhopadhyayauthor=A.+A.+Rajeauthor=R.+Nagarajauthor=V.+Jamdarauthor=R.+Gavhaneauthor=M.+Lohoteauthor=P.+Sherkarauthor=M.+Balaauthor=R.+Petlaauthor=A.+Meruauthor=D.+Umraniauthor=S.+Rouduriauthor=S.+Joshiauthor=S.+Reddyauthor=V.+Kandikereauthor=D.+Bhuniyaauthor=B.+Kulkarniauthor=K.+A.+Mookhtiar&title=Discovery+and+pharmacological+evaluation+of+indole+derivatives+as+potent+and+selective+ROR%CE%B3t+inverse+agonist+for+multiple+autoimmune+conditions&doi=10.1016%2Fj.bmcl.2019.06.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and pharmacological evaluation of indole derivatives as potent and selective RORγt inverse agonist for multiple autoimmune conditions</span></div><div class="casAuthors">Shaikh, Nadim S.; Iyer, Jitesh P.; Munot, Yogesh S.; Mukhopadhyay, Partha P.; Raje, Amol A.; Nagaraj, Ranganayaki; Jamdar, Vijay; Gavhane, Ravindra; Lohote, Mahendra; Sherkar, Prasad; Bala, Madhu; Petla, Rajkanth; Meru, Ashwinkumar; Umrani, Dhananjay; Rouduri, Sreekanth; Joshi, Sachin; Reddy, Satyanarayan; Kandikere, Vishwottam; Bhuniya, Debnath; Kulkarni, Bheemashankar; Mookhtiar, Kasim A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2208-2217</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Targeting nuclear receptor RORγ is recognized to be beneficial in multiple autoimmune disorders.  We disclosed new indole analogs as potent RORγ inverse agonists.  RO-2 as one of the potent and orally bioavailable compds. was evaluated in various models of autoimmune disorder.  It showed potent suppression of downstream markers of RORγt activity in murine and human primary cells, ex vivo PD assay and in multiple animal models of autoimmune diseases.  The results indicate the potential of these indole analogs as orally bioavailable small mol. inverse agonists of RORγt, efficacious in various Th17 driven models of autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTZNKPrT6CpbVg90H21EOLACvtfcHk0lj1CmwpjSPi4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlaqt7fN&md5=c74da1da9ce3fc636a60aac9fd02f627</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.06.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.06.044%26sid%3Dliteratum%253Aachs%26aulast%3DShaikh%26aufirst%3DN.%2BS.%26aulast%3DIyer%26aufirst%3DJ.%2BP.%26aulast%3DMunot%26aufirst%3DY.%2BS.%26aulast%3DMukhopadhyay%26aufirst%3DP.%2BP.%26aulast%3DRaje%26aufirst%3DA.%2BA.%26aulast%3DNagaraj%26aufirst%3DR.%26aulast%3DJamdar%26aufirst%3DV.%26aulast%3DGavhane%26aufirst%3DR.%26aulast%3DLohote%26aufirst%3DM.%26aulast%3DSherkar%26aufirst%3DP.%26aulast%3DBala%26aufirst%3DM.%26aulast%3DPetla%26aufirst%3DR.%26aulast%3DMeru%26aufirst%3DA.%26aulast%3DUmrani%26aufirst%3DD.%26aulast%3DRouduri%26aufirst%3DS.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DReddy%26aufirst%3DS.%26aulast%3DKandikere%26aufirst%3DV.%26aulast%3DBhuniya%26aufirst%3DD.%26aulast%3DKulkarni%26aufirst%3DB.%26aulast%3DMookhtiar%26aufirst%3DK.%2BA.%26atitle%3DDiscovery%2520and%2520pharmacological%2520evaluation%2520of%2520indole%2520derivatives%2520as%2520potent%2520and%2520selective%2520ROR%25CE%25B3t%2520inverse%2520agonist%2520for%2520multiple%2520autoimmune%2520conditions%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D2208%26epage%3D2217%26doi%3D10.1016%2Fj.bmcl.2019.06.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapointe, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azevedo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cals, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correll, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Eenenaam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karstens, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maclean, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moy, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagpal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oubrie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palte, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parthasarathy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciammetta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Stelt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodhouse, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trotter, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, K.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune Diseases</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00431</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00431" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtVGnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=114-119&author=H.+Zhangauthor=B.+T.+Lapointeauthor=N.+Anthonyauthor=R.+Azevedoauthor=J.+Calsauthor=C.+C.+Correllauthor=M.+Danielsauthor=S.+Deshmukhauthor=H.+van+Eenenaamauthor=H.+Fergusonauthor=L.+G.+Hegdeauthor=W.+J.+Karstensauthor=J.+Macleanauthor=J.+R.+Millerauthor=L.+Y.+Moyauthor=V.+Simovauthor=S.+Nagpalauthor=A.+Oubrieauthor=R.+L.+Palteauthor=G.+Parthasarathyauthor=N.+Sciammettaauthor=M.+van+der+Steltauthor=J.+D.+Woodhouseauthor=B.+W.+Trotterauthor=K.+Barr&title=Discovery+of+N-%28Indazol-3-yl%29piperidine-4-carboxylic+Acids+as+ROR%CE%B3t+Allosteric+Inhibitors+for+Autoimmune+Diseases&doi=10.1021%2Facsmedchemlett.9b00431"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune Diseases</span></div><div class="casAuthors">Zhang, Hongjun; Lapointe, Blair T.; Anthony, Neville; Azevedo, Rita; Cals, Jos; Correll, Craig C.; Daniels, Matthew; Deshmukh, Sujal; van Eenenaam, Hans; Ferguson, Heidi; Hegde, Laxminarayan G.; Karstens, Willem Jan; MacLean, John; Miller, J. Richard; Moy, Lily Y.; Simov, Vladimir; Nagpal, Sunil; Oubrie, Arthur; Palte, Rachel L.; Parthasarathy, Gopal; Sciammetta, Nunzio; van der Stelt, Mario; Woodhouse, Janice D.; Trotter, B. Wesley; Barr, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">114-119</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The clin. success of anti-IL-17 monoclonal antibodies (i.e., Cosentyx and Taltz) has validated Th17 pathway modulation for the treatment of autoimmune diseases.  The nuclear hormone receptor RORγt is a master regulator of Th17 cells and affects the prodn. of a host of cytokines, including IL-17A, IL-17F, IL-22, IL-26, and GM-CSF.  Substantial interest has been spurred across both academia and industry to seek small mols. suitable for RORγt inhibition.  A variety of RORγt inhibitors have been reported in the past few years, the majority of which are orthosteric binders.  Here the authors disclose the discovery and optimization of a class of inhibitors, which bind differently to an allosteric binding pocket.  Starting from a weakly active hit 1, a tool compd. 14 was quickly identified that demonstrated superior potency, selectivity, and off-target profile.  Further optimization focused on improving metabolic stability.  Replacing the benzoic acid moiety with piperidinyl carboxylate, modifying the 4-aza-indazole core in 14 to 4-F-indazole, and incorporating a key hydroxyl group led to the discovery of I, which possesses exquisite potency and selectivity, as well as an improved pharmacokinetic profile suitable for oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXx2w5vE5C97Vg90H21EOLACvtfcHk0lgO7PreAX0fbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtVGnuw%253D%253D&md5=701fad0e447fda063dc61a0ca2197d67</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00431%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLapointe%26aufirst%3DB.%2BT.%26aulast%3DAnthony%26aufirst%3DN.%26aulast%3DAzevedo%26aufirst%3DR.%26aulast%3DCals%26aufirst%3DJ.%26aulast%3DCorrell%26aufirst%3DC.%2BC.%26aulast%3DDaniels%26aufirst%3DM.%26aulast%3DDeshmukh%26aufirst%3DS.%26aulast%3Dvan%2BEenenaam%26aufirst%3DH.%26aulast%3DFerguson%26aufirst%3DH.%26aulast%3DHegde%26aufirst%3DL.%2BG.%26aulast%3DKarstens%26aufirst%3DW.%2BJ.%26aulast%3DMaclean%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DJ.%2BR.%26aulast%3DMoy%26aufirst%3DL.%2BY.%26aulast%3DSimov%26aufirst%3DV.%26aulast%3DNagpal%26aufirst%3DS.%26aulast%3DOubrie%26aufirst%3DA.%26aulast%3DPalte%26aufirst%3DR.%2BL.%26aulast%3DParthasarathy%26aufirst%3DG.%26aulast%3DSciammetta%26aufirst%3DN.%26aulast%3Dvan%2Bder%2BStelt%26aufirst%3DM.%26aulast%3DWoodhouse%26aufirst%3DJ.%2BD.%26aulast%3DTrotter%26aufirst%3DB.%2BW.%26aulast%3DBarr%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520N-%2528Indazol-3-yl%2529piperidine-4-carboxylic%2520Acids%2520as%2520ROR%25CE%25B3t%2520Allosteric%2520Inhibitors%2520for%2520Autoimmune%2520Diseases%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D11%26spage%3D114%26epage%3D119%26doi%3D10.1021%2Facsmedchemlett.9b00431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaudari, S. S.</span>; <span class="NLM_string-name">Thomas, A.</span>; <span class="NLM_string-name">Dhone, S. V.</span>; <span class="NLM_string-name">Khairatkar-Joshi, N.</span>; <span class="NLM_string-name">Bajpai, M.</span></span> <span> </span><span class="NLM_article-title">Bicyclic Heterocyclic Compounds as ROR gamma Modulators</span>. PCT Int. Appl. <span class="NLM_patent">WO 2015008234 A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+S.+Chaudari&author=A.+Thomas&author=S.+V.+Dhone&author=N.+Khairatkar-Joshi&author=M.+Bajpai&title=Bicyclic+Heterocyclic+Compounds+as+ROR+gamma+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChaudari%26aufirst%3DS.%2BS.%26atitle%3DBicyclic%2520Heterocyclic%2520Compounds%2520as%2520ROR%2520gamma%2520Modulators%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vries, R. M. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doveston, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunsveld, L.</span></span> <span> </span><span class="NLM_article-title">Elucidation of an Allosteric Mode of Action for a Thienopyrazole RORγt Inverse Agonist</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">565</span>, <span class="refDoi"> DOI: 10.1002/cmdc.202000044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1002%2Fcmdc.202000044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=32053744" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=561-565&author=R.+M.+J.+M.+Vriesauthor=R.+G.+Dovestonauthor=F.+A.+Meijerauthor=L.+Brunsveld&title=Elucidation+of+an+Allosteric+Mode+of+Action+for+a+Thienopyrazole+ROR%CE%B3t+Inverse+Agonist&doi=10.1002%2Fcmdc.202000044"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.202000044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.202000044%26sid%3Dliteratum%253Aachs%26aulast%3DVries%26aufirst%3DR.%2BM.%2BJ.%2BM.%26aulast%3DDoveston%26aufirst%3DR.%2BG.%26aulast%3DMeijer%26aufirst%3DF.%2BA.%26aulast%3DBrunsveld%26aufirst%3DL.%26atitle%3DElucidation%2520of%2520an%2520Allosteric%2520Mode%2520of%2520Action%2520for%2520a%2520Thienopyrazole%2520ROR%25CE%25B3t%2520Inverse%2520Agonist%26jtitle%3DChemMedChem%26date%3D2020%26volume%3D15%26spage%3D561%26epage%3D565%26doi%3D10.1002%2Fcmdc.202000044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brunsveld, L.</span>; <span class="NLM_string-name">Doveston, R. G.</span>; <span class="NLM_string-name">Leysen, S. F. R.</span>; <span class="NLM_string-name">Milroy, L.-G.</span>; <span class="NLM_string-name">Meijer, F. A.</span>; <span class="NLM_string-name">Scheepstra, M.</span>; <span class="NLM_string-name">Ottmann, C.</span></span> <span> </span><span class="NLM_article-title">Substituted heterocyclic compounds and their use as retinoic acid receptor-related orphan receptor (ROR) gamma-t inhibitors</span>. PCT Int. Appl. <span class="NLM_patent">WO 2020149740 A1</span>, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=L.+Brunsveld&author=R.+G.+Doveston&author=S.+F.+R.+Leysen&author=L.-G.+Milroy&author=F.+A.+Meijer&author=M.+Scheepstra&author=C.+Ottmann&title=Substituted+heterocyclic+compounds+and+their+use+as+retinoic+acid+receptor-related+orphan+receptor+%28ROR%29+gamma-t+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrunsveld%26aufirst%3DL.%26atitle%3DSubstituted%2520heterocyclic%2520compounds%2520and%2520their%2520use%2520as%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor%2520%2528ROR%2529%2520gamma-t%2520inhibitors%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klicic, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenkin, P. S.</span></span> <span> </span><span class="NLM_article-title">Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1739</span>– <span class="NLM_lpage">1749</span>, <span class="refDoi"> DOI: 10.1021/jm0306430</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+A+New+Approach+for+Rapid%2C+Accurate+Docking+and+Scoring.+1.+Method+and+Assessment+of+Docking+Accuracy&doi=10.1021%2Fjm0306430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0lgO7PreAX0fbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520A%2520New%2520Approach%2520for%2520Rapid%252C%2520Accurate%2520Docking%2520and%2520Scoring.%25201.%2520Method%2520and%2520Assessment%2520of%2520Docking%2520Accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749%26doi%3D10.1021%2Fjm0306430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beard, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, J. L.</span></span> <span> </span><span class="NLM_article-title">Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1750</span>– <span class="NLM_lpage">1759</span>, <span class="refDoi"> DOI: 10.1021/jm030644s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030644s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1750-1759&author=T.+A.+Halgrenauthor=R.+B.+Murphyauthor=R.+A.+Friesnerauthor=H.+S.+Beardauthor=L.+L.+Fryeauthor=W.+T.+Pollardauthor=J.+L.+Banks&title=Glide%3A+A+New+Approach+for+Rapid%2C+Accurate+Docking+and+Scoring.+2.+Enrichment+Factors+in+Database+Screening&doi=10.1021%2Fjm030644s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span></div><div class="casAuthors">Halgren, Thomas A.; Murphy, Robert B.; Friesner, Richard A.; Beard, Hege S.; Frye, Leah L.; Pollard, W. Thomas; Banks, Jay L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1750-1759</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Glide's ability to identify active compds. in a database screen is characterized by applying Glide to a diverse set of nine protein receptors.  In many cases, two, or even three, protein sites are employed to probe the sensitivity of the results to the site geometry.  To make the database screens as realistic as possible, the screens use sets of "druglike" decoy ligands that have been selected to be representative of what we believe is likely to be found in the compd. collection of a pharmaceutical or biotechnol. company.  Results are presented for releases 1.8, 2.0, and 2.5 of Glide.  The comparisons show that av. measures for both "early" and "global" enrichment for Glide 2.5 are 3 times higher than for Glide 1.8 and more than 2 times higher than for Glide 2.0 because of better results for the least well-handled screens.  This improvement in enrichment stems largely from the better balance of the more widely parametrized GlideScore 2.5 function and the inclusion of terms that penalize ligand-protein interactions that violate established principles of phys. chem., particularly as it concerns the exposure to solvent of charged protein and ligand groups.  Comparisons to results for the thymidine kinase and estrogen receptors published by Rognan and co-workers (J. Med. Chem. 2000, 43, 4759-4767) show that Glide 2.5 performs better than GOLD 1.1, FlexX 1.8, or DOCK 4.01.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT2ptubbKbvLVg90H21EOLACvtfcHk0lh8OZxKO1A2ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D&md5=33d68dd968e65626b449df61e44e37be</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm030644s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030644s%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DPollard%26aufirst%3DW.%2BT.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26atitle%3DGlide%253A%2520A%2520New%2520Approach%2520for%2520Rapid%252C%2520Accurate%2520Docking%2520and%2520Scoring.%25202.%2520Enrichment%2520Factors%2520in%2520Database%2520Screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1750%26epage%3D1759%26doi%3D10.1021%2Fjm030644s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degorce, F.</span></span> <span> </span><span class="NLM_article-title">HTRF: A Technology Tailored for Drug Discovery - A Review of Theoretical Aspects and Recent Applications</span>. <i>Curr. Chem. Genom.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.2174/1875397300903010022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.2174%2F1875397300903010022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=20161833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFWnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2009&pages=22-32&author=F.+Degorce&title=HTRF%3A+A+Technology+Tailored+for+Drug+Discovery+-+A+Review+of+Theoretical+Aspects+and+Recent+Applications&doi=10.2174%2F1875397300903010022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">HTRF: a technology tailored for drug discovery - a review of theoretical aspects and recent applications</span></div><div class="casAuthors">Degorce, Francois; Card, Amy; Soh, Sharon; Trinquet, Eric; Knapik, Glenn P.; Xie, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Current Chemical Genomics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22-32</span>CODEN:
                <span class="NLM_cas:coden">CCGUAQ</span>;
        ISSN:<span class="NLM_cas:issn">1875-3973</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  HTRF (Homogeneous Time Resolved Fluorescence) is the most frequently used generic assay technol. to measure analytes in a homogenous format, which is the ideal platform used for drug target studies in high-throughput screening (HTS).  This technol. combines fluorescence resonance energy transfer technol. (FRET) with time-resolved measurement (TR).  In TR-FRET assays, a signal is generated through fluorescent resonance energy transfer between a donor and an acceptor mol. when in close proximity to each other.  Buffer and media interference is dramatically reduced by dual-wavelength detection, and the final signal is proportional to the extent of product formation.  The HTRF assay is usually sensitive and robust that can be miniaturized into the 384 and 1536-well plate formats.  This assay technol. has been applied to many antibody-based assays including GPCR signaling (cAMP and IP-One), kinases, cytokines and biomarkers, bioprocess (antibody and protein prodn.), as well as the assays for protein-protein, protein-peptide, and protein-DNA/RNA interactions.  Since its introduction to the drug-screening world over ten years ago, researchers have used HTRF to expedite the study of GPCRs, kinases, new biomarkers, protein-protein interactions, and other targets of interest.  HTRF has also been utilized as an alternative method for bioprocess monitoring.  The first-generation HTRF technol., which uses Europium cryptate as a fluorescence donor to monitor reactions between biomols., was extended in 2008 through the introduction of a second-generation donor, Terbium cryptate (Tb), enhancing screening performance.  Terbium cryptate possesses different photophys. properties compared to Europium, including increased quantum yield and a higher molar extinction coeff.  In addn. to being compatible with the same acceptor fluorophors used with Europium, it can serve as a donor fluorophore to green-emitting fluors because it has multiple emission peaks including one at 490 nm.  Moreover, all Terbium HTRF assays can be read on the same HTRF-compatible instruments as Europium HTRF assays.  Overall, HTRF is a highly sensitive, robust technol. for the detection of mol. interactions in vitro and is widely used for primary and secondary screening phases of drug development.  This review addresses the general principles of HTRF and its current applications in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKDP8Vd8k247Vg90H21EOLACvtfcHk0lh8OZxKO1A2ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFWnsr4%253D&md5=9590149ceeed17ce424522ef85aa32f9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2174%2F1875397300903010022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1875397300903010022%26sid%3Dliteratum%253Aachs%26aulast%3DDegorce%26aufirst%3DF.%26atitle%3DHTRF%253A%2520A%2520Technology%2520Tailored%2520for%2520Drug%2520Discovery%2520-%2520A%2520Review%2520of%2520Theoretical%2520Aspects%2520and%2520Recent%2520Applications%26jtitle%3DCurr.%2520Chem.%2520Genom.%26date%3D2009%26volume%3D3%26spage%3D22%26epage%3D32%26doi%3D10.2174%2F1875397300903010022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muegge, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terenzio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labadia, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrow, N. A.</span></span> <span> </span><span class="NLM_article-title">Structural studies unravel the active conformation of apo RORγt nuclear receptor and a common inverse agonism of two diverse classes of RORγt inhibitors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">11618</span>– <span class="NLM_lpage">11630</span>, <span class="refDoi"> DOI: 10.1074/jbc.m117.789024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1074%2Fjbc.M117.789024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=28546429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFOjtbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=11618-11630&author=X.+Liauthor=M.+Andersonauthor=D.+Collinauthor=I.+Mueggeauthor=J.+Wanauthor=D.+Brennanauthor=S.+Kuglerauthor=D.+Terenzioauthor=C.+Kennedyauthor=S.+Linauthor=M.+E.+Labadiaauthor=B.+Cookauthor=R.+Hughesauthor=N.+A.+Farrow&title=Structural+studies+unravel+the+active+conformation+of+apo+ROR%CE%B3t+nuclear+receptor+and+a+common+inverse+agonism+of+two+diverse+classes+of+ROR%CE%B3t+inhibitors&doi=10.1074%2Fjbc.m117.789024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structural studies unravel the active conformation of apo RORγt nuclear receptor and a common inverse agonism of two diverse classes of RORγt inhibitors</span></div><div class="casAuthors">Li, Xiang; Anderson, Marie; Collin, Delphine; Muegge, Ingo; Wan, John; Brennan, Debra; Kugler, Stanley; Terenzio, Donna; Kennedy, Charles; Lin, Siqi; Labadia, Mark E.; Cook, Brian; Hughes, Robert; Farrow, Neil A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">11618-11630</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The nuclear receptor retinoid acid receptor-related orphan receptor γt (RORγt) is a master regulator of the Th17/IL-17 pathway that plays crucial roles in the pathogenesis of autoimmunity.  RORγt has recently emerged as a highly promising target for treatment of a no. of autoimmune diseases.  Through high-throughput screening, we previously identified several classes of inverse agonists for RORγt.  Here, we report the crystal structures for the ligand-binding domain of RORγt in both apo and ligand-bound states.  We show that apo RORγt adopts an active conformation capable of recruiting coactivator peptides and present a detailed anal. of the structural determinants that stabilize helix 12 (H12) of RORγt in the active state in the absence of a ligand.  The structures of ligand-bound RORγt revealed that binding of the inverse agonists disrupted crit. interactions that stabilized H12.  This destabilizing effect was supported by ab initio calcns. and exptl. by a normalized crystallog. B-factor anal.  Of note, the H12 destabilization in the active state shifted the conformational equil. of RORγt toward an inactive state, which underlies the mol. mechanism of action for the inverse agonists reported here.  These findings highlight that nuclear receptor structure and function are dictated by a dynamic conformational equil. and that subtle changes in ligand structures can shift this equil. in opposite directions, leading to a functional switch from agonists to inverse agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzicB5efbjf7Vg90H21EOLACvtfcHk0lh8OZxKO1A2ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFOjtbjJ&md5=8224bb328772787a2e1df0aec43566d6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.789024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.789024%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DCollin%26aufirst%3DD.%26aulast%3DMuegge%26aufirst%3DI.%26aulast%3DWan%26aufirst%3DJ.%26aulast%3DBrennan%26aufirst%3DD.%26aulast%3DKugler%26aufirst%3DS.%26aulast%3DTerenzio%26aufirst%3DD.%26aulast%3DKennedy%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DLabadia%26aufirst%3DM.%2BE.%26aulast%3DCook%26aufirst%3DB.%26aulast%3DHughes%26aufirst%3DR.%26aulast%3DFarrow%26aufirst%3DN.%2BA.%26atitle%3DStructural%2520studies%2520unravel%2520the%2520active%2520conformation%2520of%2520apo%2520ROR%25CE%25B3t%2520nuclear%2520receptor%2520and%2520a%2520common%2520inverse%2520agonism%2520of%2520two%2520diverse%2520classes%2520of%2520ROR%25CE%25B3t%2520inhibitors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D11618%26epage%3D11630%26doi%3D10.1074%2Fjbc.m117.789024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soroosh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sablad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelen, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dandridge, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bittner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tootoonchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenkrants, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sachen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung-Leung, W.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Leon-Tabaldo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blevitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milla, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span> <span> </span><span class="NLM_article-title">Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiation</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">12163</span>– <span class="NLM_lpage">12168</span>, <span class="refDoi"> DOI: 10.1073/pnas.1322807111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1073%2Fpnas.1322807111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=25092323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1GqtLnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=12163-12168&author=P.+Sorooshauthor=J.+Wuauthor=X.+Xueauthor=J.+Songauthor=S.+W.+Suttonauthor=M.+Sabladauthor=J.+Yuauthor=M.+I.+Nelenauthor=X.+Liuauthor=G.+Castroauthor=R.+Lunaauthor=S.+Crawfordauthor=H.+Banieauthor=R.+A.+Dandridgeauthor=X.+Dengauthor=A.+Bittnerauthor=C.+Kueiauthor=M.+Tootoonchiauthor=N.+Rozenkrantsauthor=K.+Hermanauthor=J.+Gaoauthor=X.+V.+Yangauthor=K.+Sachenauthor=K.+Ngoauthor=W.-P.+Fung-Leungauthor=S.+Nguyenauthor=A.+de+Leon-Tabaldoauthor=J.+Blevittauthor=Y.+Zhangauthor=M.+D.+Cummingsauthor=T.+Raoauthor=N.+S.+Maniauthor=C.+Liuauthor=M.+McKinnonauthor=M.+E.+Millaauthor=A.+M.+Fourieauthor=S.+Sun&title=Oxysterols+are+agonist+ligands+of+ROR%CE%B3t+and+drive+Th17+cell+differentiation&doi=10.1073%2Fpnas.1322807111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Oxysterols are agonist ligands of RORγt and drive Th17 cell differentiation</span></div><div class="casAuthors">Soroosh, Pejman; Wu, Jiejun; Xue, Xiaohua; Song, Jiao; Sutton, Steven W.; Sablad, Marciano; Yu, Jingxue; Nelen, Marina I.; Liu, Xuejun; Castro, Glenda; Luna, Rosa; Crawford, Shelby; Banie, Homayon; Dandridge, Rose A.; Deng, Xiaohu; Bittner, Anton; Kuei, Chester; Tootoonchi, Mandana; Rozenkrants, Natasha; Herman, Krystal; Gao, Jingjin; Yang, Xia V.; Sachen, Kacey; Ngo, Karen; Fung-Leung, Wai-Ping; Nguyen, Steven; de Leon-Tabaldo, Aimee; Blevitt, Jonathan; Zhang, Yan; Cummings, Maxwell D.; Rao, Tadimeti; Mani, Neelakandha S.; Liu, Changlu; McKinnon, Murray; Milla, Marcos E.; Fourie, Anne M.; Sun, Siquan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">12163-12168</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The RAR-related orphan receptor gamma t (RORγt) is a nuclear receptor required for generating IL-17-producing CD4+ Th17 T cells, which are essential in host defense and may play key pathogenic roles in autoimmune diseases.  Oxysterols elicit profound effects on immune and inflammatory responses as well as on cholesterol and lipid metab.  Here, we describe the identification of several naturally occurring oxysterols as RORγt agonists.  The most potent and selective activator for RORγt is 7β,27-dihydroxycholesterol (7β, 27-OHC).  We show that these oxysterols reverse the inhibitory effect of an RORγt antagonist, ursolic acid, in RORγ- or RORγt-dependent cell-based reporter assays.  These ligands bind directly to recombinant RORγ ligand binding domain (LBD), promote recruitment of a coactivator peptide, and reduce binding of a corepressor peptide to RORγ LBD.  In primary cells, 7β,27-OHC and 7α,27-OHC enhance the differentiation of murine and human IL-17-producing Th17 cells in an RORγt-dependent manner.  Importantly, we showed that Th17, but not Th1 cells, preferentially produce these two oxysterols.  In vivo, administration of 7β,27-OHC in mice enhanced IL-17 prodn.  Mice deficient in CYP27A1, a key enzyme in generating these oxysterols, showed significant redn. of IL-17-producing cells, including CD4+ and γδ+ T cells, similar to the deficiency obsd. in RORγt knockout mice.  Our results reveal a previously unknown mechanism for selected oxysterols as immune modulators and a direct role for CYP27A1 in generating these RORγt agonist ligands, which we propose as RORγt endogenous ligands, driving both innate and adaptive IL-17-dependent immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopdx3pchXTabVg90H21EOLACvtfcHk0liHjv3uQ_3SMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1GqtLnF&md5=4070bdf42ff542d3cf75e7a712dec298</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1322807111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1322807111%26sid%3Dliteratum%253Aachs%26aulast%3DSoroosh%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DSutton%26aufirst%3DS.%2BW.%26aulast%3DSablad%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DNelen%26aufirst%3DM.%2BI.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DCastro%26aufirst%3DG.%26aulast%3DLuna%26aufirst%3DR.%26aulast%3DCrawford%26aufirst%3DS.%26aulast%3DBanie%26aufirst%3DH.%26aulast%3DDandridge%26aufirst%3DR.%2BA.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DBittner%26aufirst%3DA.%26aulast%3DKuei%26aufirst%3DC.%26aulast%3DTootoonchi%26aufirst%3DM.%26aulast%3DRozenkrants%26aufirst%3DN.%26aulast%3DHerman%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%2BV.%26aulast%3DSachen%26aufirst%3DK.%26aulast%3DNgo%26aufirst%3DK.%26aulast%3DFung-Leung%26aufirst%3DW.-P.%26aulast%3DNguyen%26aufirst%3DS.%26aulast%3Dde%2BLeon-Tabaldo%26aufirst%3DA.%26aulast%3DBlevitt%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DRao%26aufirst%3DT.%26aulast%3DMani%26aufirst%3DN.%2BS.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DMilla%26aufirst%3DM.%2BE.%26aulast%3DFourie%26aufirst%3DA.%2BM.%26aulast%3DSun%26aufirst%3DS.%26atitle%3DOxysterols%2520are%2520agonist%2520ligands%2520of%2520ROR%25CE%25B3t%2520and%2520drive%2520Th17%2520cell%2520differentiation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2014%26volume%3D111%26spage%3D12163%26epage%3D12168%26doi%3D10.1073%2Fpnas.1322807111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeSantis, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinking, J. L.</span></span> <span> </span><span class="NLM_article-title">Use of Differential Scanning Fluorimetry to Identify Nuclear Receptor Ligands</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1443</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-3724-0_3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1007%2F978-1-4939-3724-0_3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=27246332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFKjtrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1443&publication_year=2016&pages=21-30&author=K.+A.+DeSantisauthor=J.+L.+Reinking&title=Use+of+Differential+Scanning+Fluorimetry+to+Identify+Nuclear+Receptor+Ligands&doi=10.1007%2F978-1-4939-3724-0_3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Use of differential scanning fluorimetry to identify nuclear receptor ligands</span></div><div class="casAuthors">DeSantis, Kara A.; Reinking, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1443</span>
        (<span class="NLM_cas:issue">Nuclear Receptor Superfamily</span>),
    <span class="NLM_cas:pages">21-30</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Identification of small mols. that interact specifically with the ligand-binding domains (LBDs) of nuclear receptors (NRs) can be accomplished using a variety of methodologies.  Here, we describe the use of differential scanning fluorimetry to identify these ligands, a technique that requires no modification or derivatization of either the protein or the ligand, and uses an instrument that is becoming increasingly affordable and common in modern mol. biol. labs., the quant., or real-time, PCR machine.  Upon being introduced to specific ligands, nuclear receptors undergo structural and dynamic changes that tend to increase mol. stability, which can be measured by the resistance of the protein to heat denaturation.  Differential scanning fluorimetry (DSF) uses a dielec. sensitive fluorescent dye to measure the thermal denaturation, or "melting" point (Tm) of a protein under different conditions, in this case in the absence and presence of a candidate ligand.  Using DSF, multiple candidates can be screened at once, in nos. corresponding to plate size of the instrument used (e.g., 96- or 384-well), allowing significant throughput if a modest library of compds. needs to be tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIzidMgIwKsbVg90H21EOLACvtfcHk0liHjv3uQ_3SMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFKjtrjM&md5=3b6c8fbebe013880cfe974b0f6f498a4</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-3724-0_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-3724-0_3%26sid%3Dliteratum%253Aachs%26aulast%3DDeSantis%26aufirst%3DK.%2BA.%26aulast%3DReinking%26aufirst%3DJ.%2BL.%26atitle%3DUse%2520of%2520Differential%2520Scanning%2520Fluorimetry%2520to%2520Identify%2520Nuclear%2520Receptor%2520Ligands%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2016%26volume%3D1443%26spage%3D21%26epage%3D30%26doi%3D10.1007%2F978-1-4939-3724-0_3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niesen, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berglund, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedadi, M.</span></span> <span> </span><span class="NLM_article-title">The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">2212</span>– <span class="NLM_lpage">2221</span>, <span class="refDoi"> DOI: 10.1038/nprot.2007.321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1038%2Fnprot.2007.321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=17853878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFagsb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=2212-2221&author=F.+H.+Niesenauthor=H.+Berglundauthor=M.+Vedadi&title=The+use+of+differential+scanning+fluorimetry+to+detect+ligand+interactions+that+promote+protein+stability&doi=10.1038%2Fnprot.2007.321"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability</span></div><div class="casAuthors">Niesen, Frank H.; Berglund, Helena; Vedadi, Masoud</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2212-2221</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Differential scanning fluorometry (DSF) is a rapid and inexpensive screening method to identify low-mol.-wt. ligands that bind and stabilize purified proteins.  The temp. at which a protein unfolds is measured by an increase in the fluorescence of a dye with affinity for hydrophobic parts of the protein, which are exposed as the protein unfolds.  A simple fitting procedure allows quick calcn. of the transition midpoint; the difference in the temp. of this midpoint in the presence and absence of ligand is related to the binding affinity of the small mol., which can be a low-mol.-wt. compd., a peptide or a nucleic acid.  DSF is best performed using a conventional real-time PCR instrument.  Ligand solns. from a storage plate are added to a soln. of protein and dye, distributed into the wells of the PCR plate and fluorescence intensity measured as the temp. is raised gradually.  Results can be obtained in a single day.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomViqp6Tq7krVg90H21EOLACvtfcHk0liHjv3uQ_3SMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFagsb7N&md5=8a74dbb348ab81179614ab4ae5797d94</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2007.321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2007.321%26sid%3Dliteratum%253Aachs%26aulast%3DNiesen%26aufirst%3DF.%2BH.%26aulast%3DBerglund%26aufirst%3DH.%26aulast%3DVedadi%26aufirst%3DM.%26atitle%3DThe%2520use%2520of%2520differential%2520scanning%2520fluorimetry%2520to%2520detect%2520ligand%2520interactions%2520that%2520promote%2520protein%2520stability%26jtitle%3DNat.%2520Protoc.%26date%3D2007%26volume%3D2%26spage%3D2212%26epage%3D2221%26doi%3D10.1038%2Fnprot.2007.321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oerlemans, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groves, M. R.</span></span> <span> </span><span class="NLM_article-title">Theory and applications of differential scanning fluorimetry in early-stage drug discovery</span>. <i>Biophys. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1007/s12551-020-00619-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1007%2Fs12551-020-00619-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=32006251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtFyltbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=85-104&author=K.+Gaoauthor=R.+Oerlemansauthor=M.+R.+Groves&title=Theory+and+applications+of+differential+scanning+fluorimetry+in+early-stage+drug+discovery&doi=10.1007%2Fs12551-020-00619-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Theory and applications of differential scanning fluorimetry in early-stage drug discovery</span></div><div class="casAuthors">Gao, Kai; Oerlemans, Rick; Groves, Matthew R.</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Reviews</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-104</span>CODEN:
                <span class="NLM_cas:coden">BRIECG</span>;
        ISSN:<span class="NLM_cas:issn">1867-2450</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Abstr.: Differential scanning fluorimetry (DSF) is an accessible, rapid, and economical biophys. technique that has seen many applications over the years, ranging from protein folding state detection to the identification of ligands that bind to the target protein.  In this review, we discuss the theory, applications, and limitations of DSF, including the latest applications of DSF by ourselves and other researchers.  We show that DSF is a powerful high-throughput tool in early drug discovery efforts.  We place DSF in the context of other biophys. methods frequently used in drug discovery and highlight their benefits and downsides.  We illustrate the uses of DSF in protein buffer optimization for stability, refolding, and crystn. purposes and provide several examples of each.  We also show the use of DSF in a more downstream application, where it is used as an in vivo validation tool of ligand-target interaction in cell assays.  Although DSF is a potent tool in buffer optimization and large chem. library screens when it comes to ligand-binding validation and optimization, orthogonal techniques are recommended as DSF is prone to false positives and negatives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUrggrBr-7BLVg90H21EOLACvtfcHk0lhsH0LivdDJEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtFyltbs%253D&md5=e6b941952c4cd97537f12b744d5ebf5c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2Fs12551-020-00619-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12551-020-00619-2%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DK.%26aulast%3DOerlemans%26aufirst%3DR.%26aulast%3DGroves%26aufirst%3DM.%2BR.%26atitle%3DTheory%2520and%2520applications%2520of%2520differential%2520scanning%2520fluorimetry%2520in%2520early-stage%2520drug%2520discovery%26jtitle%3DBiophys.%2520Rev.%26date%3D2020%26volume%3D12%26spage%3D85%26epage%3D104%26doi%3D10.1007%2Fs12551-020-00619-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leijten-van de Gevel, I. A.</span>; <span class="NLM_string-name">van Herk, K. H. N.</span>; <span class="NLM_string-name">de Vries, R. M. J. M.</span>; <span class="NLM_string-name">Brunsveld, L.</span></span> <i>PDB ID: 6TDC. PPAR gamma ligand binding domain in complex with MRL-871</i>; <span class="NLM_publisher-name">National Center for Biotechnology Information</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=I.+A.+Leijten-van+de+Gevel&author=K.+H.+N.+van+Herk&author=R.+M.+J.+M.+de+Vries&author=L.+Brunsveld&title=PDB+ID%3A+6TDC.+PPAR+gamma+ligand+binding+domain+in+complex+with+MRL-871"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3DLeijten-van%2Bde%2BGevel%26aufirst%3DI.%2BA.%26jtitle%3DPDB%2520ID%253A%25206TDC.%2520PPAR%2520gamma%2520ligand%2520binding%2520domain%2520in%2520complex%2520with%2520MRL-871%26pub%3DNational%2520Center%2520for%2520Biotechnology%2520Information%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuzzocrea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisano, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dugo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ianaro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maffia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di
Paola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ialenti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genovese, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Rosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caputi, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiemermann, C.</span></span> <span> </span><span class="NLM_article-title">Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>483</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2003.10.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.ejphar.2003.10.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=14709329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpt1ei" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2004&pages=79-93&author=S.+Cuzzocreaauthor=B.+Pisanoauthor=L.+Dugoauthor=A.+Ianaroauthor=P.+Maffiaauthor=N.+S.+A.+Patelauthor=R.+Di%0APaolaauthor=A.+Ialentiauthor=T.+Genoveseauthor=P.+K.+Chatterjeeauthor=M.+Di+Rosaauthor=A.+P.+Caputiauthor=C.+Thiemermann&title=Rosiglitazone%2C+a+ligand+of+the+peroxisome+proliferator-activated+receptor-gamma%2C+reduces+acute+inflammation&doi=10.1016%2Fj.ejphar.2003.10.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-γ, reduces acute inflammation</span></div><div class="casAuthors">Cuzzocrea, Salvatore; Pisano, Barbara; Dugo, Laura; Ianaro, Angela; Maffia, Pasquale; Patel, Nimesh S. A.; Di Paola, Rosanna; Ialenti, Armando; Genovese, Tiziana; Chatterjee, Prabal K.; Di Rosa, Massimo; Caputi, Achille P.; Thiemermann, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">483</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-93</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone receptor superfamily of ligand-activated transcription factors that are related to retinoid, steroid and thyroid hormone receptors.  The PPAR-γ receptor subtype appears to play a pivotal role in the regulation of cellular proliferation and inflammation.  The thiazolidinedione rosiglitazone (Avandia) is a peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist, that was recently approved by the Food and Drug Administration for treatment of type II diabetes mellitus.  In the present study, we have investigated the effects of rosiglitazone in animal models of acute inflammation (carrageenan-induced paw edema and carrageenan-induced pleurisy).  We report here for the first time that rosiglitazone (given at 1, 3 or 10 mg/kg i.p. concomitantly with carrageenan injection in the paw edema model, or at 3, 10 or 30 mg/kg i.p. 15 min before carrageenan administration in the pleurisy model) exerts potent anti-inflammatory effects (e.g. inhibition of paw edema, pleural exudate formation, mononuclear cell infiltration and histol. injury) in vivo.  Furthermore, rosiglitazone reduced: (1) the increase in the staining (immunohistochem.) for nitrotyrosine and poly (ADP-ribose) polymerase (PARP), (2) the expression of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), intercellular adhesion mols.-1 (ICAM-1) and P-selectin in the lungs of carrageenan-treated rats.  In order to elucidate whether the protective effect of rosiglitazone is related to activation of the PPAR-γ receptor, we also investigated the effect of a PPAR-γ antagonist, bisphenol A diglycidyl ether (BADGE), on the protective effects of rosiglitazone.  BADGE (30 mg/kg i.p.) administered 30 min prior to treatment with rosiglitazone significantly antagonized the effect of the PPAR-γ agonist and thus abolished the anti-inflammatory effects of rosiglitazone.  We propose that rosiglitazone and other potent PPAR-γ agonists may be useful in the therapy of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoskKXJ_92uWbVg90H21EOLACvtfcHk0lhsH0LivdDJEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpt1ei&md5=50dd379c9346a616db914bb55a52b833</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2003.10.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2003.10.056%26sid%3Dliteratum%253Aachs%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DPisano%26aufirst%3DB.%26aulast%3DDugo%26aufirst%3DL.%26aulast%3DIanaro%26aufirst%3DA.%26aulast%3DMaffia%26aufirst%3DP.%26aulast%3DPatel%26aufirst%3DN.%2BS.%2BA.%26aulast%3DDi%2BPaola%26aufirst%3DR.%26aulast%3DIalenti%26aufirst%3DA.%26aulast%3DGenovese%26aufirst%3DT.%26aulast%3DChatterjee%26aufirst%3DP.%2BK.%26aulast%3DDi%2BRosa%26aufirst%3DM.%26aulast%3DCaputi%26aufirst%3DA.%2BP.%26aulast%3DThiemermann%26aufirst%3DC.%26atitle%3DRosiglitazone%252C%2520a%2520ligand%2520of%2520the%2520peroxisome%2520proliferator-activated%2520receptor-gamma%252C%2520reduces%2520acute%2520inflammation%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D483%26spage%3D79%26epage%3D93%26doi%3D10.1016%2Fj.ejphar.2003.10.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bass, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caravella, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creech, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deaton, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madauss, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marr, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFadyen, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parks, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisely, G. B.</span></span> <span> </span><span class="NLM_article-title">Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2969</span>– <span class="NLM_lpage">2973</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.04.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=10.1016%2Fj.bmcl.2009.04.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=19410460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVeku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2969-2973&author=J.+Y.+Bassauthor=R.+D.+Caldwellauthor=J.+A.+Caravellaauthor=L.+Chenauthor=K.+L.+Creechauthor=D.+N.+Deatonauthor=K.+P.+Madaussauthor=H.+B.+Marrauthor=R.+B.+McFadyenauthor=A.+B.+Millerauthor=D.+J.+Parksauthor=D.+Toddauthor=S.+P.+Williamsauthor=G.+B.+Wisely&title=Substituted+isoxazole+analogs+of+farnesoid+X+receptor+%28FXR%29+agonist+GW4064&doi=10.1016%2Fj.bmcl.2009.04.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064</span></div><div class="casAuthors">Bass, Jonathan Y.; Caldwell, Richard D.; Caravella, Justin A.; Chen, Lihong; Creech, Katrina L.; Deaton, David N.; Madauss, Kevin P.; Marr, Harry B.; McFadyen, Robert B.; Miller, Aaron B.; Parks, Derek J.; Todd, Dan; Williams, Shawn P.; Wisely, G. Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2969-2973</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Starting from the known FXR agonist GW 4064 (I) (R1 = i-Pr, R2 = 2,6-Cl2C6H3), a series of alternately 3,5-substituted isoxazoles was prepd.  A subset of this series, with a tether between the isoxazole ring and the 3-position aryl substituent, were equipotent FXR agonists to GW 4064, with the analog I (R1 = i-Pr, R2 = 2,6-Me2C6H3OCH2) having greater FRET FXR potency than GW 4064.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmilCrO1yO1LVg90H21EOLACvtfcHk0lghuP7AVjbD1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVeku70%253D&md5=38b2a1b54be6ef8a3d58f6550a1ff16f</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.04.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.04.047%26sid%3Dliteratum%253Aachs%26aulast%3DBass%26aufirst%3DJ.%2BY.%26aulast%3DCaldwell%26aufirst%3DR.%2BD.%26aulast%3DCaravella%26aufirst%3DJ.%2BA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DCreech%26aufirst%3DK.%2BL.%26aulast%3DDeaton%26aufirst%3DD.%2BN.%26aulast%3DMadauss%26aufirst%3DK.%2BP.%26aulast%3DMarr%26aufirst%3DH.%2BB.%26aulast%3DMcFadyen%26aufirst%3DR.%2BB.%26aulast%3DMiller%26aufirst%3DA.%2BB.%26aulast%3DParks%26aufirst%3DD.%2BJ.%26aulast%3DTodd%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DS.%2BP.%26aulast%3DWisely%26aufirst%3DG.%2BB.%26atitle%3DSubstituted%2520isoxazole%2520analogs%2520of%2520farnesoid%2520X%2520receptor%2520%2528FXR%2529%2520agonist%2520GW4064%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2969%26epage%3D2973%26doi%3D10.1016%2Fj.bmcl.2009.04.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sepe, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchianò, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finamore, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baronissi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Leva, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biagioli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorucci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassiano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Gaudio, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limongelli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorucci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zampella, A.</span></span> <span> </span><span class="NLM_article-title">Novel Isoxazole Derivatives with Potent FXR Agonistic Activity Prevent Acetaminophen-Induced Liver Injury</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">407</span>– <span class="NLM_lpage">412</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00423</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00423" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVegu7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=407-412&author=V.+Sepeauthor=S.+Marchian%C3%B2author=C.+Finamoreauthor=G.+Baronissiauthor=F.+S.+Di+Levaauthor=A.+Carinoauthor=M.+Biagioliauthor=C.+Fiorucciauthor=C.+Cassianoauthor=M.+C.+Montiauthor=F.+del+Gaudioauthor=E.+Novellinoauthor=V.+Limongelliauthor=S.+Fiorucciauthor=A.+Zampella&title=Novel+Isoxazole+Derivatives+with+Potent+FXR+Agonistic+Activity+Prevent+Acetaminophen-Induced+Liver+Injury&doi=10.1021%2Facsmedchemlett.8b00423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Isoxazole Derivatives with Potent FXR Agonistic Activity Prevent Acetaminophen-Induced Liver Injury</span></div><div class="casAuthors">Sepe, Valentina; Marchiano, Silvia; Finamore, Claudia; Baronissi, Giuliana; Di Leva, Francesco Saverio; Carino, Adriana; Biagioli, Michele; Fiorucci, Chiara; Cassiano, Chiara; Monti, Maria Chiara; del Gaudio, Federica; Novellino, Ettore; Limongelli, Vittorio; Fiorucci, Stefano; Zampella, Angela</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">407-412</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acetaminophen misuse is a leading cause of acute liver failure and liver transplantation for which therapy is poorly effective.  FXR ligands have shown effective in reducing liver injury in several exptl. and clin. settings.  In this Letter, we have elaborated on the structure of GW4064, the first nonsteroidal agonist for FXR, to identify novel isoxazoles endowed with FXR agonistic activity and improved ADME properties.  The pharmacol. characterization and mol. docking studies for the structure-activity rationalization allowed the identification of several FXR agonists with nanomolar potency in transactivation and SRC-1 recruitment assays.  This characterization resulted in the identification of a potent FXR agonist, compd. I that was orally active, and rescued mice from acute liver failure caused by acetaminophen overdose in a FXR-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQmzVjonQgsrVg90H21EOLACvtfcHk0lghuP7AVjbD1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVegu7zK&md5=a5a1905bc917c8cf240bfdbb53a944f1</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00423%26sid%3Dliteratum%253Aachs%26aulast%3DSepe%26aufirst%3DV.%26aulast%3DMarchian%25C3%25B2%26aufirst%3DS.%26aulast%3DFinamore%26aufirst%3DC.%26aulast%3DBaronissi%26aufirst%3DG.%26aulast%3DDi%2BLeva%26aufirst%3DF.%2BS.%26aulast%3DCarino%26aufirst%3DA.%26aulast%3DBiagioli%26aufirst%3DM.%26aulast%3DFiorucci%26aufirst%3DC.%26aulast%3DCassiano%26aufirst%3DC.%26aulast%3DMonti%26aufirst%3DM.%2BC.%26aulast%3Ddel%2BGaudio%26aufirst%3DF.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DLimongelli%26aufirst%3DV.%26aulast%3DFiorucci%26aufirst%3DS.%26aulast%3DZampella%26aufirst%3DA.%26atitle%3DNovel%2520Isoxazole%2520Derivatives%2520with%2520Potent%2520FXR%2520Agonistic%2520Activity%2520Prevent%2520Acetaminophen-Induced%2520Liver%2520Injury%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D407%26epage%3D412%26doi%3D10.1021%2Facsmedchemlett.8b00423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khojasteh-Bakht, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J. P.</span></span> <span> </span><span class="NLM_article-title">Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">269</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1021/tx015574b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx015574b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=269-299&author=D.+K.+Dalvieauthor=A.+S.+Kalgutkarauthor=S.+C.+Khojasteh-Bakhtauthor=R.+S.+Obachauthor=J.+P.+O%E2%80%99Donnell&title=Biotransformation+Reactions+of+Five-Membered+Aromatic+Heterocyclic+Rings&doi=10.1021%2Ftx015574b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Biotransformation Reactions of Five-Membered Aromatic Heterocyclic Rings</span></div><div class="casAuthors">Dalvie, Deepak K.; Kalgutkar, Amit S.; Khojasteh-Bakht, S. Cyrus; Obach, R. Scott; O'Donnell, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">269-299</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 278 refs. is given on the biotransformation pathways of most commonly used 5-membered arom. heterocyclic rings.  The effect of physicochem. properties such as the electronic effects of heteroatoms, aromaticity, and acidity/basicity (pKa) of the rings are correlated on their biotransformation.  The generation of reactive metabolites following oxidn. or redn. of these heterocycles and the subsequent toxicol. consequences are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpNaEz19aehbVg90H21EOLACvtfcHk0lghuP7AVjbD1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtVWrsLc%253D&md5=e8e2dfd12772f9ff2289b173bdefa590</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Ftx015574b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx015574b%26sid%3Dliteratum%253Aachs%26aulast%3DDalvie%26aufirst%3DD.%2BK.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKhojasteh-Bakht%26aufirst%3DS.%2BC.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BP.%26atitle%3DBiotransformation%2520Reactions%2520of%2520Five-Membered%2520Aromatic%2520Heterocyclic%2520Rings%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2002%26volume%3D15%26spage%3D269%26epage%3D299%26doi%3D10.1021%2Ftx015574b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span> </span><span class="NLM_article-title">Molecular property explorer OSIRIS</span>. <span class="NLM_year">2021</span>, Available from: <a href="http://www.organic-chemistry.org/prog/peo/drugScore" class="extLink">http://www.organic-chemistry.org/prog/peo/drugScore</a> (accessed Feb 26, 2021).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular+property+explorer+OSIRIS.+2021%2C+Available+from%3A+http%3A%2F%2Fwww.organic-chemistry.org%2Fprog%2Fpeo%2FdrugScore+%28accessed+Feb+26%2C+2021%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DMolecular%2520property%2520explorer%2520OSIRIS%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kallepalli, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onyeozili, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maleczka, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. R.</span></span> <span> </span><span class="NLM_article-title">Boc Groups as Protectors and Directors for Ir-Catalyzed C–H Borylation of Heterocycles</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">9199</span>– <span class="NLM_lpage">9201</span>, <span class="refDoi"> DOI: 10.1021/jo901822b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo901822b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOksrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=9199-9201&author=V.+A.+Kallepalliauthor=F.+Shiauthor=S.+Paulauthor=E.+N.+Onyeoziliauthor=R.+E.+Maleczkaauthor=M.+R.+Smith&title=Boc+Groups+as+Protectors+and+Directors+for+Ir-Catalyzed+C%E2%80%93H+Borylation+of+Heterocycles&doi=10.1021%2Fjo901822b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Boc Groups as Protectors and Directors for Ir-Catalyzed C-H Borylation of Heterocycles</span></div><div class="casAuthors">Kallepalli, Venkata A.; Shi, Feng; Paul, Sulagna; Onyeozili, Edith N.; Maleczka, Robert E.; Smith, Milton R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9199-9201</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ir-catalyzed C-H borylation is found to be compatible with Boc protecting groups.  Thus, pyrroles, indoles, and azaindoles can be selectively functionalized at C-H positions β to N.  The Boc group can be removed on thermolysis or left intact during subsequent transformations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodzdE1QRfDHLVg90H21EOLACvtfcHk0ljs1sQhduM4Iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOksrjM&md5=d3e4927fdc04ca35db39a05469289d2c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjo901822b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo901822b%26sid%3Dliteratum%253Aachs%26aulast%3DKallepalli%26aufirst%3DV.%2BA.%26aulast%3DShi%26aufirst%3DF.%26aulast%3DPaul%26aufirst%3DS.%26aulast%3DOnyeozili%26aufirst%3DE.%2BN.%26aulast%3DMaleczka%26aufirst%3DR.%2BE.%26aulast%3DSmith%26aufirst%3DM.%2BR.%26atitle%3DBoc%2520Groups%2520as%2520Protectors%2520and%2520Directors%2520for%2520Ir-Catalyzed%2520C%25E2%2580%2593H%2520Borylation%2520of%2520Heterocycles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D9199%26epage%3D9201%26doi%3D10.1021%2Fjo901822b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6SAL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6SAL','PDB','6SAL'); return false;">PDB: 6SAL</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YPQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YPQ','PDB','4YPQ'); return false;">PDB: 4YPQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NPC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NPC','PDB','7NPC'); return false;">PDB: 7NPC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NP5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NP5','PDB','7NP5'); return false;">PDB: 7NP5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NEC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NEC','PDB','7NEC'); return false;">PDB: 7NEC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NP6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NP6','PDB','7NP6'); return false;">PDB: 7NP6</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i82"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00475">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_80501"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00475?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00475</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Chemical structure of AlexaFluor-MRL probe; dose–response curves; schematic representation of TR-FRET assays; docking poses of <b>4</b> and <b>12</b> in overlay with <b>3</b>; protein–ligand interaction plot for <b>3</b>; electron density around compounds <b>3</b>, <b>9</b>, <b>10</b>, and <b>11</b>; fluorescence polarization assay; synthesis route for isoxazole scaffold <b>14</b>; original synthesis route for isoxazole compound <b>FM26</b>; library of compounds used in docking studies; toxicity risks, drug likeness, and drug score for all compounds; data collection and refinement statistics (molecular replacement) of <b>3</b>, <b>9</b>, <b>10</b>, and <b>11</b>; synthesis, biochemical assays, and docking experiments; NMR and LC–UV spectra for assayed compounds; and details on crystallography experiments (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_001.pdf">jm1c00475_si_001.pdf (3.9 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00475/suppl_file/jm1c00475_si_002.csv">jm1c00475_si_002.csv (1.13 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors for the RORγt bound to compounds <b>3</b>, <b>9</b>, <b>10</b>, and <b>11</b> have been deposited in the Protein Data Bank under accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NPC">7NPC</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NP5">7NP5</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NEC">7NEC</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7NP6">7NP6</a>. The authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00475&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00475%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-13%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00475" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799219b7fe33c82","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
